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ABSTRACT 
Autism is a severe developmental disorder that was first described by Kanner 
in 1943. It is characterised by four major criteria: marked social deficits, delay in 
language development, a restricted range of stereotyped repetitive behaviours and 
onset of the disease within the first three years of life. 
The last decade of research has provided support for a strong genetic basis in 
the aetiology of autism. Firstly, a number of genetic conditions, such as fragile X 
syndrome, chromosome 15 anomalies and tuberous sclerosis, have been associated 
with autism. Secondly, family studies have demonstrated that the recurrence risk for 
autism among siblings of autistic children is 50-200 times higher compared to the 
risk of autism in the general population (4-5 in 10 OOO births). Thirdly, twin studies 
show a significantly higher concordance rate among monozygotic twins compared to 
dizygotic twins. 
To explore the theory of a biological basis of autism, molecular genetic 
strategies were employed in this study. Two collaborative groups (Stanford 
University in the U.S.A. and Edith Cowan University/Graylands Hospital in Perth, 
Australia) scanned the entire human genome for autism susceptibility genes in 90 
American multiplex families, making this the largest genome screen in autism to 
date. Candidate regions were also run in an additional group of 41 Australian 
multiplex families. One hundred of the total of 519 markers were analysed as part of 
this PhD project. Since autism is most likely a complex disorder involving 
interacting genes with unknown modes of inheritance, non-parametric linkage 
analysis utilising the multipoint sib-pair approach is the best method presently 
available for identifying these susceptibility genes. 
ii 
Using this method and given the power of the study to reliably detect genes 
of moderate effect, findings from this PhD project and the overall genome scan 
provide substantial evidence for the absence of such genes in autism. Regions that 
may, however, contain these disease-predisposing loci were identified. These 
include regions on chromosomes l p  and 22q. Results from other smaller genome 
scanning studies also indicate these two candidate regions as possibly containing loci 
involved in the aetiology of autism. Our results could also not exclude chromosomes 
7q, 9q, l Oq, 1 l p  and 17, regions that have previously been suggested by other studies 
to contain susceptibility loci. Overall, our data were most consistent with a model of 
2::: 15 susceptibility loci, each with a small effect on autism. 
These results are important for future studies. In particular, they have shown 
the requirement for a large sample size to detect genes of small effect contributing to 
a disorder. Whilst it may be difficult for individual research groups to recruit an 
adequate sample size, collaboration with other groups may provide sufficient power 
to detect these susceptibility loci. By combining our results with those from other 
linkage studies on autism, we may also be able to eliminate some genetic models for 
this disease and provide an insight into the boundaries of the autistic phenotype. 
With advances in the Human Genome Project and the development of 
rigorous statistical approaches to the analysis of multifactorial diseases, the 
molecular characterisation of genes that have a small effect on the overall aetiology 
of complex polygenic disorders, such as autism, could soon be feasible. 
iii 
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CHAPTER 1 
INTRODUCTION AND LITERATURE REVIEW 
1.1 Introduction 
Autism is a severe, lifelong neuropsychiatric disorder with a profound impact 
on the affected individuals, their families and society at large. The causes of autism 
remain unknown, however a large number of observations suggest that genetic factors 
may play a role in its aetiology. This PhD project explores this hypothesis via the 
search for susceptibility genes for autism throughout the human genome. 
The introduction and literature review begin by giving a historical perspective 
on the study of autism and the changes in diagnostic criteria throughout the last 40 
years, resulting in what is thought to be a more valid method of diagnosis (ICD-10 & 
DSM-IV). The findings from epidemiological research in autism are then described, 
followed by an account of the aetiological models of autism. Specific reference is 
made to the genetic model and diseases thought to co-occur with autism that could 
point to candidate regions in the genome. A brief review on the brain mechanisms 
that are thought to be involved in autism follows. Although there is extensive 
literature on this subject, only areas relevant to the genetics of autism are reviewed. 
The introduction concludes by suggesting the modes of inheritance which are most 
pertinent to this disorder. Using these models, the methods ·of linkage analysis that 
could be applied to locate susceptibility loci are described. 
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1.2 Historical Overview of Autism 
Children exhibiting symptoms similar to autism have been recognised for a 
long time, with the earliest reports made at the beginning of the 19th century (Vaillant, 
1962). Clear descriptions have been given by Haslam (1809), Itard (translation into 
English by Lane 1976), and Critchley and Earl (1932). However, it was Leo Kanner 
(1943) and Hans Asperger (1944), independent of each other, who first described the 
syndrome and assigned to it a particular name including reference to autism. Kanner 
was the first to outline the common characteristics and special qualities of the 
behaviour of children with autism. His original paper outlined 11 children carefully 
observed over 5 years. These individuals all shared "fascinating peculiarities"; 
including delayed echolalia, pronoun reversal, failure to use speech to communicate, 
an anxious desire to preserve sameness, repetitive behaviours, failure to anticipate 
being lifted, a general lack of awareness of other people' s existence or feelings and a 
lack of ability to play imaginatively with other children. He also described these 
children as having a normal intellectual potential (based mainly on their "intelligent 
physiognomies") and good physical health. Although his assumptions about normal 
intelligence were refuted in future studies due to the occurrence of mentally retarded 
individuals with autism, Kanner' s description of autism continues to be one of the 
most vivid representations of the behaviour of autistic children. 
Asperger' s ( 1944) definition of the syndrome ( autistic psychopathy) was very 
similar to the disease Kanner described at the symptom level, however, there were 
some notable differences. Asperger' s definition did not specify an age of onset, 
whereas to be diagnosed with Kanner' s definition of autism the onset of the disease 
had to be within the first 3 years of life. Also, the children described by Asperger all 
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developed speech before school age, they typically had large vocabularies and 
reasonable grammar, and, although socially isolated, they were not unaware of the 
existence of others. Asperger described the children he studied as odd in appearance 
in contrast to the alert, attractive look often mentioned as typical of the children 
Kanner studied. According to the International Classification of Diseases (ICD-10) 
the syndromes described by Kanner and Asperger are two separate disorders, namely 
autism and Asperger syndrome respectively. The main criteria that distinguish these 
two disorders are the lack of mental retardation as well as the absence of a language 
delay in individuals with Asperger syndrome. It has also been noted that Asperger 
syndrome is at least five times more common than the autistic disorder (Gillberg, 
1989; Ehlers and Gillberg, 1993). Whether Asperger disorder and autism represent 
aetiologically separate entities, rather than different degrees of severity of the same 
condition, is not yet known (Volkmar et al. , 1994; Frith, 1991). With the identity of 
the genes involved in the "core" syndrome of autism, it is hoped that the boundary of 
the autistic phenotype can be determined. 
1.3 Clinical Diagnosis of Autism 
The classification and diagnosis of autism have changed over time as the key 
features and associated characteristics of the disorder have been revised. Until 
recently, there were two predominant models for the diagnosis of psychiatric 
disorders, rnµnely "the great professor" principle and "the consensus of experts". In 
the beginning of this century, many great men in psychiatry, including Kraepelin and 
Bleuler, developed and published their own diagnostic systems of the major psychoses 
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(Kraepelin and Diefendorf, 1923 ; Bleuler and Brill, 1924). Whether these diagnostic 
criteria were accepted or rejected relied on many factors (e.g. clarity of thought and 
clinical applicability). Ultimately, however, the validity of these systems rested on the 
personal authority of their originators which was generally only feasible within the 
region of the country in which they lived (Kendler, 1990). This led to the use of 
different diagnostic systems in different countries or even different regions within the 
same country. With the development of national and international psychiatric 
organisations, committees were formed to resolve specific diagnostic issues. This was 
generally achieved by the "consensus of experts" approach, although sometimes the 
issue would be put to a vote. Examples of diagnostic criteria formulated using this 
approach are the Diagnostic and Statistical Manual of Mental Disorders I and II 
(DSM-I and DSM-II; American Psychiatric Association (APA), 1952 and 1968) 
Kanner and Eisenberg ( 1956) were the first to define a set of diagnostic 
criteria for autism. These became known as "Kanner' s criteria" and included the 
following: 
(I) profound lack of affective contact with other people, 
(II) an anxiously obsessive desire for the preservation of sameness in the child's 
routines and environment, 
(III) a fascination for objects, which are handled with skill in fine motor 
movements, 
(IV) mutism or a kind oflanguage that does not seem intended for inter-personal 
communication, 
(V) good cognitive potential shown in feats of memory or skills on performance 
tests. 
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They also emphasised that onset of autism should be from birth or before 30 months 
of age, and that the first two criteria were essential for the diagnosis. They stated in 
this paper that, if a child was diagnosed with the first two features, the rest of the 
typical clinical picture would also be found. 
Rutter (1978) developed the second set of diagnostic criteria. He suggested 
four criteria for defining childhood autism. These were: 
(I) impaired social development which has a number of special characteristics out 
of keeping with the child's  intellectual level, 
(II) delayed and deviant language development that also has certain defined 
features and is out of keeping with the child's intellectual level, 
(III) "insistence on sameness" as shown by stereotyped play patterns, abnormal 
preoccupations or resistance to change, 
(IV) Onset before 3 0 months 
The American Psychiatric Association and the World Health Organisation 
(WHO) have also published their definitions of autism in the Diagnostic and Statistical 
Manual of Mental Disorders (DSM) and the International Classification of Diseases 
(ICD), respectively. The development of DSM-III (American Psychiatric 
Association, 1980) saw a change in the way autism was defined, mainly due to the 
increased knowledge obtained through research. These organisations used available 
scientific information in the development and evaluation of proposed changes and 
used diagnostic criteria that would greatly facilitate the reliability and validity of future 
studies (Kendler, 1990). 
DSM-III and DSM-III-R (American Psychiatric Association, 1987) contained 
criteria for autism which were quite different from each other and from those of the 
International Classification of Diseases (ICD). The DSM-III-R diagnostic criteria of 
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autism tended to overdiagnose this disorder compared with the ICD-1 0  (World 
Health Organisation, 1990) and the DSM-III. DSM-III-R also elaborated the 
symptoms of autistic disorder, discarded the age criterion and did not contain the 
childhood-onset pervasive developmental disorder subgroup. The criteria used in 
ICD-1 0  and, recently, DSM-IV (American Psychiatric Association, 1 994) are 
different again from their previous versions, however, they are essentially similar to 
each other and will allow future studies conducted in different countries to be more 
comparable. 
Regardless of the diagnostic manual used, the diagnosis of autism rests on a 
set of behavioural criteria, invariably comprising communication, social interaction 
and behavioural deficits. Each manual emphasises slightly different sub-criteria for 
each class of these symptoms. However, they all agree that there must be severe 
problems: (I ) in the ability to develop relationships with people; (2) in the 
development of speech, with abnormal language patterns and communicative use of 
speech after it develops; and (3) in coping with any forced change in routine. These 
three categories of problems are now often referred to as "the triad of social, language 
and behavioural impairment" (Wing, 1981  ). Some manuals (Kanner and Eisenberg, 
1956; Rutter, 1 978; APA, 1980; WHO, 1990; WHO, 1992 ; APA, 1994) require that 
the age of onset be before 3 0-36 months, whereas others specify only that signs of the 
triad be present from infancy or childhood (APA, 1987). The set of diagnostic criteria 
of the DSM-IV and the ICD-1 0  are the ones currently most often used. The criteria 
in the ICD-1 0  manual were used to diagnose the subjects for this study (Table 1 ). 
The precision of these definitions will continue to evolve as new research 
clarifies the phenotype (visible characteristics of autism). At present, DSM-IV 
International Field Trials have indicated that the clinical diagnosis of autism remains 
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one of the most reliable diagnoses in psychiatric or developmental research (Volkmar 
et al. , 1994). 
Table 1 :  Diagnostic Criteria for Autistic Disorder 
A. Qualitative impairments in reciprocal social interaction, as manifested by at least two of 
the following four: 
( 1 )  Failure adequately to use eye-to-eye gaze, facial expression, body posture and gesture 
to regulate social interaction 
(2) Failure to develop peer relationships that involve a mutual sharing of interests, 
activities, and emotions 
(3) Lack of socio-emotional reciprocity 
( 4 )  Lack of spontaneous seeking to share enjoyment, interests, or achievements with other 
people (eg. a lack of showing, bringing, or pointing out to other people objects of 
interest to the individual) 
B .  Qualitative impainnents in communication as manifested by at least one of the following 
four 
( 1 )  a delay in, or total lack of, development of spoken language that is not accompanied 
by an attempt to compensate through alternative modes of communication 
(2) relative failure to initiate or sustain conversational interchange 
(3 ) stereotyped and repetitive use of words or phrases 
(4) lack of varied spontaneous make-believe or social imitative play 
C. Restricted, repetitive, and stereotyped patterns of behaviour, interests, and activities, as 
manifested by at least one of the following four: 
( 1 )  Encompassing preoccupation with stereotyped and restricted patterns of interest 
(2) Apparently compulsive adherence to specific, non-functional, routines/rituals 
(3) Stereotyped and repetitive motor mannerisms 
(4) Preoccupations with part-objects or non-functional elements of play material 
D. At least six of the above twelve symptoms must be present. 
E. Developmental abnormalities (in at least one of language, social interaction, or play) must 
have been present in the first 3 years for the diagnosis to be made. 
Table from ICD-10, WHO (World Health Organization) 1992. 
7 
1.4 Epidemiology 
Epidemiology is the branch of medical science that deals with the incidence, 
distribution, and control of disease in a population (Webster's) .  Prevalence refers to 
the rate of the disorder present in the population at a given point of time and 
Incidence refers to the number of new cases occurring in the population during a 
given period (Bristol et al. , 1996) .  Epidemiological surveys of autism are important 
to identify the prevalence and/or incidence of this developmental disorder, and the 
requirements for specialised educational and medical services for this group of 
children. These surveys are also important to genetic studies, in order to show the 
increase in the prevalence rate within families affected by the disease compared to the 
general population. This allows the genetic component involved in aetiology of the 
disorder to be evaluated. 
1.4.1 Prevalence 
A number of population-based studies on the prevalence of autism have been 
completed, with the rates varying enormously across studies. Recent reviews of the 
epidemiological surveys of autism (Wing, 1993; Gillberg, 1995; Honda et al., 1996; 
Fombonne et al. , 1 997; Fombonne, 1 999) show that rates vary from 0. 7 / 1 0  OOO 
(Treffert, 1 970) to 2 1 . 1/ 1 0  OOO (Honda et al. , 1996). Much of the variation across 
studies can be explained by the use of relatively small samples, and differences in 
ascertainment schemes and diagnostic criteria. A review by Honda et al. ( 1996) 
divided published prevalence studies of autism by population size (Table 2). Those 
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studies with populations ofless than 50,000 showed an average prevalence of 13.4 
per 10,000, whereas studies with populations of more than 50,000 had an average 
prevalence of approximately 5.8 per 10,000. Honda et al. (1996) suggested that the 
reason for the discrepancies between the two population sizes could be due to the 
higher number of overlooked cases in the larger populations. It is still not proven 
what population size is optimal for epidemiological studies of autism, and sizes less 
than 50,000 may be too small for this rare disorder. 
Studies in the last few years have estimated the prevalence of autism to be 
typically around 0.1 in 10,000 children (Landgren et al. , 1996; Webb et al. , 1997; 
Arvidsson et al. , 1997). This is 2-5 times greater than the figure commonly reported 
in the past (2 to 5 in 10 OOO children). The high rate reported in these more recent 
studies could be attributed to the researchers' increased awareness of the autism 
spectrum disorders and the inclusion of these disorders in their epidemiology studies. 
Autism spectrum disorders is a term used to describe all conditions involving severe 
autistic symptomatology, or those conditions with severe autistic symptomatology 
that do not meet operationalised criteria for autistic disorder/childhood autism 
(Gillberg, 1995). 
In Gillberg' s (1995) review of epidemiological studies of autism, he provided 
an estimate of the overall prevalence of autism in the population. In this report he 
reviewed all papers published in books or journals that included reference to the 
words "autism" and "prevalence", and were written in English or with comprehensive 
English summaries included. Only papers that met the follo�ing criteria were 
included in the review: 
• The study used defined diagnostic criteria for autism; 
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• The population studied referred to a specific age-cohort from a 
geographically defined population; 
• The initial screening for autistic individuals was made within a large 
population of children, including not only those who had already been 
clinically diagnosed as "autistic" or "psychotic"; and 
• The final diagnosis had been made after clinical examination of possible 
cases by a research team or by primary care clinical staff who provided the 
information requested by the research team as part of the study. 
Table 2 lists those 1 6  studies which met the criteria for inclusion and which had been 
published by 1 st of June 1993. Publications in italics were those noted in the Honda et 
al. ( 1 996) and the Fombonne ( 1999) reviews but were not included in Gillberg 
( 1995). The mean prevalence across all 1 6  studies was 6.5 per 1 0  OOO children. This 
mean was computed by adding all cases diagnosed with autism and dividing that 
figure by the total sum of all those individuals who participated in the original 
screening. If the prevalence figures were added and divided by 1 6  the figure would be 
8.4 (±4.4 (S.D.)). It is interesting to note that if the two US.A. studies were 
removed (the U.S.A.'s mobile population and the unevenly distributed health-care 
system around the country causes problems in population-based studies), the mean 
rate of reported autism in the studies published after 1985 would be 1 1 . 8 per 1 0  OOO 
children. This figure is very close to the recent prevalence estimates of around 0. 1 in 
1 0,000 (Landgren et al. , 1996; Webb et al. , 1 997; Arvidsson et al. , 1997). As 
previously mentioned, these studies also included individuals diagnosed with autism 
spectrum disorders. In this study, only children with the "core" synqrome of autism 
were included in the analysis and, in turn, a prevalence rate of 4 -5 per 1 0  000 children 
born was used throughout. 
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Table 2 :  Prevalence Studies of Autism by Population (prevalence is given as n 
per 10  OOO children born) 
Study Region Population Prevalence Male:Female 
Size 
Population size <50,000 
Honda et al. (1996) Japan 8, 537 21 . 1 2. 6: 1 
Sugiyama and Abe ( 1989) Japan 1 2,263 1 3 . 0  ? 
Bryson et al. ( 1 988)  Canada 20,800 10 . 1 2 . 5 :  1 
Matsuishi et al. ( 1 987) Japan 32,834 1 5 .5 4 .7 : 1 
Ishii and Takahashi ( 1 982) Japan 34,987 1 6 .0 6 .0 : 1 
Wing and Gould ( 1979) England 35,000 4 .9  1 6 .0 :  1 
Population size >50,000 
Fombonne (1999) Review >4, 000, 000 5. 2 3. 8: 1 
Fombonne et al. (1997) French 325, 347 5. 4 1 .8 : l  
Fombonne & du Mazaubrun (1992) French 274, 81 6 4. 9 2. 1 : 1  
Gillberg e t  al. ( 1 99 1 a) Sweden 78, 1 06 1 1 .5 2 . 8 : 1 
Ritvo et al. ( 1989) USA 1 84,822 4 .0 3 . 7: l 
Cialdella and Mamelle ( 1989) France 1 35, 1 80 1 0 . 8  2 . 0 :  1 
Tanoue et al. ( 1988) Japan 95,394 1 3 . 8  4 . 1 :  1 
Burd et al. ( 1 987) USA 1 80,986 3 .3 2 .7 : 1 
Steinhausen et al. (1986) Germany 279, 61 6 1 . 9  2. 2: 1 
Steffen burg and Gill berg ( 1 986) Sweden 78,4 1 3  7 .5  3 .0 : l 
Gillberg ( 1 984) Sweden 1 25,584 4 .0  1 .8 :  l 
McCarthy et al. (1984) Ireland 65, 000 4. 3 1 . 3 :l  
Bohman et al. ( 1 983) Sweden >50,000 6 . 1  1 .6 :  l 
Hoshino et al. ( 1982) Japan 2 1 7,626 5 .0 9 .0 : l 
Brask ( 1972) Denmark >50,000 4 . 3  1 .4 : l 
Treffert (1970) USA 899, 750 3. 1 3. 4 : 1  
Lotter ( 1966) England 78,000 4 .5  2 .6 : 1  
(Gillberg, 1995; Honda et al. , 1 996) 
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1.4.2 Incidence 
Only one paper to date (Honda et al. , 1996) has reported the cumulative 
incidence of childhood autism. A measure of incidence can often be more useful than 
prevalence, but can be difficult to calculate in childhood disorders (Stein and Susser, 
1 98 1  ) .  In autism, problems generally arise due to the difficulty in identifying the exact 
age in which the first symptoms of the disease arise. Honda et al. ( 1996) overcame 
this problem by using cumulative incidence up to five years of age within a specified 
birth cohort. They reported a cumulative incidence of 1 6.2 per 1 0  OOO in the birth 
cohort. This value was lower than the reported prevalence for this population, which 
according to the authors was a consequence of parents staying in areas where special 
facilities were available for their autistic children. 
1.4.3 Sex Ratios 
Autism is known to affect males more frequently than females. Papers on­
autism constantly report the male:female ratio to be 3-4: 1. Population studies, 
however, show a variety of values ranging from 1. 3: 1 (McCarthy et al. , 1984 )  to 1 6: 1 
(Wing and Gould, 1 979). In the reviews of sixteen population studies of autism, 
Wing ( 1993) and Gillberg ( 1995) found that the ratio was closer to 2-3: 1 (Table 2). 
Wing ( 1 993) pointed out, that "the exceptionally high ratio in the Wing and Gould 
( 1 979) study ( 1 6 :  1 )  was most probably a chance finding due to the small number of 
autistic children identified". There have also been several studies suggesting that the 
ratio is associated with IQ levels, with an equal proportion of males to females seen 
12 
among autistic children with severe and profound mental retardation (Wing, 1 98 1 ;  
Gillberg, 1 984). 
The reason for the higher vulnerability of males to autism is unknown. Many 
speculations have been put forth to explain the skewed sex ratios, and one rationale 
could be due to a genetic involvement. Skuse et al. ( 1997) recently presented 
evidence for one or more loci on the human X chromosome influencing social 
cognition. Males do not express these imprinted loci as they are only expressed from 
a paternally inherited X chromosome. Skuse et al. ( 1997) suggested that such a locus 
might offer some explanation of why boys are more vulnerable than girls to 
developmental disorders of speech and language. The X-chromosome was examined 
in detail within this study to determine whether any susceptibility loci were present on 
this chromosome. Alternatively, because girls have better developed superficial social 
and language skills early in life, the basic disabilities associated with autism could go 
unrecognised for longer periods of time. This would lead to an underestimate of the 
prevalence of autism in girls and elevate the difference in the sex ratio (Gillberg, 
1995). 
1.4.4 Mental Retardation and Epilepsy in Autism 
Intellectual handicap ( defined as IQ under 70) has been shown to be present in 
75-90% of cases of autism (Gillberg, 1 990) (Figure 1 ). It has also been shown to be 
the single most powerful predictor of outcome in autism (Venter et al. , 1 992),  since 
the severity of autistic symptoms is related to verbal IQ (Bolton et al. , 1 994). 
Although autism and mental retardation are strongly associated, the accompanying 
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risks and neurological findings are different. Mental retardation is associated with an 
increased rate of major pre- and perinatal abnormalities, while autism is associated 
with mainly minor abnormalities (Finnegan and Quarrington, 1979). In addition, 
although autism and mental retardation are associated with the same disorders ( eg. 
infantile spasm and congenital rubella), other conditions that are usually associated 
with intellectual handicap rarely give rise to autism ( eg. cerebral palsy). These 
different associations suggest that while there is some overlap in the specific disorders 
known to cause the two conditions, that overlap is small (Folstein and Rutter, 1988). 
Also, since it is difficult to distinguish between mental retardation and autism in 
children with low IQs (< 30), such individuals were removed from the study to 
prevent misdiagnosis (see section 2. 1.3). 
Mental 
Retardation 
Autism 
Epilepsy 
Figure 1 :  The co- morbidity of mental retardation, epilepsy and autistic disorder. 
Epilepsy is also common in people with autism, particularly between early 
childhood and adolescence (Figure 1 ). About 20% of autistic individuals develop 
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non-febrile seizures before the age of about 3 years. Another 1 5-20% develop 
seizures around the time of puberty or later (Olsson et al. , 1 988; Volkmar & Nelson, 
1 990; Gillberg and Coleman, 1992). The increased incidence of epilepsy and 
abnormal electroencephalograms (EEG) in autistic children, compared with other 
psychiatric patients, was the first piece of evidence that autism is a biological disorder 
of the brain rather than a psychogenic disorder (Ornitz, 1978). Although epilepsy is 
not strongly associated with IQ, it does seem to have a higher prevalence in autistic 
individuals who are mentally retarded (Bailey et al. , 1 996). The prevalence of 
epilepsy among the individuals used in this study is not discussed as it is beyond the 
scope of this project. 
1.5 Aetiological Models of Autism 
The causes of autism still remain uncertain, and opinions about the aetiology 
have varied over the years. It was first put forth by Kanner ( 1 943) that autism was 
due to an inborn defect, since the onset of the disorder occurs very early in life. Other 
views suggested that the condition is the outcome of parental neglect, rejection, or 
indifference (Bene, 1958; Bettelheim, 1967; Despert, 1956). Numerous clinical and 
epidemiological studies, however, have failed to show a positive association between 
autism and qualities of upbringing or frequency of stress experiences (Cantwell et al. , 
1 978; Bailey et al. , 1 996). Accordingly, it seems unlikely that psychosocial 
environmental risk factors are involved in the aetiology of autism. Current research 
findings support Kanner' s initial interpretations, and it is now generally accepted that 
autism has a biological cause. 
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Like other behavioural syndromes, autism is an aetiologically heterogeneous 
disorder. A number of neurological conditions, some traumatic, some infectious, and 
some genetic in aetiology, have been reported to be associated with autism. These 
conditions are presumably the cause of the syndrome in a small number of cases and 
so they will be reviewed below. Fragile X syndrome, chromosome 1 5  deletions and 
several other disorders are discussed in more detail; since these conditions are 
frequently reported to co-occur with autism, the chromosomal regions involved have 
been included in this study as candidate regions for susceptibility loci to autism. 
Although the exact figures are unknown, cases with a known or presumed aetiology 
constitute a small proportion ( 1 0-25%; see section 1. 5. 1. 2) of all autistic children. 
The majority of cases are of unknown aetiology and several observations suggest that 
genetic factors may play a role. This theory, supported by family and twin studies as 
well as the presence of other related conditions within the family, is also reviewed in 
the following section. 
1.5.1 Neurological Conditions Associated with Autism 
1.5.1.1 Prenatal, Perinatal and Neonatal Factors 
Pre-, peri- and neonatal complications have been reported to be more 
prevalent in individuals with autism than in control groups (Deykin and MacMahon, 
1980; Finnegan and Quarrington, 1 979; Torrey et al., 1975). These factors include 
abnormal obstetrical presentation (Finnegan and Quarrington, 1979; Levy et al. , 
1988), advanced maternal age (Gillberg and Gillberg, 1 983 ;  Tsai and Stewart, 1 983) ,  
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low birth weight (Knobloch and Pasamanick, 1975), prematurity (Gilberg and 
Gilberg, 1983), use of medication during pregnancy (Deykin and MacMahon, 1980), 
viral illness (Deykin and MacMahon, 1979), low Apgar score (Finnegan and 
Quarrington, 1979), vaginal bleeding (Gilberg and Gillberg, 1983; Knobloch and 
Pasamanick, 1975 ; Torrey et al. , 1975) and hyperbilirubinemia (Finnegan and 
Quarrington, 1979). In studies controlling for birth order, no differences in the rates 
of pre-, peri- and neonatal problems between autistic subjects and control subjects 
were detected (Lord et al. , 1991; Piven et al. , 1993). The association of pre-, peri­
and neonatal factors with autism has an uncertain significance (Rutter et al. , 1990), 
and it has been suggested that these factors could be consequences of underlying 
genetic problems in the fetus (Bailey et al. , 1995 ; Bolton et al. , 1994). 
1.5.1.2 Associated Disorders 
A number of pathological conditions have been reported to be associated with 
autism. These range from infectious diseases to chromosomal abnormalities, and 
neurocutaneous and metabolic disorders. Gillberg and Coleman ( 1996) recently 
reviewed all population studies on autism published in the English language with 
particular reference to co-morbidity. Seven studies met the criteria for inclusion in the 
survey. These criteria were similar to those used in Gillberg's  (1995) paper for 
estimating the overall prevalence of autism in the population ( see above). They found 
that approximately one in four people (24.4%) with autism have an associated 
disorder. There was also a trend for higher rates of associated disorders among 
individuals with severe mental retardation. It still remains unclear whether the 
associated disorders are aetiologically linked to the symptoms of autism or whether 
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the individuals have two separate and unrelated disorders (Gillberg and Coleman, 
1996). Other studies regard additional disorders as rather rare ( up to 10%) among 
autistic children (Ritvo et al. , 1990; Smalley, 1991; Rutter et al. , 1994). The reasons 
for the discrepancy could be due to differences in the stringency of diagnostic criteria 
for the associated conditions as well as ethnic differences in the aetiology of the 
disorders (Gillberg, 1992a). 
Infectious Diseases 
Pre- and postnatal infections associated with autism include encephalitis 
(Deykin and MacMahon, 1979; Markowitz, 1983), syphilis (Stubbs, 1978; Stubbs and 
Crawford, 1977), toxoplasmosis (Todd, 1986), CMV-infection (Stubbs et al. , 1984), 
herpes simplex (Ghaziuddin et al. , 1992a) and congenital rubella (Chess, 1971). The 
evidence for these associations is not convincing in the majority of cases. 
The association between congenital rubella and autism was first shown by 
Chess (1971). However in a follow-up study, Chess (1977) noted that the autistic 
symptoms in these children with congenital rubella improved over time. A review of 
epidemiological studies in autism (Fombonne, 1998) reported a 0.9% median rate of 
congenital rubella, a value not significantly different from the rates in control groups. 
A recent Japanese survey of autism conducted in the aftermath of a rubella epidemic 
also failed to document any single case of autism associated with congenital rubella 
(Honda et al. , 1996). 
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Chromosomal Abnormalities 
Autism has been linked to different chromosomal abnormalities. While most 
of these abnormalities involve sex chromosomes, structural autosomal defects have 
also been reported. Recent reviews of the literature (Gillberg, 1998; Lauritsen et al. , 
1 999) have reported abnormalities in each of the autosomes and of the gonosomes 
among individuals with autism / autism-like behaviour. These include a partial 
trisomy 8q (Ritvo et al. , 1990), a partial trisomy 6p2 l -6p25-ter (Burd et al. , 1988), a 
partial trisomy 1 5  (Gillberg et al. , 199 1  b; Schinzel, 1990), a 1 q deletion (Murayama et 
al. , 1 99 1 )  and several other defects such as a translocation t(3 ; 12)(p26.3;q23.3) 
(F ahsold et al. , 199 1 )  or a complex chromosome rearrangement involving 
chromosomes 1 ,7 and 2 1  (Lopreiato and Wulfsberg, 1992). Most of these 
abnormalities have only been reported in isolated cases of autism and it is not known 
whether they are associated with autistic behaviour by chance alone (Gillberg and 
Coleman, 1992). In a review of the literature on autosomal chromosome 
abnormalities from January 1987 to June 1998, Lauritsen et al. ( 1999) detected three 
interesting regions with multiple reports of cases with abnormalities in the same area. 
These include l 5q 1 1 - 13 ,  I 6q23 and l 7p 1 1.2, with chromosome 1 5  being the most 
frequently reported aberrant site. These regions are good candidates for containing 
susceptibility loci involved in the aetiology of autism, and were studied within the 
course of this study. Chromosome 1 5  abnormalities (Gillberg et al. , 1 99 1 b) together 
with Down syndrome (trisomy 2 1 )  (Wakabayashi, 1 979), and fragile X (Hagerman, 
1989), have also all been reported to co-occur with autism in a number of studies and 
are reviewed in detail below. 
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Chromosome 15 Aberrations 
Aberrations, including duplications and to a lesser extent deletions, on the 
proximal long arm of chromosome 15,  have been reported to be the single most 
common identifiable cause of autism (Schroer et al. , 1998). Kerbeshian et al. ( 1990) 
first reported an individual with autism who had a supernumerary inversion on 
chromosome 1 5 .  Since then, there have been a number of reports that associate 
deletions, uniparental disomy (UPDs), or supernumerary inverted duplications on 
chromosome 1 5  with autism. Autistic patients with these aberrations commonly have 
mental retardation and epilepsy as well (Baker et al. , 1994 ;  Bundey et al. , 1994 , 
Schroer et al. , 1998). 
The most common abnormality involves duplications within the 15q 1 1-q 13 
region (Gillberg et al. , 1 99 1b, Martinsson et al. , 1994 ; Bundey et al. , 1994 ; Baker et 
al. , 1994; Flejter et al. , 1996; Cook et al. , 1 997a). This is the critical region for 
Prader-Willi syndrome (PWS) and Angelman syndrome (AS). Both of these 
syndromes involve developmental abnormalities and mental retardation, and show 
abnormalities in the 4Mb-region spanning 15q 1 1 -q 13 .  In the case of PWS, both . 
alleles at this specific location on chromosome 1 5  have been inherited from the 
mother or the paternal allele has been deleted. AS, on the other hand, is the 
deficiency of normal maternal DNA at 1 5ql 1-ql3 (Chan et al. , 1993) .  Although 
PWS and AS have not been shown to be directly associated with autism, duplications 
in this region have. All duplications of the PWS/ AS critical region in autistic patients 
have been maternal in origin (Robinson et al. , 1993 ; Leana-Cox et al. , 1 994 ; Schinzel 
et al. , 1 994 ; Flejter et al. , 1 996; Cook et al. , 1997a) . These studies found that 
paternally inherited duplications of 15q 1 1 -q 13  lead to a non-autistic phenotype, 
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whereas maternally inherited duplications usually lead to autism or atypical autism. 
This suggests that an imprinted gene at chromosome 15 may contribute to 
susceptibility to autism in some cases. 
Down Syndrome 
Wakabayashi (1979) first described the association of Down syndrome (DS) 
with autism. Since then, a number of studies have reported the occurrence of autism 
in individuals with Down syndrome (Wing and Gould, 1979; Gath and Gumley, 1986; 
Bregman and Volkmar, 1988; Myers and Pueschel, 1991; Gillberg et al. , 1986; 
Ghaziuddin et al. , 1992b; Howlin et al., 1995; Ghaziuddin, 1997). The association 
reported in these studies could be explained by ( 1) a family history and genetic 
predisposition to autism (Ghaziuddin, 1997), (2) complicating physical conditions that 
occur in DS (such as brain damage) and may increase the risk of autism symptoms 
( Gill berg et al. , 1986), (3) the wide range of deficits caused by trisomy 21 that could 
contribute to the emergence of autistic features (Howlin et al., 1995), and ( 4) 
neuropathological aberrations present in both disorders might reflect altered patterns 
of functional organisation that are common to both (Ghaziuddin et al. , 1992b). 
Overall the occurrence of Down syndrome in people with autism is relatively rare. 
Presently, it does not seem that Down syndrome, as such, predisposes to the 
development of autistic behaviour (Gillberg, 1993). 
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Fragile X 
The association of fragile X syndrome and autism is well established, however 
the prevalence of this association differs significantly between studies. The fragile X 
syndrome is the most common cause of hereditary mental retardation. It is a recessive 
X-linked disease with incomplete penetrance and affects boys and girls at a ratio of 
3: 1 (Davies, 199 1  ). Originally it was detected cytogenetically by the presence of the 
fragile site (FraX) Xq27.3. In 199 1 ,  Verkerk et al. identified the FMR- 1 gene (fragile 
X mental retardation) that is responsible for this disorder, and the syndrome can be 
detected with molecular genetic methods. 
Studies before the identification of the FMR- 1 gene reported the rate of fragile 
X in individuals with autism to range from O to 25%, with an average of 7% (Bolton 
and Rutter, 1990). The wide variation between studies could be due to the 
ascertainment procedures utilised, to the use of small sample sizes, as well as different 
diagnostic methods (F olstein and Piven, 199 1  ). In addition, the common fragile site 
at Xq27.2 could have produced frequent false-positive results in individuals with low 
levels ofFraX (Xq27.3) expression (ie. 1 %  to 3%) (Ramos et al. , 1989; Sutherland 
and Baker, 1990). 
More recent investigations, which use standard techniques and the same valid 
and reliable clinical diagnostic criteria (ADI, see section 2. 1.2), have tended to report 
lower rates of co-occurrence between the two syndromes (Bailey et al. , 1993a; Piven 
et al. , 1 99 1 a). Bailey et al. ( 1 993a) replicated the Piven et al. ( 1 99 1 a) study, and 
detected the fragile X anomaly in 1.6% of autistic individuals from a combined sample 
of autistic twins, hospital patients, and individuals from families with several members 
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affected by autism or related cognitive phenotypes. Bailey et al. (1993a) surmised 
that the similarity of the two findings supports the conclusion that the fragile X 
anomaly accounts for only a small proportion of the genetic influences in autism. It 
should also be noted that most medical centres currently test patients with autistic 
behaviour for fragile X. If positive, these individuals are usually diagnosed with 
fragile X or fragile X with autistic features instead of autism itself. 
Neurocutaneous Disorders 
Three neurocutaneous disorders have been described in association with 
autism or autistic symptomatology. These include tuberous sclerosis (mapped to 
chromosomes 9 and 16), neurofibromatosis (NF 1 maps to chromosome 17 and NF2 
to chromosome 22), and hypomelanosis of lto (believed to reside on chromosome 
l 5q) (Gillberg and Coleman, 1992). The association between hypomelanosis of lto 
and autism has only been reported in case studies (Akefeldt and Gillberg, 1991; 
Zappella, 1993). Tuberous sclerosis and neurofibromatosis have been reported in 
epidemiological studies of autistic populations at rates greater than would be expected 
by chance. 
Tuberous Sclerosis 
Tuberous sclerosis (TSC) is an autosomal dominant disorder involving benign 
tumour growth in various organs, including skin, brain, eye, kidney, and heart 
(Gomez, 1988). It has a variable expression and exhibits genetic heterogeneity. This 
disorder, like fragile X, has been investigated in detail with respect to its association 
with autism. Smalley et al. (1992) reviewed the literature regarding the frequency of 
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autism in TSC and found rates ranging from 17-58% in studies using various 
diagnostic instruments. This related to a frequency of TSC among autistic individuals 
in the order of 0.4-3%. They also noted an increase in the estimated frequency (8-
14%) in a subgroup of autistic subjects with seizures (Gillberg, 1 99 1 ;  Riikonen and 
Simell, 1 990). Since then, three population-based studies of TSC have examined 
autism rates. Hunt and Shepherd ( 1 993 )  found that 24% (5 of2 1 )  of children with 
TSC in Western Scotland met the criteria for autism. These individuals were 
diagnosed using a 13-item scale, with a score of 7 or greater indicating autism. 
Gillberg et al. ( 1 994), in their study in Western Sweden, found a rate of 6 1  % ( 17 of 
28) of individuals with TSC meeting the DSM-III-R (APA, 1 987) criteria for autistic 
disorders. In a Californian study, Gutierriz et al. ( 1 998) found the frequency of 
autism in their sample of28  TSC probands to be 29%. These probands were all 
diagnosed using the revised Autism Diagnostic Interview, based on ICD- 1 0  and 
DSM-IV criteria (see section 2. 1.2 ;  WHO, 1 992; APA, 1 994 ). In an overview of all 
of these epidemiological studies, Gutierrez et al. ( 1 998) surmised that autism occurs 
in approximately 25% of individuals with TSC, with the majority of these people 
showing evidence of mental retardation as well. He also noted that infantile seizures 
and mental retardation are significant risk factors for the development of autism in 
TSC, for example in the Gillberg et al. ( 1 994 )  sample, 13 of the 17  children with 
autism and TSC had a history of infantile spasms. Overall, if the population 
prevalence ofTSC is taken to be 1 /6,800 (Ahlsen et al. , 1 994), it could be suggested 
that TSC accounts for up to 4% of all cases of autism. 
24 
Neurofibromatosis 
Neurofibromatosis is also an autosomal dominant disorder with a variable 
severity of symptoms that primarily affect the nervous system. So far, two types of 
neurofibromatoses have been identified. Neurofibromatosis type 1 (NFl) has been 
mapped to chromosome 17 and occurs with an incidence of 1 /3 OOO (Barker et al. , 
1987). NF 1 predisposes individuals to the development of skin spots ( cafe au lait 
macules) and tumours within the peripheral nervous system (Rouleau et al. , 1993 ). 
Neurofibromatosis type 2 (NF2), which occurs with an incidence of 1 /33000-50000 
(Kanter et al. , 1980; Evans et al. , 1992), is characterised by a predisposition to the 
development of tumours of the central nervous system, including acoustic neuromas, 
meningiomas, neurofibromas and ependymomas (Martuza and Eldridge, 1988). The 
chromosomal region containing mutation(s) responsible for NF2 was narrowed, 
through a combination of family studies and deletion mapping in tumours, to 
chromosome 22q 1 2  (Seizinger et al. , 1986; Rouleau et al. , 1987; Seizinger et al. , 
1987; Couturier et al. , 1990; Rouleau et al. , 1 989). Recently, two groups of 
investigators independently isolated a candidate gene for this disease (Rouleau et al. , 
1993 ; Trofatter et al. , 1993) .  They showed that this gene, designated Schwannomin 
(SCH), is the site of the mutations causing NF2 by demonstrating germline and 
somatic SCH mutations in NF2 patients and in NF2-related tumours. Most of the 
variants were nonsense, frameshift, or splice mutations predicted to lead to the 
synthesis of a truncated SCH protein. 
Gillb�rg and Forsell ( 1 984) were the first to report an association between 
autism and neurofibromatosis. A systematic community study was carried out in 
individuals born in the Goteborg region of Sweden between the years of 1962- 1976 . 
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From this total population screening, 2 children out of the 26 diagnosed with infantile 
autism were reported to have NFI.  This corresponds to a rate of 7.7%. Future 
studies, however, have failed to replicate these results. Fombonne et al. ( 1997) in the 
French epidemiological survey of autism noted that the rate of neurofibromatosis was 
very low. Their rate of 0.3% was similar to the median rate of four other surveys 
(reviewed in Fombonne, 1998) and identical with the rate found in a large sample of 
34 1 referred autistic children in Denmark (Mouridsen et al. , 1992). This rate is not 
significantly different from what would be found by chance alone. Fombonne et al. 
( 1997) concluded that, when these results are amalgamated, they strongly go against 
the claim of an association between autism and neurofibromatosis (Gillberg and 
Forsell, 1984 ). 
Recent studies, therefore, show no specific association with neurocutaneous 
disorders and autism, however, they may be useful in the investigation of the 
neuropathology or pathophysiology of autism. Since both tuberous sclerosis and 
neurofibromatosis present with brain lesions that are variable in location, 
neuropathological studies comparing cases with and without associated autism may 
suggest brain areas that are focal points of the pathophysiology of autism (Folstein 
and Rutter, 1988; Hunt, 1995). 
Metabolic Disorders 
Disorders caused by a metabolic deficit have also been associated with autism 
at a level that is possibly greater than suggested by chance alone. These include 
phenylketonuria (PKU) (Friedmann, 1969), lactic acidosis (Coleman and Blass, 1985) 
and hypothyroidism (Gillberg et al. , 1 992a). PKU was the first genetic condition to 
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be reported in association with autism. It is an inborn error of metabolism that is 
inherited in an autosomal recessive fashion, and is usually, but not always, associated 
with mental retardation (Felling, 1934). Since the initiation of programmes for the 
screening of newborns for PKU and the institution of a phenylalanine-restricted diet 
within the first weeks oflife, the frequency of this disorder rapidly decreased. 
However, there have been reported cases of autistic children with classic untreated 
PKU (Miladi et al. , 1992; Chen and Hsiao, 1989; Pueschel et al. , 1985; Friedman, 
1969; and others). After the initiation of a phenylalanine-restricted diet, the autistic 
symptoms improved (Friedman, 1969). From the above observation and after noting 
that autistic symptoms were present in children with PKU and normal intelligence, 
Friedman (1969) concluded that autism and mental retardation were separate 
disorders. This supports the hypothesis that, on a pathophysiological level, autism 
and mental retardation have different mechanisms (Folstein and Rutter, 1988). At 
present, PKU is the metabolic disorder most frequently reported to co-occur with 
autism, however this association is rare, as shown by a review of six recent 
epidemiological studies (Fombonne, 1998) which failed to report any single case. 
1 .5.2 Autism as a Genetic Disorder 
It is generally considered that some cases of autism have a genetic basis 
(Bolton and Rutter, 1990) as shown by the data above and the publications reviewed 
below. The proportion of cases of autism with a genetic aetiology, however, is 
unknown. As mentioned above, the percentage of cases of autism associated with 
other disorders range from 10 to 25%, including 5 to 14% with a known genetic 
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disorder or chromosomal anomaly (Smalley, 1997). However, there is uncertainty as 
to the proportion of autism cases that have a genetic basis without demonstrable 
associated disorders. 
Nevertheless, there is a general consensus as to the importance of genetic 
factors in the development of autism. Evidence that supports this view has been 
derived by family and twin studies, as well as the family aggregation of other 
conditions. 
1.5.2.1 Family Studies 
Publications by Smalley et al. (1988) and Bolton and Rutter (1990) reviewed a 
number of epidemiological and family studies of autism and estimated the prevalence 
of autism in siblings of autistic children to be about 2 - 3%. A more recent family 
study by Bolton et al. (1994) that examined 153 siblings of 99 autistic individuals 
found the sib recurrence risk to be 2.9%. Also, a study by Jorde et al. (1991), based 
on a large scale epidemiologic survey in Utah, reported a recurrence risk of 3. 7% if 
the first autistic child was male and 7. 0% for female pro bands. Studies have shown 
that parents with an autistic child may limit further childbearing since the disease is so 
severe. However, if families that have stopped further child-bearing after having a 
child with autism are removed from the family studies, the recurrence risk in siblings 
may be greater than the average noted by Smalley et al. (1988) and Bolton and Rutter 
(1990). Indeed, a family study by Ritvo et al. (1989) took into account the "stoppage 
rules" evident in families with autism and reported a risk of autism for siblings born 
after the pro.band of 8.6%. In summary, the recurrence risk in siblings is in the region 
of 2 - 9%. This represents a 45 - 200-fold increase in risk relative to the population 
prevalence (4. 5 in 10,000, see section 1.4.1). 
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1.5.2.2 Twin Studies 
Since family studies cannot separate genetic and non-genetic ( environmental) 
influences, twin studies are also used for establishing a genetic aetiology. In twin 
studies, a disease that is at least partially determined genetically is expected to show a 
higher concordance rate among monozygotic (MZ) twins compared to dizygotic (DZ) 
twins. MZ twins normally have 1 00% of their genes in common, while DZ twins 
have, on average, 50% of their genes in common. This genetic relationship results in 
the phenotypic differences between MZ twins being attributed to environmental 
influences, while phenotypic differences between DZ twins are attributed to both 
genetic dissimilarity and environment. There have been three major twin studies of 
autism (Table 3) .  Ritvo et al. ( 1 985a) found a MZ concordance of 95% (22/23) and 
DZ concordance of 24% ( 4/17), whilst Steffenburg et al. ( 1989) found a MZ 
concordance of9 1 %  ( 1 0/ 1 1 )  and a 0% (0/ 1 0) concordance in same sex DZ twins. In 
a recent study that uses some of the same twins described in an earlier study by 
Folstein and Rutter ( 1 977), Bailey et al. ( 1 995) found a MZ concordance of 73% 
(27/37) and a DZ concordance of O (0/20). The first study by Ritvo et al. ( 1985a) 
was not systematic (the subjects were collected by advertisement) and there were also 
problems in the re-diagnosis of affected individuals (including failing to take into 
account the possibility of a broader phenotype). This may have inflated the 
concordance rates reported. Combining the data from the last two studies, the 
average MZ concordance rate is 77% and the average DZ concordance rate is zero. 
The DZ concordance rates were calculated from a small sample size and are not 
significantly different from the approximate sib recurrence rate of 3%. It may be 
concluded from these studies that the MZ concordance is much higher than the DZ 
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concordance rate, providing further support that genetic influences predominate in the 
aetiology of many cases of autism. 
Table 3 :  Systematic Twin Studies on Autism 
Study 
Ritvo et al. ( 1 985a) 
Steffenburg et al. ( 1 989) 
Bailey et al. ( 1 995) 
( update of F olstein and Rutter ( 1 977) twin study) 
MZ Twins 
95% (22/23) 
9 1% ( 1 0/ 1 1 )  
73% (27/37) 
DZ Twins 
24% (4/ 1 7) 
0% (0/ 1 0) 
0% (0/20) 
Twin studies can also be utilised to estimate the heritability of liability to 
autism. Bailey et al. (1995) used their calculated MZ concordance rate of73% and, 
since no DZ twins were ascertained during the course of the study, the 2. 9% rate of 
autism among siblings of autistic individuals was applied (Bolton et al. , 1994). They 
also utilised two different prevalence estimates, 1.75 in 10,000 (Wing et al. , 1976) 
and 10 in 10,000 (Gillberg et al. , 1991a) in their calculations. Using structural 
equation modelling (Bentler, 1989), they estimated the broad heritability of liability to 
autism to be 93% and 91 % for the base rates of 1.75 and I O in 10,000 respectively. 
This again supports the role of genetic factors in the aetiology of autism. 
1.5.2.3 Family Aggregation of Other Conditions 
Clinical observations have noted the social peculiarities present in some 
parents of autistic children, as well as a history of developmental disorders of reading 
and spelling in parents as well as siblings of autistic probands (Folstein and Piven, 
1991 ). Recent studies using standardised assessment procedures have reported that 
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cognition, language and personality deficits, and psychiatric disorders are present in 
families with autistic probands. These are discussed below. 
Cognitive Deficits 
A high rate of cognitive deficits (ie. reading, spelling and articulation 
disorders; language delay and mental retardation) has been noted in families of autistic 
children. A study by Bartak et al. ( 1975) found that reading or language disabilities 
were present in first-degree relatives in 26% of families. Folstein and Rutter ( 1 977) 
reported similar results in their twin study. They found that the concordance rate for 
cognitive deficits was 82% for MZ twins and 1 0% for DZ pairs. A twin study by Le 
Couteur et al. ( 1989a) replicated Folstein and Rutter's results and suggested that 
cognitive abnormalities might be a milder expression of a common underlying genetic 
abnormality in autism. 
Piven et al. ( 1989a) interviewed mothers of autistic children (N=3 7) about 
their other children (N=67). Fifte�n percent of non-autistic siblings were reported to 
have had cognitive disorders as children. It was also noted that most of these 
cognitive problems were in reading and spelling, and none of these non-autistic 
siblings were mentally retarded. 
Specific Language Abnormalities 
Landa et al. ( 1989) assessed social communication in parents of autistic 
individuals and control subjects matched for IQ scores and educational level. They 
reported a significantly higher rate of deficits in both social use of language 
(pragmatic language) and in story telling (narrative discourse) in the parents compared 
to the controls. 
3 1  
Personality Characteristics 
Particular personality characteristics have been reported in parents and siblings 
of autistic probands, at a rate greater than expected by chance alone. Kanner and 
Eisenberg ( 1 956) noted that the parents in their study were perfectionists with 
interests in abstract ideas and lacked interest in developing relationships with others. 
Although they interpreted these findings as being evidence that "faulty" child rearing 
was the cause of autism, this has later been disproved (Cantwell et al. , 1 978). Recent 
studies using the family history method (Macdonald et al. , 1989; DeLong and Dwyer, 
1988; Wolff et al. , 1 988) and a standardised interview (Piven et al. , 1989b ), have 
shown an increase of incidence of social deficits in these families. 
Psychiatric Disorders 
Several studies have also reported an increased rate of psychiatric disorders in 
first-degree relatives of autistic probands (Piven et al. , 199 1  b ). Major affective 
disorder (Piven et al. , 1989a; DeLong and Dwyer, 1988) and anxiety disorders (Piven 
et al. , 1989a) were found to have significantly higher rates compared with control 
groups. Since these disorders occurred, in most cases, prior to the birth of the 
proband, they could not be attributed to the stress of having an autistic child. 
Schizoaffective disorders have been diagnosed in a number of families in which the 
pro bands have autism and fragile X syndrome (Hagerman, 1989; Gillberg, 1992b). 
Finally, there have been several reports on the co-existence of autism and elective 
mutism within first-degree relatives (Gillberg et al. , 1992b ). 
A variety of different abnormalities aggregate in families of autistic individuals 
as shown by the above studies examining cognitive deficits, personality 
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characteristics, language, and psychiatric disorders in relatives of autistic individuals. 
It has been suggested (Folstein and Piven, 1991) that these deficits may be 
manifestations of an underlying genetic liability to autism or part of the broader 
phenotype, since they are often mild and share similar characteristic features of autism 
(eg. aloofness and pragmatic language deficits). These deficits were not explored 
further in this project, due to the small number of studies published on this topic and 
the diagnostic problems, at present, in separating individuals with these deficits from 
normal controls. 
1.5.2.4 Summary of Genetic Involvement in Autism 
In summary, there are a few specific genetic conditions that can be associated 
with autism. Among cases of unknown aetiology, the evidence shown above 
proposes a 50-200-fold increase in genetic liability to autism in siblings of autistic 
probands, relative to the population prevalence. Family studies have also indicated 
that both parents and siblings have a higher liability for social and cognitive deficits 
that are milder but conceptually similar to those found in autism. Whilst other factors 
may alter this underlying genetic liability such as sex, IQ, and prenatal and perinatal 
injury, the overall evidence suggests that the liability to autism is largely genetically 
determined. This hypothesis was examined in this study by searching for susceptibility 
loci involved in the aetiology of autism. 
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1.6 Neurobiological Factors 
There is substantial evidence that autism is associated with abnormalities in the 
brain. However, the link between neurobiological findings and symptomatology in 
this genetically influenced developmental disorder has yet to be identified. The 
neurobiology of autism has been studied in great detail and there is an extensive 
literature on the subject, which is often complex and inconsistent. The poor 
replicability of neurobiological investigations arises for at least two reasons. First, 
there is lack of methodological consistency between studies. Results seem to be 
dependent upon the comparison group used and the variable on which the groups are 
matched (Dawson, 1996). Second, immense heterogeneity exists in the behavioural 
expression of autism, and studies differ in the subject populations they examine. 
Variability in clinical diagnosis and differences in the specificity of individual 
diagnostic instruments used in each study can also lead to heterogeneity of the sample 
and contribute to the differences observed (Bailey et al. , 1996). 
Current views about the localisation of abnormalities in the brain associated 
with autism are the product of neuropsychological, neuroanatomical (including 
neuroimaging and postmortem studies), and neurochemical studies. As previously 
mentioned, there exists a vast amount of literature on the neurobiology of autism. 
The majority of this is not within the scope of this project and only areas relevant to 
the overall understanding of this study will be reviewed. 
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1.6.1 Neuropsychological 
Indirect evidence of abnormal brain function has been derived from 
neuropsychological studies (Happe, 1994a). These investigations have been uniform 
in finding deficits in certain aspects of higher order cognitive functions, including 
abstract and pragmatic language, encoding of complex information, and executive 
(frontal) functions (Bristol et al. , 1996). Deficits in executive functioning in autism 
include impairments in thinking about consequences and the context of the activity, 
and in planning for and appropriately solving problems in a flexible, efficient manner. 
It has been proposed that these impairments result in the repetitive behaviours and 
inflexible style of thinking characteristic of autism (Ozonoff et al. , 1991 ). The 
universal impairment in social cognition found in neuropsychological studies of autism 
suggests the involvement of certain brain regions known to mediate social and 
emotional behaviour, namely, regions of the limbic system, such as the amygdala and 
orbital frontal cortex. Other studies have found an association between "theory-of­
mind" impairments and autistic symptoms (McEvoy et al. , 1993; Ozonoff et al. , 
1991). "Theory of mind" abnormalities refer to the inability to take notice of, and 
think about, the mental states of others (Frith, 1989), and may be related to the 
deficits in social interaction and social use of language found in autism (Lainhart and 
Piven, 1995). This theory has resulted in a great deal of research over the past 5-10 
years to determine how it relates to autism, and has been revised recently to 
accommodate the large amount of neurobiological research. These studies have 
shown autistic children to be impaired on a variety of experimental tasks requiring 
theory of mind for successful solutions (Baron-Cohen et al. , 1985; Happe, 1994b ). 
35 
1.6.2 Neuroanatomical 
Mental retardation is present in approximately three-quarters of autism cases 
(Rutter, 1 979). Mental handicap syndromes have often been associated with gross 
abnormalities in brain development, with a reduction in brain size frequently observed, 
as well as abnormalities in the cerebral hemispheres and overlying cortex (Bailey et 
al. , 1 996). In turn, it has been proposed that autism may be associated with gross 
abnormalities in brain development and that one such abnormality may be responsible 
for the distinctive symptomatology present in autism. A number of structural imaging 
and postmortem studies have been conducted to test this theory. 
1.6.2.1 Neuroimaging Studies 
In viva structural and functional imaging studies in autism have shown that the 
most consistent neuroanatomical lesions involve the cerebellar vermis (Courchesne et 
al. , 1994). Magnetic resonance imaging (MRI) studies, in particular, have shown a 
reduction in the cross-sectional area of the cerebellar vermis (hypoplasia) (Courchesne 
et al. , 1987; Gaffney et al. , 1987; Courchesne et al., 1988; Hashimoto et al. , 1995). 
The largest of these studies was by Hashimoto et al. ( 1995), who found hypoplasia of 
lobules VI and VII when a group of 1 02 people with autism were compared to 1 12 
control subjects. This difference was also found in children less than 2 years old who 
were later diagnosed with autism. Studies by other groups using similar anatomical 
methods have failed to replicate these findings (Garber and Ritvo, 1 992; Holttum et 
al. , 1 992; Kleiman et al. , 1992; Piven et al. , 1992). Reasons given for the 
discrepancy in the "failed" replication studies include small sample size and the use of 
patient controls versus healthy volunteer controls. 
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Another MRI study has suggested that minor malformations of the cerebral 
cortex may be important in a subgroup of autistic individuals (Piven et al. , 1990). 
Also, a positron emission tomography study showed that the functional relationship 
between the frontal and parietal cortex and subcortical structures in autistic subjects 
appear to differ from normal (Horwitz and Rumsey, 1994). These findings correlate 
with the severity of autism and specific clinical deficits and may be related to less 
efficient information processing (Minshew, 1994). 
Abnormalities in the medial temporal lobe and related structures have also 
been associated with autism. Hetzler and Griffin ( 1981) and DeLong ( 1992), 
recognised the similarities between autistic behaviour and Kluver-Bucy syndrome, and 
characterised autism as the effect of developmental dysfunction in structures of the 
medial temporal lobe, especially the hippocampus and amygdala. This was supported 
by Bachevalier' s ( 1994) finding that lesions of medial temporal lobe structures 
induced in newborn monkeys result in behaviour resembling autism, whereas no such 
changes were noted to result from similar lesions induced in adult monkeys. 
A number of neuroimaging studies have also reported both indirect and direct 
evidence of enlarged brain size in autism. These studies have shown: (1) head 
circumference greater than the 97th percentile in approximately 20-40% of autistic 
people (Bailey et al. , 1996; Davidovitch et al. , 1996; Woodhouse et al. , 1996; 
Lainhart, 1997); (2) increased brain weight at autopsy (Bailey et al. , 1993b) and; (3) 
increased brain volume (Piven et al. , 1995; Filipek, 1996). It is surprising to note that 
a number of disorders reported to be associated with autism ( eg. tuberous sclerosis, 
neurofibromatosis and hypomelanosis of lto; see above), are also occasionally 
associated with increased brain size or head circumference (Bailey et al. , 1996). 
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1.6.2.2 Post-Mortem Studies 
To date, fewer than 35  brains from autistic individuals have been examined, 
and none of these with current immunocytochemical techniques for synaptic, 
cytoskeletal, or glial markers. The early studies suggest abnormal neuronal 
development, evidenced by reduced neuronal cell size and increased cell packing 
density of limbic system structures, with decreased dendritic branching in the 
hippocampus, and reduced numbers of Purkinje cells in the cerebellar hemispheres 
(Bauman, 1996; Raymond et al. , 1996). An investigation of a single autistic brain by 
Rodier et al. ( 1 996) also suggested a decrease in the number of neurons in the motor 
cranial nerve nuclei. These findings have not been associated with seizures, use of 
medication, nor the severity of clinical symptoms. Since Purkinje cell loss is a 
recognised complication of epilepsy (Meldrum and Bruton, 1992), and autopsy 
studies have lacked mental retardation controls, the degree to which any finding is 
specific to autism remains unknown (Bailey, 1993). 
1.6.3 Neurochemistry 
N eurochemical studies of neurotransmitters and immunological abnormalities 
can provide much information for most neurobiological studies. Interpretation of the 
results, however, is problematic since the biological variable being assayed is usually 
rather remote from either brain function or structure. Also, in the case of autism, it is 
difficult to know whether the difference between subjects and controls is due to 
aetiological factors or consequences of some aspect of autistic behaviour or cognition 
(Bailey et al. , 1 996). Many changes in neurochemicals have been associated with 
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autism ( eg. serotonin (Gillberg and Coleman, 1992), dopamine (Cook, 1990), 
norepinephrine (Gillberg and Svennerholm, 1987), endogenous opioids (Sahley and 
Panksepp, 1987) and glial proteins and gangliosides (Ahlsen et al. , 1993)), however, 
most of these findings have been inconclusive. 
The most commonly replicated biological abnormality in autism is 
hyperserotoninaemia. The interest in serotonin is due to its effects on central nervous 
system (CNS) development, social behaviour, sleep, aggression, anxiety, and affective 
regulation (Cook and Leventhal, 1996). There is a significant amount of evidence 
that serotonin in the blood is raised (hyperserotoninaemia) in approximately one-third 
of patients with autism, and that this increase is due to increased platelet serotonin 
(Gillberg and Coleman, 1992). However, since increased blood levels of serotonin 
have been found in about one-half of non-autistic severely retarded children, it is still 
not clear whether this finding is only obtained in mentally retarded autistic individuals 
(Gillberg, 1993). Recent studies from behavioural neuroscience, pharmacological, 
and genetic studies have indicated that serotonin is involved in many of the symptoms 
of autistic disorder, such as aggression, anxiety and inflexible rituals and routines 
( Cook and Leventhal, 1996). These results led Cook et al. ( 1997b) to examine a 
possible linkage between the serotonin gene and autism (see below). Advances in the 
molecular biology of serotonin-related pathways are likely to provide an increased 
understanding about the underlying neurobiological mechanisms in autism and help in 
developing appropriate treatment of the social and cognitive dysfunction associated 
with autism (Piven, 1997). 
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1.6.4 Summary of the Brain Mechanisms Involved in Autism 
The available evidence suggests that autism involves widespread brain 
dysfunction at both the cortical and subcortical levels, however the primary site of the 
brain injury has not as yet been identified. Investigators have been recently debating 
whether there is only one pathway in the brain that is not functioning normally due to 
one or multiple mutations and this is what is causing autism, or whether there are 
multiple deficits that, in combination, cause what is known as autism. Bristol et al. 
( 1996), in a report to the National Institutes of Health on the state of the science in 
autism, stated that "the pathophysiology of autism, or the structural and functional 
abnormalities of the brain and how precisely they result in the abnormal behaviour of 
autism is far more complex than what brain structures or neurochemicals are involved. 
Each level of analysis is highly complex and, at present, only pieces of this puzzle in 
autism have been identified." 
1. 7 Mode of Inheritance 
Given the evidence of a genetic predisposition to autism, studies on the 
familial segregation of the disorder have been undertaken in order to identify a 
specific mode of genetic transmission. Segregation analysis can be used to estimate 
key parameters such as the allele frequency, penetrance, and proportion of cases 
explained by. the proposed model of inheritance. However, problems with segregation 
analysis exist, especially for genetically complex disorders. A complex disorder is one 
that does not exhibit classical Mendelian recessive or dominant inheritance attributable 
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to a single gene locus. First of all, segregation analysis can be extremely sensitive to 
ascertainment biases ( eg. the preferential inclusion of affected individuals may cause 
the penetrance to be greatly overestimated). Secondly, it may not be able to 
distinguish between the many possible modes of inheritance for complex traits. Some 
examples of these include: (a) a single gene disorder with reduced penetrance, (b) 
heterogeneity ( caused by two or more independent genes), ( c) oligogenic inheritance 
(interaction of a small number of different genes with at least one of moderate effect 
on the disorder), and (d) polygenic inheritance (interaction of a large number of 
different genes, each with a small effect on the disease). Thirdly, the number of genes 
influencing the trait is especially difficult to estimate (Lander and Schork, 1994). 
Many genetic models have been postulated for autism. These include autosomal 
recessive (Ritvo et al. , 1 985b), polygenic (Jorde et al. , 199 1 ;  Tsai et al. 198 1 ), and X­
linked (Gurling, 1 986; Szatmari and Jones, 199 1 ). 
Ritvo et al. ( 1985b) applied simple segregation analysis to a sample of 46  
multiplex families (with two or more autistic children). Multiplex families were 
selected in preference to sporadic cases, to minimise the probability of detecting single 
events due to environmental incidents, phenocopies, or new mutations (Smalley et al. , 
1 988). The authors found a segregation ratio of 0. 19  ± 0.07, which is consistent with 
that expected under autosomal recessive transmission (ie. 0.25). While one would 
expect the frequency of affected sib-pairs for an autosomal recessive inheritance to be 
around 25%, the "stoppage rules" prevalent in autistic families could account for the 
low sibling recurrence observed (-3%). Indeed, when Jones and Szatmari ( 1 988) 
reanalysed these data, adjusting for truncated family size due to "stoppage", the 
results were also consistent with an autosomal recessive model of inheritance ( 0. 2 7). 
The results obtained by Ritvo et al. ( 1985b) are inconclusive, however, due to the 
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biased nature of the sample (which was ascertained in part by advertising for multiple­
incidence families) and uncertainties about diagnosis (Bailey et al. , 1 996). 
A further study by the same research group (Jorde et al. , 199 1  ), calculated a 
different result. This investigation carried out a complex segregation analysis using 
data collected in the UCLA-Utah Epidemiological Survey. The uniform collection of 
data helped to circumvent difficulties caused by selective ascertainment and thus 
produced a sample more appropriate for segregation analysis. In this segregation 
analysis they used a mixed model, compared to the simple segregation analysis 
employed in the previous study. The authors concluded that a single major locus 
model of inheritance is unlikely, but could not rule out a multifactorial threshold 
model (ie. a large number of genes or environmental effects contributing to an 
underlying liability). However, they also noted that a major gene could be segregating 
in a small proportion of families that could not be detected by the mixed-model 
segregation analysis, even with the large data set used. The revised analysis was 
repeated assuming that eleven parents initially considered unaffected were affected 
(these individuals showed clinical deficits in the three major areas characteristic for 
autism). This analysis resulted in a shift in the model to a dominant major single 
locus. It could be concluded that, to predict the exact mode of inheritance of autism, 
accurate diagnostic information is required on the parents. Since autistic individuals 
generally do not marry and there are no clear-cut diagnostic criteria for milder forms 
of autism, this could prove very difficult. 
X-linked recessive inheritance has also been proposed (Szatmari and Jones, 
1 99 1  ), which could explain the increase in risk in males compared to females (3 : 1 ). 
Again, since it is difficult to diagnose parents, it is hard to assess directly the lack of 
male-to-male transmission. 
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The excess proportion of males affected with autism could also be accounted 
for by the following models (Szatmari and Jones, 199 1 ) :  
1 .  Autosomal inheritance, with a lower penetrance for females compared to  males; 
2. Polygenic inheritance, with a higher genetic load required for females to express 
the phenotype; 
3.  X-linked recessive inheritance for some individuals and an environmental cause for 
others (mixed aetiology); 
4 .  X-linked recessive or autosomal inheritance (genetically complex aetiology). 
The results from these segregation studies on autism have been inconclusive. 
Even though modifying factors, such as sex-influenced inheritance, reduced 
penetrance, and variable expression, could account for some of the deviations present, 
overall a multifactorial model ( with the interaction of multiple genes) is more likely 
than a monogenic model (Bailey et al. , 1996). This conclusion was drawn from two 
observations (Bailey et al. , 1996). First of all there is a significant difference between 
the concordance rate of MZ and DZ twins (Bailey et al. , 1995; Steffenburg et al. , 
1989; Folstein and Rutter, 1977). If it is assumed that the MZ concordance rate is 
77% and the DZ concordance rate is 3% (see section 1.5.2), this gives a MZ to DZ 
concordance ratio of 77 /3 = 25. This high ratio cannot be explained by one or two 
loci predisposing to the disorder: if a single recessive gene was responsible, a ratio of 
only 4 ( 1 00/25 = 4 )  would be calculated; and a dominant gene would contribute even 
less (ie. 1 00/50 = 2 or 1 00/75 = 1 .3 ). There is also a larger drop in cases of autism 
when looking at second-degree and third-degree relatives compared to first-degree 
relatives (DeLong and Dwyer, 1988; Jorde et al. , 1 99 1 ;  Szatmari et al. , 1995). For 
any disorder caused by a single major gene, the risk to relatives should fall by roughly 
a half as genetic distance increases (Risch, 1990b ). Combined data from the four 
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studies gives a O. 18% risk of autism for second degree relatives with a O. 12% risk for 
third-degree relatives. However, these data were collected from family histories 
which may underestimate the risk of disorder in extended relatives (Weissman et al. , 
1986). 
Secondly, Pickles et al. (1995) estimated that the number of genes responsible 
for autism, using latent class analysis, ranged between two and ten, however a three 
gene model was the most likely. Similar results were also obtained in simulations 
performed by our group, using the same approach but with individuals diagnosed with 
a "core", less broad definition of autism (Risch, unpublished). The population 
prevalence was assumed to be 1/2500, the MZ concordance rate was 77% and the sib 
risk value was presumed to be 3%. These figures lead to a MZ twin concordance to 
population prevalence ratio AM = 1925, and a sib risk ratio As = 75 (see section 
1.8.3.1). Assuming a multiplicative model and fixing the value of As, the value of AM 
was predicted under a number of epistatic genetic models (Table 4). As can be seen 
from the table, models specifying only 1 or 2 contributing loci or infinite contributing 
loci give a poor fit to AM. Models with three or more loci begin to provide an 
adequate fit to AM, depending on the degree of recessivity. In turn, these simulations 
showed that numerous plausible genetic models fit the data used, however, there must 
be at least 3 contributing susceptibility loci and the number depends on the degree of 
recessivity. 
In conclusion, it is clear that autism is not a single major gene disorder and the 
data at present point to a multifactorial complex disorder with many genes implicated. 
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Table 4: Predicted Values of the Population Prevalence Ratio (AM) (Observed = 1925), 
Fixing As = 75 for Several Multiplicative Multilocus Models (Note: loci are referred to as 
additive, recessive or intermediate, depending on the effect of that particular locus/loci). 
Genetic Model 
1 locus, additive (As(i) = 75) 
1 locus, recessive (As(i) = 75) 
Infinite loci, additive 
2 loci, additive (11,s(i) = 8 .66 each) 
2 loci, recessive (As(i) = 8 .66 each) 
3 loci, additive (11,s(i) = 4.22 each) 
3 loci, recessive (As(i) = 4.22 each) 
3 loci, intermediate (11,s(i) = 4.22 each) 
6 loci, additive (11,s(i) = 2 .05 each) 
6 loci, intermediate (As(i) = 2.05 each) 
l locus, additive (As(i) = 4), infinite others 
l locus, additive (As(i) = 6), infinite others 
2 loci, additive (11,s(i) = 4), infinite others 
1.8 Linkage Analysis 
Predicted AM 
149 
299 
5625 
266 
I 1 32  
4 1 1  
3996 
1 582 
900 
2222 
246 1 
1 7 1 9  
1 846 
The convincing evidence of a genetic component in the liability to autism 
makes the disease an obvious candidate for molecular genetic strategies (Rutter et al. , 
1994). These strategies search for susceptibility genes to a disorder, which could be 
particularly helpful in elucidating the biological basis of autism since biochemical and 
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neuroanatomical studies have been inconclusive. Presently, there are two major 
approaches that use markers to identify genes underlying human diseases. The first is 
"genetic linkage analysis". This method is most commonly used for determining the 
chromosomal location of genes for inherited disorders, where the causative genes are 
unknown. The second is the "candidate gene" method, which presupposes that there 
is prior information on pathogenesis pointing to specific genes where variation is 
likely to occur. The frequency of different alleles in the candidate gene is in turn 
compared between affecteds and controls using statistical tests for association. There 
are some diseases, mutations and specific alleles that have been shown to co-occur 
with autism ( eg. Fragile X, chromosome 1 5  deletions, HLA alleles). Although the 
traditional candidate gene approach was not used in this study, these "candidate 
regions" were investigated in greater detail in this project, using genetic linkage 
analysis to identify susceptibility loci. 
1.8.1 Principles of Genetic Linkage Analysis in Mendelian Inheritance 
In principle, genetic mapping of disease loci involves locating the relative 
position of a gene or genetic marker within the genome, by measuring its tendency to 
segregate together with some other measurable trait through several generations. The 
method of mapping genes by virtue of their co-segregation with other loci on a 
chromosome through meiosis is termed genetic linkage analysis. Thus, genetic 
mapping is a. description of a gene's  meiotic behaviour rather than its physical location 
(Thompson et al. , 1991 ). Genetic linkage analysis is a tremendously important and 
powerful approach in medical genetics because it allows mapping of genes, such as 
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some disease genes, in which neither their biochemical nor their molecular basis has 
yet been detected (Thompson et al. , 1991). 
The production of accurate and high-resolution genetic linkage maps is 
necessary for positional, as opposed to functional, cloning of genes. "Functional 
cloning" refers to the identification of a disease gene based on fundamental 
information about the basic biochemical defect, without reference to its chromosomal 
map position. Pure "positional cloning" assumes no functional information, and the 
responsible gene is located solely on the basis of genetic map position with the use of 
linkage analysis (Collins, 1995). Even before the identification of a disease gene, its 
placement on a genetic map is useful for identifying susceptible individuals and for 
genetic counselling (Cox Matise et al. , 1994). The unit of measurement for genetic 
linkage is the genetic length of a chromosome over which, on average, one 
recombination event is observed ("recombination" referring to the process of crossing 
over between homologous chromosomes during meiosis). This unit is called a 
Morgan (in honour of Thomas Mor�an who discovered the process of crossing over 
in 1910). A centiMorgan (cM) is the genetic length over which one observes 
recombination in one percent of recombination events or meioses. In the human 
genome, one cM translates roughly into one million base pairs (bp ), when taking into 
account the physical length of the genome (3 x 109 bp) (Thompson et al. , 1991 ). 
In principle, the smaller the genetic distance between two loci, the greater the 
probability that they will be linked and transmitted together to the next generation. 
This goes against Mendel' s law of independent assortment which states that an 
individual's genes will be transmitted to the next generation independently of one 
another. Mendel' s law holds true for most pairs ofloci, except those that occupy the 
same region of a chromosome. Under the process of independent assortment, 
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recombinations in a particular chromosome occur 50% of the time. A recombination 
frequency less than 50% or a genetic distance less than 50cM between two loci on the 
same chromosome, infers that these two loci are linked. 
Linkage studies look at the transmission of alleles in a family to estimate the 
recombination frequency between known loci and the disease gene. The direct 
method of linkage analysis involves observing and counting recombinants and 
nonrecombinants. The recombination fraction is then calculated by dividing the 
number of observed recombinants (k) by the number of opportunities for 
recombination (n) : 
e = kin 
To do this, it is important to know the linkage phase, ie. the chromosome on which 
each allele is located. Generally, this can only be known in three or greater generation 
families. For example, Figure 2 shows a three generation family with individuals 
affected with the dominant disorder NFl (shaded symbol). The genotypes for a two­
allele marker locus ( lF l O) are shown below each individual in the pedigree. Since the 
genotypes of the grandparents are known, the linkage phase of the grandchildren is 
known. Allele 1 seems to co-segregate with the disease phenotype (ie. this marker is 
linked to the disease) ,  therefore children in this family who are affected with NF  1 
usually have allele 1 at lFlO. In seven out of eight children in generation three this 
seems to be correct, however in one child a recombination has occurred (individual 
III.6). The recombination frequency for this family is, therefore, 1 /8 = 1 2.5%, ie. the 
marker and the disease locus are approximately 1 2.5cM apart. 
48 
I I  
I l l  
1 
1 , 2 
1 
2 ,2 
2 3 
1 ,2 2 ,2  
1 
1 , 2 
4 5 
l , 2  2 ,2  
2 
1 ,2  
2 
2 , 2  
6 7 
2 , 2  1 , 2 
8 
2 , 2  
Figure 2 :  An NFI pedigree in which each member has been typed for the I F I O  polymorphism 
(A). A recombination has occurred at individual Ill-6. (from Jorde, Carey and White, 1 995) 
When the parental phase is unknown the recombination fraction is estimated 
using the method of maximum likelihood (Fisher, 1921 ). In this method, the 
likelihood (ie. the probability of occurrence of the data) is calculated for a variety of 
assumed values of 8, and the e value associated with the highest likelihood is selected 
as the best estimate (8max). A lod score (Z; Bernard, 1949) is the logarithm (log10) of 
the likelihood that two loci are linked at a given recombination frequency (8), versus 
the likelihood that the two loci are not linked (8 = 0.5). The likelihood principle is 
defined as: 
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Z(8) = log1o (L (8) / L (8=0.5)) 
The lod scores are then graphed against the 8 values, as shown in Figure 3. The 
estimate of the recombination fraction is, in turn, that value of 8 at which Z(8) is 
highest (Zmax) . 
LOO score 
3. 5 
3 
2.5 
2 
1 .5 
0.5 
-------------------
0 0. 1 0.2 0.3 0.4 
Recombination frequency 
0.5 
Figure 3: The lod score is plotted against the recombination frequency to determine the most 
likely recombination frequency for a pair of loci (from Jorde, Carey and White, 1995). 
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Positive lod scores indicate evidence for linkage, and negative lods indicate 
absence of linkage. If linkage exists between the two loci, the lod score is expected to 
become larger with the addition of more families. Conventionally, a lod score of3.0 
is the threshold used to declare linkage, since a score of 3. 0 indicates that the 
likelihood in favour of linkage is 1 OOO times greater than the likelihood against 
linkage. Conversely, a lod score less than -2 (odds of 1 00 to 1 against linkage) is 
considered to be evidence that two loci are not linked. Morton ( 1955) originally 
proposed these particular values. In calculating these values, Morton used a power 
(to detect linkage if present) of0.99 at the chosen recombination fraction (8< 1/2) and 
a significance level (probability of a false-positive result) of O.00 1. His choice of 
power and significance level was determined to ensure that the rate of false positive 
results stay below 5 percent. The significance level of the test for linkage (0.00 1 )  is 
much smaller than the significance levels of 0.05 or 0.0 1  customarily used in statistical 
tests. The reason for this is that a large proportion of statistically significant false 
positives are calculated using these values. When using a significance level of O.001 ,  
all but a few percent of results are real. Whilst this holds true in a sequential test ( the 
sampling of a number of small families in a sequential manner), in large-sample theory 
( use of a large amount of informative data in the analysis) the rate of false positive 
results increases and the lod score drops from 3 to 2.07. To obtain a lod score of 3 in 
large sample theory, a significance level of a = 0.000 1 is required (Morton, 1 998). 
This relates to a reliability of 0. 996. Overall, in genetic linkage analysis a lod score of 
3 is commonly used to declare a significant result of linkage between two loci. 
A linkage map consisting of polymorphic DNA markers is the most 
appropriate map, as it allows the inheritance of different alleles of each marker to be 
traced in the families (informative genetic markers are ones that are highly 
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polymorphic and are heterozygous in a large proportion of individuals). The closer 
the genetic distance between the marker and the trait, the lower the probability that a 
meiotic crossover between the two loci will occur to prevent co-inheritance of the 
genetic marker (Thompson et al. , 1991 ). Linkage maps at 5-10 cM resolution are 
sufficient to identify the map location of diseases with Mendelian patterns of 
segregation, but for polygenic disorders which are characterised by multiple loci, 
higher resolution maps may be necessary (Cox Matise et al. , 1994). When linkage 
analysis is carried out as a sequence of pairwise comparisons between a trait locus and 
each of a number of marker loci, this is referred to as "two-point" analysis. For this 
type of analysis, lod scores are computed for each comparison (ie. trait vs. ith marker 
or marker vs. marker) and combined with the results of the same comparison from 
other families and/or investigators. With the production of dense genetic maps, it has 
become possible to analyse several linked loci simultaneously. This is referred to as 
"multipoint" linkage analysis (Lathrop et al. , 1984) and it is shown to be at least 5 
times as efficient as two-point analysis in estimating the recombination value (Lathrop 
et al. , 1985) (see section 1.8.3.2). Once the allele(s) of genetic markers are shown to 
co-segregate with the disease phenotype, these markers provide information on the 
position of the gene in the genome. With refined experimentation, the disease gene 
can be located more precisely. 
The prerequisites for linkage analysis in mapping disease genes responsible for 
Mendelian disorders are that the locus linking to the disease must be present in 
different forms in the population (ie. polymorphic genetic markers), and the 
availability of a sufficient number of informative meioses where the same disorder 
segregates. The following sections explore these prerequisites of linkage analysis for 
a Mendelian trait. 
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1.8.1.1 DNA Polymorphism 
The term genetic polymorphism is used to describe variation in DNA 
sequence. Polymorphic loci are characterised by a number of different alleles, which 
allows members of a population to be categorised into distinct genotypes. 
Polymorphic loci occur mainly throughout regions of the genome that do not contain 
genes. Genetic polymorphism is, in turn, defined as the occurrence of multiple alleles 
at a locus, where at least two alleles appear with frequencies greater than one percent. 
By convention, then, polymorphic loci are those at which at least two percent of the 
population are heterozygous (Ott, 1992). Polymorphic markers with a high 
heterozygosity index (ie. the percentage of individuals that are expected to be 
heterozygous at that locus) are desirable, as the presence of multiple alleles increases 
the chance that the segregation of normal and disease-carrying chromosomes can be 
traced within the pedigree. 
1.8.1.2 Polymorphic DNA Markers 
Several types of DNA polymorphism have been utilised as genetic markers. 
These include (i) single nucleotide substitutions and (ii) repetitive DNA sequences. 
Single nucleotide polymorphisms (SNPs) have recently been systematically identified 
within the mapped sequence tagged sites (STS) distributed over the whole genome. 
One type of SNP are restriction fragment length polymorphisms (RFLPs) and these 
are detectable by restriction enzyme analysis (Kan and Dozy, 1 978). The variations 
within these single nucleotides are usually biallelic (2 common alleles) and they have 
the potential ,for a +/- assay. These polymorphisms are also particularly suitable for 
genomic analysis using microarrays, due to their simple structure. Microarrays, or 
DNA chips, can contain as many as 3 000 SNPs (Sapolsky et al. , 1 999) and would 
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therefore potentially allow whole genome analysis of many DNA samples in a 
relatively fast and economic way. SNPs, however, are only about a third as 
informative as microsatellites (see below) and a complete map will probably not be 
available until the entire genome is sequenced (Tynan, 1998). 
Tandem repeat sequences are sites where the same short DNA sequence is 
repeated a number of times. These repeats are thought to arise by slippage during 
replication and unequal crossing over (Efstratiadis et al. , 1980; Jeffreys et al. , 1986; 
Levinson and Gutman, 1987). Replication errors during cell division can cause the 
number of repeats to change. The frequency of this kind of replication error is high 
enough to make alternative repeat lengths at the site common, but the rate of change 
in the length of repeats is low enough that the size of the repeat sequence at the site 
serves as a stable polymorphic trait in family studies (Housman, 1995) . 
Tandem repeat DNA elements include satellite DNA, minisatellite DNA and 
microsatellite DNA. The polymorphism present in satellite DNA (which is present in 
heterochromatin) is in the length of the clusters of tandem arrays, which can be up to 
several megabases in length (Cooper and Krawczak, 1993). A number of different 
families of satellite DNA tandem arrays have been identified, including a simple 
sequence of 5-25 bp repeats, alphoid (171 bp repeat) and Sau3A (-68 bp repeat) 
(reviewed by Vogt, 1990). Minisatellite sequences, which are also known as variable 
number of tandem repeat (VNTR) polymorphisms, are variations in the length of 
stretches of DNA containing a variable number of units of the same short sequence. 
This core consensus sequence is GGTGGGCAGARG, where R is equal to a purine, 
and there is t_hought to be approximately l 04 copies of VNTRs in the human genome. 
Finally, microsatellites are short (less than 500bp) tandem repeats, interspersed 
throughout the genome with sequence motifs of one to five nucleotides (Hearne et al. , 
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1992). The most abundant of these are the (CA/GT)n dinucleotide repeats, with 
approximately 50,000 copies per haploid genome (Weber and May, 1989). 
Micro satellites are the most useful of these DNA polymorphisms as they are 
easily isolated and characterised, and they display considerable polymorphism due to 
the large variation in the number of repeat units. Microsatellites are therefore the 
most ideal markers, at present, for the construction of high-resolution genetic maps, 
which can then be used to identify susceptibility loci involved in common genetic 
diseases. RFLPs, on the other hand, exhibit a low degree of polymorphism, and 
VNTRs are not evenly distributed throughout the genome, with clustering in the 
telomeric and centromeric regions (Royle et al. , 1988), making them less useful in the 
construction of genetic maps. 
The first genetic linkage map in man was constructed using RFLPs (Donis­
Keller et al. ,  1986). Botstein et al. ( 1980) were the first to propose that differences in 
the DNA sequence should be treated like allelic variants of a gene, allowing their use 
as genetic markers for gene mapping. With the rapid rate of increase in the number of 
polymorphic markers identified (Figure 4), many laboratories have used these markers 
to construct genetic maps of whole chromosomes or particular portions of a 
chromosome (NIH/CEPH, 1992 ; Weissenbach et al. , 1 992). Due to the number of 
CA repeats dispersed throughout the genome (-50,000; see above), these new genetic 
maps consist mainly of these types of microsatellites. The Human Genome Project 
(HGP) has completed mapping the entire human genome with polymorphic markers at 
1 -cM intervals. This project, which officially began in 1990, also aims at locating all 
the 60,000 to 70,000 genes of the haploid genome and sequencing the entire 3 billion 
or more nucleotides within it. 
55 
Thousands 
8 ....-----------------. 
Figure 4: The number oflmown polymorphic markers from 198 1 till 1 993 (from Jorde, Carey 
and White, 1 995). 
1.8.1.3 Family Material 
As mentioned previously, the possibility of obtaining a significant result in 
genetic linkage studies relies on the availability of enough polymorphic markers and 
the number of informative meioses. With recent progress in recombinant DNA 
technologies and the completion of stage I of the Human Genome Project, which 
aimed at constructing the genetic map, the availability of polymorphic markers poses 
no significant problem. Genome-wide scans of the entire human genome with 
microsatellite markers in informative families have been widely performed. Indeed, a 
large number of important disease genes have been localised using this approach and 
many have been cloned ( eg. Early Onset Breast Cancer [Hall et al. , 1990], 
neurofibromatosis type II [Rouleau et al. ,  1993]). The availability of sufficient family 
material is, however, a crucial point, and it is important to know how many 
informative meioses are required before attempting a genome search by linkage 
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analysis. This can be calculated by means of computer simulations, in which 
segregation of a potentially informative marker is simulated in the available family 
material. The simulation also estimates the expected and maximum lod-score which 
could be attained in the selected number of families if the marker was linked to the 
disease gene at a certain recombination fraction ( estimate of the power of the 
proposed study), and if the marker was unlinked to the disease gene (estimate of the 
false positive rate). Traditionally, simulation analysis also requires the genetic model 
(ie. the mode of inheritance) to be specified, and the results obtained are only valid 
within the context of this model. It is important to specify an accurate genetic model, 
since mis-specifying genetic parameters may cause a loss of power in localising 
disease genes using the traditional lod-score method of genetic linkage analysis. The 
sib-pair method of genetic linkage analysis was used in this study (see below in 1.8.3) 
and does not rely on the specification of a genetic model, so the results are not reliant 
on this parameter. However, once a reasonable genetic model can be postulated for 
the transmission of the disease in the affected families, and there is enough family 
material available, genetic linkage analysis using the traditional lod-score method is 
known to work effectively to localise susceptibility loci. 
Our group, assuming multilocus inheritance, completed computer simulations 
on the first 100 families collected, to determine the expected maximum lod score 
(EMLS) that could be obtained from this number of informative meioses. From these 
simulations it is plausible to expect that we can identify any loci (EMLS > 3.0) with 
As = 3 or more with a 1 OcM marker map, if all markers have an average 
heterozygosity of 0.67 (Table 5). With the addition of 100 more families we can 
expect to detect any susceptibility loci with As � 2 using a 1 OcM genetic map (het. = 
0.67) (Table 5). As described in section 1.5.2.1, our estimate of As for autism is 
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between 50-200, thus our sample size should give enough power to discover at least 
several gene effects. 
Table 5 :  EMLS for Multipoint Analysis, 10cM map, Het. = 0.67. 
� 
1 00 
200 
1.8.2 Complex Disorders 
2 .0  
1 .9 1  
3 . 82 
As 
3 . 0  
3 .43 
6 .85 
4 .0 
4 .36 
8 .76 
The use of linkage analysis in mapping complex traits is problematic since it is 
difficult to find a precise model that adequately explains the inheritance pattern. As 
previously defined, the term "complex trait" refers to any disorder that does not 
exhibit classic Mendelian recessive or dominant inheritance attributable to a single 
gene locus. Cystic fibrosis and Huntington's  disease are classic examples of 
Mendelian disorders. In both cases, genetic linkage analysis was used to localise the 
disease gene. Finding a genetic marker that co-segregates with a complex trait, 
however, may be complicated by many factors including reduced penetrance, presence 
of phenocopies (non-genetic cases), genetic heterogeneity, polygenic inheritance and 
high frequency of disease-causing alleles in the population (Lander and Schork, 
1 994). Reduced penetrance, phenocopies and heterogeneity can be problems relevant 
to some Mendelian disorders as well. 
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(I) Incomplete Penetrance and Phenocopy: Incomplete penetrance can be seen 
when individuals carry the predisposing allele but do not show phenotypic 
signs of the disease. Phenocopy, on the other hand, is seen when affected 
individuals do not carry the predisposing allele but develop the disease due to 
other causes (eg. environmental agents). These factors may affect genetic 
mapping studies, since the predisposing allele may either be present in some 
unaffected individuals or absent in some affected individuals. 
(II) Genetic Heterogeneity: Genetic heterogeneity is present in those disorders that 
are caused by multiple mutations at several genes. This can result in identical 
phenotypes, especially when the products of the affected genes are part of a 
common biochemical pathway. An example is retinitis pigmentosa, which 
involves retinal degeneration, and can result from mutations in any of at least 
14 different loci (Bleeker-Wagemakers et al. , 1992; Kumar-Singh et al. , 
1993). Genetic heterogeneity affects genetic mapping because a certain 
chromosome region will co-segregate with the disease in some families but not 
others. Allelic heterogeneity (the presence of multiple disease-causing 
mutations in a single gene), however, does not affect genetic mapping since 
the disease locus co-segregates with the same chromosomal region in all 
affected families. 
The effect of genetic heterogeneity and incomplete penetrance was 
examined in our sample of families using computer simulations. Assuming all 
markers had an average heterozygosity of 0.67, we concluded that 200 
families would detect linkage under the lowest penetrance model at a 
recombination fraction of0.05, if at least 50% of the families are linked to this 
gene. Approximately 33% oflinked families would be sufficient in models 
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with higher penetrance or at lower recombination fractions. In the case that 
only 25% of the families are linked, a sample size of 290 would be needed. 
(III) Polygenic Inheritance: Some complex traits require the simultaneous presence 
of mutations in multiple genes and this is known as polygenic inheritance. 
These multiple interacting genes may consist of either oligogenes 
(incompletely penetrant genes with a relatively large and therefore potentially 
recognisable effect on the trait) and/or polygenes (genes with a minor 
individual effect on the trait that may make their isolation by linkage analysis 
difficult) (Morton, 1998). Polygenic ( complex) traits may be classified as 
distinct traits, measured by a specific outcome, or quantitative traits, measured 
by a continuous variable (eg. diastolic blood pressure) whose level may be 
determined by the combined action of individual quantitative trait loci. 
(IV) High Frequency of Disease-Causing Alleles: If the disease-causing allele 
occurs at a high frequency in the population, it could be difficult to localise. 
An example of this is late-onset Alzheimer' s disease. Linkage studies showed 
weak evidence of linkage to chromosome l 9q. However, due to the low lod 
scores, these results were dismissed. It was not until the discovery that the 
apolipoprotein E type 4 allele on chromosome 19 was a predisposing factor 
that it was realised that these linkage results were correct. The reason behind 
the calculation of a low lod score was found when the frequency of this allele 
was shown to be -16% in most populations, thus interfering with the 
traditional linkage analysis (Corder et al. , 1993). 
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1 .8.2. 1 Defining the Disease Phenotype 
Narrowing the definition of a disease, or restricting the patient population so 
that only individuals with the "core" form of the disease are diagnosed, can assist in 
overcoming some of the difficulties mentioned above in mapping complex diseases. 
The selection of families is based on the presence of one or more of the following 
characteristics: 
(I) Unusual phenotypic features: Identifying a subset of families with an unusual 
phenotypic feature may reduce the number of genes involved in the disorder. 
For example, it was found that colon cancer with extreme polyposis was 
caused by a single dominant gene, and that other forms of colon cancer can be 
distinguished by the phenotype of replication errors in tumours (Aaltonen et 
al. , 1 993). 
(II) Age of Onset: Strictly genetic forms of disease often exhibit an earlier onset 
compared to complex or sporadic forms. For example, genetic homogeneity 
was found in breast cancer when only families with disease onset below 4 7 
years were included in the analysis (Hall et al. , 1990). 
(III) Extreme Severity: Particularly in the case of quantitative traits, it is often 
shown that inclusion of individuals with phenotypic values in the tails of the 
distribution increases the power to detect linkage (Risch and Zhang, 1995). 
In this study, only individuals diagnosed with the "core" syndrome of autism 
were included (ie. individuals diagnosed with Asperger syndrome and/or autistic 
spectrum disorders were excluded). All individuals with an IQ below 3 0  and/or 
associated with another disorder were also excluded from the analysis. By creating a 
homogeneous set of families with a diagnosis that is replicable between clinicians, our 
chance of detecting susceptibility loci should be increased. 
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Age of onset was also examined as a basis of discriminating distinct subgroups 
of families in our study. Results from the analysis of the first 37 families showed that 
there was great variability in the ages of onset, ranging from briefly after birth to 78 
months and that the ages of onset between siblings were not significantly different. 
However, when both parents' reports of age of onset were examined separately, there 
was high variability between the ages specified. From these data, it was concluded 
that the use of retrospective parent reports of age of onset may be too unreliable and 
we could find no evidence to support the value of dividing autistic families on the 
basis of age of onset. 
1.8.2.2 Linkage Analysis Methods Used for the Study of Complex Disorders 
Genetic linkage analysis relies on the specification of an accurate genetic 
model. However, it is difficult to use classical segregation analysis to accurately 
model a complex trait since it requires a significant amount of pedigree data to 
estimate the large number of unknown parameters required. In light of this problem, 
many linkage analysis methods that differ from the traditional lod score method have 
been proposed for complex traits. One involves using parametric linkage analysis 
under several simple modes of inheritance (Risch et al. , 1989). This type of analysis is 
called parametric because parameters such as penetrances and allele frequencies must 
be specified for the disease gene. However, analysing data under a clearly "wrong" 
model is expected to result in a loss of power and in biased estimation ( overestimation 
of the recombination fraction). For some two-locus models, the degree of 
information loss has been shown to vary depending on the mode of inheritance 
(Schork et al. , 1990). Other methods involve non-parametric linkage analysis. These 
methods do not assume that a single major disease locus (with a specific mode of 
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inheritance) accounts for the majority of the genetic variance, and are best suited for 
searching for susceptibility loci involved in genetically complex disease. One non­
parametric method is the affected sib pair approach, and this is the method of choice 
in this study. 
1 .8.3 Sib-Pair Methodology 
Affected sib-pair analysis examines siblings (both with the disease) for the 
sharing of marker alleles at multiple sites in the genome. The more often the affected 
siblings share the same allele at a particular site, the more likely it is that the site is 
close to the disease gene (Penrose, 1935). Although allele-sharing methods are often 
less powerful (in terms of the chance to detect linkage) than parametric analysis with a 
correctly specified model, they tend to be more robust. Affected siblings show an 
excess of allele sharing even in the presence of incomplete penetrance, phenocopy, 
genetic heterogeneity and high-frequency disease alleles (Lander and Schork, 1994 ). 
This method is very useful in studying autism, since the unknown parameters such as 
affection status of the parents and the mode of inheritance do not need to be specified. 
Sib-pair analysis involves testing whether affected siblings inherit a region that 
is identical-by-descent (IBD) more often than expected under random Mendelian 
segregation. Under random segregation the probabilities of sharing zero, one or two 
alleles IBD are 25%, 50% and 25% respectively. If both parents are available, the 
data can be partitioned into separate IBD sharing for the maternal and paternal 
chromosomes. In this case, each affected sibling could share zero or one allele with 
the other sibling, with a 50%-50% distribution expected under random segregation. 
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A deviation from the expected 50% IBD allele sharing suggests the presence of a 
trait-causing gene (Lander and Schork, 1994). 
1.8.3.1 Power to Detect Linkage 
The power of sib-pair methods to detect linkage to a disease-susceptibility 
locus for a given sample size, depends only on the risk ratio As (ie. increase in risk to 
siblings compared with the population prevalence) and on no other genetic model 
parameters (such as number of alleles at a given locus, gene frequencies and 
penetrance; Risch, 1990b). In autism, the increase in risk to siblings is equal to an 
overall lambda (As) value of 50-200. This lambda value (As) is an overall risk ratio 
that summarises the collective effect of all the disease loci. The higher the As value, 
the stronger the genetic effect. A locus with a small genetic influence on the disease 
corresponds to a As < 2 (ie. it determines <2-10% of the total genetic variance), 
whereas a moderate to large gene effect coincides with a As > 4 (ie. it determines >4-
20% of the total genetic variance). There is a high observed As value for autism, 
suggesting that affected sib-pair analysis may be a powerful approach for mapping 
susceptibility genes in this disorder. However, this still depends on the number of 
genes involved and on their interaction with each other. 
Genes for a specific disease can interact in either a multiplicative or additive 
manner depending on the penetrances of the individual loci (ie. the probability of 
being affected given a certain genotype). The genes responsible for autism are 
generally thought to interact in a multiplicative manner. This means that if there are N 
loci involved, the overall As is the product of the locus-specific risk ratios, ie. As = 
A 1A2A3 . . .  AN-IAN (Risch, 1990b ). Since the locus-specific risk ratios are not known at 
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the beginning of a study, exclusion mapping is generally conducted over a range of 
lambda values. The range used in this study was between 1.5 and 1 0, representing 
weak to strong gene effects. 
The maximum likelihood statistic (MLS) T, is used to detect evidence for 
linkage of a specific marker in a set of affected sib pairs. MLS is analogous to the lod 
score statistic (Z) in that its value is the log 10 of the odds in favour of linkage 
(Morton, 1955). A T value of3.0 corresponds to odds of 1 000: 1 in favour of linkage 
and is considered to provide evidence of linkage. The MLS statistic T can be shown 
mathematically as follows: 
Where N is the number of affected sib-pairs, n0 is the number of sib-pairs that share 0 
marker alleles IBD, N-no is the number that share 1 or 2 marker alleles IBD, and Naso 
denotes the probability that a sib-pair share O alleles at a random locus IBD. 
As evident from the above formula, the power to detect linkage at a given 
value of As is directly proportional to the number of sib-pairs studied. Figure 5 shows 
this relationship diagrammatically. 
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Figure 5: Power to detect linkage at differing lambda values (As), using N affected sib pairs 
and assuming zero recombination and a completely informative marker (From Risch, 1 990b) 
Figure 5 shows that if the relative risk for a locus is 2, a sample size greater than 200 
will be required to detect linkage with 80% power. However if As = 5, a sample size 
of 60 will be sufficient to detect linkage with 80% power. This value represents the 
minimal sample size required, since recombination (8) is assumed to be zero, and the 
marker is assumed to be completely informative (100% polymorphic) . .  With 
increasing 8, the power to detect linkage decreases drastically. A study by Risch 
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( 1 990b ), found that the power to detect linkage using the MLS approach on a sample 
of 3 00 sib-pairs dropped by approximately 50% at a recombination fraction of about 
0. 1 0. However, the effects of recombination can be reduced by using multi-marker 
analysis (Goldgar, 1990; Fulker et al. , 1995; Olson, 1995; Kruglyak and Lander, 
1995). 
1.8.3.2 Multipoint Sib-Pair Analysis 
Multipoint linkage analysis examines several linked loci simultaneously to 
locate disease susceptibility loci. Not only is this method able to detect linkage when 
recombination between the marker and the disease locus is not equal to zero, but it 
can increase the power to detect linkage (Risch, 1990b) and also can be used to 
exclude regions of the genome from linkage to a disease gene (Risch, 1993). 
Multipoint sib-pair analysis also allows for maximal use of marker information when 
assessing linkage, and determines a confidence region likely to contain a susceptibility 
gene. In this method of analysis, a lad score is calculated for each sib-pair at each 
marker locus and at a number of intervals between these markers, under the 
assumption of a specific lambda value. The lod scores at each interval are then added 
up over all sib-pairs, which gives the total lod score. As in the lad score method, a 
lod score of< -2 suggests lack of linkage and a lad score >3 is suggestive oflinkage. 
1.8.3.3 Genes Localised in Complex Disorders Using Multipoint Sib-Pair 
Analysis 
Multipoint sib-pair analysis has been used to localise susceptibility loci for 
some complex disorders. Three examples are insulin-dependent diabetes mellitus 
(IDDM), multiple sclerosis (MS) and ankylosing spondylitis (AS). 
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Insulin-Dependent Diabetes 
Insulin-dependent or type 1 diabetes mellitus (IDDM) is an autoimmune 
disease associated with loss of tolerance to several pancreatic islet cell molecules 
(Krause et al., 1 979). It is a complex disorder determined both genetically and 
environmentally, and frequently occurs in childhood. Mouse model studies have 
shown that this severe form of diabetes is caused by a combination of a major effect at 
the major histocompatability complex (MHC) and at least ten other susceptibility loci 
elsewhere in the genome (Risch et al. , 1993 ;  Podolin et al. , 1998). A genome-wide 
scan of 356 affected sib-pair families from the United Kingdom indicated a similar 
genetic basic for human IDDM. A major gene component was located at the MHC 
locus (IDDMl) and can explain 34% of the familial clustering of the disease (MLS = 
34, As = 2.5) (Davies et al. , 1994 ; Cucca et al. , 1998). Two other loci showed 
evidence of linkage including chromosome 1 0pl3-pl  1 (MLS = 4.7, As = 1.56) and 
chromosome l 6q22- 16q24 (MLS = 3 .4, As = 1.6) (Mein et al. , 1998). The 
programme used to calculate the multipoint MLS values and the information content 
and exclusion maps was MAPMAKER/SIBS. 
Multiple Sclerosis 
Multiple sclerosis (MS) is a chronic neurological disorder which presents with 
progressive sensory or motor dysfunction that can ultimately lead to disability and 
death (Cumings et al. , 1 965). Strong evidence indicates that MS is a complex 
autoimmune disorder, with its definition based solely on clinical criteria and its mode 
of inheritance non-Mendelian. Genetic influence in the disorder has been shown 
through population and twin studies, with a 20-fold increase in risk for first degree 
relatives over the general population (Sadovnick et al. , 1 988), and MZ concordance 
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rates of 25-30% compared to 4% for DZ twins and siblings (Ebers et al. , 1986; 
Mumford et al. , 1994). A genome-wide search using 257 microsatellite markers in 
100 Canadian sib-pairs showed evidence oflinkage at chromosome 5p (D5S406) with 
a maximum multipoint lod score of 3.1 (maximum pointwise lod score = 4.24). This 
value increased to 3.6 with the addition of 44 extra sib-pairs, but diminished to 1.6 
when an extra 78 sib-pairs were analysed. It was suggested that there was significant 
heterogeneity in the third data set compared to the first two, and evidence for a 
susceptibility locus in that region of chromosome 5p could not be considered 
confirmed (Ebers et al. , 1996). 
Ankylosing Spondylitis 
Ankylosing spondylitis (AS) or spondylarthritis is a common inflammatory 
condition that is strongly associated with the filA region (Brown et al. , 1998). The 
reduction in recurrence risk among increasingly distant relatives of AS patients 
suggested that the genetic component of AS involved multiple interacting genes 
(Lawrence, 1977). A genome-wide linkage screen was undertaken using 254 
microsatellite markers in 121 affected sibling pairs with AS from Britain. Multipoint 
analysis using the programme GeneHunter showed significant linkage to the MHC 
region (MLS (D6S273) = 3. 8 ;  MLS (82-2) = 8.1) , and suggested that 31 % of the 
susceptibility to AS is coded by genes linked to this region. A MLS of 2.6 was also 
obtained on chromosome 16 at the locus D l 6S422, suggesting that non-MHC genes 
may also influence susceptibility to the disease (Brown et al. , 1998). 
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1.8.4 Association Analysis 
Association studies can be used in conjunction with linkage analysis to assist in 
the detection of disease-susceptibility genes. This is particularly the case for genetic 
effects too weak to be identified by current methods of linkage analysis (Risch and 
Merikangas, 1996). Association studies examine the difference in frequencies of a 
marker allele between patients and controls. An association will be detected if the 
marker investigated is a susceptibility gene, or if it is in linkage disequilibrium (LD) 
with the susceptibility gene locus. 
Linkage disequilibrium is a term used to describe a situation in which an 
arrangement of alleles at different loci on the same chromosome ( the haplotype) 
occurs at a frequency greater than would be expected by chance. This can be caused 
by a variety of factors including: (I ) recent admixture of populations with different 
allele frequencies, (2) selection in favour of a specific allele (which increases the 
frequency of haplotypes containing this allele), and (3) genetic drift or population 
bottlenecks and new mutation ( creates disequilibrium with closely linked markers) 
(Weeks and Lathrop, 1995). Since LD decreases with time in proportion to the 
recombination fraction between the loci, disequilibrium between closely linked loci 
will decay less rapidly. If these linked loci in LD are in the vicinity of a gene, this may 
lead to the identification of a disease-susceptibility gene in the affected individuals. 
Using LD to map disease loci is more efficient in genetically isolated 
populations. This is because there is a greater chance that there is only one ancestral 
haplotype 01' which the disease mutation arose and, if the population is relatively 
young, LD could extend over substantial distances increasing the probability of 
detection. An example of an isolated population is the Finnish population which is 
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believed to have settled in the region over I ,  OOO years ago, with little immigration 
until at least the middle of the 14th century (Virtaranta-Knowles et al. , 199 1  ). 
A significant problem with association studies, however, is that the results are 
highly sensitive to mis-specification of allele frequencies in the study population. This 
can be due to recent admixture of different populations (with each sub-population 
contributing different allele frequencies) (Knowler et al. , 1988), or to inappropriate 
matching of patients and controls. The haplotype-relative-risk (HRR) approach 
overcomes this problem by constructing an "artificial" control population from the set 
of alleles that were not transmitted to affected offspring from their parents (Falk and 
Rubinstein, 1987). The estimation of allele frequencies in this case is only conditional 
on the transmitted versus non-transmitted alleles. A similar analysis is termed the 
transmission-disequilibrium-test (TDT) (Spielman et al. , 1993). This method 
compares the observed transmission of an allele of interest from heterozygous parents 
with the expected rate of transmission (ie. 50%). The additional cost of typing more 
individuals in these methods compared to traditional association analysis is well 
justified, since population stratification problems leading to false positive results are 
overcome. These family-based association methods have been used to detect disease 
genes (Thomson, 1995), and since they do not require any additional genotyping to 
sib-pair linkage analysis, the two methods can be used in parallel to assist in the 
detection of disease susceptibility loci. To ensure, however, that LD is independent of 
any linkage present when multiple sibs from the same family are tested, a Monte Carlo 
simulation is used (see Risch et al. , 1 999; Appendix 6.3). 
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1.8.5 Linkage and Association Studies in Autism 
Due to the sufficiently large familial relative risks and the data mentioned 
above supporting autism as a genetic disorder, mapping studies can be undertaken to 
identify the genetic loci that contribute to the disorder (Bristol et al. , 1996). To date 
there have been only three systematic genome scans in autism research and the 
number of association studies in this disorder has been relatively limited. The results 
from these molecular genetic studies are outlined below, in order of the area of the 
genome they covered and the year in which they were completed. 
1.8.5.1 HLA and 19 Autosomal Markers (Spence et al. , 1985) 
The first linkage study in autism was accomplished by Spence et al. ( 1985). 
They studied 34 multiplex families (two or more autistic children) from the UCLA 
Registry for Genetic Studies of Autism, for linkage to the HLA region ( chromosome 
6) and 19 other autosomal markers. No evidence oflinkage was obtained between 
the disease and the HLA region using the lod score method. When an association test 
was performed by comparing the number of shared HLA haplotypes in autistic 
siblings to what would be expected by chance, a significant result was still not found. 
The largest lod score calculated from these 34 families was 1.04 for haptoglobin, a 
marker whose gene lies on chromosome 1 6. When the families were divided into two 
groups, ie. families with only affected males and families with at least one affected 
female, a marker suggestive of linkage was identified in the second group of families. 
This marker was linked to the ABO blood group locus on chromosome 9 and the 
calculated lod score was 1.54. 
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1.8.5.2 HLA (Warren et al. , 1991/1992/1996a; Daniels et al., 1995) 
Investigators have reported associations between alleles of the HLA complex 
and autism when compared to normal controls. These autism-associated alleles include 
the null allele of the C4 B gene (Warren et al. , 1991 ), the extended haplotype B44-S3 O­
DR4 (Warren et al. , 1992; Daniels et al. , 1995), the third hypervariable region of HLA­
DRB 1 (Warren et al. , 1996a) and two alleles of the DR beta 1 gene (Warren et al. , 
1996b ). The third hypervariable region of HLA-DRB 1 has shown the strongest 
association with autism. Warren et al. (1996a) calculated that the relative risk of 
developing the disorder if you have this marker was 19. 8 for allele 1 of this marker and 
4 .2  for allele 3. This region is essential for the presentation of peptides to T 
lymphocytes by antigen-presenting cells (APC), and is therefore necessary for the 
development of cell-mediated and antibody immune responses to pathogens and other 
foreign antigens (Warren et al. , 1996b ). 
1.8.5.3 Chromosome 15 (Gillberg et al. , 1991b; etc.) 
A number of case studies have reported the association of autism with partial 
trisomy / tetrasomy and duplication of chromosome 15 (see section 1.5.1.2). Hotopf 
and Bolton ( 1995) offered a number of explanations for these finding, hypothesising 
that autism has a heterogeneous genetic basis or, alternatively, that autism may have a 
consistent genetic basis in an aberration of chromosome 15. 
1.8.5.4 Fragile X (Hallmayer et al. , 1994) 
The association of the Fragile X syndrome (FraX) with autism is well known 
(see section 1. 5 . 1. 2). The gene responsible for FraX is FMR-1 (Oberle et al. , 1991; 
Verkerk et al. , 1991) and the syndrome is usually caused by an amplification of the 
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CGG trinucleotide repeat region of this gene (Rousseau et al. , 1991). Hallmayer et 
al. (1994) examined the possibility that a mutation elsewhere in the FMR-1 gene was 
involved in the aetiology of autism. This was achieved by carrying out linkage 
analysis on 3 5 multiplex families using microsatellite markers that were tightly linked 
to the FMR-1 gene (DXS548, FRAXAl ,  FRAXA2, CGG repeat). Using four 
different dominant models of varying penetrance values and a recessive model, linkage 
to the FMR-1 gene was excluded (lod score between -24 and -62) in all models. 
1.8.5.5 X-Chromosome (Hallmayer et al. , 1996) 
Due to the increased ratio of autistic males to females, even in multiplex 
families (see section 1. 4.3), a search for an autism susceptibility gene on the X­
chromosome has been conducted. This was the first reported application of the sib­
pair approach to the search for genetic influences in this disorder. Thirty-eight 
multiplex families were tested for linkage to 3 5 micro satellite markers using 
multipoint sib-pair analysis, and linkage to the entire X-chromosome could be 
excluded for As = 4. A maximum lod score of 1.24 was obtained between DXS424 
and DXS1001 for a As = 1.5. Another lower peak (0.93) was observed at DXSYXl .  
Overall, a moderate to major gene effect for autism was excluded on the X­
chromosome. A susceptibility gene increasing the sibling risk between 1.5 to 3 fold 
could, however, not be excluded, in particular a gene of small effect located between 
DXS424 and DXS1001 (Hallmayer et al. , 1996). 
1.8.5.6 X-Chromosome (Petit et al. , 1996) 
An association study was completed on 90 autistic children from a Child 
Psychiatry Day Care Unit in France and unrelated controls. Eight markers on the X-
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chromosome were tested using x2 analysis. DXS287 was the only marker that 
showed a different allele distribution between control and patient groups. This 
difference was enhanced in the more severely autistic and least retarded children. 
Investigators noted that if this locus on the X-chromosome is specific for autism, the 
result would have to be replicated on another group of autistic children, as well as a 
non-retarded autistic population. Also, the accuracy of the result could be increased if 
the parents were typed and the haplotype relative risk method (HRR) was employed. 
1.8.5. 7 Harvey-Ras Factors (Berault et al. , 1995) 
Herault et al. (1995) compared five polymorphic markers in a sample of 50 
autistic children and 50 controls, and found that the HRAS marker B3/B3 
homozygous genotype was significantly less frequent in autistic children than in 
controls. The HRAS gene (chromosome 1 l p l5.5) codes for the ras protein, which is 
active in neuron development, and the researchers hypothesise that it may be the basis 
of autism. However, this has been only a "preliminary study and a further study with 
a larger population and a wider IQ distribution must be performed". 
1.8.5.8 Serotonin (Cook et al. , 1997b) 
Since serotonin transporter inhibitors have been shown to be partially efficient 
in the treatment of autistic symptoms such as restricted and repetitive behaviours, 
language use and aggression (Gordon et al. , 1993; McDougle et al. , 1996), Cook et 
al. ( 1997b) considered the serotonin transporter (HTT) as a candidate gene in autism. 
They examined possible linkage and linkage disequilibrium between two 
polymorphisms reported for the serotonin transporter gene (a VNTR in the second 
intron ofHTT and a short variant of the HTT promoter) with autism, using the TDT 
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test. TDT analysis of 86 US families showed no evidence for linkage or linkage 
disequilibrium between autism and the VNTR, however, preferential transmission of 
the short variant of the HTT promoter was found (TDT x2 = 4.69, 1 d.f. , P = 0 .0 30 )  
(Cook et al. , 1 998). It should also be noted that another haplotype at HTT was found 
to be preferentially transmitted in a sample of German subjects with autistic disorder 
(Klauck et al. , 1997). These results need clarification by further studies with different 
populations and larger groups of autistic individuals. 
1.8.5.9 Whole Genome Scan (International Molecular Genetic Study of Autism 
Consortium, 1998) 
A two-stage genome search for susceptibility loci in autism was performed by 
the International Molecular Genetic Study of Autism Consortium (IMGSAC; 1998). 
They used 99 affected relative pairs, which included 87 affected sib-pairs and 1 2  
affected non-sib relative pairs. Fifty-six of the sib-pair families were from the United 
Kingdom (UK). A least one individual in each pair had a clinical diagnosis of autism, 
satisfying the ADI criteria (see section 2.1.2)  for autism and showing abnormalities 
before the age of 3 years. The other individual had to have either a clinical diagnosis . 
of Asperger syndrome, Pervasive Developmental Disorder (PDD), autism 
unaccompanied by language delay, or had one of these clinical diagnoses but fell 1 
point below the threshold on one of the behavioural domains of the ADI algorithm 
(IMGSAC, 1998). 
In stage one of the genome screen, 3 54 micro satellite markers were typed in 
39 families. Using ASPEX (for the sib-pair families; Hinds and Risch, 1 996) and 
GeneHunter (for the relative-pair families; Kruglyak et al. , 1996), pairwise and 
multipoint MLS were calculated. Sixty-two markers had an MLS > 0 .5. In stage 
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two, 60 additional families were genotyped using a subset of 175 markers that 
focused on the regions of interest identified in stage 1. Based on all 87 sib-pair 
families, approximately 32% of the genome was excluded for 'As = 2.5, which included 
the entire X-chromosome. In these sib-pair families, regions on six chromosomes ( 4, 
7, 10, 16, 19 and 22) were identified that had lod scores (MLS) > 1. The most 
significant result was found on chromosome 7q between the markers D7S530 and 
D7S684, with a MLS of3.55 in the subset of UK families and an MLS of 2.53 in all 
families. The next most significant result was near the telomere on chromosome 16p, 
with an MLS of 1. 97 in the UK families and 1. 51 in all families. Linkage 
disequilibrium was tested for 13 markers in the regions of interest on chromosome 7 
and 16. This was achieved using the transmission disequilibrium test (TDT), as 
implemented in the ASPEX programme. There was no evidence of linkage 
disequilibrium in either of these regions. The investigators explained that the large 
distance between these markers (5-10 cM) could have affected these results. 
1.8.5.10 Whole Genome Scan (Bass et al. , 1998) 
A genome screen has also been completed by Bass et al. (1998) and reported 
at The American Society of Human Genetics 481h Annual Meeting in Denver, 
Colorado in 1998. They reported analysing 49 affected sib-pairs and 3 affected 
cousin pairs using 430 markers that were around 7cM apart. Results from this 
analysis identified a number of regions with a p-value < 0. 05 or a MLS ;?:: 1, including 
sections on chromosomes 1, 2, 3, 7, 18 and 20. The exact chromosomal location of 
these findings was not explained in this report. 
77 
1.8.5.11 Whole Genome Scan (Philippe et al. , 1999) 
The third published genome-wide screen for autism susceptibility loci was 
performed with 264 microsatellite markers in 51 multiplex families, using non­
parametric linkage analysis. Families with at least two siblings fulfilling the DSM-IV 
criteria for autistic disorder and the ADI algorithm for ICD-10 childhood autism were 
recruited from Sweden, France, Norway, USA, Italy, Austria and Belgium. Using 
two-point and multipoint affected sib-pair analysis they revealed 11 chromosomal 
regions with a maximum lod score (MLS) greater than 0.6 (P<0.05). Four of these 
regions overlapped with regions on chromosomes 2q, 7 q, 16p and 19p identified in 
the IMGSAC genome scan. Another overlapped with the 15q 11-q 13 region identified 
in previous candidate gene studies. The remaining six regions were on chromosomes 
4q, 5p, 6q, 1 Oq, 18q and Xp. The most significant result overall was obtained for a 
region close to marker D6S283 (MLS=2.23), however this result was not statistically 
significant for linkage (MLS>3). 
1.9 Conclusion 
In summary, autism is described as a chronic developmental disorder 
characterised by behavioral, communication and social abnormalities that manifest in 
the first years of life. While the aetiology of autism is unknown, there is general 
agreement that it results from early neurodevelopmental dysfunction. 
Family studies demonstrate that the prevalence for autism among siblings of 
autistic children vary between 2% and 9% (Jorde et al. , 1991 ). Since the prevalence 
of autism in the general population is about 4-5 in I 0, OOO births, the recurrence risk 
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for autism among siblings is 50-200 times greater than in the general population 
(Bolton et al. , 1994). 
Studies have also reported an association with autism of a number of other 
genetic conditions. These include: fragile X syndrome; chromosome 15 anomalies; 
tuberose sclerosis; and phenylketonuria, just to name a few. These associations 
though, are not sufficient to explain the strong familial clustering of autism. 
It has been suggested that the increase in prevalence of autism in families is 
due to genetic factors and a number of twin studies have supported this theory. These 
studies estimate that the concordance rate in monozygotic twins is approximately 
77%, while the concordance rate reported for dizygotic twins is about 0% (Folstein 
and Rutter, 1977; Ritvo et al. , 1985; Steffenburg et al. , 1989; Bailey et al. , 1995). 
The dizygotic concordance rate is not significantly different from the approximate 
sibling recurrence rate of 3%. 
This evidence of a genetic component in the aetiology of autism allows 
molecular genetic strategies to be used to determine the biological basis of autism. 
Since autism is most likely a complex disorder involving several interacting genes of 
unknown mode of inheritance, non-parametric linkage analysis utilising the multipoint 
sib-pair approach is, at present, one of the best methods for identifying susceptibility 
loci in this disorder. This method detects how frequently two affected sibs share the 
same chromosomal region identical-by-descent (IBD). Sib-pair analysis is very useful 
in studying autism because it is independent of both the affection status of parents and 
the mode of inheritance. The power of sib-pair method to detect linkage depends on 
the risk ratio 1,  The risk ratio As is the increase in the risk of the disorder in sibs of 
an affected individual, compared with the general population prevalence. 
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Assumptions about genetic model parameters, such as number of alleles at a 
given locus, gene frequencies, and penetrances are not required in sib-pair analysis 
(Risch, 1 990b ). In the case of autism, the overall As (increase in risk to siblings) is 
approximately 50-200. Due to the high As value in autism, affected sib-pair analysis 
may be a powerful tool for mapping susceptibility genes in this disorder, depending on 
how many individual genes determine the total value of As. 
1.10 Rationale of the Study 
In this study, multipoint sib-pair analysis was employed to identify 
susceptibility genes involved in the aetiology of autism. From our simulations we 
concluded that at least 3 loci are involved in the disorder and, assuming As = 75, the 
study has the power to detect up to 5 loci of equal effect on autism using this method 
of analysis (section 1. 7). 
From additional computer simulations (see Table 5), we showed that it is 
plausible to expect that we can identify any loci (MLS>3) with As � 3 ,  using a 
microsatellite map consisting of markers spaced approximately 1 OcM apart and at 
least 1 00 multiplex families. If 200 families are used in the genome scan, 
susceptibility loci with As � 2 should be detectable using the sib-pair method. 
Also, to ensure a more reliable diagnosis of autism and a smaller chance of 
obtaining false positive and negative results, we only used individuals diagnosed with 
the "core" syndrome of autism (ie. no individuals with Asperger syndrome or 
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pervasive developmental disorder-not otherwise specified, were included). This 
homogeneous set of families should enhance our chances of detecting linkage. 
1.11 Research Aims and Significance 
The objective of the study is to search for DNA markers linked to autism in a 
large sample of clinically well-characterised families. In the longer term, such markers 
will allow the identification of a gene or genes that are responsible for familial forms 
of autism. 
1.11.1 Specific Aims 
This linkage study on autism is a large-scale project that began in 1992 and is 
run in collaboration with universities in Australia and the United States of America. 
This PhD project addresses certain goals set out in the overall study design. The goal 
of the large-scale project is to complete the ascertainment and collection of samples in 
180 families, create an exclusion map of the entire genome based on these families, 
identify regions not excluded and investigate them in greater detail by saturating them 
with markers. More specifically the aims of the large-scale project are: 
I. Recruit and evaluate approximately 140 U.S.A. and 40 Australian 
families with at least two autistic sibs, using strict diagnostic criteria. 
A research diagnosis is made using the Autism Diagnostic Interview 
(ADI) and with the Autism Diagnosis Observation Schedule (ADOS). 
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Only those children satisfying the pre-specified cut-off scores in all 
three-symptom areas of the ADI and with an age-of-onset prior to 
three years are considered affected for the purposes of the project. 
II. Immortalise cell lines from the affected sibs and their parents in these 
180 families. For families with one parent missing, unaffected sibs are 
included, as available, to increase genetic information. 
III. Genotype at least 350 highly polymorphic (PIC > 0.70) microsatellite 
loci at approximately 10 cM intervals in 90 sib-pair families, including 
affected sibs and parents, and unaffected sibs when a parent is missing. 
IV. Construct an exclusion map using multipoint sib-pair analysis assuming 
As values between 1. 5 and 10 for the 90 families of the initial screen. 
Through this, regions that cannot be excluded will be identified. 
V. For those regions not excluded in (IV), the remaining 50 U.S.A. and 
40 Australian families will be genotyped. Additional microsatellite 
markers in these regions will be identified and all previously recruited 
families will be genotyped with these markers. Thus, the regions not 
initially excluded will be either excluded or confirmed as candidate 
regions containing autism susceptibility gene( s). Confidence intervals 
for any susceptibility loci identified will be constructed. 
VI. Candidate regions for susceptibility genes will be saturated with 
microsatellites. The confidence regions will be further narrowed using 
multipoint linkage analysis. Final candidate regions will be examined 
for linkage disequilibrium with these markers using the transmission 
disequilibrium test with the 180 sib-pairs and their parents. 
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The aims specific to the present PhD project are divided into two parts 
depending on the families analysed: 
A. U.S.A. Families 
I. Isolation of DNA from cell-lines of some of the 90 U.S.A. multiplex 
families. 
II. A systematic scan of chromosomes 19-22, as part of the first stage 
screening on 90 multiplex families from the U.S.A. 
III. Refined study of candidate regions identified previously, such as the 
HLA region on chromosome 6 and the long arm of chromosome 15. 
IV. Construction of exclusion maps. 
V. Replication of the data obtained by us and the Stanford group, of 
regions showing positive lod scores ( chromosome 1, 10, 15, 17 and 
18). 
B. Australian Families 
I. Establishment of immortalised cell lines for some of the 40 Australian 
families with 2 or more children diagnosed with autism and extraction 
of DNA from whole blood and white blood cell (WBC). 
II. Duplication of positive findings (lod score > 1) that were obtained in 
the initial genome scan on the U.S.A. families and replicated by the 
Perth group (see part V. above). 
III. Duplication of the analysis of chromosomal regions showing positive 
. lod scores in other studies, eg. chromosome 7q (IMGSAC, 1998), 
using the Australian group of families. 
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1.11.2 Significance 
The identification of genes responsible for autism may lead to an accurate and 
reliable biological marker being discovered. Since autism cannot be diagnosed 
confidently before the age of 4 - 5 years with current techniques, a biological marker 
could help identify children at risk for autism at a younger age if it was used in high­
risk families. This would help in treatment and/or intervention strategies, which are 
most effective with early diagnosis and intervention. 
A marker would also help in the determination of the boundaries of the autistic 
phenotype. At present there is much debate as to whether siblings of autistic children 
who have communication or cognitive disabilities suffer from a mild form of autism, 
and if these are part of an autistic spectrum. 
Thirdly, genetic research will provide essential information about the 
regulation of brain development. This will allow the development of a more effective 
treatment for autism and its spectrum disorders. 
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CHAPTER 2 
SUBJECTS AND METHODS 
2.1 Clinical Methods 
2.1.1 Ascertainment of Families 
Families from the U.S.A. were recruited nationwide by advertisement 
targeted at local and national parent support groups and referrals from clinicians. 
The Australian families were recruited through peak agencies, clinic/assessment 
centres/hospitals, private agencies/self help or parent groups, special needs schools 
and prior autism research teams. Once families were identified, they were contacted 
via "mail-outs" by the above mentioned organisations. These "mail-outs" included 
information on the research project and asked whether or not they would like to 
participate in the study. 
Families willing to partake were asked to contact the research group and a 
preliminary screen was performed over the telephone to indicate whether or not the 
specific family was suitable for the study. If this telephone-screen indicated that a 
family may be suitable, the aims of the project were explained and they were asked 
to sign a consent form allowing the clinicians on the project to view all participating 
family members clinical records. If these records verified that a family had a 
minimum of two children with a preliminary diagnosis of autism, they were 
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investigated further using standardised diagnostic procedures (see below; Le Couteur 
et al., 1989b; Lord et al., 1994 ; Lord et al., 1989). 
2.1.2 Diagnosis 
Uniform, reliable and well-documented diagnostic tools are important to 
allow legitimate comparisons between studies. For this study, two standardised 
instruments were used for gathering the diagnostic information: the Autism 
Diagnostic Interview (ADI; Le Couteur et al., 1989b and Lord et al., 1994)  and the 
Autism Diagnostic Observation Schedule (ADOS; Lord et al., 1989). The ADI is an 
investigator-based interview, which reviews four specific areas relevant to autism: 
social interaction and behaviour, language and communication, interests and daily 
routines and age of onset. It is designed to provide a definition of autism for research 
and can not be used to disprove a clinical diagnosis. The ADOS is a behaviour 
observation instrument, which involves particular tasks that elicit specific behaviours 
in the child over a 20 -45 minute time frame. ADI and ADOS were obtained for all 
children within a family regardless of the clinical history. 
The ADI was used in this research project for the following reasons: 
(I) The interviewer asks the parent or caregiver to elicit certain examples of the 
child's behaviour, social activity etc. These can be used to evaluate particular 
signs of autism and allowed the interviewer to interpret the quality of the 
child's behaviour, rather than relying on the parent's  description. 
(II) The interview has been specifically structured to include questions about all 
the behaviours used to diagnose autism. 
86 
(III) Information on past and present signs and symptoms is collected in a 
systematic way. This is important, since the application of the diagnostic 
criteria requires data only from the year period between the ages of 4 and 5. 
This in turn allowed children who have been evaluated at different ages to be 
compared on a common scale. 
(IV) The ADI includes all the information on the individual needed to apply the 
ICD-1 0  criteria. 
(V) Both the ADI and the ADOS were videotaped, allowing other diagnosticians 
to independently verify each assessment. This permitted ongoing quality 
control of diagnosis. 
A recent study on the reliability of administering and scoring AD Is between 
two diagnostic groups has shown a good interrater reliability, with a kappa 
coefficient for autistic verses non-autistic groups of 0. 90 (Spiker et al. , 1994). Also, 
research by Lord et al. ( 1 994) and Fombonne ( 1992) has indicated that the ADI has 
good reliability and validity for diagnosing autism and distinguishing this diagnosis 
from mental retardation. 
Certified interviewers, who had completed the ADI training course given by 
Catherine Lord and Michael Rutter, conducted the ADI and ADOS evaluations. 
Donna Spiker, PhD, Linda Lotspeich, MD, and Patty McCague evaluated the 
majority of the U.S.A. families, whereas Amelia Nikolova, Wayne Hill, Robyn 
Young and Patty McCague interviewed the Australian families. To achieve the 
greatest possible blindness of evaluators, different interviewers were used for each 
child in a family whenever possible. Also, to check the reliability of the ADI 
administration and scoring, all interviews were videotaped and some randomly 
selected and independently scored by a second blinded, trained diagnostician. 
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An autistic individual was defined as one that had scores above the pre­
specified cut-off points in the four areas in the I CD- 1 0  system (ie. social impairment; 
language and communication impairment; unusual and restricted interests and 
routines; age of onset prior to three years) . Multiplex families with at least one 
parent and two or more siblings who met full ADI definitions of autism were 
required in this study. Children were classified as unaffected if their scores were 
below the cut-off points in all four areas. Children falling into the ambiguous or 
uncertain diagnostic category (ie. with scores above the cut-off point in one, two, or 
three areas) were excluded from the linkage analysis, even though they met clinical 
definitions of syndromes related to autism ( eg. pervasive developmental disorder). 
The unaffected and uncertain children were only used to reconstruct parental 
genotypes if parents were missing from the pedigree, and to check the accuracy of 
the data. Since there were no reliable diagnostic criteria for diagnosing autism in 
adults, the affection status of all parents Wil.S considered unknown. This conservative 
strategy tried to minimise the misclassification errors that have proved to be a major 
obstacle in psychiatric genetics. The ADI area scores for children in the first 37 
multiplex families collected are shown in Table 6. 
2.1.3 Intelligence Test Scores 
Intelligence test scores (IQ) and mental age data were obtained from existing 
school or clinical records for the U.S.A. affected children. When available, 
nonverbal IQ scores were obtained from the performance subtests of the Wechsler 
Scales or Stanford-Binet Intelligence - 4th Edition, or the full Leiter International 
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Table 6 :  ADI Area Scores for Children in Autism Multiplex Sibling Families 
(N = 37 Families, 1 1 7  Children)* 
Autistic (N = 83) Not Autistic (N = 26) Uncertain (N = 8) 
(In 37 families) (In 22 families) (In 6 families) 
Social total 
Range 1 7-44 0-9 0- 14  
Median 3 6  1 . 5 
Language total (V)3 
No. of children 5 8  26 8 
Range 1 1 -29 0-8 0-7 
Median 2 1  0 .5 0 
Language total (NV)" 
No. of children 25 0 0 
Range 9- 1 6  
Median 1 5  
Ritual total 
Range 3 - 12  0-2 0-4 
Median 8 0 1 . 5 
Onset present?< 
N (% Yes) 83 ( 1 00) 0 (0) 6 (75) 
* Social cut-off point = 1 2, range = 0-42; language cutpoint = 10 for verbal subjects, 
range = 0-30, and cut-off point for nonverbal subjects is 8, range = 0- 16 ;  rituals cutpoint = 3, 
range = 0- 12 .  
•v = verbal: having phrase speech by age 5 years. 
hNV = non-verbal: not having phrase speech by age 5 years . 
cMeets onset criteria; developmental delays or deviance < 3 years 
Performance Scale or Merrill-Palmer Scale. When these scores were unavailable, 
scores from such tests as the Stanford-Binet Intelligence Scale - 3
rd Edition, Slossen 
Intelligence Scale, or McCarthy Scales were used. For a small number of children, 
mental age estimates and ratio IQ scores were based on nonverbal scores from 
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various developmental inventories (eg. Daily Living Domain of the Vineland 
Adaptive Behavior Scale, the full Bayley Scales, or Developmental Profile II). 
If both individuals in the affected sib-pair had a mental age (MA) less than 1 8  
months and/or a nonverbal IQ below 3 0, families were removed from the study 
because of the difficulties in diagnosing individuals in this group. 
In the Australian families, affected individuals were classified under different 
categories of mental retardation as outlined in ICD- 1 0  (World Health Organisation, 
1993). Those individuals classified as mildly mentally retarded generally displayed 
delay in motor skills and had reasonable school achievement but still required 
support. Moderately mentally retarded children had difficulties in understanding 
instructions and displayed academic problems. Severely mentally retarded autistic 
children generally exhibited a lack of speech with no participation in the ADOS, 
whereas profoundly mentally retarded individuals displayed the same characteristics 
as those with severe mental retardation but with passiveness. 
2.1.4 Ethical Considerations 
This study has met the requirements of the Ethics Committees at Edith 
Cowan University, WA; Graylands Hospital, WA; The University of Western 
Australia; and Stanford University, U.S.A. Protocols and justification for the use of 
human subjects were renewed annually through the Human Subjects Committee at 
Stanford University. The subjects used in this project were from families in which 
there were two or more siblings with autism. Families were identified as"potentially 
eligible based on diagnostic information provided by the parents. There were no 
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gender or ethnic restrictions on recruitment. The research staff who interviewed the 
parents about their children and videotaped a structured behaviour observation of 
each child collected the relevant information required for diagnosis. Additional 
records (medical and diagnostic evaluations) were collected from the parents or from 
appropriate medical or educational personnel, after the parent(s) signed a "release of 
information form". To ensure confidentiality, all data were coded and stored in the 
computer by subject number; records containing names were stored in securely 
locked cabinets, available only to trained project staff Project personnel could 
access computerised data with a password only. All staff on the project had been 
given specific training about issues of confidentiality in clinical research. 
2.2 Clinical Characteristics of Autism Multiplex Families 
2.2.1 U .S.A. Families 
A total of 98 affected sib-pairs from the sub-group of 90 US.A. families were 
analysed in the first part of the study. These families encompassed a total of 1 87 
affected children, 3 0  unaffected sibs, and 1 57 parents. The affected siblings in these 
families ranged in age at the time of the ADI administration from 2.9 to 4 0.9 years 
(mean = 9.8 yrs, S.D. = 7.3, median = 7.3 ,  25th - 75th percentiles = 4.9 - 1 1.3 years). 
The male to female ratio for this sub-group was 3. 6 :  1 for the affected individuals and 
0. 8 :  1 for the unaffected individuals. Of these 90 families; two have four affected 
children, three families have three and 85 families have two affected children. For 
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families with n affected children, where n was greater than 2 ,  n- 1 sib-pairs were 
formed by matching the first child in the pedigree with each of the subsequent 
children; these pairs were fully independent. Both parents were available for 
analysis in 67 families. In those families were one parent was absent, unaffected 
siblings were included when possible (8 families) to reconstruct missing parental 
genotypes for identity-by-descent (IBD) tallies. 
The mean nonverbal IQ was 66 (S.D. = 28, range = 1 6- 1 60) for the affected 
children in this group of 90 US.A. autistic families. One hundred and eight children 
(56%) had scores below 70 in this same group of families, and were classified as 
mentally retarded. The mean mental age was 68 months (sd = 55 months, range = 
13-373 months). All families had at least one affected sibling with an IQ above 30  
and a mental age greater than 1 8  months. 
The second set ofU.S.A. families used to conduct genotyping studies of 
regions not excluded by the first 90 families, consisted of 49 multiplex families that 
were ascertained in a manner similar to the first set. These families were not used as 
part of this PhD project. For more information on these families refer to Risch et al 
( 1999). 
2.2.2 Australian Families 
Forty-one Australian families were recruited for analysis. These families 
consisted of a total of 86 affected children, and 73 parents. Thirty-seven of these 
families had two affected children and four families had three affected siblings. Both 
parents were available for analysis in 32 families. The ratio of males to females in 
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the affected individuals was 3. 0: 1. When the AD I was administered to the affected 
siblings in these families they ranged in age from 3 to 46 years (mean = 12 yrs, S.D. 
= 8, median = 10, 25th - 75th percentiles = 7 - 13 years). 
In this group of 45 ASPs from Australia, the majority of children were 
classified as being either mildly (35%) or moderately (32%) mentally retarded (see 
section 2.1.3). Nine percent of these children with autism were severely mentally 
retarded and 24% were classified as normal. No individuals were classified as 
profoundly mentally retarded and therefore all families were kept in the study. 
2.3 Laboratory Methods 
The laboratory methods used in this PhD project are stated below. Whilst 
some cell lines were established and DNA extracted by myself, the majority were 
prepared by collaborators in Standford University and by co-worker Boyd Salmon at 
the Medical Research Institute in Royal Perth Hospital. I did the majority of 
genotypes, stated as part of this project. 
2.3.1 DNA Isolation 
Blood samples were obtained from all available family members at the time 
of evaluation. Blood was collected by venipuncture, with 20ml obtained from most 
patients. These samples were immediately transported to the laboratory. Cell 
cultures were started upon arrival and transformed with Epstein-Barr virus (EBV) 
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into lymphoblastoid cell lines, providing a renewable source of DNA. Genomic 
DNA was extracted either from whole blood (if an adequate supply had been drawn 
from the individual) and/or from immortalised cell-lines, by using standard 
proteinase K digestion and salting out procedures (Miller et al., 1988). 
2.3.1.1 Cell Lines 
Epstein-Barr virus (EBY) transformed lymphoblast cell lines were 
established using standard procedures (Anderson and Gusella, 1984). B­
lymphocytes were isolated from peripheral blood in cell culture by using EBV to 
immortalise cells. The peripheral blood cells may then be cryogenically stored for 
subsequent DNA extraction. The procedure of Anderson and Gusella (1984) differs 
slightly from the original procedures. The method was greatly improved by the use 
of cyclosporine A, a drug that proved very efficient in preventing the regression of 
newly established lymphoblastoid cell lines (Ventura et al . ,  1988). 
Lymphoblastoid cell lines were established from 10ml of whole blood that 
had been collected in a I 0ml venipuncture vial containing heparin. The first step was 
to isolate the peripheral blood lymphocytes (a class of white blood cells) from the 
whole blood and place these in liquid nitrogen (lqN) for future use. Blood was 
centrifuged at 2000 rpm for 7min, collecting the huffy coat in a Nunc tube under 
sterile conditions using a transfer pipette, cooling on ice, and then adding 
dimethylsulphoxide (DMSO; ACS grade, ICN Biomedicals) at a concentration of 
I 00µ1/ml. The cell lines were established by defrosting the aliquoted huffy coat in 
warm water and adding 7ml of 12% FCS/RPMI  (Fetal Calf Serum / 16.36g/L RPM! 
1640; 2g/L sodium bicarbonate; 20ml/L penicillin / streptomycin; pH 7.2; stored at 
-20°C; Trace Biosciences [see Appendix 6.2 for solution protocol]) in a small 25cm2 
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tissue culture flask. Infection was achieved by mixing cells with O . 1-1 ml of active 
EBV supernatant. The virus activates the enzyme telomerase, preventing the 
telomeres from shortening during each cell replication. This stabilises the telomeres 
and allows the cells to continue to proliferate, making them immortal. Cell lines 
were incubated at 37°C in a 5% C02 atmosphere and fed every third day with 12% 
FCS/RPMl. When a sufficient number of transformed cells (-50-100 million cells) 
were obtained, they were either transferred to a 50ml Falcon tube containing fresh 
culture medium (5ml of 12% FCS/RPMl), aliquoted out into 5 Nunc tubes and 
frozen in lqN with 10% DMSO, or placed in a 50ml Falcon tube containing no 
medium for DNA extraction (see below). 
2.3.1.2 Salting-Out Method of DNA Extraction 
DNA from lymphoblastoid cell lines was isolated and purified using standard 
procedures (Miller et al., 1988). DNA is purified from whole blood or cell 
suspensions following cell membrane lysis and precipitation in the presence of high 
salt concentrations. Subsequent alcohol washes further purify the DNA, making it 
suitable for use in PCR. The salting-out method is simple, rapid and inexpensive and 
provides high, reproducible yields of pure genomic DNA. 
If sufficient blood was drawn from the individual, DNA could also be 
extracted from whole blood. The procedure involved centrifuging approximately 
10ml of whole blood that had been collected in a venipuncture vial with the 
anticoagulant ethylenediaminetetraacetic acid (EDT A), in a 50ml Falcon tube 
containing -40ml of red cell lysis buffer (RCLB: lOmM Tris, pH 7.6; lOmM NaCl; 
5mM ofMgCh; stored at 25°C) at 2000 rpm for 7min. The supernatant was removed 
and the above step repeated 2 to 3 times to remove all red blood cells. The pellet was 
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then incubated overnight at 37°C with 3 0µ1 of proteinase K (20mg/ml of dH20, 
stored at -20°C; Prokay™ : Biotech Laboratories), 2ml of red cell lysis buffer 
(RCLB: lOmM Tris, pH 7.6; lOmM NaCl; 5mM of MgCh; stored at 25°C) and 13ml 
of white cell lysis buffer (WCLB: lOmM Tris-HCl, pH 7.6; I OmM EDTA, di­
Sodium salt; 50mM NaCl; 0.2% SDS; stored at 25°C). If cell lines were used the 
DNA isolation procedure began at this incubation step, without the addition of 
RCLB. On the next day, 7ml of 6M NaCl was added to the proteinase K mixture 
with vigorous mixing and centrifuged at 5000 rpm for 45min. The DNA was then 
precipitated out of the resulting supernatant with an equal volume of cold 
isopropanol (AR grade, stored at -20°C) and placed in a 1 .5ml microcentrifuge tube 
using a transfer pipette. The DNA was washed once with 70% ethanol (AR grade, 
stored at -20°C) and then again with 1 00% ethanol (AR grade, stored at -20°C). The 
DNA pellet was dried, then resuspended in 1 ml of sterile water and incubated 
overnight at 37°C to dissolve the DNA. 
2.3. 1 .3 Measurement of DNA Concentration 
The optical density (OD) of the DNA solution was measured at 260nm and 
280nm using a DUR 640 Spectrophotometer (Beckman), which was blanked at both 
wavelengths using distilled water. A 260/280 ratio greater than 1.5 indicated the 
presence of relatively pure DNA. Readings at 260nm allowed the calculation of the 
concentration of the nucleic acid in the sample, since an OD of 1 corresponds to 
approximately 50µg/ml of double-stranded DNA (Sambrook et al., 1989). Using 
these calculated concentration values, DNA was diluted to 5ng/µl using dH20 and 
this "working" DNA solution was stored at 4°C. DNA samples were labelled with 
the family ID number, the individuals' sample numbers and the concentration of the 
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sample. The original "stock" DNA solutions were aliquoted into 3 separate Nunc 
tubes and stored at -20
°C. 
2.3.1.4 Evaluation of DNA Samples 
Agarose gel electrophoresis was used to evaluate the quality of the DNA by 
viewing the amount of shearing present in the sample. Pure DNA should show a 
discrete single band without smearing (see Figure 6). Preparation and examination 
of agarose gels were carried out according to Sambrook et al. ( 1989). In brief, a 
0.8% agarose gel (4g of agarose powder [Promega] in 500ml of l xTAE buffer 
[0.04M Tris-acetate; 0.001M EDTA], with 0.05µ1/ml of ethidium bromide [Sigma 
Molecular Biology]) was poured onto an 80ml mini-gel tray, small toothed combs 
were inserted at the top and middle of the gel, and the gel allowed to set for 
approximately 40 minutes ( due precautions were taken at all times in regard to the 
chemical hazard generated by ethidium bromide). The combs were removed and the 
gel placed in a mini-sub electrophoresis tank (BIORAD) with l xTAE buffer. The 
sample consisting of 1 Oµl of 5ng/µl DNA and 1 µl of 6 x Fi coll loading buffer 
(0.25% bromophenol blue; 0.25% xylene cyanol FF; 15% Ficoll [Type 400; 
Pharmacia] in water) was in tum loaded on to the gel. DNA samples of known 
concentrations and a Lamba size control (APstl 9: 0.5µg/µl, HpaII cut [Fisher 
Biotec]) were also loaded as standards. The gel was run at a constant 50 Volts for 1 
hour, then viewed under UV light on a Hoefer Mighty Bright ultraviolet 
transilluminator (Hoefer Scientific Instruments). The gel was then photographed 
with a Polaroid camera. 
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Figure 6 :  Agarose gel of genomic DNA 
2.3.2 Microsatellite Analysis 
2.3.2.1 Microsatellites 
The human genome contains many polymorphic microsatellite markers. 
Microsatellites are short (less than 500 bp) tandem repeats interspersed throughout 
the genome at about 30 kb distances, with repeat sequence motifs of one to five 
nucleotides (Weber, 1990a). The high degree of polymorphism displayed is due to 
the variability in the number of tandem repeats and it is noted that the greater the 
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number of repeats at a locus, the more likely that the locus is polymorphic (Weber, 
1990b ). The number of times a sequence is reiterated at a particular locus has been 
shown to be sufficiently stable within pedigrees, but polymorphic among members of 
a population (Weber and May, 1989). Hence, microsatellites are very useful genetic 
markers (see section 1 . 8 . 1 .2) .  
Microsatellites can be analysed efficiently using the PCR technique due to the 
small size of the microsatellite amplification products ( 1 00 to 500 bp; Edwards et al., 
1992). These amplification products can also be easily detected on polyacrylamide 
gels. 
2.3.2.2 Selection of Microsatellites and Synthesis of Primers 
In recent years, microsatellite maps covering the whole human genome have 
been developed. For the majority of the genotyping experiments in this study, 
existing polymorphic microsatellites that have been mapped meiotically by Genethon 
(Gyapay et al., 1994), the Cooperative Human Linkage Centre (CHLC; Murray et 
al., 1994), and other groups (Buetow et al., 1994 ; Collins et al. ,  1996) have been 
used. The majority of the marker distances used in the analysis were obtained from 
the Genetic Location Database (LDB; http://cedar.genetics. soton.au.uk), generated 
by the Wessex Human Genetics Institute and the Genetic Epidemiology Research 
Group. These map locations have been obtained by integrating data of different 
types (genetic linkage maps, physical maps, cytogenetic data and mouse homology) 
and constructing a single "summary" map (Collins et al., 1996). A total of 3 62 
micro satellites were chosen for stage one of this study and were genotyped in 90 
US.A. familles by two collaborative groups (Stanford University in the {!.S.A. and 
the Edith Cowan University/Graylands Hospital in Perth, Australia) . One hundred 
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and fifty seven additional markers were typed in these 90 families in stage two of the 
project. These additional markers were chosen to ( 1 )  saturate genomic regions where 
evidence of linkage (lod score > 1 )  had been obtained during stage one; (2) follow-up 
specific candidate regions, such as chromosome regions 6p and l 5q, as well as some 
reported by the IMGSAC ( 1 998) (chromosome region 7q); (3) fill in regions with 
large gaps in the initial screen that had not been excluded in the preliminary analysis. 
A total of 50 stage one microsatellites and 50 stage two microsatellites were 
run on the 90 US.A. families as part of this PhD project. A further 4 1  Australian 
families were genotyped using a subset of 24 markers. The microsatellites analysed 
in this PhD study are listed in Appendix 6. 1 ,  together with the heterozygosity values 
( amount of polymorphism) and the number of nucleotides in the repeat sequence for 
each marker. Assuming a sex-averaged total autosomal map length of 3500cM, the 
average distance between all markers used in stage one of the study was 1 0cM (see 
Appendix 6. 1 ). 
The use of these markers was facilitated by commercially available pairs of 
oligonucleotide primers, with one of each pair (usually the forward primer) labelled 
with a fluorescent dye on its 5 '  end. In those cases where the markers were analysed 
using radioactive methods (see Appendix 6. 1 )  the primers were unlabelled. The 
fluorescent primers were available as sets that allowed multiplexing (analysis of 
more than one primer at a time) to occur both in the PCR reaction and during 
electrophoretic separation (see ABI PRISM™ Linkage Mapping Set [PE Applied 
Biosystems, 1994] for more detail). Forward and reverse primer pairs were supplied, 
or custom synthesised if not commercially available, by commercial suppliers 
(Bresatec, Australia; Applied Biosystems (ABI), Australia; Research Genetics, USA) 
and couriered in either a lyophilised form at ambient temperature or diluted to 8-
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lOµM with dH20. Upon arrival, lyophilised primers were resuspended in dH20 to a 
stock concentration of 1 µg/µl. These primers were further diluted to a working 
concentration of 1 OOng/µl, in most cases, by adding 50µ1 of forward primer to 50µ1 
ofreverse primer and 400µ1 dH20. Primers supplied at 8- lOµM were generally 
diluted to 4-5µM by adding equal volumes of forward and reverse primers (see 
Appendix 6 .1 for dilution protocol of each microsatellite used in this PhD project). 
Both the "stock" and the "working" solution of primers were stored at -20°C. 
2.3.2.3 PCR Amplification and Different Methods of Labelling the PCR 
Products for Subsequent Detection 
Microsatellites were amplified using the polymerase chain reaction (PCR). 
PCR is an in vitro method for enzymatically synthesising defined sequences of DNA. 
The reaction uses two oligonucleotide primers that hybridise to opposite strands and 
flank the target DNA sequence that is to be amplified. The elongation of the primers 
is catalysed by Taq DNA Polymerase, a heat-stable DNA polymerase (Saiki et al., 
1988) that has been isolated from the thermophilic eubacterium Thermus aquaticus. 
A repetitive series of cycles involving template denaturation, primer annealing, and 
extension of the annealed primers by Taq DNA Polymerase results in exponential 
accumulation of a specific DNA fragment, where the ends of the fragment are 
defined by the 5' ends of the primers (Ausubel et al., 1991). 
There are a number of different methods for detecting the target DNA 
sequence. Examples include; silver staining of conventional PCR products, 
incorporation of radioactive ( a-P32) labelled deoxycytosine triphosphate ( dCTP) 
nucleotides into the PCR reaction, incorporation of fluorescently-labelled 
deoxyuridine trip hosp hate ( dUTP) into the PCR products and labelling the 5' end of 
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the primer with a fluorescent tag. Most primers used in this study were labelled with 
a fluorescent tag at the 5' end, and the PCR products were identified using the ABI 
PRISM 310 DNA Analyser (capillary electrophoresis) or the ABI PRISM 373 DNA 
Analyser (gel electrophoresis). In the cases where the primers were not fluorescently 
labelled, radioactive nucleotides were incorporated into the PCR products and 
products were separated on polyacrylamide gels and detected by autoradiography. 
For a diagrammatic representation of the overall genotyping method see Figure 7. 
The PCR procedure used in this study was a slight modification from the 
original (Mullis and Falcona, 1987). Polymerase chain reactions (Erlich et al., 1991) 
were carried out using different protocols depending on the thermocycler utilised and 
the condition optimised for each specific microsatellite. Generally, PCR reactions 
carried out in a MJ Research thermocycler were performed in 5µ1 total volume and 
contained lOng DNA, 200µM dNTPs, 0.13-2.0µM or 1.0-20ng/µl of each primer 
(the forward primer had been fluorescently labelled using either HEX, TET and 
FAM dyes), 50mM KCl, lOµM Tris-HCl, 1.5mM MgCh, and 1.25U Taq­
Polymerase (Perkin Elmer) (refer to Appendix 6.1 for the reaction mixture of each 
micro satellite). 
The solutions were pipetted into a capillary tube (Biotech) using a 
programmable pipettor (Corbett Research), and processed in a thermocycler (MJ 
Research). After denaturation for 5-1 Omin at 94°C ( 5min for standard AmpliTaq and 
1 Omin for AmpliTaq Gold (Perkin Elmer); see Appendix 6.1 ), 27 cycles were carried 
out, each cycle consisting of 30sec at 94°C, 75sec at 55°C, and 15sec at 72°C. A 
final extension step was performed for 5min at 72°C. The DNA polymerase 
AmpliTaq Gold is activated by heat and allows "hot start" PCR to be introduced into 
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Figure 7: Outline of the genotyping method. The electropherograms in the bottom section 
show the results from one family with two affected sibs that were produced by the analysis 
programme Genotyper (see 2.3 .2.6) (diagram from Maestrini et al., 1998). 
existing amplification systems with little to no modification of cycling parameters or 
reaction conditions. Hot start PCR can improve amplification of most templates by 
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lowering "background" and increasing the amplification of specific products. This is 
achieved by the covalently bound moiety to the polymerase. When the enzyme is 
heated to approximately 94°C, the moiety is detached from the polymerase and the 
polymerase becomes active. Since this temperature is above the minimum required 
for the primers to anneal, it prevents the primers annealing to non-specific regions 
(mis-priming) and, in turn, prevents the formation of artifact peaks, which can 
complicate the analysis. 
The majority of microsatellites were amplified using the 2400 or 9600 Perkin 
Elmer Thermocyclers. PCR conditions differed slightly between markers (see 
Appendix 6.1), however they basically involved a final reaction volume of 5µ1, in 
which 2µ1 was DNA (5µg/ml). The remaining volume contained 250µM dNTPs, 
0.04- l .92µM or 13-25ng/µl of each primer (the forward primer had been 
fluorescently labelled using HEX, TET and FAM dyes), 50mM KCl, lOµM Tris­
HCl, l .56-3.12mM MgCh, and l .25U Tag-Polymerase or Amplitaq Gold (Perkin 
Elmer). All PCR reactions were performed in 200µ1 tubes on a 24 or a 96 well plate, 
under either a standard or a touchdown cycling programme (see Appendix 6. 1 ). The 
touchdown cycling programme was used when amplification resulted in poor yields 
of a specific product using the standard programme. The touchdown programme 
differs from the standard programme by reducing the annealing temperature in the 
second group of cycles. By reducing the annealing temperature, the primers are 
prevented from annealing to non-specific regions. The lower temperature also 
prolongs the activity of the DNA polymerase, increasing the total yield of product. 
The standard programme involved an initial denaturation time of 5min at 94°C for 
standard Taq polymerase and l 5min at 94°C if Amplitaq Gold was used in the 
solution. This was followed by 10 cycles of 15sec at 94°C, 15sec at 55°C and 30sec 
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at 72°C. Then 20 cycles of 1 5sec at 89°C, 1 5sec at 55°C, 30sec at 72°C were 
performed with a final elongation step of 1 Omin at 72°C. The touchdown 
programme also entailed an initial denaturation at 94°C for 1 Omin or 5min depending 
on the type ofTaq polymerase used. The first 1 5  cycles of this programme 
comprised 20sec at 94°C, 60sec at 63°C - 55°C (-0.5°C annealing temp. /cycle) and 
3 0sec at 72°C. The second 1 5  cycles involved 20sec at 94°C, 60sec at 55°C and 
30sec at 72°C, with a final extension at 72°C for 5min. For microsatellites where 
radioactive labelling was used, the reaction mix was a slight modification of the 
original procedure by Saiki et al. ( 1988) and included 0.05µ1 of l OmCi/ml a-P32 
dCTP nucleotides per reaction (see Appendix 6. 1 for PCR conditions). 
After completion of PCR reactions, products analysed on the Perkin Elmer 
3 1 0 DNA Analyser were diluted with water and an aliquot (see Appendix 6. 1 )  added 
to 12µ1 of formamide and 0.8µ1 of GS500 Tamra standard dye (Figure 8). Samples 
loaded on to the Perkin Elmer 373 DNA Analyser were multiplexed to a total volume 
of 1.5µ1 and combined with 0.5µ1 of the internal lane size standard (Tamra GS500; 
Applied Biosystems), 2.5µ1 of deionised formamide and 0.5µ1 of Blue Dextran 
EDTA ( 1 mg Blue Dextran per 1ml EDTA [20-50mM, pH 8.0]). Formamide was 
added to disrupt the hydrogen bonds within the PCR products and prevent the 
products from re-annealing at a lower temperature once they were denatured. At 
least 50% of the final sample loaded on to the gel was formamide. The samples 
loaded on to the 3 1 0 DNA Analyser contained an excess offormamide to allow up to 
1 Oµl of PCR products to be run in each injection. PCR products loaded on to the 
SE1 600 Poker Face II sequencer were combined with 8µ1 offormamide loading 
buffer in a 0.65ml microcentrifuge tube. All samples were denatured for 5min at 
94°C before loading on to the detection apparatus. 
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Figure 8: Load ing samples onto the Perkin  Elmer 3 1 0 DNA analyzer 
2.3.2.4 Electrophoretic Separation and Detection of the PCR Products of 
Different Length 
The PCR products for each microsatel l ite (ie. the al le les) were discriminated 
by length fractionation using polyacrylamide gel electrophoresis (PAGE). PAGE 
operates via the movement of negatively charged DNA towards the positive 
electrode, under the influence of an electrical current. In the case of capil lary 
electrophoresis (see below) the al leles separate according to size in a polymer 
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solution instead of a polyacrylamide gel, however the principle of separation is 
similar. 
The Perkin Elmer 310 Genetic Analyser uses real-time four-colour 
fluorescent detection technology (Connell et al. , 1987) to detect the alleles for each 
individual. The dye-labelled DNA fragments electrophorese through the polymer, 
and DNA fragments separate according to size. As the labelled samples travel 
through the capillary and into the detector window they are illuminated. The 
fluorescent dyes attached to the fragments are excited by the laser and emit light at a 
specific wavelength for each dye. The colours and wavelengths of fluorescence of 
the four dyes are; blue for the 6-F AM dye at 531 nm, green for the TET dye at 
545nm, yellow for the HEX dye at 560nm, and red for the TAMRA dye at 580nm. 
The signal is collected on to a charge-coupled device (CCD) camera and digitised by 
a photomultiplier tube (PMT). The resulting fluorescence data are transmitted to a 
Macintosh computer (Apple Computer) for analysis. 
A small number of microsatellites used in this PhD project were analysed on 
an ABI PRISM 373 Genetic Analyser. Collaborators at Stanford University used a 
similar machine to visualise and size all of their PCR products (Perkin Elmer 3 77 
DNA Analyser). The Perkin Elmer 373 system operates in a similar way to the 
Perkin Elmer 3 77 system, except that it contains different filters and the products are 
run for a longer period of time. The ABI Prism 373 system also uses real time, four­
dye, one-lane technology to detect the DNA fragments for each microsatellite. 
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2.3.2.5 Preparation of Detection Systems for Analysis 
The ABI Prism™ 310 DNA Analyzer (Figure 9) 
A detailed description of the running of the GeneScan application for this 
apparatus can be found in the ABI Prism™ 310 Genetic Analyzer User's  Manual 
(1995)[Chapter 4, Running GeneScan] , distributed by PE Applied Biosystems Inc. 
In brief, the polymer (Performance Optimized Polymer 4, PE Applied 
Biosystems) was added to a 1ml glass syringe and set into position, being sure no air 
bubbles were present in either the syringe or the block. The buffer (1 Ox Genetic 
Analyzer Buffer with added EDTA, PE Applied Biosystems) was diluted to lx with 
distilled water and poured into the buffer vial located on the autosampler, as well as 
the buffer reservoir attached to the pump block. Distilled water was also added to a 
buffer vial and an Eppendorf tube located on the autosampler. GeneScan capillaries 
were cut down to 30cM length and the laser detection window on the capillary 
washed with 70% methanol to remove any particulate or fluorescent matter that may 
also be detected by the laser. The autosampler was then re-calibrated and the 
samples (PCR products with formamide and standard added) placed into the 
autosampler tray. Finally a GeneScan Injection List was prepared which states the 
sample names and the assignment to an autosampler position. The Injection List also 
specifies the order of samples and the modules containing the parameters to be used 
for the run. In this project most samples were injected into the capillary for 5-10sec 
and run through the capillary and past the laser detection window for l 7min. This 
gave enough time for micro satellites up to the size of 3 50bp to be accurately 
separated and analysed. After 96 samples have been analysed, the polymer and 
buffer were exchanged for fresh media. After 200 runs the GeneScan capillary was 
also replaced. 
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3 1 0 DNA analyzer 
The ABI Prism™ 373 DNA Analyzer (Figure JO) 
The protocol for the preparat ion of gels generally followed the instructions of 
the manufacturer (GeneScan 672 Software User' s Manual, 1 993) . A detailed 
de cription of the procedure can be found in the 373 DNA Sequencer User' s Manual 
( 1 996)[Chapter 2 ,  Preparing Gels] ,  distributed by PE Applied Biosystems Inc. 
Special care wa taken to el iminate any particulate or fluorescent matter from the 
acrylamide gel solutions and to keep the glass plates extremely clean and free of 
dust, as the laser system detected any fluorescence present interrupting the reading of 
the fluorescent DNA fragments. All solutions were filtered and only ultrapure, high­
grade reagents and distilled, deionised water were used to prepare the solutions. 
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In brief, 75ml of fresh 6% acrylamide-urea gel solution (6% acrylamide, 
8.3M urea [Molecular Sigma Biology], lxTBE; see Appendix 6.2 for protocol) was 
poured into a 1 50ml beaker, and to this, 400µ1 of 1 0% ammonium persulphate 
(Molecular Sigma Biology) and 45µ1 ofTEMED (N,N,N',N'­
tetramethylethylenediamine;  Molecular Sigma Biology) were added. The acrylamide 
solution was carefully poured between the two plates by holding them in an upright 
position and resting the lip of the solution vessel against the edge of the notched 
plate. The plates were then placed in a horizontal position and a 48-tooth comb 
secured with two large binder clamps. Gels were left to set for a minimum of two 
hours to ensure complete polymerisation prior to use. 
Before the gel was placed in the electrophoresis chamber, the comb and the 
clamps were removed and both sides of the plates were rinsed with water (to clean 
away the excess acrylamide and urea), and then air-dried. To ensure that no peaks 
were produced by fluorescent particles either on the plates or in the gel, the gel and 
plates were scanned before loading the samples. lxTBE buffer (89mM Tris-base, 
89mM Boric acid, 2mM EDTA; pH-8.3 at ambient temp.) was then placed in the 
upper and lower buffer chambers and the sample wells were flushed with this 
running buffer using a pipette. The run parameters were set at Filter set B, field 2500 
volts, a current of 40mAmp, power at 30 watts, a laser setting of 40mW, and a PMT 
voltage between 600-800 Volts. Once the wells were loaded with the samples, the 
gel was run for 1 0  hours. 
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Figure 10 :  ABI Prism 373 DNA analyzer 
SE1600 Poker Face II 
The protocol for preparation of these sequencing gels was similar to that used 
for the 373 DNA Sequencer (see above). Since radioactive products were detected 
using this system, care taken to prevent any fluorescent particles in the acrylamide 
gel solutions and on the glass plates was not required. Hot tap water and l iquid 
Pyroneg (Diversey) detergent was used to wash the p lates before use and 70% 
ethanol assisted in drying. The smaller of the two plates was treated with Sigmacote 
(Molecular Sigma Biology). This silicone solution prevented the gel from sticking 
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tightly to both plates, and reduced the possibility that the gel would tear when 
removed from the mould after electrophoresis. 
A 6% polyacrylamide gel was used since it provides best resolution for 
products with sizes within the range of 100-3 50 base pairs. The gel mix was 
prepared in a 250ml beaker and contained 70ml ofliquid acrylamide (19: 1 
acrylamide:bis-acrylamide; Gradipore Liqui-Mix; see Appendix 6.2 for protocol), 
170µ1 ofTEMED and 170µ1 of 25% ammonium persulfate. Using a 50ml syringe, 
the solution was quickly drawn up and injected between the glass plates, which were 
held on an incline of approximately 20°. Once the gel mix had reached the top of the 
plates, the plates were laid down horizontally and the wedge removed. A "well­
forming" spacer was then inserted and the gel left to set at room temperature for 
approximately one hour. If the gel was to be used the following day, the top and 
bottom of the gel were kept moist with paper towels and sealed in plastic wrap. It 
was then stored flat at 4°C. 
The electrophoresis tank used was a SE1600 Poker Face II sequencer (Hoefer 
Scientific Instruments). This was attached to a 3000Xi-electrophoresis power supply 
(Bio-Rad). The first step was to fill the lower buffer chamber with lxTBE buffer 
(see Appendix 6.2 for protocol) to a depth of approximately 2cm. The masking tape 
on the glass plates was then removed and an aluminium and perspex backing plate, 
which provides even heat distribution across the gel, was clamped against the smaller 
glass plate. This was done with two side clamps of the same length as the larger 
glass plate. This apparatus was placed in the lower buffer tank and secured, and the 
upper buffer tank was filled with lxTBE buffer. The "well-forming" spacer was 
removed and the well flushed with 1 xTBE buffer to remove excess urea and prevent 
distorted migration of DNA due to unpolymerised acrylamide. The top "safety lid" 
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and top and bottom connectors were then plugged into the unit, and the electrodes 
were connected to the power pack. 
Before loading the PCR products, each gel was pre-warmed for 20 minutes at 
1400 volts. A 66-well comb or a 44-well comb was placed in the well formed by the 
"well-forming" spacer, and 1 to 2µ1 of each sample was loaded into each well ( l µl 
was loaded if the 66-well comb was used, 2µ1 for the 44-well comb). The top "safety 
lid" was replaced and the gels were run for 1.5-3.5 hours at 1400 volts depending on 
the size range of the alleles. 
After gel electrophoresis, the glass plates were detached using a wedge and 
the upper plate (without the gel), as well as the spacers, were removed. Each gel was 
fixed by gently flooding with at least 200ml of 10% methanol (AnalaR, BDH 
LabSupplies) and 10% acetic acid (AnalaR, BOH LabSupplies) for 15 minutes. 
After removing any excess moisture by placing the plate on a slight incline, a piece 
of blotting paper, slightly larger than the gel, was placed over it. The adhering gel 
was peeled off the glass plate, covered with plastic wrap, and dried under vacuum on 
a slab gel dryer (Savant SGD4050) for 1 hour at 80°C. The dry gel was placed in an 
X-ray cassette (Amersham Hypercassette™) with a sheet of X-ray film and held 
overnight at room temperature. The X-ray film was developed using a Curix 
benchtop automatic processor (Agfa). 
2.3.2.6 Allele Assignment 
The size of the microsatellite PCR products was determined by reference to 
the internal lane size standards by applying the method of Carrano et al. (1989). The 
310 GeneScan TM Analysis 2.1 (PE Applied Biosystems, 1996) software 
automatically recognises the fragment size distribution of the size standards labelled 
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with the TAMRA dye. The size of the unknown DNA fragments labelled with the 
other three dyes (HEX, TET and FAM) is determined by correlation with the internal 
GeneScan size standard Tamra (GS SOO; see Figure 11 ). The GeneScan Analysis 
software generates a calibration or sizing curve based upon the migration times of the 
known sized fragments in the standard, relative to which the unknown fragments are 
mapped and converted from migration times to sizes. Since the DNA fragments of 
the standard are being electrophoresed under the same conditions as the sample, this 
is a very precise way to size unknown DNA fragments. It is also very replicable and 
allows genotypes run in different lanes and on different gels to be compared. 
The data collected by the GeneScan TM Analysis 2. 1 software were analysed 
by the GenotyperR 2.0 software (PE Applied Biosystems, 1 993-6) to determine the 
microsatellite allele sizes for each individual at each locus. Products detected 
radioactively were sized relative to a control PCR product run on the same gel whose. 
alleles had already been assigned a number. This was achieved by numbering each 
allele in a "top-down" fashion, such that the largest fragment was numbered one, the 
second largest numbered two, and so on. This procedure allowed easier 
identification of the allele number for the newly run products. 
1 14 
. . .. 
' •a..1 .. .. 
, ... · ·-
'""' 
IIOO 0 "" 0 
0 .... 
"" IIO 
- � � 
J>. CJl Ol 
0 o o  
... .,. ..., :r,a 
N 
0 
N 
CJl 
0 
, . n • " . . - - ) ,... � .... ... ... - II() ... ... - 110 
w w w A 0 .,,. u, 
0 0 c:, 0 ,,. A CJl 0 ' w 
_uJJ_Jjji 
CJl 
,1 ""' 
i ""  
""' J I : -- 1\- , • ...ll !' 0 
Figure 1 1 :  Tamra GeneScan-500 size standard 
2.3.3 Verification and Processing of Genotyping Data 
Most data in this study (except those obtained using the radioacti ve 
procedure) were collected using an automated procedure. The data for the sizes of 
each allele were produced by the GeneScanR Analysis 2 . 1 software (PE Applied 
Biosystems, 1 996) and analysed by the Genotypel 2.0 software (PE Applied 
Biosystems, 1 993-96). The analysed data were then transferred into "Cyrillic for 
Pedigree Drawing" programme (Chapman, 1 993- 1 996) where the haplotypes were 
checked and then automatically moved into MUNK (Chapman, 1 993- 1 996) where it 
could be directly analysed by the linkage programme ASPEX (see section 2.4 ) .  This 
automatic d�ta collection, transfer and storage system produced reliable scoring of 
allele sizes, and human error caused by manually entering the data was minimised. 
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To ensure the accuracy of results, an independent party manually checked 
random genotypes. Two monozygotic twin pairs were also included in the analyses 
as a positive control and to estimate the rate of genotyping error. Chromosomal 
regions showing positive lod scores were also replicated in either the Perth or 
Stanford laboratory depending on where the results originated, using the same 90 
U.S.A. families. As an added quality control on the accuracy of marker typing, the 
order and distances of microsatellites were calculated using the data collected from 
our sample of individuals. Since the genetic map positions for those markers have 
already been determined in other large collections of families ( eg. the CEPH 
families), the correlation between these maps showed the accuracy of our data. The 
programme used to construct these genetic maps is a component of the linkage 
programme ASPEX (see below). 
To ensure that the methodology was sufficiently sensitive to detect a real 
excess of sharing when such excess was present, the pseudoautosomal marker 
DXYSI 54 was included in the analysis. This marker does not recombine between 
the X and Y chromosome, making it completely sex-linked. Since 73% of the 
U.S.A. ASPs are concordant for sex (63% males and 10% females), we would 
expect, at locus DXYS 154, excess sharing of alleles inherited from the fathers, but 
not of those inherited from the mothers. This provided an additional positive control. 
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2.4 Statistical Analysis 
2.4.1 Statistical Model 
The power of the overall study to detect susceptibility loci to autism has 
been determined under an oligogenic model, with the assumption that autism is 
caused by at least three genes. Using multipoint analysis formulae described by 
Risch ( 1990b ), the expected maximum lod scores (EMLS) for various values of As 
and numbers of sib pairs (N) were calculated (Table 5). Based on the assumptions 
that all parents are typed and the polymorphic information content (PIC) of all 3 50 
markers (I OcM map) is 0.70, it is reasonable to expect that we can identify loci with 
As=2.0 or more in a sample of 1 00 affected sib pairs. With these values we can also 
expect to exclude 87% of the genome for a locus with As=2.0. Calculations show 
that with the typing of extra markers and the addition of l 00 more multiplex families, 
we should be able to exclude the entire genome for a As greater than or equal to 2.0 
(ie. a gene of moderate effect on the disease), if a gene of this influence is not present 
in the disorder (Table 7). 
Table 7: Expected Proportion of Genome Excluded, PIC=O. 70 
N As =2.0 As =2.0 
10cM map 5cM map 
1 00 0.87 0 .92 
200 0.99 0 .99 
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2.4.2 Linkage Analysis 
Statistical analyses were based entirely on identity-by-descent (IBD) data 
since at least one parent was available for all sibling pairs. These data were 
calculated by identifying the parental origin of each sibling allele, and comparing the 
corresponding alleles for each member of an affected sibling pair, at a given locus, 
for each parent. If both alleles could be uniquely identified, the pair was scored as 
either identical or non-identical by descent from that parent at that position. If the 
match was ambiguous, the position was scored as uninformative. 
In a family with more than two affected siblings, the first affected sibling was 
paired with each remaining affected child, allowing the contribution of several 
independent sib-pairs within the one family. While this did not bias the observed 
sharing results, it did mean that data -from large families carried more weight than 
data from small families. 
Multipoint sib-pair analysis (see section 1.8.3 ) was employed (Risch, 1990b; 
Risch, 1993) in this study to test for a susceptibility gene(s) to autism. This method 
of analysis has already been used to construct an exclusion map of chromosome 17 
for type 1 diabetes (Williams et al. , 1994), to suggest evidence of a susceptibility 
locus in chromosome 6 for schizophrenia (Schwab et al. , 1995), and to construct an 
exclusion map of the X chromosome for autism (Hallmayer et al. , 1996). The 
multipoint sib-pair method of linkage analysis has also suggested evidence for 
susceptibility loci in autism, with a lod score of 2.53 calculated in one region on 
chromosome 7 assuming As = 5 (IMGSAC, 1998). 
The multipoint lod score at a particular locus was determined by finding the 
nearest informative markers flanking the locus on either side, for both the maternal 
1 1 8 
and paternal alleles. The probability of the given marker data (ie. the probability of 
sharing vs. non-sharing of alleles), assuming the locus was in a particular IBD state, 
was calculated from the IBD states of these flanking alleles, and the recombination 
distances to the locus. These probabilities were then used to determine the odds of 
the marker data (lod score) given a disease gene of known penetrance at the locus, 
versus the odds of the marker data if the disease gene had zero penetrance. The 
calculation of marker allele frequencies was not required in this method of analysis, 
since all statistical analyses were based entirely on IBD data. 
Multipoint lod scores were calculated for a fixed model (ie. fixed value of 
As), allowing an exclusion map to be formulated. For a fixed value of As, negative 
lod scores can be obtained if the model gives a poorer representation of the marker 
data than does no gene effect. The conservative lod score criterion of -2 was used in 
this study for exclusion of a locus with a given As value (Hauser et al., 1 996). 
Maximum lod scores at each locus were also obtained by maximising the likelihood 
of the marker data at each point, as a function of the genetic model (As value). These 
results never drop below zero, the value obtained when As = 1. 
Regions identified as possibly containing susceptibility loci (Lod Score > 1) 
were analysed further using two-point linkage analysis. Two-point linkage analysis 
calculates the probability that a marker and a disease locus are linked and does not 
consider the adjacent markers on the genetic map. This was evaluated by calculating 
the number of alleles shared versus the number of alleles unshared at each marker 
across sib-pairs and comparing with a chi-square (x2) distribution. 
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2.4.3 Linkage Disequilibrium Analysis (LD) 
Linkage disequilibrium was examined in chromosomal regions showing 
suggestive evidence of linkage (lod > 1 )  using the transmission/disequilibrium test 
(TDT) of Spielman et al. ( 1 993 ; see section 1 .8.4 ). This programme identified all 
parents who were heterozygous at the marker locus, and defined two alleles for each 
affected child, the one transmitted to the affected child and the one that was not. All 
transmitted alleles from these heterozygous parents were then tallied with all non­
transmitted alleles. A significant difference (by the x2 test) in the frequencies of 
alleles in these two groups indicated that an allele (or alleles) was (were) 
preferentially transmitted to affected children, and hence associated with disease 
susceptibility. 
2.4.4 Computer Programme 
All statistical analyses, including the multipoint and two-point sib-pair 
analyses and the TDT analyses, were performed with the ASPEX computer package 
(Hinds and Risch, 1996). It was also used to confirm the relationship between 
members of each family, and to search for and eliminate unlikely double crossovers 
in the multipoint analyses in regions that had dense markers. 
The programme used in the ASPEX computer package to perform multipoint 
exclusion mapping using affected sibling pair data for discrete traits (Hinds and 
Risch, 1996).was SIB IBD. This programme produces a default output file that 
summarises the sharing at each locus, broken down by parent. The markers were 
1 20 
sorted into order along the chromosome, as specified in the loc (location) parameter. 
A loc file was generated at the beginning of each analysis of a chromosome and 
states the markers used, the distances between each marker in Morgans, as well as 
the lambda value specified in the analysis. 
A multipoint exclusion map was also generated by the programme and the 
genetic recombination distance (offset) and the lod scores were specified for each 
marker at each lambda value. Multipoint lod scores calculated at specified points 
between and at each marker for different lambda values (1.5 < As >  10) were graphed 
using the "Microsoft Excel for Windows 95" computer programme (Microsoft, 1985-
1996), to view areas of linkage and/or exclusion. Lambda values or the sibling risk 
ratio (As) were used to quantify the effect of a locus. For this study, loci with a small 
genetic influence on the disease corresponded to a As :s; 2, whereas a large gene effect 
coincided with a As :::: 5 .  A moderate influence on the disease gene corresponded to a 
As value between those stated for a small and large gene effect (3 :s; As :s; 4). 
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CHAPTER 3 
RESULTS 
Two collaborative groups (Stanford University in US.A and Graylands 
Hospital/Edith Cowan University in Perth, Australia) performed a hierarchical search 
of the genome for autism susceptibility genes on 90 U.S.A multiplex families. A 
10cM map containing 362 markers was used in the initial screen. Genomic regions 
of interest were investigated further during the second stage, with a denser map 
containing 157 additional markers. Using the ASPEX computer programme, 
multipoint sib-pair analysis was performed on the genotype data to detect linkage. 
Exclusion maps were generated under different lambda values to show the regions of 
the genome which show no evidence of linkage. Regions indicating suggestive 
linkage (lod > 1) were analysed further using two-point linkage analysis. 
A total of 50 microsatellites in the initial screen and 50 additional markers in 
the follow-up screen were analysed as part of this PhD project on the 90 US.A. 
families. An additional group of 41 Australian multiplex families were analysed 
using a subset of 24 microsatellites. The results below are presented in the order in 
which they were obtained (see Figure 12). The analysis of the US.A. families is 
shown first by displaying the results of the systematic scan of part of the genome, 
followed by the refined study of candidate regions and concluding with the results 
from the duplication of the positive regions identified by us and the Stanford group. 
The section on the study of the Australian families presents our findings for 
the regions identified as possibly significant during the initial scan on the US.A 
families and by the IMGSAC (1998). Finally, the results from the linkage 
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disequilibrium (LD) analysis are presented on regions where results suggestive of 
linkage have been obtained in the combined U.S.A. and Australian group of families. 
STAGE 1 
GENOME SEARCH 
ON 90 U.S.A. FAMILIES 
USING MULTIPOINT LINKAGE ANALYSIS 
�
(362 Microsatellites) 
� 
STANFORD UNIVERSITY EDITH COW AN UNIVERSITY / 
Chrl-18 GRAYLANDS HOSPITAL 
STAGE 2 
Chrl9-22
/ 
Additional 
157 Microsatellites 
typed • 
IN CANDIDATE REGIONS 
Chr6 & 15 
(Perth Group) • 
REGIONS MLS> 1 IN ST AGE 1 
DUPLICATED WITH A MORE DENSE MAP 
Chrlp, lq, 7p, IOq, I I p, 13q, 15q, 17p, 18q, 20p & 22 
(Perth and Stanford Groups) • 
REGIONS MLS> 1 IN ST AGE 1 
TESTED WITH 49 ADDITIONAL U. S.A. FAMILIES 
( 149 Micro satellites) 
(Stanford Group) • 
REGIONS MLS> 1 IN ST AGE 2 and 
IMGSAC (1999) POTENTIAL REGION 
TESTED WITH 40 AUSTRALIAN FAMILIES 
Chrlp, 7q & 22 
(Perth Group) 
Figure 12 :  Flow-chart of the linkage study on autism (Note: Perth Group includes 
collaborators from E.C .U. and Graylands Hospital) 
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3.1 Linkage Results from the U.S.A. Families 
3.1.1 Genotyping Error Rate 
To ascertain the accuracy of the results that follow as well as the degree to 
which potential biases might be confounding the results, the genotyping error rate for 
this study was determined. A marker completely linked to sex was also run to ensure 
that the method was sensitive enough to determine excess in sharing at a specific 
locus if indeed present for this disease. 
In the analysis a number of controls were employed to identify potential 
typing errors in the results. Firstly a pair of monozygotic twins were genotyped with 
the other sib-pair families to determine the genotyping error rate in the entire genome 
scan. Additionally, random genotypes, as well as regions showing positive Iod 
scores (MLS > 1.0), were manually checked by an independent party using the same 
protocol. For the entire genome scan, a genotyping error rate of 1 % was calculated. 
This result was derived from the analysis of the monozygotic twins where 1 0  loci out 
of a total of 946 were found to be genotypically discordant (Risch et al. , 1999). 
The error rate for the genotypes included in this Ph.D. study was calculated 
by the analysis of random genotypes by an independent party. Five hundred and 
sixty-eight genotypes in total were re-analysed and 7 errors in total were found. This 
corresponds to a genotyping error rate of approximately 1 .2%. 
To ensure this method of analysis was sufficiently sensitive to detect 
susceptible genes, if present, DXYS 1 54 was analysed in the U.S.A. sib-pair families 
(see 2.3.3) to see if linkage to sex was detected. Since the majority of ASPs are 
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brother pairs we would expect to an excess of sharing of alleles inherited from the 
fathers, but not of those inherited from the mothers. In total, there were 58 paternal 
alleles shared and 22 paternal alleles not shared, giving a x2 of 1 6.2. This 
corresponded to a lod score of3.52 , displaying significant linkage of this marker to 
sex. By contrast, there was no difference in the sharing of maternal alleles ( 42 alleles 
were shared and 45  alleles were not shared). Since 73% of the U.S.A. ASPs are 
concordant for sex, these results indicate that the methodology was sufficiently 
sensitive to detect an excess of sharing of this magnitude when present. 
3.1.2 Systematic Scan of Chromosomes 19-22 
A systematic scan of part of the genome, namely chromosomes 19-22 ,  was 
completed as part of the first stage screening on 90 multiplex families from the 
United States of America. Multipoint linkage analysis on the 50 microsatellites 
genotyped was performed under different lambda values (ie. A-s = 2 ,  3 ,  4 ,  5 & 1 0) 
using the ASPEX programme. The results of these analyses are depicted graphically. 
The figures show the lod scores calculated at each marker typed and at a number of 
intervals between these markers. The order of the microsatellites on the figures 
follows that given in the Genetic Location Database (LOB; see section 2.3.2.2) and 
the distance between the markers is stated in cM. A dividing line at lod score -2 
shows the values of A-s (below this line) that could be excluded from linkage to an 
autism susceptibility gene in that interval. 
The allele sharing data at each locus are shown in table format. The 
"Paternal" and "Maternal" tables show the number of shared alleles that were 
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inherited from each parent, the number of alleles inherited from the respective parent 
that are not shared, the percentage of alleles shared at this locus, and whether or not 
there is a significant difference between shared and non-shared alleles at the 
designated 5% level of significance (x2 test). The "Combined" table shows the 
summary of allele sharing at each locus irrespective of parent of origin. In the cases 
where there was no way of differentiating whether the allele was maternal or paternal 
in origin, these results were included in the "Combined" sharing table. The "Most­
Likely Model" table has five columns tabulating the percentage sharing and the lod 
score obtained by the maximum likelihood calculation (MLS). The middle three 
columns show the ratio of sharing of zero, one and two alleles. The results for each 
chromosome are described below. 
3.1.1.1 Chromosome 19 
Genes of Large Effect 
As depicted in Figure 13 ,  genes with effects corresponding to a As :2: 5 could 
be excluded from linkage to autism for over 90% of chromosome 19. The region 
that could not be excluded was between the markers D19S420 and D19S4 l8. 
Genes of Moderate Effect 
Twenty seven percent of chromosome 19 could be excluded from linkage to a 
gene of moderate effect (3 s As s4). This region included markers D19S22 l, 
D19S226 and D19S4 l4. 
Genes of Small Effect 
No region on chromosome 19  could be excluded from the presence of genes 
of small effect on autism (As s 2). 
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Most Likely Lad Scores 
The paternal and maternal alleles that were shared between sib-pairs at all 
markers on chromosome 19 showed a significant difference only for the paternally 
inherited alleles at marker D l 9S2 l O when assessed by the x2 test (Table 8). The 
percent sharing at this marker was 65.9% (x2 = 4.45, p = 0.035). When the 
percentage of alleles shared was calculated without taking in account parental origin 
of the alleles, the results did not deviate significantly from what was expected under 
the null hypothesis of no linkage (50%). 
The percentage sharing and the lod score (MLS) obtained by the maximum 
likelihood calculation for each locus, also did not show any significant linkage on 
this chromosome. The highest lod score calculated was 0. 73 at D l 9S220. 
Table 8 :  Most Likely Lod Scores for Chromosome 19 (U.S.A. Families) 
Locus Paternal Maternal 
+ % x: + % - - X* 
D1 9S209 26 22 54.2% 0.33 31 24 56.4% 0.89 
D1 9S216  23 24 48.9% 0.02 33 2 1  6 1 . 1 %  2 .67 
D1 9S221 30 31  49.2% 0 .02 26 29 47.3% 0. 1 6  
D1 9S226 29 28 50.9% 0.02 32 30 51 .6% 0 .06 
D1 9S414 1 7  27 38.6% 2.27 26 22 54.2% 0 .33 
D1 9S220 29 25 53.7% 0.30 35 23 60.3% 2.48 
D1 9S420 26 27 49. 1 %  0.02 32 28 53.3% 0.27 
1�1 9S41 8 24 1 8  57. 1 %  0.86 22 24 47.8% 0 .09 
1 9S21 0 29 1 5  65.9% 4.45 27 27 50.0% 0.00 
Locus Combined Most -Likely Model 
+ - % x2 %shr zO z1 z2 MLS 
D1 9S209 58 47 55.2% 1 . 1 5  56.9 0. 1 9  0.49 0 .32 0.50 
D1 9S216  56 45 55.4% 1 .20 52.7  0.22 0 .5  0.28 0.08 
D1 9S221 56 60 48.3% 0 . 14  51 .5 0.24 0 .5  0.26 0.03 
D1 9S226 6 1  58 51 .3% 0 .08 51 .6 0.23 0 .5  0 .27 0.03 
D1 9S414 46 52 46.9% 0.37 53.4 0.22 0 .5  0 .29 0. 1 3  
220 ·67 51 56.8% 2 . 1 7  57.8 0 . 18  0 .49 0 .33 0.73 
420 59 56 51 .3% 0.08 53.4 0.22 0 .5  0 .28 0. 1 3  
41 8 47 43 52.2% 0. 1 8  54.2 0.21 0.5 0.29 0. 1 7  
2 10  58 44 56.9% 1 .92 57. 1 0 . 1 8  0 .49 0 .33 0.49 
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Figure 1 3 : Chromosome 1 9  mult ipoint results using USA fami l ies 
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3.1.2.2 Chromosome 20 
Genes of Large Effect 
Genes of large effect on chromosome 20 could be excluded from linkage to 
autism in over 86% of the chromosome (Figure 14). Two areas could not be 
excluded, namely an 8. 8cM region between D20S 1 17 and D20S95, as well as a 
6.2cM region between D20Sl 1 5  and D20Sl89. 
Genes of Moderate Effect 
A high percentage of chromosome 20 ( 69%) could also be excluded as 
containing a gene of moderate effect. The region not excluded spans all markers 
between D20S 1 17 and D20S 1 86.  
Genes of Small Effect 
Forty four percent of chromosome 20 could be excluded from the presence of 
genes of small effect on autism. This includes a 22. 1 cM region involving D20S 1 1 8 
and D20S 195,  a 22 .3cM region between D20S 178, D20S 196 and D20S 1 00, and a 
16 . 1 cM region surrounding D20S 173 and D20S 171 . 
Most Likely Lad Scores 
No significant deviation from the null hypothesis of 50% sharing was noted 
in the percentage of paternal alleles shared between sib-pairs at all markers on 
chromosome 20 (Table 9). Significant sharing, however, was noted for the 
maternally inherited alleles at both markers D20S1 89 (x2 = 4 .57; p = 0 .033 ) and 
D20S1 00 (x2 = 3 .92; p = 0.048) . The percentages of alleles shared at these markers, 
however, were not significant at the 5% level of significance in the combined data 
set. 
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Maximum likelihood calculations also showed no susceptibility region on this 
chromosome. Linkage results for 62% of the chromosome (between markers 
D20S 118 to D20S 171) did not deviate significantly from the distribution that would 
be expected by chance (50% sharing). The amount of sharing identical-by-descent 
for the remaining 3 8% of the chromosome was also non-significant, with the greatest 
amount of sharing calculated at D20S95 (57.3%), corresponding to a MLS of 0.67. 
Table 9: Most Likely Lod Scores for Chromosome 20 (U.S.A. Families) 
Locus Paternal 
aili 
Maternal 
� 
+ - % - % 
D20S1 1 7  30 27 52.6% 32 50.0% 
D20S95 37 23 6 1 .7% 3.27 34 32 5 1 .5% 0 .06 
D20S1 1 5  25 1 9  56.8% 0.82 24 22 52.2% 0 .09 
D20S1 89 24 27 47. 1 %  0 . 1 8  36 20 64.3% 4 .57 
D20S1 86 31  28  52.5% 0. 1 5  38 28 57.6% 1 .52 
D20S1 1 8  2 1  32 39.6% 2.28 26 29 47.3% 0 . 1 6  
D20S1 95 26 29 47.3% 0 . 1 6  2 8  3 1  47.5% 0. 1 5  
D20S1 07 29 28 50.9% 0 .02 32 24 57. 1 %  1 . 1 4  
D20S1 1 9  22 30 42.3% 1 .23 36 22 62. 1 %  3.38 
D20S1 78 23 3 1  42.6% 1 . 1 9  26 25 5 1 .0% 0 .02 
D20S1 96 22 37 37.3% 3 .81  36 32 52.9% 0.24 
D20S1 00 22 26 45.8% 0.33 32 1 8  64.0% 3 .92 
D20S 2 24 47.8% 0 .09 22 21 5 1 .2% 0 .02 
D20S 0 24 45.5% 0. 25 27 48. 1 %  0 .08 
Locus Combined Most -Likely Model 
+ - % x2 o/oshr zO z1 z2 MLS 
D20S1 1 7  3 60 5 1 .2% 0.07 52 .8 0 .22 0 .50 0 .28 0.09 
D20S95 2 56 56.3% 2.00 57.3 0 . 1 8  0 .49 0 .33 0.67 
D20S1 1 5  50 42 54.3% 0.70 57.2 0 . 1 8  0 .49 0 .33 0.60 
D20S1 89 60 47 56. 1 %  1 .58 56.4 0. 1 9  0.49 0 .32 0.50 
20S1 86 69 56 55.2% 1 . 35 55.4 0.2 0.49 0 .31  0.37 
20S1 1 8  47 6 1  43.5% 1 .8 1  50.0 0.25 0 .50 0 .25 0.00 
D20S1 95 55 6 1  47.4% 0 .31  50.0 0.25 0 .50 0.25 0.00 
D20S1 07 6 1  52 54.0% 0.72 5 1 .8 0 .23 0 .50 0.27 0.04 
D20S1 1 9  58 52 52.7% 0.33 5 1 .6 0 .23 0 .50 0 .27 0.03 
D20S1 78 49 56 46.7% 0.47 50.0 0 .25 0 .50 0.25 0.00 
D20S1 96 59 70 45.7% 0 .94 50.0 0 .25 0 .50 0 .25 0. 
D20S1 00 54 44 55. 1 %  1 .02 50.0 0.25 0 .50 0.25 0.00 
D20S1 73 45 46 49.5% 0 .01  50.0 0.25 0 .50 .  0 .25 0.00 
D20S1 71 48 54 47. 1 %  0 .35 50.0 0.25 0 .50 0 .25 0.00 
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Figure 1 4 : Chromosome 20 mu ltipoint resu lts using USA fam i l ies 
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3.1.2.3 Chromosome 21 
Genes of Large Effect 
Genes that have a large effect on autism could be excluded from the entire 
length of chromosome 21 using microsatellite markers spaced approximately l OcM 
apart (Figure 15). 
Genes of Moderate Effect 
A gene of moderate effect could also be excluded from 84% of chromosome 
21. This includes the region between D21 S 1256 to D21 S266, excluding the first 
8cM between D21Sl 256 and D21S1253. 
Genes of Small Effect 
However, a gene a small effect on the disorder could only be excluded from 
30% of chromosome 21. The exclusion region was 13cM in total and was defined by 
markers D21S1253 and D21S263. 
Most Likely Lod Scores 
The percentage sharing of alleles at all markers on chromosome 21 did not 
differ significantly from the null hypothesis (50% sharing), even when the paternal 
and maternal inherited alleles were viewed separately (Table 10). The only 
significant result was at locus D21 S 1253 which showed the percent of paternal 
alleles shared to be lower than what would be expected by chance (25% sharing, x2 = 
9.00, p = 0.0027). 
The maximum likelihood calculations showed no significant linkage of 
chromosome 21 to an autism gene, with the MLS scores over the entire chromosome 
infrequently differing from zero. This is the value obtained when As = 1, i .e. , the 
increase in risk to siblings approaches the population prevalence of the disorder. 
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Figure 1 5 : Chromosome 21 mu ltipo int results using USA fami l ies 
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Table 1 0 :  Most Likely Lod Scores for Chromosome 21 (U.S.A. Famil ies) 
Locus Paternal Maternal 
+ - % x2 
= 
+ - % x2 
D21 S1 256 1 1  1 2  47.8% 0 .04 1 5  7 68.2% 2 .91  
D21 S1 253 9 27 25.0% 9.00 27 1 5  64.3% 3.43 
D21 S263 1 5  23 39.5% 1 .68 22 23 48.9% 0 .02 
D21 S1 252 22 30 42.3% 1 .23 33 24 57.9% 1 .42 
D21 S266 1 9  1 8  5 1 .4% 0 .03 I 22 1 7  56.4% 0.64 
Locus Combined Most -Likely Model 
+ - % x2 %shr zO z1 z2 MLS 
D21 S1 256 26 1 9  57.8% 1 . 09 53.4 0.22 0 .5  0.29 0.06 
D21 S1 253 36 42 46.2% 0.46 50.0 0.25 0.5 0.25 0.00 
D21 S263 38 47 44.7% 0 .95 50.0 0.25 0 .5  0.25 0.00 
D21 S1 252 55 54 50.5% 0 .01  5 1 .8  0.23 0 .5  0.27 0.03 
1 S266 4 1  35 53.9% 0.47 5 1 .3 0 .24 0 .5  0 .26 0.01 
3.1.2.4 Chromosome 22 
Genes of Large Effect 
Only seventeen percent of chromosome 22 could be excluded from 
containing a gene of large effect on autism. As illustrated in Figure 16, the exclusion 
region is located from approximately 2cM centromeric of D22S272 to D22S274. 
Genes of Moderate Effect 
Most of chromosome 22 (96%) could not be excluded from linkage to a gene 
of moderate effect on autism. The area that could be excluded was -3cM telomeric 
ofD22S423 to D22S274. 
Genes of Small Effect 
No region on chromosome 22 could be excluded from the presence of genes 
of small effect on autism. 
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Most Likely Lad Scores 
The percentage of alleles shared by the affected sib-pairs at each locus on 
chromosome 22 is shown in Table 1 1. Whilst the percentage of shared alleles 
inherited from the mother did not deviate significantly from the expected value of 
50%, the null hypothesis was rejected at a number of loci on chromosome 22 when 
the percentage of shared paternal inherited alleles was calculated. These loci include 
all markers between D22S3 l 5 and D22S272. The most significant result was at 
D22S278 with 82.1 % of alleles shared IBD in the 90 U.S.A. sib-pairs analysed (x2 = 
1 1.57, p = 0.00067). When the results of the allele sharing from both parents were 
combined, significant deviation from the null hypothesis was still calculated at eight 
loci. The three most significant results were at D22S273 (65.9%, x2 = 8.58, p = 
0.0034), D22S280 (62.9%%, x2 = 7.76, p = 0.0053 ) and D22S278 (7 1.2%, x2 = 
1 0.59, p = 0.00 1 14) .  
The maximum likelihood results for chromosome 22 are shown in Table 1 1. 
Ten markers had MLS scores greater than 1 on this chromosome, with D22S929 
exceeding the genome wide significance level of 3 (3 .08). The percentage of allele 
sharing at this marker was 65.4%. This marker was linked to the disorder 
Neurofibromatosis 2 in 1987 by Seizinger et al. 
Two-Point Lad Scores 
Two-point lod scores at this locus, however, showed a lower probability of 
linkage with a MLS of 1 .52 calculated at D22S929 (Table 1 2). The highest two­
point lod score was 2.46 at D22S278 (7 1 .9% sharing). This marker is located 
1 2.3cM telomeric from D22S929, the marker showing significant linkage to autism 
in the multipoint sib-pair analysis. 
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Figure 1 6 : Chromosome 22 m ultipoint resu lts using USA fami l ies 
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Table 1 1 :  M ost Likely Lod Scores for Chromosome 22 (U.S.A. Famil ies) 
Locus Paternal M aternal 
+ - % x2 + - % x2 
D22S420 28 20 58.3% 1 .33 26 22 54.2% 0 .33 
D22S31 5  33 1 7  66.0% 5 . 12  26 32 44.8% 0 .62 
D22S929 35 1 4  71 .4% 9 .00 27 22 55. 1 %  0 .51  
D22S1 1 63 39 1 7  69.6% 8 .64 28 25 52.8% 0. 1 7  
D22S1 1 50 37 1 3  74.0% 1 1 .52 22 2 1  5 1 .2% 0 .02 
D22S275 27 1 0  73.0% 7 .81  2 1  2 1  50.0% 0 .00 
D22S273 28 9 75.7% 9 .76 25 1 7  59.5% 1 .52 
D22S280 39 1 7  69.6% 8 .64 33 25 56.9% 1 . 1 0  
D22S281 39 1 6  70.9% 9.62 27 31 46.6% 0.28 
D22S277 40 1 8  69.0% 8 .34 33 30 52.4% 0 . 1 4  
D22S278 23 5 82. 1 %  1 1 .57 1 8  1 1  62. 1 %  1 .69 
D22S283 34 1 9  64.2% 4.25 35 27 56.5% 1 .03 
D22S272 23 1 1  67.6% 4.24 25 26 49.0% 0 .02 
D22S423 1 3  1 5  46.4% 0 . 1 4  2 1  20 5 1 .2% 0 .02 
D22S274 27 22 55. 1 %  0 .51  2 1  27 43.8% 0 .75 
Locus Combined Most -Likely Model 
+ - % x2 %shr zO z1 z2 MLS 
D22S420 55 43 56. 1 %  1 .47 58.2 0 . 1 7  0 .49 0 .34 0.65 
D22S31 5  60 50 54.5% 0.91 58 . 1  0 . 1 8  0 .49 0 .34 0.86 
D22S929 63 37 63.0% 6 .76 65.4 0 . 1 2  0 .45 0 .43 3.08 
D22S1 1 63 69 44 6 1 . 1 %  5 .53 60.8 0 . 1 5  0 .48 0 .37 1 .68 
D22S1 1 50 60 35 63.2% 6 .58 60.7 0 . 1 5  0.48 0 .37 1 .65 
D22S275 48 3 1  60.8% 3.66 60. 1 0 . 1 6  0 .48 0 .36 1 .47 
D22S273 56 29 65.9% 8 .58 62.5 0 . 14  0 .47 0 .39 2. 1 9  
D22S280 73 43 62.9% 7 .76 62.5 0 . 1 4  0 .47 0 .39 2.21 
D22S281 67 48 58.3% 3. 1 4  60.2 0 . 1 6  0 .48 0 .36 1 .45 
D22S277 73 48 60.3% 5. 1 7  59.9 0 . 1 6  0 .48 0 .36 1 .37 
D22S278 42 1 7  7 1 .2% 1 0.59 60.8 0 . 1 5  0 .48 0 .37 1 .57 
D22S283 7 1  48 59.7% 4.45 6 1 .6 0 . 1 5  0 .47 0 .38 1 .81  
D22S272 49 38 56.3% 1 . 39 57.6 0 . 1 8  0 .49 0 .33 0.74 
D22S423 34 35 49.3% 0 .01  58 .8  0 . 1 7  0 .48 0 .35 0.97 
D22S274 50 5 1  49.5% 0 .01  50.5 0 .24 0 .5  0 .26 0.00 
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Table 1 2 :  Two-Point Lod Scores for Chromosome 22 (U.S.A. Famil ies) 
Locus Paternal Maternal 
+ - % x2 + - % x2 
D22S420 28 20 58% 1 .33 26 22 54.20% 0 .33 
D22S31 5  I 33 1 7  66% 5 . 1 2  26 32 44.80% 0 .62 
D22S929 35 1 4  7 1 % 9 .00 27 22 55. 1 0% 0 .51  
D22S1 1 63 39 1 7  70% 8 .64 28 25 52.80% 0 . 1 7  
D22S1 1 50 37 1 3  74% 1 1 .52 22 2 1  5 1 .20% 0 .02 
D22S275 27 1 0  73% 7.81  21  21  50.00% 0 .00 
D22S273 28 9 76% 9.76 25 1 7  59.50% 1 .52 
D22S280 39 1 7  70% 8 .64 33 25 56.90% 1 . 1 0  
D22S281 39 1 6  7 1 % 9 .62 27 31  46.60% 0 .28 
D22S277 40 1 8  70% 8 .34 33 30 52.40% 0. 1 4  
D22S278 23 5 82% 1 1 .57 1 8  1 1  62. 1 0% 1 .69 
D22S283 34 1 9  64% 4.25 35 27 56.50% 1 .03 
D22S272 23 1 1  68% 4 .24 25 26 49.00% 0 .02 
D22S423 1 3  1 5  46% 0. 1 4  2 1  20 5 1 .20% 0 .02 
D22S274 27 22 55% 0 .51  21  27 43.80% 0 .75 
Locus Combined Most -Likely Model 
+ - % x2 %shr zO - _2 Pat Mat. MLS 
D22S420 55 43 56% 1 .47 56.2 0 . 1 9  0 .49 0 .32 0.3 0.0 0.33 
D22S315  60 50 54% 0 .$1  54.6 0 .21  0 .50 0 .30 0.6 -0.4 0.20 
D22S929 63 37 63% 6 .76 63.3 0 . 1 3  0.46 0 .40 1 .7 -0.2 1 .52 
D22S1 1 63 69 44 6 1 %  5 .53 6 1 .5 0 . 1 5  0 .47 0 .38 1 .6 -0.3 1 .26 
D22S1 1 50 60 35 63% 6 .58 63.4 0 . 1 3  0 .46 0 .40 2. 1 -0.6 1 .48 
D22S275 48 3 1  6 1 %  3.66 60.8 0 . 1 5  0 .48 0 .37 1 .2 -0.4 0.80 
D22S273 56 29 66% 8 .58 67. 1 0 . 1 1  0 .44 0.45 1 .9 0 .1  2.04 
D22S280 73 43 63% 7.76 63.2 0 . 1 4  0 .47 0 .40 1 .7 0.0 1 .73 
D22S281 67 48 58% 3 . 1 4  58.4 0 . 1 7  0 .49 0 .34 1 .4 -0.7 0.70 
D22S277 73 48 60% 5. 1 7  60.3 0 . 1 6  0.48 0 .36 1 .5 -0.3 1 . 1 3  
D22S278 42 1 7  7 1 % 1 0.59 71 . 9  0 .08 0 .40 0 .52 2.4 0 .1  2.46 
D22S283 71  48 60% 4 .45 60.0 0 . 1 6  0 .48 0 .36 0.9 0.2 1 .01 
D22S272 49 38 56% 1 .39 56.5 0 . 1 9  0 .49 0 .32 0.6 -0. 
D22S423 34 35 49% 0 .01  50 0 .25 0 .5  0 .25 0.0 0.0 0.00 
D22S274 � 5 1  50% 0 .01  50 0 .25 0 .5  0.25 0.0 0.0 0.00 
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3.1.3 Candidate Regions 
The 90 US.A. multiplex families were also used to conduct a refined analysis 
of genomic regions that have produced positive results in previous studies carried out 
by other groups. These regions included the HLA region on chromosome 6 and a 
large section of chromosome 1 5. In this analysis the entire length of chromosome 1 5  
was studied. 
3.1.3.1 HLA Region on Chromosome 6 
In total, 8 markers with an average inter-marker distance of 3cM were 
genotyped in the HLA region on chromosome 6. Multipoint sib-pair analysis results 
under different gene effects (As) are presented in Figure 17. The entire HLA region 
on chromosome 6 could be excluded from linkage to a gene of moderate effect for 
autism (As � 2). All markers showed a distribution of sharing that would be expected 
under a model of no linkage (ie. z0=0.25,  z l=0.50, z2=0.25) (Table 13). Therefore 
the amount of sharing of alleles at each locus did not exceed 50%, corresponding to a 
most-likely lod score of zero at each marker. When viewed separately by 
transmitting parent, the shared alleles at each locus also did not exceed what was 
expected by chance, with the majority of markers showing a percentage sharing 
lower than 50%. 
3.1.3.2 Chromosome 15 
Nineteen microsatellites that were approximately 7.5cM apart from each 
other and spanned the entire length of chromosome 1 5  were analysed in the 97 
US.A. affected sib-pairs. The results for this chromosome were very similar to those 
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displayed by the HLA region on chromosome 6 .  Linkage to a susceptibility gene 
that has a large effect on autism could be excluded throughout the entire 
chromosome (As � 5) (Figure 1 8). ASPEX results also showed that linkage to a gene 
of moderate effect could be excluded for 8 1  % of the chromosome between the region 
spanning D 15Sl65 and D15Sl20. However, a gene of small effect was only 
excluded from 1 0% of this chromosome near markers D15Sl 17, D15S152 and 
D15S205. When viewing the maximum likelihood calculations for this chromosome 
(Table 14), it can be seen that allele sharing greater than 55% was not observed for 
any of the chromosome 1 5  markers. The highest lod score within this region was 
0.22 at D15Sl58.  Allele sharing by parental origin also showed no significant 
deviation from the null hypothesis of no linkage. 
Table 1 3 :  Most Likely Lod Scores for Chromosome 6 (U.S.A. Famil ies) 
Locus Paternal Maternal 
+ - % x: + - % x2 
D6S285 27 26 50.9% 0 .02 28 28 50.0% 0 .00 
D6S1 029 1 2  1 7  41 .4% 0 .86 1 6  23 41 .0% 1 .26 
D6S276 27 36 42.9% 1 .29 32 35 47.8% 0 . 1 3  
D6S1014  29  30 49.2% 0 .02 2 1  27 43.8% 0 .75 
D6S497 1 8  1 9  48.6% 0 .03 20 32 38.5% 2 .77 
D6S439 20 23 46.5% 0.21 1 7  24 41 .5% 1 .20 
D6S1 0 1 9  20 23 46.5% 0.21 2 1  27 43.8% 0.75 
D6S426 30 39 43.5% 1 . 1 7  33 37 47. 1 %  0 .23 
Locus Combined Most-Likely M odel 
+ - % x2 o/oshr zO 21 z2 M LS 
D6S285 56 55 50.5% 0 .01  50 0 .25 0 .5  0 .25 0.00 
D6S1 029 33 45 42.3% 1 .85 50 0.25 0 .5  0 .25 0.00 
D6S276 60 72 45.5% 1 .09 50 0.25 0 .5  0 .25 0.00 
D6S 1 0 1 4  52 59 46.8% 0.44 50 0.25 0 .5  0.25 0.00 
D6S497 39 52 42.9% 50 0.25 0 .5 0 .25 0.00 
D6S439 37 47 44.0% 1 . 1 9  50 0.25 0 .5  0.25 0.00 
D6S1 0 1 9  44 53 45.4% 0 .84 50 0 .25 0 .5  0.25 0.00 
S426 64 77 45.4% 1 .20 50 0.25 0 .5  0 .25 0.00 
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Figure 1 7: Chromosome 6 m ultipoint resu lts using USA fami l ies 
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Figure 1 8 : Chromosome 1 5  multipoint results using USA fami l ies 
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Table 1 4: Most Likely Lod Scores for Chromosome 1 5  (U.S.A. Famil ies) 
Locus Paternal Maternal 
+ - % x2 + - % x2 
D1 5S541 1 1  9 55.0% 0.20 7 1 3  35.0% 1 .80 
D1 5S1 28 22 1 5  59.5% 1 .32 23 1 9  54.8% 0.38 
D1 5S1 56 I 8 4 66.7% 1 .33 8 7 53.3% 0 .07 
D1 5S1 65 I 1 4  1 3  5 1 .9% 0 .04 22 1 7  56.4% 0 .64 
D 1 5S1 1 8  5 1 0  33.3% 1 .67 8 5 6 1 .5% 0 .69 
D1 5S2 1 4  2 4 33.3% 0.67 4 1 3  23.5% 4 .76 
01 5S1 32 1 1  8 57.9% 0.47 7 1 5  3 1 .8% 2 .91  
D1 5S209 1 0  1 1  47.6% 0 .05 1 5  1 1  57.7% 0 .62 
01 5S1 1 7  26 32 44.8% 0.62 24 38 38.7% 3. 1 6  
D1 5S1 59 6 6 50.0% 0 .00 8 6 57. 1 %  0.29 
01 5S1 53 28 33 45.9% 0.41 32 28 53.3% 0.27 
01 5S1 31 20 2 1  48.8% 0 .02 22 20 52.4% 0 . 1 0  
D1 5S1 52 7 8 46.7% 0 .07 4 1 2  25.0% 4 .00 
D1 5S205 36 3 1  53.7% 0 .37 38 39 49.4% 0 .01  
01 5S1 58 9 7 56.3% 0.25 7 6 53.8% 0 .08 
01 5S1 27 35 34 50.7% 0 .01  34 31  52 .3% 0 . 1 4  
D1 5S1 30 1 8  1 9  48.6% 0 .03 25 2 1  54.3% 0 .35 
D1 5S212  8 7 53.3% 0 .07 1 2  1 1  52.2% 0 .04 
D1 5S1 20 22 20 52 .4% 0. 1 0  26 23 53. 1 %  0 . 1 8  
Locus Combined Most-Likely Model 
+ - % x2 o/oshr zO z1  z2 MLS 
D1 5S541 20 24 45.5% 0 .36 5 1 .9  0 .23 0 .5  0 .27 0.03 
D1 5S1 28 46 35 56.8% 1 .49 53.0 0.22 0 .5  0 .28 0.08 
D1 5S1 56 1 6  1 1  59.3% 0 .93 54.0 0.21 0 .5  0 .29 0 . 10  
D1 5S1 65 36 30 54.5% 0.55 52. 1  0.23 0 .5  0 .27 0.03 
D1 5S1 1 8  1 3  1 5  46.4% 0. 1 4  50.0 0.25 0 .5  0 .25 0.00 
D1 5S214  6 1 7  26. 1 %  5.26 50.0 0.25 0 .5  0.25 0.00 
01 5S1 32 1 8  23 43.9% 0 .61  50.0 0 .25 0 .5  0 .25 0.00 
D1 5S209 25 22 53.2% 0. 1 9  50.0 0.25 0 .5  0.25 0.00 
D1 5S1 1 7  50 70 4 1 .7% 3 .33 50.0 0.25 0.5 0.25 0.00 
D1 5S1 59 1 6  1 4  53.3% 0 . 1 3  50.6 0.24 0 .5 0 .26 0.00 
D1 5S1 53 6 1  62 49.6% 0 .01  =52 .4 0 .23 0 .5 0 .27 0.07 
D1 5S1 31 42 4 1  50.6% 0 .01  53.9 0.21 0 .5  0 .29 0. 1 8  
D1 5S1 52 1 1  20 35.5% 2 .61  50.0 0.25 0 .5  0.25 0.00 
D1 5S205 74 70 5 1 .4% 0 . 1 1  50.3 0.25 0 .5  0 .25 0.00 
D1 5S1 58 1 6  1 3  55.2% 0 .31  54.2 0 .2 1  0 .5 0.29 0.22 
D1 5S1 27 70 66 5 1 .5% 0 . 1 2  5 1 .5 0 .23 0 .5  0.27 0.03 
D1 5S1 30 43 40 5 1 .8% 0. 1 1  5 1 .8 0.23 0 .5 . 0.27 0.03 
D1 5S2 1 2  2 0  1 8  52.6% 0. 1 1  50.8 0 .24 0 .5  0 .26 0.01 
D1 5S1 20 49 44 52 .7% 0.27 54.6 0 .21  0 .5 0 .3 0.21 
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3.1.4 Duplication of Positive Regions Detected by the Stanford and Perth 
Research Groups 
At the completion of stage one of the project, 346 autosomal and 14 X-linked 
markers had been analysed in all 97 affected sib-pairs from the US.A. The results 
from the multipoint analysis on this data identified eleven regions that gave a 
maximum lod score greater than or equal to one (MLS � I ). These included 
chromosome I p  (MLS = I. 87), I q (MLS = 1. 19), 7p (MLS = 1. 00), 1 Oq (MLS = 
1.00), 1 l p  (MLS = 1.25), I3q  (MLS = 1.49), 15q (MLS = 1.75), 17p (MLS = 1.30), 
l 8q (MLS = I. 00), 20p (MLS = 1. 09) and 22q (MLS = 3. 08). MLS curves for each 
of these chromosomes were generated from maximum likelihood calculations and 
are shown in Risch et al. ( 1999). Results for chromosome 22 are also presented in 
section 3 . 1.2.4. 
The analysis of six of these regions (I p, lq, I Oq, 15q, 17p & 1 8q) was 
duplicated in this study using the same families as an additional control. The genetic 
maps utilised, however, contained different microsatellites to those analysed in stage 
one of the project (refer to Appendix 6. 1 for the microsatellites analysed in each 
chromosomal region and the distances between each marker) . The results of these 
analyses are stated below. 
3.1.4.1 Chromosome l p  
A region on the short arm of chromosome 1 showed a MLS > 1 when 
analysed by the Stanford group (MLS = 1.87). When three markers within this 
region were re-analysed by the Perth group, positive linkage to this region was still 
found and no area could be excluded for any gene effect (As) (Figure 19). Based on 
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the calculated sharing probabilities in the interval between D 1 S 1 63 1  to D 1 S534 (zo 
= 0. 13 ,  zl  = 0.46, z2 = 0.4 1 ), this region had a MLS of 1 .55 (Table 1 5). The MLS at 
D 1 S 1 63 1  was 1 .26 ( 60. 9% sharing). Although slightly lower than that calculated by 
the Stanford group, this linkage result (MLS > 1 )  still suggests that a susceptibility 
locus to autism may reside in this region. We performed two-point analysis as an 
additional test for linkage at this locus (Table 1 6) .  Results again were suggestive of 
an autism gene near D 1 S 1 63 I (MLS = 1 . 1 3 ,  60. 1 % sharing) . The percentage of 
allele sharing at this locus in the combined data set was also significant at the 
designated 5% level of significance (x2 = 5.14, p = 0.0234 ) . 
Table 1 5 :  Most Likely Lod Scores for Chromosome 1 p  (U.S.A. Famil ies) 
Locus Paternal Maternal 
�I + - % x2 + - % D1 S551 22 1 3  62.9% 2.31 1 7  20 45.9% 
D1 S1 631 32 1 7  65.3% 4 .59 36 27 57. 1 %  1 .29 
D1 S534 26 1 9  57.8% 1 .09 34 22 60.7% 2 .57 
Locus Combined Most -Likely Model 
+ - % x2 o/oshr zO z1 z2 M LS 
D1 S551 40 ".l.A 54. 1 %  0.49 56. 1 0. 1 9  0.49 0 .31 0.25 
D1 S1631 68 44 60.7% 5. 1 4  60.9 0 . 15  0.48 0 .37 1 .26 
S534 61  42 59.2% 3.50 60.7 0. 1 5  0.48 0.37 1 . 1 4  
Table 16 :  Two-Point Lod Scores for Chromosome l p  (U.S.A. Families) 
Locus Paternal Maternal 
+ - % x2 + - % x2 
D1 S551 22 1 3  62.9% 2.31 1 7  20 45.9% 0 .24 
D1 S 1 631 32 1 7  65.3% 4 .59 36 27 57. 1 %  1 .29 
D1 S534 26 1 9  57.8% 1 .09 34 22 60.7% 2 .57 
Locus Combined Most -Likely M odel 
+ - % x2 o/oshr zO z1 z2 M LS 
D1 S551 40 34 54. 1 %  0.49 54.2 0.21 0 .50 0.29 0.1 1  
D 1 S1 631 68 44 60.7% 5 . 14  60.7 0 . 1 5  0.48 0 .37 1 . 1 3  
D1 S534 6 1  42 59.2% 3 .50 59.4 0 . 16  0.48 0 .35 0.78 
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Figure 1 9 : Chromosome 1 p mu ltipoint results using USA fami l ies 
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3.1.4.2 Chromosome lq  
A region on chromosome 1 q suggesting linkage to an autism gene in stage 
one of the genome scan (J\1:LS = 1. 19), was re-analysed in the same affected sib-pairs 
using microsatellite markers mapping in the same area. Whilst no region in this 
section of chromosome 1 could be excluded from linkage to autism, the multipoint 
lod scores calculated at all As values were less than one (Figure 20). Maximum 
likelihood calculations were also lower than those calculated in stage one of the 
study (Table 17). A J\1:LS of 0.71 (58.8% sharing) was calculated at D1S1609. The 
percentage of alleles shared by sib-pairs at each locus was also not significantly 
different to that expected under the null hypothesis of no linkage ( 5 0%) .  Our 
findings make it unlikely that a gene for autism resides in this region of the genome. 
Table 1 7: Most Likely Lod Scores for Chromosome 1 q  (U.S.A. Fami lies) 
Locus Paternal Maternal 
+ - % x
2 + - % x2 
D1 S3462 1 8  22 45.0% 0 .40 26 1 9  57.8% 1 .09 
D1 S235 26 1 8  59. 1 %  1 .45 24 23 5 1 . 1 %  0 .02 
D 1 S1 609 36 22 62. 1 %  3 .38 24 20 54.5% 0 .36 
Locus Combined Most -Likely Model 
+ - % x
2 %shr zO z1 z2 MLS 
D1 S3462 46 43 51 .7% 0 . 1 0  54.8  0 .2  0 .50 0 .30 0.21 
D1 S235 53 44 54.6% 0 .84 54.6 0 .21  0 .50 0 .30 0.20 
D1 S1 609 60 42 58.8% 3 . 1 8  58.8 0 . 1 7  0 .48 0 .35 0.71 
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Figure 20: Chromosome 1 q multipoint results using USA fami l ies 
-1 
-2 -+-As = 2 
CIJ ---As = 3 
0 - As = 4 en -3 
....._As = 5 
0 
_As = 1 0  ...J 
-4 
-5 
-6 I D1 S3462 I 
0 5 1 0  1 5  20 26 31 36 41 46 51 
Distance (cM) 
3.1 .4.3 Chromosome lOq 
Re-analysis of a 1 OcM region of chromosome 1 Oq excluded this area from 
containing a gene conferring susceptibility to autism. This region showed a MLS = 
1.00 when analysed by the Stanford research group. Through the analysis of three 
markers approximately 5cM apart, chromosome 1 Oq was excluded from linkage to a 
gene of large effect on the disorder (Figure 21). A gene of small to moderate effect, 
however, could not be excluded over this entire region of chromosome 1 Oq. 
Multipoint analysis using the "most-likely" model showed no significant excess of 
allele sharing in the combined data set with the calculation of a MLS = 0. 76 (58.3% 
sharing) at D 10S606 (Table 18). Significant excess sharing, however, was noted for 
the maternally inherited alleles at locus D10S2327 (x2 = 4. 57, p = 0.033). 
Table 1 8 :  Most Likely Lod Scores for Chromosome 1 0q (U.S.A. Famil ies) 
Locus Paternal Maternal 
+ - % x2 + - % x2 
D1 0S1 432 25 1 4  64. 1 %  3. 1 0  24 24 50.0% 0 .00 
D1 0S606 30 1 8  62.5% 3.00 20 21  48.8% 0 .02 
D1 0S2327 1 7  20 45.9% 0.24 25 1 2  67.6% 4 .57 
Locus Combined Most -Likely Model 
+ % ' %shr zO z1 z2 MLS - x-
D1 0S1 432 49 38 -56 .3% 1 .39 56.8 0. 1 9  0.49 0.32 0.49 
D1 0S606 50 39 -56.2% 1 .36 58.3 0 . 1 7  0.49 0 .34 0.76 
D1 0S2327 42 32 -56.8% 1 . 35 57.6 0. 1 8  0 .49 0 .33 0.54 
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Figure 21 : Chromosome 1 Oq multipoint resu lts using USA fami l ies 
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3.1.4.4 Chromosome 15q 
Results similar to those obtained for chromosome 1 Oq (3. 1 .4. 1 )  were also 
found in the region of chromosome 1 5q, identified by the Stanford group as possibly 
containing a gene for autism (MLS = 1.75). The results from this analysis are shown 
in Figure 1 8  and Table 14 and are explained previously in section 3.1.3.2. The area 
previously identified in stage one of the study as possibly containing a susceptibility 
gene to autism was between markers 0 1  SS 1 59 and 0 1  SS 130. Our results (section 
3 . 1 .3 .2) clearly show the exclusion of a gene of moderate to large effect in this 
region and the results of the maximum likelihood calculations did not differ 
significantly from those expected by chance. 
3.1.4.5 Chromosome 17p 
When chromosome l 7p was re-examined in the 90 U. S.A. multiplex families 
using three different microsatellites, suggestive linkage (MLS > 1 )  to an autism gene 
was excluded at all loci. This region previously showed a MLS = 1.30 when 
analysed by the Stanford research group. Two of these markers (0 17S938 and 
0 l 7S945) could be excluded from linkage to a gene of small effect on the disorder 
(Figure 22). The marker, which could not be excluded as linked to a gene of small 
effect, was D l 7S849. This marker also showed significant excess of sharing in the 
paternal and combined data sets (x
2 = 5. 1 6  & 4.05 respectively; Table 19). The MLS 
that was calculated at this marker on chromosome l 7p was 0.8 1  (60.4% sharing) 
(Table 19) ,  which was not significant at the genome-wide level of significance. 
1 5 1  
Table 19:  Most Likely Lod Scores for Chromosome 17p (U.S.A. Families) 
Locus Paternal Maternal 
+ - % x2 
-
+ - % x2 
D1 7S849 26 1 2  68.4% 5 . 1 6  22 1 8  55.0% 0.40 
D1 7S938 2 1  23 47.7% 0 .09 29 27 5 1 .8% 0 .07 
D1 7S945 23 32 41 .8% 1 .47 28 27 50.9% 0 .02 
Locus Combined Most -Likely Model 
+ - % x2 %shr zO z1 z2 MLS 
D1 7S849 49 3 1  6 1 .3% 4.05 60.4 0. 1 6  0.48 0 .36 0.81 
D1 7S938 51  5 1  50.0% 0 .00 50.6 0.24 0 .50 0 .26 0.00 
D1 7S945 52 60 46.4% 0.57 50.0 0.25 0 .50 0 .25 0.00 
1 52 
Figure 22 : Chromosome 1 7p multipoint resu lts using USA fami l ies 
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3.1.4.6 Chromosome 18q 
Four markers spanning the region of chromosome 18 that showed a MLS of 
1 .00 for the Stanford group were tested using the same families. Both D l 8S474 and 
D1 8S6 l could be excluded from linkage to an autism gene of small to large effect on 
the disorder (Figure 23). However, the region between these markers could not be 
excluded. The MLS calculated in this region was 1.05 at D1 8S64 (60.5% sharing) 
based on the estimated sharing probabilities at this marker (zO = 0. 1 6, zl  = 0. 4 81 z2 = 
0. 37) (Table 20) . When viewed separately, the percentage of shared compared to 
non-shared alleles inherited from the father were not significant at any locus when 
related to a x2 distribution. Similar results were obtained for the sharing of 
maternally inherited alleles except at marker D1 8S64 , which showed significant 
excess of sharing (x2 = 5.00, p = 0. 025). 
Table 20: Most Likely Lod Scores for Chromosome 1 8q (U.S.A. Famil ies) 
Locus Paternal Maternal 
+ - % x2 + - % x2 
D1 8S474 23 26 46.9% 0. 1 8  27 22 55. 1 %  0 .51  
D1 8S64 21  1 8  53.8% 0 .23 30 1 5  66.7% 5 .00 
D1 8S68 22 2 1  51 .2% 0 .02 29 1 8  6 1 .7% 2 .57 
D1 8S61 26 27 49. 1 %  0 .02 26 23 53. 1 %  0 . 1 8  
Locus Combined Most -Likely Model 
+ - % x2 %shr zO z1  z2 MLS 
D1 8S474 52 50 51 .0% 0 .04 53.5 0.22 0 .50 0 .29 0. 1 1  
D1 8S64 53 35 60.2% 3.68 60.5 0 . 16  0 .48 0 .37 1 .05 
D1 8S68 52 40 56 .5% 1 .57 57.3 0 . 1 8  0.49 0 .33 0.57 
D1 8S61 53 51 51 .0% 0 .04 5 1 .9 0.23 0 .50 0 .27 0.04 
1 54 
Figure 23: Chromosome 1 8q multipoint results using USA fami l ies 
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3.2 Linkage Results from Australian Families 
3.2.1 Extension Study of Positive Regions Detected Using U.S.A. Families 
An "extension study" refers to the process of testing additional families in the 
hope of reaching the genome-wide significance level (Lander and Kruglyak, 1995). 
After re-analysis of regions of the genome showing MLS 2: l in stage one of the 
study which was performed on the 97 U.S.A. sib-pairs, two regions still showed 
suggestive evidence of linkage to an autism susceptibility gene. These included a 
region within chromosome 1 p and a large part of chromosome 22. These regions 
were genotyped in the sub-set of 41 families using the same microsatellite markers 
and identical analysis procedures. Due to the small number of availabie Australian 
families at present, the U.S.A. and the Australian families were analysed together 
rather than treating the Australian families as a "replication" data set. The results 
from this analysis are described below. 
3.2.1.l Chromosome l p  
With the addition of the Australian families the overall lod scores dropped 
slightly with 20% of this region on chromosome l p excluded from linkage to a gene 
of large effect on autism (Figure 24). This compares to no exclusion of any gene 
effect when the first 90 U.S.A. multiplex families were analysed. When the 
Australian data were added to the maximum likelihood calculations, the maximum 
lod score at this region dropped from 1.55 (6cM centromeric ofD1�1631) to 1.21 
(8cM centromeric of D 1 S 1631) (Table 21 ). Two-point linkage analysis on this 
1 56 
region showed a reduction in the MLS at D 1 S 1631 from 1.13 to 0.58 (Table 22). 
The MLS at this region on chromosome I p  was 0.88 at D1S534. This marker, when 
analysed using multipoint and two-point analysis, also had a percentage of allele 
sharing significantly different to that expected under the null hypothesis of no 
linkage (x2 = 3.98, p = 0.046). 
Table 21: Most Likely Lod Scores for Chromosome l p  (All Families) 
Locus Paternal Maternal 
+ - % x2 + - % x2 
D1 S551 38 23 62.3% 3.69 32 3 1  50.8% 0 .02 
D1 S1 631 44 35 55.7% 1 .03 49 37 57.0% 1 .67 
D1 S534 42 32 56.8% 1 .35 55 39 58.5% 2 .72 
Locus Combined Most -Likely Model 
+ - % x2 %shr zO z1 z2 I MLS 
D1 S551 7 1  55 56.3% 2.03 57.4 0. 1 8  0.49 0.33 0.62 
D1 S 1 631 93 72 56.4% 2.67 56.9 0. 1 9  0.49 0.32 0.75 
D1 S534 98 72 57.6% 3.98 58. 1  0 . 1 8  0 .49 0.34 1 .04 
Table 22: Two-Point Lod Scores for Chromosome l p  (All Families) 
Locus Paternal Maternal 
+ % , + % x2 - XM -
D1 S551 38 23 62.3% 3.69 32 3 1  50.8% 0 .02 
D1 S 1 631 44 35 55.7% 1 .03 49 37 57.0% 1 .67 
D1 S534 42 32 56.8% 1 .35 55 39 58.5% ? 7-, II 
Locus Combined Most -Likely Model 
+ - % x2 %shr zO z1 z2 MLS 
D1 S551 7 1  55 56.3% 2 .03 56.5 0 . 1 9  0.49 0 .32 0.45 
D1 S 1 631 93 72 56.4% 2 .67 56.4 0 . 1 9  0 .49 0 .32 0.58 
D1 S534 98 72 57.6% 3 .98 57.7 0 . 1 8  0.49 0 .33 0.88 
157 
2 
1 
0 
- 1  
-2 
-3 
-4 
-5 
-6 
-7 
-8 
-9 
0 5 
Figure 24: Chromosome 1 p multipoint results using a l l  fami l ies 
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3.2.1.2 Chromosome 22 
Chromosome 22 results showed similar trends to those seen in chromosome 
1 p when the Australian autistic families' data were added. With the new data set, 
20% of the chromosome could be excluded from linkage to a gene of large effect on 
the disorder (37%) (Figure 25). Genes of small to moderate effect on autism, 
however, could not be excluded from a location on chromosome 22. 
Maximum likelihood calculations using the most-likely model showed a drop 
in MLS below the genome-wide significance level for linkage (lod > 3)  at the marker 
locus D22S929. With the addition of the Australian families the lod score was 
reduced from 3.08 to 2.70 (Table 23). Percentage sharing compared to non-sharing 
between alleles in the combined data set was significantly different for a number of 
markers on this chromosome, including D22S929 (x2 = 6.92, p  = 0.009), D22Sl  1 63 
(x2 = 7. 1 1 , p  = 0.008), D22Sl  1 50 (x2 = 8.26, p = 0 .004), D22S273 (x2 = 1 0.4 5, p = 
0 .00 1 ), D22S280 (x2 = 7.4 1 , p  = 0.006), D22S28 l  (x2 = 4.03 , p = 0.045) and 
D22S278 (X2 = 1 0.59, p = 0.001). 
When these alleles were divided into those inherited from the father and the 
mother, significant differences were noted only for the paternally inherited alleles. 
The number of alleles shared by siblings compared to those not shared was most 
significant at D22Sl  1 50 (x2 = 1 3.6, p = 0.0002), with 73% of alleles inherited from 
the father by one sibling being identical to the other member of the sibling pair. 
When maximum likelihood calculations were performed on just the paternally 
inherited alleles, the MLS for this chromosome again exceeded the genome-wide 
level for significant linkage (lod > 3 ). This was noted at D22S280 with a MLS of 
3 .2 .  D22S280 is located 8.6cM telomeric ofD22S929, the marker where the most 
significant linkage result was detected using only the 90 U .S.A. sib-pairs (MLS = 
159  
3.08). However, maximum likelihood calculations using the data on sharing of 
maternal alleles produced negative lod scores throughout most of the chromosome 
(except D22S420, MLS = 0.5). When the multipoint lod scores for the paternal and 
maternal inherited alleles were graphed under different lambda values, a similar 
trend was observed (Figures 26 and 27, respectively). As seen in these figures, the 
region most positive in the paternal multipoint graph (D22S3 I 5 to D22S28 I )  was 
also the region most negative in the maternal multipoint graph. Sixty three percent 
of chromosome 22 could be excluded from containing a maternally inherited gene of 
large effect on autism. No region of this chromosome could be excluded from 
containing a paternally inherited gene for autism. These results indicate that a 
paternally derived gene could reside in the chromosome 22 region. 
When two-point linkage analysis was run on this chromosome, the lod scores 
calculated showed a shift in MLS to marker D22S273. The calculated MLS was 
2.47 with 67.4% sharing (Table 24). This marker is located 6. l cM distal from 
D22S929. Percentage sharing at markers between D22S929 and D22S278 was still 
significantly different to that expected ·by chance when the paternally inherited 
alleles were analysed. Alleles inherited from the mother at all loci were not different 
to what was expected under the null hypothesis of no linkage. 
Although the addition of the results of the Australian families to the 
chromosome 22 data reduced the overall lod scores, they were still above 1 for some 
markers and therefore suggestive of linkage to an autism gene. To increase the 
power to detect linkage, we combined our data with those obtained by the Stanford 
group. Chromosome 22 was re-analysed by the Stanford group to determine if the 
high positive linkage results obtained on this chromosome in stage one of the project 
could be duplicated. The results of the Stanford group were obtained using a number 
160 
of different microsatellite markers and these were analysed in the entire group of 1 39 
US.A. multiplex families. The additional 49 US families were collected for stage 
two of the project and used by the Stanford group to saturate regions giving positive 
linkage evidence in stage one of the project (Risch et al. , 1999). The results of this 
analysis are shown in Table 25. With the addition of these new US.A. families, the 
maximum likelihood lod scores dropped significantly. The MLS for this 
chromosome was still at the marker locus D22S929 (the marker showing significant 
linkage to autism in the multipoint sib-pair analysis using the first 90 U.S.A. 
families), however it dropped well below the threshold for suggestive linkage with a 
value of O. 3 7. The presence of a gene on this chromosome could not be excluded 
since the percentage sharing, throughout the entire chromosome, was still above that 
expected by chance. Also, the percentages of shared alleles at the some loci were 
still significantly different in the combined data set when compared to a x2 
distribution. These loci include D22S 1 1 63 (x2 = 4.44, p = 0.035), D22S273 (x2 = 
4.26, p = 0.039), D22S278 (X2 = 5.33, p = 0.02 1 )  and D22S283 (x2 = 4.4 1 , p  = 
0.036). Significant sharing was also noted in the percentage of paternal alleles 
shared between sib-pairs at all loci between D22S429 and D22S2 8 1 ,  as well as at 
D22S278 and D22S277. The most significant result was at D22S278 (x2 = 8. 9 1 , p  = 
0.003), with 82% of alleles inherited from the father by one sibling being identical to 
the other member of the sibling pair. No significant deviation from the null 
hypothesis of 50% sharing, however, was noted in the percentage of maternal alleles 
shared between sib-pairs at all markers on chromosome 22 in this combined data set. 
This strengthens the indication that if a gene for autism does reside on chromosome 
22, it is most probably paternally derived. 
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Figure 25: Chromosome 22 mu ltipoint results using a l l  fami l ies 
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Table 23: Most Likely Lod Scores for Chromosome 22 (All Families) 
Locus Paternal Maternal 
+ - % ' x� + - % xz 
D22S420 33 25 57% 1 . 1  36 25 59% 2 .0  
D22S31 5  40 22 65% 5.2 34 39 47% 0 .3 
D22S929 43 20 68% 8.4 36 29 55% 0 .8  
D22S1 1 63 51  22 70% 1 1 .5 35 32 52% 0 . 1 
D22S1 1 50 48 1 8  73% 1 3.6 29 27 52% 0 . 1  
D22S275 38 1 7  69% 8.0 29 3 1  48% 0 . 1  
D22S273 3 1  1 2  72% 8.4 31  1 8  63% 3.5 
D22S280 52 25 68% 9.5 42 35 55% 0.6 
D22S281 50 22 69% 1 0.9 39 42 48% 0. 1 
D22S277 51  26 66% 8 . 1 39 43 48% 0.2 
D22S278 23 5 82% 1 1 .6 1 8  1 1  62% 1 . 7 
D22S283 44 27 62% 4. 1 42 40 5 1 % 0 . 1 
D22S272 30 1 5  67% 5.0 3 1  36 46% 0.4 
D22S423 2 1  1 9  53% 0. 1 26 31 46% 0.4 
D22S274 33 24 58% 1 .4 27 31 47% 0 .3 
Locus Combined Most -Likely Model 
+ - % xz %shr zO z1 z2 p M MLS 
D22S420 70 51 58% 2 .98 59 0 . 1 7  0.48 0 .35 0.5 0.5 1 .0 
D22S31 5 75 62 55% 1 .23 57 0 . 1 8  0.49 0 .33 1 .2 -0.3 0.9 
D22S929 80 50 62% 6 .92 63 0 . 1 4  0 .47 0 .39 2.4 0.3 2.7 
D22S1 1 63 88 56 6 1 %  7. 1 1  60 0 . 1 6  0 .48 0 .35 2.5 -0.9 1 .6 
D22S1 1 50 78 46 63% 8.26 59 0 . 1 6  0 .48 0.35 2.7 -1 .0 1 .6 
D22S275 67 48 58% 3. 1 4  59 0 . 1 7  0.48 0 .35 2.6 -1 . 1  1 .5 
D22S273 65 33 66% 1 0.45 6 1  0 . 1 5  0.48 0 .37 2.9 -0.7 2. 1 
D22S280 95 61 6 1 %  7.41 6 1  0 . 1 5  0 .48 0 .37 3.2 -1 . 1  2. 1 
D22S281 90 65 58% 4.03 60 0 . 1 6  0.48 0 .36 2.6 -0.9 1 .8 
D22S277 90 69 57% 2.77 57 0 . 1 9  0 .49 0 .32 1 .5 -0.6 0.8 
D22S278 42 1 7  7 1 % 1 0.59 58 0 . 1 8  0.49 0 .33 1 .6 -0.6 1 .0 
D22S283 88 69 56% 2.30 59 0 . 1 7  0 .48 0 .35 1 .6 -0. 1  1 .5 
D22S272 62 52 54% 0.88 57 0 . 1 8  0.49 0.33 1 .0 -0.2 0.8 
D22S423 47 50 49% 0 .09 59 0 . 1 7  0 .49 0 .34 1 .4 -0.3 1 .2 
D22S274 62 57 52% 0 .21  53 0 .22 0 .5  0.28 0.4 -0.2 0 .1  
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Figure 26: Chromosome 22 multipoint resu lts (paternal inheritance) using al l  fami l ies 
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Figure 27: Chromosome 22 mult ipoint results (maternal inheritance) using al l  fami l ies 
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Table 24: Two-Point Lod Scores for Chromosome 22 (All Famil ies) 
Locus Paternal Maternal 
+ - % x
2 + - % x
2 
D22S420 33 25 57% 1 . 1 0  36 25 59.00% 1 . 98 
D22S315  40  22 65% 5.23 34 39 46.60% 0 .34 
D22S929 43 20 68% 8.40 36 29 55.40% 0 .75 
D22S1 1 63 5 1  22 70% 1 1 .52 35 32 52.20% 0. 1 3  
D22S1 1 50 48 1 8  73% 1 3.64 29 27 5 1 .80% 0 .07 
D22S275 38 1 7  69% 8 .02 29 31 48.30% 0 .07 
D22S273 31  12  72% 8.40 3 1  1 8  63.30% 3 .45 
D22S280 52 25 68% 9.47 42 35 54.50% 0 .64 
D22S281 50 22 69% 1 0.89 39 42 48. 1 0% 0 . 1 1  
D22S277 51  26 66% 8 . 12  39 43 47.60% 0.20 
D22S278 23 5 82% 1 1 .57 1 8  1 1  62. 1 0% 1 .69 
D22S283 44 27 62% 4 .07 42 40 51 .20% 0 .05 
D22S272 30 1 5  67% 5 .00 31  36 46.30% 0 .37 
D22S423 2 1  1 9  52% 0. 1 0  26 31  45.60% 0.44 
D22S274 34 24 59% 1 .72 28 31 47.50% 0. 1 5  
Locus Combined Most -Likely Model 
+ - % x2 %shr zO z1 z2 Pat Mat. MLS 
D22S420 70 51 57.9% 2 .98 58.0 0. 1 8  0.49 0.34 0.2 0.4 0.66 
D22S31 5  75 62 54.7% 1 .23 54.8 0.20 0.50 0 .30 0.6 -0.4 0.27 
D22S929 80 50 6 1 .5% 6 .92 6 1 .7 0. 1 5  0.47 0 .38 1 .6 -0. 1  1 .54 
D22S1 1 63 88 56 6 1 . 1 %  7. 1 1  61 .4 0 . 1 5  0.47 0 .38 2.1  -0.5 1 .60 
D22S1 1 50 78 46 62.9% 8.26 63. 1 0 . 1 4  0.47 0.40 2.5 -0.6 1 .84 
D22S275 67 48 58.3% 3 . 14  58.3 0. 1 7  0.49 0.34 1 .2 -0.5 0.68 
D22S273 65 33 66.3% 1 0 .45 67.4 0. 1 1  0.44 0.45 1 .8 0.7 2.47 
D22S280 95 6 1  60.9% 7.41 61 .0 0 . 1 5  0.48 0.37 1 .8 -0.2 1 .64 
D22S281 90 65 58. 1 %  4.03 58.2 0. 1 7  0.49 0 .34 1 .6 -0.7 0.89 
D22S277 90 69 56.6% 2.77 56.6 0 . 1 9  0.49 0 .32 1 .2 -0.5 0.60 
D22S278 42 1 7  71 .2% 1 0.59 71 .9  0 .08 0 .4 0 .52 2.4 0 .1  2.46 
D22S283 88 69 56. 1 %  2.30 56.2 0 . 1 9  0.49 0 .32 0.7 -0.2 0.51 
D22S272 62 52 54.4% 0 .88 54.5 0 .21 0 .5 0 .3  0.5 -0.3 0. 1 9  
D22S423 47 50 48.5% 0.09 50.0 0 .25 0 .5  0.25 0:0 0.0 0.00 
D22S274 64 57 52 .9% 0 .40 53.0 0 .22 0.5 0 .28 0.2 -0. 1  0.09 
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Table 25 : Most Likely Lod Scores for Chromosome 22 (Combined Data) 
Locus 
+ 
D225420 8 
225264 37 
D22531 1 29 
D225686 28 
GCT1 0
�
21 
D225315 49 
D225429 30 
D225929 25 
D225 1 1 63 32 
l[mH
89 36 
1 50 31 
D225275 24 
D225273 24 
D225280 36 
D225281 33 
D225685 35 
D225683 42 
D225278 1 8  
D225277 1 8  
225283 1 6  
25445 27 
272 1 3  
3 35 
74 1 2  
Locus 
+ 
D225420 1 9  
D225264 74 
D22531 1 60 
D225686 60 
GCT1 0C1 0 39 
D225315 93 
D225429 52 
D225929 41 
D2251 1 63 55 
D225689 60 
D2251 1 50 50 
D225275 42 
D225273 47 
D225280 64 
D225281j 56 
D225685 61 
D225683 77 
D225278 32 
D225277 34 
D225283 33 
D225445 55 
D225272 24 
D225423 77 
D225274 24 
Paternal 
- % 
1 0  44.4% 
24 60.7% 
25 53 .7% 
20 58 .3% 
1 2  63.6% 
39 55.7% 
1 5  66.7% 
1 2  67.6% 
1 3  71 . 1 %  
1 9  65.5% 
1 3  70.5% 
1 0  70.6% 
8 75.0% 
20 64 .3% 
1 5  68.8% 
23 60.3% 
27 60.9% 
4 81 .8% 
7 72.0% 
9 64.0% 
1 8  60.0% 
5 72.2% 
29 54.7% 
6 66.7% 
"i.2 + 
0.22 1 1  
2.77 37 
0.30 28 
1 .33 32 
2
�
1 6  
1 . 1 4  42 
5. 22 
4.57 1 6  
8.02 22 
5.25 24 
7.36 1 7  
5 .76 1 8  
8 .00 20 
4 .57 28 
6 .75 22 
2.48 25 
3 .26 35 
8 .91  1 3  
4 .84 1 6  
1 .96 1 7  
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- % 
1 1  50.0% 
37 50.0% 
31 47.5% 
25 56. 1 %  
1 8  47. 1 %  
43 49.4% 
26 45.8% 
1 8  47. 1 %  
21 51 .2% 
38 38.7% 
1 9  47.2% 
1 9  48.6% 
1 8  52.6% 
31 47.5% 
29 43 . 1 %  
30 45.5% 
41 46 . 1 % 
1 1  54.2% 
1 5  51 .6% 
9 65.4% 
22 54.2% 
1 5  40.0% 
34 54. 1% 
8 55.6% 
Combined Most -Likely Model 
-
�,' 
21 0 . 1 0 
61  54.8° .25 
59 50.4% 0 .01 
45 57. 1 %  2 . 1 4  
32 54 .9% 0.69 
84 52.5% 0 .46 
41 55.9% 1 .30 
30 57.7% 1 .70 
35 61 . 1 %  4 .44 
57 51 .3% 0 .08 
34 59.5% 3.05 
29 59.2% 2.38 
29 61 .8% 4 .26 
51  55.7% 1 .47 
45 55.4% 1 .20 
54 53.0% 0 .43 
68 53. 1 %  0.56 
1 6  66.7% 5 .33 
22 60.7% 2.57 
1 8  64.7% 4.41 
42 56.7% 1 .74 
21  53.3% 0 .20 
65 54.2% 1 .0 1  
1 6  60.0% 1 .60 
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3.2.2 Replication of Potential Susceptibility Regions 
A genome screen by IMGSAC ( 1998) on 39 multiplex autism families, with 
follow up in an additional set of 60 families, found suggestive evidence of linkage to 
six chromosomal regions. The long arm of chromosome 7 from D7S530 to D7S684 
( 16.6cM apart) was the most significant region, with a multipoint MLS of2.53 (p = 
0.0022) calculated when all families were analysed. When the subset of 66 UK 
families were used, a MLS of 3.55 (p = 0.00057) was detected. Based on the sharing 
probabilities in this region (zo = 0 .05, z1 = 0.50, z2 = 0. 45), the significant linkage 
result in the UK families corresponds to a gene effect (As) of 5. 0. 
Results from our genome scan in the same region showed a maximum lod 
score of 0.62 at the marker D7S684 (Risch et al. , 1999). This result was based on a 
total of 139 families and 147 affected sib-pairs. A slightly more positive result was 
found at marker D7Sl804 (MLS = 0.93 )  which was located 1 0.3cM proximal of 
D7S684. 
Using our Australian sub-set of families we examined 7 markers in the region 
found to be positive by IMGSAC ( 1998). These microsatellites were the same as 
utilised by the IMGSAC group to produce their suggestive evidence of linkage to the 
chromosome 7q region. The results of the analysis are shown in Figure 28. No 
region within this section of chromosome 7 could be excluded from linkage to a gene 
of large effect, with a MLS of 0.62 at D7S684 (Table 26). The MLS calculated using 
the Australian families was equal to that found in the U.S.A. data set. Significant 
excess of sharing was also found at D7S684 for the paternally inherited alleles, when 
compared to a x2 distribution (x2 = 5.40, p = 0.02; Table 26). However, if a 
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susceptibility locus does reside in this region, its effect is likely to be small since no 
suggestive linkage (MLS > I )  was detected at any marker on chromosome 7q. 
Table 26: Most Likely Lod Scores for Chromosome 7 (Austral ian Famil ies) 
Locus Paternal Maternal 
+ - % x2 + - % x2 
D7S524 1 0  7 58.8% 0 .53 8 5 6 1 .5% 0.69 
D7S527 1 0  9 52.6% 0 .05 9 7 56.3% 0.25 
D7S486 7 5 58.3% 0 .33 1 1  7 61 . 1 %  0 .89 
D7S530 8 9 47. 1 %  0 .06 8 8 50.0% 0 .00 
D7S684 1 2  3 80.0% 5.40 5 5 50.0% 0 .00 
D7S2513  6 5 54.5% 0 .09 9 8 52.9% 0 .06 
D7S483 9 8 52.9% 0 .06 1 3  6 68.4% 2 .58 
Locus Combined Most -Likely Model 
+ - % x2 %shr zO z1 z2 MLS 
D7S524 1 8  1 2  60.0% 1 .20 59.3 0 . 1 7  0 .48 0 .35 0.25 
D7S527 20 1 7  54. 1 %  0 .24 57.9 0 . 1 8  0 .49 0 .34 0.21 
D7S486 1 8  1 2  60.0% 1 .20 58.7 0 . 1 7  0.48 0 .35 0.25 
D7S530 1 6  1 7  48.5% 0 .03 50.0 0.25 0 .50 0 .25 0.00 
D7S684 1 7  8 68.0% 3.24 63.7 0. 1 3  0 .46 0 .41 0.62 
D7S2513  16  1 4  53.3% 0 . 1 3  59.7 0 . 16  0.48 0 .36 0.31 
D7S483 22 1 4  61 . 1 % 1 .78 62.8 0 . 14  0 .47 0.39 0.57 
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Figure 28: Chromosome 7q mu ltipoint resu lts using Austral ian fami l ies 
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3.3 Linkage Disequilibrium Results 
Linkage disequilibrium can be used in an exploratory fashion to investigate 
regions of the genome with suggestive evidence of linkage. Using the genotyping 
data from the combined US. A and Australian families, transmission/disequilibrium 
tests (TDT) were run on chromosomes 1 p and 22q to calculate linkage 
disequilibrium. The results from these analyses are shown below (Table 27 and 28) .  
For each marker, the table lists the number of alleles (Al) and the percentage 
of parents who are heterozygous at that position (%Het). The table also lists the 
most significant results on allele transmission frequency at each locus in the form of 
a x
2 score (x
2 Max). 
Table 27: TDT Tests on Chromosome l p  Using All Families 
Locus Al %Het x2 Max 
D 1 S55 l 7 72.0 2 .06 (p = 0 .6 1 9) 
D I S  1 63 1 10  8 1 .5 3 . 85 (p = 0.542) 
D 1 S534 1 2  85.4 2 .5 1 (p = 0.787) 
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Table 28: TDT Tests on Chromosome 22 Using All Families 
Locus Al %Het x2 Max 
D22S420 1 4  65 .6 0 .72 (p = 0.990) 
D22S3 l 5  1 7  79.8 6 .00 (p = 0.4 1 9) 
D22S929 I I  78 .3  4 .45 (p = 0.465) 
D22S1 163 9 76.1 12.34 (p = 0.005) 
D22S l l 50 13 73 .4 3 .77 (p = 0.676) 
D22S275 1 0  80.0 2.28 (p = 0.770) 
D22S273 9 68 .5 2 . 1 3  (p = 0.856) 
D22S280 1 0  79.8 2 .47 (p = 0.752) 
D22S28 I 1 1  83 .5 3 .00 (p = I .OOO) 
D22S277 1 7  86.5 4.00 (p = 0.756) 
D22S278 7 77.0 2 .00 (p = I .OOO) 
D22S283 1 6  86.5 5 . 3 1  (p =  0.2 8 1 )  
D22S272 1 3  66. 1 2 .25 (p = 0. 867) 
D22S423 1 6  83 .7 5 .  83 (p = 0 . 1 7 1 )  
D22S274 1 1  77.5 3 .33 (p = 0.60 1 )  
There was no evidence of linkage disequilibrium between the markers on 
chromosome 1 p and autism, however this could be due to the large inter-marker 
distances (-19cM). In contrast to this, significant linkage disequilibrium was 
detected on chromosome 22q at marker D22S 1 1 63 (P = 0. 005). This marker 
(D22Sl  1 63 )  is only 4.9cM away from D22S929, the marker showing significant 
linkage (MLS ;?: 3 )  to autism in the multipoint sib-pair analysis using the first 90 
US.A. families (see Appendix 6. 1 ) .  These TDT results provide further evidence that 
a susceptibility gene for autism may reside in this region on chromosome 22. 
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CHAPTER 4 
DISCUSSION 
In this study, a large genome-wide screen was conducted by collaborating 
groups from Stanford, USA and Perth, Australia with the aim of detecting 
susceptibility loci for autism. Linkage to markers in genes that may be involved in 
possible pathobiochemical pathways of the disorder was also examined. The project 
is the largest genome screen of autism families conducted to date, with a total of 519 
markers analysed in the initial set of 90 U.S.A. multiplex families and 149 markers 
studied in the second set of 49 U.S.A. multiplex sibships. An additional sample of 
41 Australian families was analysed with 24 microsatellites in regions showing 
suggestive evidence of linkage to autism. The results of this PhD project formed part 
of an overall study whose findings were published recently in the American Journal 
of Human Genetics (Risch et al. 1999; see Appendix 6.3), the Journal of Autism and 
Developmental Disorders (Rogers et al., 1999), and the American Journal of Medical 
Genetics (Salmon et al., 1999). 
4.1 Findings from the Study 
4.1.1 Genome Scan 
4.1.1.1 Susceptibility Loci 
Since the first linkage study in autism, by Spence et al. (1985), there has been 
a number of advances in molecular biology techniques that have allowed genome 
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screens for susceptibility loci to be performed on a much larger scale. However, to 
date, there have been a limited number of linkage and association studies in autism 
and only three published genome scans (in addition to our study) that systematically 
span the entire genome (see section 1 . 8.5). Table 29 shows a summary of the 
positive findings reported in these studies. Only regions displaying significant 
associations or suggestive linkage results (MLS � 1 )  are shown. 
Table 29: Chromosomal Regions Showing Positive Linkages and Associations to 
Autism (NOTE: MLS scores shown in brackets represent those results calculated by 
IMGSAC (1998) using the UK families only). 
Chromosome (Locus) Cytogenctic MLS or Publication 
Position (in cM) TDT y2 
1 - ;:: 1 Bass et al. ( 1 998) 
2 - ;:: 1 Bass et al. ( 1998) 
3 - ;:: 1 Bass et al. ( 1998) 
4 (D4S4 1 2) p l6.3 (4.8) 1 .55  ( 1 . 10) IMGSAC ( 1 998) 
6 (HLA-DRBl )  p2 1 . 3  (56.7) TDT x2 = 19 .8  Warren et  al. ( 1 996a) 
6 (D6S283) q2 1 -23 ( 132.8) 2.23 Philippe et al. ( 1 999) 
7 - ;:: 1 Bass et al. ( 1 998) 
7 (D7S487) q3 l -35  ( 1 35 . 1 )  1 .2 1  Pericak-Vance et al. ( 1 998) 
7 (D7S530) q3 1 -35  ( 144.7) 2.53 (3 .55) IMGSAC ( 1998) 
9 (ABO blood group) q34. l -34.2 ( 138 .  l) 1 . 54 Spence et al. ( 1 985) 
10  (D l0S l 97) ql 1 .2 (5 1 .9) 1 . 36 (0.69) IMGSAC ( 1 998) 
1 1  (c-Harvey-ras gene) p l5 . 5  (6.2) Herault et al. ( 1 994); Herault et 
al. ( 1 995); Comings et al. ( 1996) 
15 (GABRB3 locus) q l l .2-q l2  (4. 1 )  TDT x2 = 28.63 Cook et al. ( 1 998) 
15 (D l 5S l 56) q l  l -q l 2  (9.6) 2 . 5  Pcricak-Vance et  al. ( 1997) 
1 5  (Dl 5 S l  18)  ql4-q2 1 (4 1 . 1 ) 1 . 1 0  Philippe et al. ( 1 999) 
16 (D l6S407) p l3 .3 ( 17.3) 1 . 5 1 ( 1 . 97) IMGSAC ( 1 998) 
16 (haptoglobin) q22 .2  (86.7) 1 .04 Spence et al. ( 1985) 
17 (5-HTTLPR; serotonin) q l l .2-qI2 (57.4) TDT , / = 4.69 Cook et al. ( 1998) 
18  - ;:: 1 Bass et al. ( 1998) 
19 (D l 9S226) p l3 . 3  (24. l )  1 . 37 Philippe et al. ( 1 999) 
1 9  (Dl 9S49) p 1 3 . l (48.2) 0 .99 ( 1 . 1 1 ) IMGSAC ( 1 998) 
20 - ;:: 1 Bass et al. ( 1 998) 
22 (D22S264) q l l (5.0) 1 .3 9  ( 1 . 36) IMGSAC ( 1 998) 
X (DXS424) q24-q26 ( 1 25 . 1 )  1 .24 Hallmayer et al. ( 1996) 
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Our genome scan of 97 affected U.S.A. sib-pairs revealed 1 1  chromosomal 
regions linked to autism with MLS values greater than 1 (Table 3 0). These included 
two regions on chromosome 1 ( 1 p [MLS = 1. 87], 1 q [MLS = 1.19] )  and one region 
on each of chromosomes, 7p (MLS = 1.00), lOq (MLS = 1 .0), 1 lp (MLS = 1.25), 
13q (MLS = 1.49), 15q (MLS = 1.75), 17p (MLS = 1.30), 1 8q (MLS = 1.00), 20p 
(MLS = 1.09) and 22q (MLS = 3.08). While maximum lod scores as low as 1.0 are 
not regarded as conclusive evidence for linkage, they may indicate intervals worthy 
of further investigation (Elston, 1992; Hauser et al. , 1 996). The proportion of 
regions that represent false-positive findings is, however, difficult to assess. Hauser 
et al. ( 1996) demonstrated by simulation that, when studying 1 00 nuclear families 
using a genetic map with an average intermarker distance of 1 0cM, there is a 2.4% 
false positive rate for regions with a lod score of 1. 0. This represents approximately 
8 false positives, on average, in a genome scan of 300 markers. A lod score of 2.0 
represents no more than one false positive in the same data set. In our genome scan, 
where 362 microsatellites were used in the initial analysis (- 1 OcM map), this would 
be equivalent to around 9 false positive localisations using the same assumptions. 
The observation of 1 1  regions with a lod score of� 1. 0 is therefore not different to 
what could be expected by chance. 
To help discriminate between the false positive and genuine results, more 
markers in these regions were analysed in the same group of families, to provide 
more dense or completely different chromosomal maps. The maximum lod scores 
for all the suggestive regions, except those on chromosomes 1 p and 22q, dropped 
below 1. 0 (Table 3 0). It has recently been demonstrated that, for true positive 
localisations, the positive findings span wider genetic areas than false positive 
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localisations of similar lod scores (Terwilliger et al. , 1997). The two chromosomal 
regions showing MLS > 1 with the addition of more markers (regions 1 p and 22q) 
were also flanked by further markers with lod scores > 0 .5 .  This increases the 
probability that these regions represent true positive localisations. 
Table 30: Maximum Lod Scores (MLS) at Regions Previously Suggestive of Containing 
Susceptibility Loci for Autism, After the Addition of More Markers Within the Region. 
Chromosome MLS in Stage 1 MLS in Stage 2 
l p  1 . 87 1 .55 
l q  1 . 1 9  0 .7 1  
7p 1 .00 1 .00 
l Oq 1 . 00 0 .76 
l lp 1 .25 0.90 
1 3q  1 .49 0 .70 
1 5q 1 .75 0.22 
1 7p 1 .30  0 . 8 1 
1 8q 1 .00 1 .00 
20p 1 .39 0 .80 
22q 1 .40 3 .08 
Chromosome 22q 
The original analysis of 6 markers on chromosome 22 indicated that a gene 
might reside in a region on chromosome 22q (MLS = 1 .40), and subsequent analysis 
using a more dense marker map still resulted in positive lod scores. A literature 
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search was undertaken to see if any relevant genes resided in this region. The gene 
for Neurofibromatosis 2 (NF2), designated Schwannomin (SCH), was found to be 
located in this region on chromosome 22 (22q12.2). A marker known to link to NF2, 
D22S929, was analysed for linkage to autism and the calculation of a MLS of3.0 8  
indicates that this gene may be involved in the disorder. 
NF2 is a neurocutaneous disorder characterised by tumours within the central 
and peripheral nervous system (see section 1.5. 1.2). There are many similarities 
between neurofibromatosis and autism. In particular, they are both associated with 
brain dysfunction and mental retardation (Gillberg et al. , 1987; Wadsby et al. , 1989). 
They both show characteristic impairment of cognitive functioning, displaying a 
verbal/language disability (Rutter, 1983 ;  Eldridge et al. , 1989). Two genetic studies 
have also noted an association of autism with neurofibromatosis. Gillberg and 
Forsell ( 1 984) reported mild cases of NF l  in 3 out of 5 1  (6%) autistic children 
collected through a community survey, and Gaffney and Tsai ( 1987) found the 
occurrence of both disorders in 2 out of 14 ( 1 5%) autistic children seen in a child 
psychiatric clinic over one year. However, a study (Mouridsen et al. , 1992) 
comprising 34 1 children with autism and other types of childhood psychoses seen in 
two university clinics of child psychiatry in Denmark (Copenhagen and Arrhus) 
during a 25-year period found only one case (0 .3%) with both autism and 
neurofibromatosis. This sample has a bias of hospital selection with only seriously 
affected individuals who required hospitalization included in the study. This bias, as 
well as the fact that there was no information about the diagnositic criteria used to 
diagnose neurofibromatosis in these subjects, could have resulted in milder cases 
being missed·. Due to these published associations and suggestive linkage between 
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these two disorders in a sub-group of the analysed families in this study, NF2 should 
be considered as a candidate gene in future studies. 
Further evidence suggesting that a gene for autism may reside on 
chromosome 22 comes from the full genome screen for autism by the IMGSAC 
(1998). They calculated a W.,S of 1.39 (59. 7% sharing) in a region close to 
D22S264 (22q 11.2) using all 99 affected sib-pair families. This locus is 
approximately 21.ScM centromeric ofD22S929. When only the UK families were 
analysed, the MLS at this region was 1.36 with 63.7% sharing. Figure 29 shows the 
relative positions of these positive findings on the chromosome 22 cytogenetic map. 
The results from this study are shown in bold. 
Chromosome 22 
13 ® 
1 1.2 
1 1.2 
12.2 
13. 1 
13.3 
I D22S264 
I D22S929 
Ilv!GSAC (1 998) 
[MLS = 1 .39 (1 .36)) 
Risch et al. (1999) [MLS = 0.37) 
US Fam's (MLS • 3.08) 
Aust. + US Fam's [MLS = 2.7) 
Figure 29: Cytogenetic map of chromosome 22 showing positive linkage results 
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To increase the power to detect true positive regions with statistical 
parameters that are significant at the genome-wide level, more families ( 45  
Australian ASPs) were added to the analysis. With the addition of the 4 1  Australian 
families the lod score dropped below the genome-wide significance level to a MLS 
of 2. 7 (D22S929; 22q 12.2). The highest two-point lod score was calculated at 
D22S273 (MLS = 2.47), a marker 6. lcM telomeric ofD22S929. It was also noted 
that with the addition of these families, the MLS scores for the paternally inherited 
alleles were still very positive, with the highest multipoint MLS calculated at 
D22S280 (MLS = 3 .2) and the highest two-point MLS computed at D22S 1 1 50 (MLS 
= 2. 5). The percentage of maternally inherited alleles shared by the siblings, 
however, was not greater than that expected by chance. If a gene resides in this 
region on chromosome 22, it is most probably paternally derived. 
TDT analyses on this chromosome using the combined US.A. (97 ASPs) and 
Australian ( 45 ASPs) data showed significant association between D22S 1 163 and 
autism. This marker is 4.9cM telomeric of D22S929, providing further evidence that 
a susceptibility gene may reside in this region. 
Multipoint linkage results from a further group of 50 affected US.A. sib­
pairs were added to the combined U .S.A. (97 ASPs) and Australian (45 ASPs) data 
on chromosome 22q. The lod scores in chromosome 22q dropped significantly with 
the highest MLS of only 0.37 at D22S929. The percentage sharing over this region 
was still above that expected by chance, therefore a gene of small effect could not be 
entirely excluded from the region on chromosome 22q. 
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Chromosome lp 
Overall, the most significant finding in the present study was on chromosome 
1 p. In the initial analysis of this region with 90 multiplex families, a MLS of 1.55 
was calculated between markers D 1 S 1631 and D 1 S534 (1 p 13 .3). The lod score at 
this locus dropped to 1.21 with the addition of the Australian families ( 45 ASPs ). 
However, with the addition of 50 affected U.S.A. sib-pairs to the original U.S.A. data 
(97 ASPs) already analysed on chromosome 1 p, linkage results showed an increase 
in MLS to 2.15 with 60% allele sharing between the. siblings (results not shown, see 
Risch et al. , 1999 [Appendix 6.3]). Since the lod scores at a region on chromosome 
1 p stayed positive (MLS � 1. 0) with the addition of more markers and the expansion 
on the number of families analysed, this suggests that a gene causing susceptibility to 
autism may reside in this region. 
Preliminary analysis by Bass et al. (1998) on 52 multiplex families also 
identified chromosome 1 as a promising region with the calculation of a lod score � 
1.0. The exact chromosomal position of this finding was not explained in the Bass et 
al. (1998) report, therefore it remains unclear whether the positive region on 
chromosome 1 identified in our study overlaps with that found by Bass et al. Our 
results on this chromosome are shown diagrammatically on Figure 30. 
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Figure 30: Cytogenetic map of chromosome 1 showing positive linkage results from the 
present study 
Possible candidate genes in the 1 p region, expressed in the brain, include 
glutathione-S-transferase 3 (GSTM3) and adenosine receptor A3 (ADORA3). The 
adenosine receptor is of particular interest, since these receptors have been utilised as 
targets for the development of clinically viable drugs against ischaemic brain 
disorders. A gene for Waardenburg syndrome type II (WS2B) has also been mapped 
to this region ( lp l3.3) (Lalwani et al. , 1994). This neurocutaneous disorder is 
characterised by deafness with pigmentary abnormalities, and, like autism, it is 
associated with mental retardation (Fujimoto et al. , 1998). 
1 8 1  
4.1.1.2 Excluded Regions 
Results from this PhD study can exclude an average of94% of chromosomes 
15 ,  1 9, 20 and 2 1  from containing a gene of large effect on susceptibility to autistic 
disorder. Genes of moderate effect can also be excluded from residing in 65% of 
these chromosomes. A gene of moderate to large effect on autism was also excluded 
in the HLA region of chromosome 6 (see section 4. 1.2) and large parts of 17q and 
1 Oq. However, a gene of moderate to large effect on autism could not be excluded 
from possibly residing on chromosomes lp, 7q, 1 8q or 22q. 
Combining the results of the entire genome scan (Risch et al., 1 999), we were 
able to exclude approximately 95% of the genome for a value 001,s = 3.0, using the 
strict exclusion criterion of -2 (Hauser et al. , 1996). Using a less strict exclusion 
criterion of - 1 ,  99% of the genome could be excluded for genes of moderate to large 
effect. Figure 3 1  shows the diagrams of regions from other studies that may contain 
a gene involved in the aetiology of autism, with our results in the same region shown 
in bold. It can be seen from these diagrams that our results exclude chromosome 4p, 
6, l 5q, 1 6, l 9p and Xq from containing an autism-causing gene. However, regions 
on chromosomes 7 q, 9q, lOq, 1 1  p, 17, 22q previously showing suggestive evidence 
could not be formally excluded in this study and should be investigated further as 
possible candidate regions for predisposing loci. 
Chromosome 7 q is of particular interest as a site of susceptibility loci in 
autism, due to the significant lod score (MLS = 3.55) obtained in this region in the 
IMGSAC ( 1999) study (see section 1.8.5.9). This chromosome was also examined 
in detail by Pericak-Vance et al. ( 1998). They examined 7q in 65 multiplex families 
using sib-pafr analysis (SIBP AL), and identified 5 markers showing suggestive 
evidence of linkage (p < 0.05), with their most significant result at D7S2527 (p = 
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Figure 3 1 :  Cytogenetic maps of chromosomal regions showing MLS� 1 (The results of the 
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0.002). A maximum lod score of 1.21 was found at D7S487. A chromosomal 
abnormality has also been identified on chromosome 7 that overlaps the potential 
linkage region identified by IMGSAC (1998). A family with two male siblings who 
have autism (as diagnosed using the ADI), and a female sibling with significant 
developmental delays and expressive language disorder, each have an identical 
paracentric inversion (Inv (7) ( q22q3 l . 2) ). 
4.1.2 Candidate Regions 
The HLA and I Sq 11-q 13 regions were considered as possible candidates for 
containing a gene(s) involved in the aetiology of autism, due to the positive 
association being found in other studies (see section 1.8.5). The results from our 
analysis of these regions have recently been published in relevant journals (see 
Appendix 6.3). 
Linkage results from the analysis of the HLA region on chromosome 6 in 90 
U.S.A. sib-pair families demonstrated that a large to moderate gene effect could be 
excluded for 100% of this region (see section 3. 1.3; Rogers et al. , 1999). With the 
addition of 49 multiplex U.S.A. sibships, the data in this region remained negative 
(Risch et al. , 1999). A gene of small effect (As '.::'.: 2), however, could not be excluded 
from this region. Similarly, TDT analysis did not produce any positive findings (see 
Rogers et al. , 1999; Appendix 6.3). These results do not entirely exclude a possible 
association between autism and the HLA region. However, if an association does 
exist, it must be weak. 
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The reported immunological abnormalities found in autistic children (Warren 
et al. , 1 986; Stubbs and Crawford, 1977; Weizman et al. , 1982; Singh et al. , 1 993; 
Plioply et al. , 1994) are unlikely to be related to susceptibility genes in the HLA 
region. The immune system is  connected to the brain in an integrated regulatory 
circuit, which is only slowly beginning to be understood. One of the integral organs 
in this network is the hypothalamus, which also plays an important role in cognitive 
and emotional processes. An altered immune response during early childhood might 
produce changes in brain development. Although it appears that genes in the HLA 
region have little or no effect on this process, the possibility that genes of 
immunological interest other than HLA might be involved in the pathophysiology of 
autism has not been excluded. 
A paper describing the results of the analysis of 5 markers in the proximal 
region of chromosome l 5q in 90 multiplex U. S.A. families has been published in the 
U.S.A. Journal of Medical Genetics (Salmon et al. , 1999; see Appendix 6.3 ). These 
results exclude this region for the presence of a susceptibility gene of strong or 
moderate effect (As > 2) on autism. Allele-sharing results at marker D1 5S156 
(maximum lod score of2.5 detected by Pericak-Vance et al. ( 1997) in this region) 
was slightly increased in our data (57%), however other nearby markers which were 
more informative (eg. Dl5S822) showed a decrease in sharing (48%). The 
multipoint results across this entire region show no significant increase in sharing 
( 5 1  % ). The International Autism Consortium ( 1998) also scanned chromosome l 5q 
in 39 multiplex families and found no evidence of  a major susceptibility gene for 
autism, consistent with the results presented here. 
The GABRB3 locus revealed linkage disequilibrium in the sample of autistic 
individuals studied by Cook et al. ( 1 998; TDT 28.63 ,  p = 0.0014). A marker within 
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this locus (GABRB3CA) was tested in our families for association with autistic 
disorder. We found no evidence of linkage disequilibrium with GABRB3CA. This 
marker is 250kB distal from the microsatellite (GABRB3 I 55CA-2) at which Cook 
et al. (1998) found suggestive evidence of linkage disequilibrium, therefore the two 
markers may not be in linkage disequilibrium. An association study by Menold et al. 
( 1998) also attempted to replicate the Cook et al. (1998) findings. Using 14 7 autistic 
families, they failed to detect significant linkage disequilibrium between autism and 
the GABRB3 155CA-2 marker. A study by Pericak-Vance et al. (1997), however, 
obtained a lod score of 1. 4 at the GABRB3 locus when analysing 38 sib-pairs and 9 
cousin pairs. Their peak lod score, assuming an autosomal recessive model, was 2. 5 
for the microsatellite marker D l 5S 156, which is located approximately 5cM distal to 
the GABRB3 locus. When non-parametric linkage analysis was employed using the 
affected sib-pair analysis, the lod score dropped to a MLS of 1. 1. 
Our results clearly indicate that, for the majority of affected sib-pairs, there is 
no major autism gene in the 15ql l-q l 3  region. Nonetheless, chromosome 15, in 
particular l 5q 11-q 13, must still be viewed as an area of interest, given the number of 
reports showing association between autism and cytogenetic abnormalities in this 
region. 
4.2 Replication Studies 
For linkage results to be credible, they must be replicated. Failure to replicate 
some of the positive results in one study does not necessarily disprove a hypothesis, 
since genes may have small effects on the disorder, which may turn out to be smaller 
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in a second study if the sample collected selects against this gene. Thus positive 
results may be replicated in some studies and not in others. To assess whether the 
overall evidence for linkage is convincing, a meta-analysis of all studies may be 
necessary. Table 3 1  lists those regions where other studies have suggested a gene 
may reside, but which were not confirmed in this study. 
Table 3 1 :  Susceptibility Loci Not Replicated in this Genome Scan 
Chromosome (Locus) Cytogenetic Position Publication 
4 (D4S4l 2) p l6 .3  IMGSAC ( 1 998) 
6 (HLA-DRBl )  p2 1 .3 Warren et al. ( 1 996a) 
6 (D6S283) q2 1 -23 Phil ippe et al. ( 1 999) 
1 5  (GABRB3 locus) q 1 1 .2-q 1 2  Cook et al. ( 1 998) 
15 (D 1 5S 1 56) q 1 1 -q l 2  Pericak-Vance et al .. ( 1 997) 
1 5  (D 15S l 1 8) q l4-q2 1 Philippe et al. ( 1 999) 
1 6  (haploglobin) q22.2 Spence et al. ( 1 985) 
19 (D 1 9S226) p l 3 . 3  Philippe e t  al. ( 1 999) 
19 (D 1 9S49) p 1 3 . 1  IMGSAC ( 1 999) 
X (DXS424) q24-q26 Hallmayer et al. ( 1 996) 
There could be several reasons why we did not replicate the positive results 
reported by IMGSAC ( 1998), Philippe et al. ( 1 999) and other studies. These 
include: false negative results due to a smaller sample size than required to replicate 
studies, false positive results in the initial study, genetic heterogeneity between data 
sets within or between studies, and differences in the diagnostic criteria used in these 
studies. These points are discussed below. 
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The accurate replication of previous results requires a very large sample of 
families. Suarez et al. ( 1994) demonstrated that the number of families required to 
reliably replicate linkage in a polygenic disease is approximately n(k-1 ), where n is 
the number of sib-pairs that were needed to demonstrate the initial linkage and k is 
the putative number of susceptibility genes. This is the case in autism where it is 
generally accepted that multiple genes are involved in the aetiology. Multiple loci 
that interact to increase disease risk are difficult to detect, since each parent may 
carry several susceptibility alleles and multiple, distinct combinations of these alleles 
might contribute to disease in different children and in different pedigrees. Thus, for 
any one locus, the pattern of allele sharing among affected relatives is variable and 
complex. With smaller samples, statistical support for linkage will vary because of 
random (stochastic) variation in the proportion of families in whom disease is 
associated with inheritance of a particular parental susceptibility allele· (Suarez et al. , 
1994). Therefore some samples will produce significant lod scores in the 
chromosomal regions containing such genes and other samples will produce weakly 
positive or negative scores in the same region. Scores in the same range may also be 
observed by chance in regions that do and do not contain disease genes, making true 
and false positive results difficult to distinguish statistically. 
The type 1 error rate could also have been higher in the initial study (ie. the 
IMGSAC [1998] study). The appearance of positive linkage results in the original 
study could be due to reasons such as the use of multiple testing in the analysis 
(Clerget-Darpoux et al. , 1990). The presence of false positives in the IMGSAC 
(1998) and Philippe et al. ( 1999) studies could be a reason why these results were not 
found in ou( genome scan. 
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The failure of replication between these studies could also be due to the 
different populations utilised in the analysis. The failure of replication between 
populations can be explained by inter-ethnic genetic heterogeneity, in which 
predisposing genotypes and their interaction with the surrounding environment may 
vary between populations (Risch and Botstein, 1996). 
4.3 The Genetics of Autism - An Overview of Findings to Date 
This study was designed under the assumption of an oligogenic model of 
inheritance, with 2 to 6 susceptibility loci involved in the aetiology of autism. The 
detailed and comprehensively defined nature of this project should have led to the 
detection of these loci if our hypothesis was true. The results from the study show 
that our hypothesis is most unlikely and they do not support the assumption of a 
small number of loci (see Risch et al. , 1999). 
Using the results from our genome scan, a statistical analysis was performed 
assuming a multiplicative epistatic model of inheritance to determine the number of 
loci most probably involved in this disorder (Risch et al . ,  1999). The data most 
closely approximate the expectations for a model with 20 susceptibility loci, with 
models involving :::;10 loci unlikely and those with �15 more plausible. These results 
are consistent with the observed recurrence risks between siblings and twins. The 
very high (25-fold) MZ:DZ concordance ratio is also indicative of the involvement 
of multiple interacting loci. Our results also show that whilst a multi locus 
inheritance model does not preclude the possibility of one or a few loci with larger 
effects, these effects can not be too large given the non significant linkage results that 
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were found. Our genome scan therefore reveals that the inheritance pattern for 
autism is multigenic, with :?: 1 5  susceptibility loci, each with a small effect on disease 
risk (As < 2), most probably involved in the aetiology. These results go against the 
Pickles et al. ( 1 995) model for autism which suggested that 3 interactive loci were 
involved in the aetiology of autism, with a range of2- 1 0  loci probable (see section 
1. 7). The results of Pickles et al. ( 199 5) were based on pro bands with a broad 
autistic phenotype, whereas our findings were based on individuals with a "core" 
diagnosis of autism. 
No chromosomal region with significant evidence of linkage (MLS>3) was 
identified in the present study, however the possibility of one or more susceptibility 
loci of moderate effect on the disorder could not be excluded. On the basis of our 
results, the most likely location for such a locus or loci is on chromosomes 1 p and 
22q. Our results could also not exclude chromosomes 7 q, 9q, 1 Oq, 1 1  p and 17, 
regions previously suggested by other studies to contain disease-predisposing loci. 
Whilst none of these regions show linkage results above the genome-wide level of 
significance, the calculated lod scores are above 1 and therefore the regions should 
be considered in future studies as candidates for further analysis. Figure 32 shows 
those regions most likely to contain autism-predisposing loci, with our results shown 
in bold. 
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Figure 32: Cytogenetic maps of chromosomal regions most likely to contain suscP,J)tibility 
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4.4 Reliability of Results 
The genome scan conducted by the Stanford and Perth groups was designed 
to maximise the chance of detecting a gene of moderate to large effect on 
susceptibility to autism. The important features of the study design include: (a) a 
statistical method that reduced ascertainment bias; (b) collection of a homogeneous 
set of families; (c) a map of highly polymorphic markers; (d) use of positive controls 
throughout the genotyping; and (e) a robust, multipoint model-free method of 
analysis. Problems do exist, however, with the current linkage maps and the 
statistical programme used. Whilst the concept and design of this project provide 
confidence in the validity of our conclusions, these problems should still be 
considered. The design of this study and the problems that exist are discussed below. 
4.4.1 Ascertainment 
Historically, it has been assumed that the mode of ascertainment used in 
obtaining data for linkage studies does not have any effect on the results, provided 
that individuals were sampled on the basis of trait data and not marker genotypes 
(Cox Matise et al. , 1996). However, studies by Vieland and Hodge ( 1995, 1 996) 
have shown the effect of ascertainment on maximum likelihood estimates of genetic 
parameters. These authors claim that the most commonly used ascertainment 
schemes for linkage studies (non-single ascertainment and proband-dependent 
sampling, in· which the observed pedigree structure depends upon who the pro bands 
were) result in asymptotically biased estimates of genetic parameters, for example 
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the recombination fraction. Although this bias is small in many situations, the 
calculated maximum likelihood based on the observed data can not be corrected to 
accommodate the bias. This project was designed to avoid the bias effect shown by 
Vieland and Hodge ( 1995, 1996), by utilising a statistical method that did not require 
the estimation of genetic parameters. 
The ethnic origin of the families used could have affected the detection of 
significant linkage in this study. By restricting the study to individuals likely to be 
descended from a small founding population, a group of related individuals with a 
reduced number of genetic and allelic contributions. to the disease can be identified. 
A homogeneous group of strictly defined affected subjects should maximise the 
chances of detecting linkage for any plausible genetic model (Risch et al. , 1 999). 
Our sample contained 88% Caucasian, 5% African or African-U.S.A., 3% Hispanic, 
and 4% Asian in the U.S.A. sample of families. In the Australian group, the families 
were primarily Caucasian. Although the majority of subjects included in the genome 
scan were Caucasian in origin, they can not be classified as a homogeneous 
population since they are of varied European and Middle Eastern background. 
An example of a relatively homogeneous population isolate would be 
families in the Botnia region of western Finland. This isolated population contains 
Swedish-speaking inhabitants surrounded by a larger Finnish-speaking population, 
and was believed to have been settled over 1 ,000 years ago, with little immigration 
until at least the middle of the 14th century (Virtaranta-Knowles et al. , 199 1 ). This 
population has been used in search for inherited diseases including non-insulin 
dependent diabetes mellitus (NIDDM; Mahtani et al. , 1996) and diastrophic 
dysplasia (DTD; Hastbacka et al. , 1992). 
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How the families are grouped together in the analysis also has an effect on 
the power of the overall study. Whilst it is generally accepted that an individual 
must inherit more than one gene in order to express the autism phenotype (see 
section 4.3), there are multiple ways in which these genes could interact to produce 
the phenotype. For example, the same genes could act together in every instance or 
they could work together in different combinations to cause autism. In the later 
scenario, there may be considerable variation from family to family with respect to 
which genes the affected individual has inherited. Another possibility is that a 
certain number of ' core' genes are required for autism, with several other genes 
influencing the severity or the expression of the phenotype. This could explain why 
the severity of autism varies widely from one affected individual to another. It could 
also explain the variance within families, where two siblings with autism may have 
significantly different language and cognitive abilities, while their parents or other 
siblings may have only social constraints or a preference for routines. How the genes 
interact is important in the analysis of the families. If individuals with different 
causative genes are grouped together, the overall power to detect one or more of 
these susceptibility loci is reduced, especially if the loci have a small effect on the 
disorder (As :S: 2). 
4.4.2 Diagnostic Criteria 
Subject misclassification has been proven to affect genetic linkage analysis 
(Ott, 1991). Problems ofphenotypic definition and diagnostic accuracy are 
particularly important in genetic studies of psychiatric disorders. For this reason, this 
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study adopted a conservative approach to phenotyping. Good inter-rater reliability 
was observed for the first 44 multiplex families. The kappa coefficient between our 
evaluators for autistic vs. non-autistic groups was 0.90. Both ADI and ADOS were 
used to evaluate the children and any questionable cases were excluded from the 
study. A total of 45  families were excluded from further analysis. One reason for 
exclusion of some families was that the second affected sibling did not have a strict 
diagnosis of autism by agreement of all diagnosticians. 
Another reason for the exclusion of a family was low mental age or extremely 
low IQ scores observed in all affected children. This approach was adopted to avoid 
the difficulty in diagnosing autism in the very young or in profoundly retarded 
children. It also helped to reduce potential heterogeneity in the sample. Families 
with more than one child with both autism and low IQ scores may have distinct 
aetiologies related to their severe to profound mental retardation. However, one 
could also argue that, by excluding these families, which could represent the more 
severe forms of autism caused by genes with a larger effect, the ability to detect 
susceptibility genes is reduced. 
The stringency of the design means that the families in this study included no 
broadly-defined, questionable, or mild cases (eg. clinical diagnoses of PDD-NOS or 
Asperger's  Syndrome). This was done in order to enhance the chance of detecting 
linkage by creating a more homogeneous set of families, as well as to gain 
confidence that any false negative or false positive results obtained would not be due 
to using too broad a diagnostic spectrum whose genetic basis is still uncertain. As 
stated previously, a homogeneous group of strictly defined affected subjects should 
maximise the chances of detecting linkage for any plausible genetic model (Risch et 
al. , 1 999). However, some investigators argue strongly for the inclusion of "mild" or 
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autism "spectrum" cases in genetic studies, which would increase the number of 
families in the analysis, and in turn the number of informative meioses. However, 
including individuals with a mild or less strict diagnosis of autism in the analysis, 
while increasing the power of the study, may also increase the probability of false 
positive results. The present study was designed to establish a balance between the 
power to accurately discover true linkage results and the rate of false positive 
findings. 
4.4.3 Linkage Maps 
In the design of this type of project, problems with current linkage maps and 
the distances between microsatellites could limit the detection of genes of moderate 
to large effect on a disorder. The average spacing between the autosomal markers 
analysed in stage one of this study was 10cM, assuming a sex-averaged total 
autosomal map length of 3500cM. Spacing of 20cM has been shown to be more 
efficient than either a 10 or 40cM in the context of screening for a simple dominant 
trait using affected relative pairs (Brown, Gorin, and Weeks, 1994). However, for a 
complex disease, a map density with a mean separation of 10-20cM probably gives 
the optimal balance between "effort" and power (Hauser et al. , 1996). Morton 
(1996) also found that it is preferable to increase sample size rather than marker 
density, since applying ever more dense sets of markers to the same cohort of 
families does not help to narrow potential domains. The effects of increasing marker 
map density liave been explored by other studies, both theoretical (Hauser et al. , 
1996; Holmans and Craddock, 1997; Chataway et al., 1998) and experimental 
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(Davies et al. , 1996). Using computer simulations, Hauser et al. ( 1996) showed that 
the most efficient way to type sibling pairs was with a 10-20cM map, with 
subsequent follow-up of regions of interest. This two stage method was employed in 
our study. 
The design minimises the chance of a missed linkage within the interval 
between flanking markers. Similarly, a linkage study of diabetes showed that 
saturation mapping of the 6q region increased the MLS from 2.2 to only 2.4 for a 
change in marker density from 8 to 2.5cM (Davies et al. , 1994). Simulations by our 
group on 100 families have also shown that, by increasing the map density from 
10cM to 5cM, you can only expect to exclude an additional 5% (87% to 92%) of the 
genome for susceptibility loci of As = 2 (see Table 7). When 200 families are 
analysed, increasing the map density from 1 OcM to 5cM has a minor effect (99% to 
99%) on the proportion of the genome that you could expect to exclude. Hauser et 
al. (1996) stated that, unless the actual sibling population was dramatically 
expanded, a dividend from the effort involved in typing more markers over a region 
of interest was unlikely to be obtained. They recommended using singletons with 
parents and additional affected siblings, when possible, for transmission 
disequilibrium testing. 
Errors in the order and distances between markers on a linkage map affect the 
probability of detecting linkage. Accurate construction of meiotic maps requires the 
use of correct data in the analysis (Buetow, 1991 ). In the database used to construct 
the CEPH consortium map of chromosome 1, errors occurred at a rate of 0.6% for 
genotypes at the same locus, even after extensive data checking by individual 
laboratories. In version 4 of the CEPH data for chromosome 4, errors were detected 
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at a rate of 1.4% for genotypes at the same locus produced by different laboratories 
(23/817 discordant pairs). 
Since more genotypes are necessary for the construction of high-resolution 
maps, the opportunities for the above mentioned primary errors increase. A typing 
error that negates a true recombination event or introduces false recombination 
events could have a large effect on a meiotic map by substantially reducing the 
accuracy of the resolved map order (Buetow, 1991 ). Since it is unlikely that even the 
most rigorous laboratory quality-control procedures wil I be successful in eliminating 
all erroneous observations from a data set, high-resolution linkage maps should be 
used with caution. However it should also be noted that studies by Hauser et al. 
(1996) have shown that multipoint analysis is robust to errors in the map distance 
between the flanking markers, except when the errors are extreme. 
Another problem of current linkage maps is the lack of microsatellite markers 
near the telomeric and the centromeric regions of chromosomes (Wintero et al. , 
1992). Whilst minisatellites or variable number of tandem repeat (VNTR) 
polymorphisms are preferentially clustered at the telomeric regions of chromosomes 
(Royle et al. , 1988) or localised near the centromeres (Willard et al. , 1986), 
microsatellites are mainly distributed throughout the chromosomal arms. To ensure 
that resolution is sufficiently high to be of use in the identification of polygenic 
disorders, VNTRs are very important in the finalisation of a genetic map. 
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4.4.4 Reliability of Genotyping 
Errors in genetic linkage data can occur because of errors in the pedigrees or 
during genotyping. A pedigree error usually involves misidentification of 
individuals and relationships (Ott, 1 99 1 ), for example nonpatemity, unidentified 
adoption, and sample mix-ups. Typing errors include the misinterpretation of 
genotypes and data-entry errors (Buetow, 199 1  ). Pedigree errors were minimised in 
this study since the parents were included in the analysis, allowing Mendelian 
segregation to be checked in all families. 
A number of controls were employed in our analysis to identify potential 
typing errors (see section 3. 1. 1 ). The error rate was found to be 1.0% for the entire 
genome scan and 1 .2% for those genotypes analysed as part of this PhD project. 
This result is comparable to other studies, such as the Levinson et al. ( 1 998) 
schizophrenia genome scan which found results concordant in over 99% of subjects, 
and the Lathrop et al. ( 1 983 ) study that estimated a typing error frequency of 1 % in 
data obtained from a population study in the south Pacific island, Tokelau. The 
estimated reliability of these results should provide confidence in their validity. 
4.4.5 ASPEX Programme 
Another factor that may have an effect on the reliability of our data is the 
statistical programme utilised. The computer package used throughout this genome 
scan was the identity-by-descent (IBD) programme of the ASPEX package. This 
programme uses only unambiguous IBD sharing to compute a multipoint lod score 
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(maximised over As), as well as an exclusion map along each chromosome. Whilst 
our analysis of marker DXYS 154 located in the pseudoautosomal regions showed the 
programme to be sufficiently sensitive to detect a significant excess in sharing, when 
present ( see section 3 .1 .1 ), there are a few shortcomings with the package that should 
be noted. Firstly, the number of parents typed per family affects the detection of 
linkage using the ASPEX-IBD programme. A study by Davis and Weeks (1997) 
comparing 23 different statistics from a total of 10 popular software packages for 
model-free linkage, found that when only one parent was typed in a family structure 
including only two affected siblings, the power to detect linkage dropped by over 
fifty percent (Figure 33a). When other siblings were included in the analysis, the 
parental genotypes could be reconstructed and the loss of power was lower (Figure 
33b). In this genome scan, 23 out of the 90 U.S.A. autism families had only one 
parent available for typing. Fifteen of these families had no unaffected siblings that 
could be used to reconstruct the parental genotypes. In the other 8 families, the 
majority (six) had only 1 unaffected sibling, which was not always adequate to 
reconstruct the parental genotypes. 
Secondly, the false positive rate for the ASPEX programme generally 
exceeds the nominal significance level of 0.05 (Figure 34 a and b). In the above 
mentioned study, Davis and Weeks (1997) found that the highest false positive rates 
in the ASPEX.IBD programme occurred when a family structure that included four 
siblings (at least two of which were affected) and one typed parent (at2. lunt) was 
used. Therefore, although the power to detect linkage was lower in families with 
only 2 affected siblings and one parent typed, the rate of false positive results was 
less using this family structure. 
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Davis and Weeks (1997) concluded in their study that the most powerful 
statistic for affected sibling linkage methods was SIB-PAL sage.asp. This statistic 
was reasonably powerful for all situations tested in the study, and they agreed with 
others who suggested that the ti test implemented in sage-asp is powerful and 
theoretically sound (Blackwelder and Elston, 1985; Knapp et al. , 1994). 
100 ,-���-�����-�----��-�---,----�===.-, 
90 . .  -------- ---·- -·--····--········-·--·--·-·-······ ··-· -······· ... -·-··-·----·-·-· ---------·-- ·-· 2o.1unt -· 
� 20 
Cl> 80 
70 
60 
50 
40 
(D 
3
0 
20 c. 
10  
0 
,a ..?;, QI Cl- � � � � E C: = ..i,: 0 '5. C: ui M ci c,; ci 
� 
)( 1 al ., ,:,;. .! 
� 
QI )( Ol .c:i c. 7ii C: iii = QI 'a ft g. C1) II) al 
0 
� 
N :g 'a � :a c. c. c. ui � ] .s::. ;g 
� i 
Cl 
:i 
IO 
ui 
:i al Cl) Ol 
Ol 
:g ! (.'II iii i i c. .s::. � ., Ill oi 
� 
2o.2unt __ _ 
[ 
Ill 0 
e, 
al Q) 8. 
� 
� 
100 ,8�������������������-,, ...... ��-.. 
--------···--·----··-···---·-----------·------------! � :�:J��� - · 90 m 80 
1 70 
:::J 60 
j 50 
.S 40 
J 
3
0 
.... 20 
1 0  
>--- - · -· - -- - - ._ ___ _. 
I 
0 -i---4J<lla...i..µ:IIU.µ21L.4fdiU,µalll..l.µIII!.: 
Figure 33: Power to detect linkage. Statistics are ordered in decreasing rank, by power. A, Family 
structure included two affected siblings and their parents, with zero ("2o"), one ("2o. l unt"), or both 
("2o.2unt") parents untyped. B, Family structure included four siblings, at least two of whom were 
affected, and their parents, with zero ("at2"), one ("at2. lunt"), or both ("at2.2unt") parents untyped. 
(Figure from Davis and Weeks, 1997) 
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Figure 34: False positive rates. Statistics are ordered in decreasing rank, by power. A, Family 
structure included two affected siblings and their parents, with zero ("2o"), one ("2o. l unt"), or both 
("2o.2unt") parents untyped. B, Family structure included four siblings, at least two of whom were 
affected, and their parents, with zero ("at2"), one ("at2. lunt''), or both ("at2.2unt") parents untyped. 
(Figure from Davis and Weeks, 1997) 
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4.5 Implications for Future Studies of the Genetics of Autism 
In light of our conclusions that autism is caused by multiple genes, each with 
a small effect on the disorder, other study designs and methods of detection may 
need to be utilised to detect these genes. In a recent perspective, Risch and 
Merikangas ( 1996) and Camp ( 1997) demonstrated that linkage analysis was likely 
to be successful only for loci with As values in the range of 4 or larger, but not for 
loci with As values of two or less. Detection of these small genetic effects using sib­
pair analysis could require larger samples than are currently available to any 
independent research group, perhaps 500- 1 OOO pedigrees (Hauser et al. , 1996; 
Kruglyak and Lander, 1995). This may be achieved if researchers pool their samples 
and data through large multicentre and multidisciplinary projects. A simultaneous 
evaluation of all available data with unified methods of analysis (same diagnostic 
techniques, markers and statistical analyses) may help to eliminate some genetic 
models for this disease, as well as define the most promising chromosomal regions 
for follow-up. 
Other methods exist that may also assist in the detection of susceptibility 
genes in autism. Examples include: using an alternative phenotype than the disease 
itself, examining family structures other than affected sib-pairs and their parents, 
analysing candidate genes within regions showing susceptibility to autism and/or 
scanning the entire genome for association of single nucleotide polymorphisms 
(SNPs) to disease loci. The positive linkage results found by genome scans using 
sib-pair analysis could be used as candidate regions in these future analyses. 
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4.5.1 Refining the Phenotype Definition 
By choosing a single trait within the illness as the target of genetic research, 
especially one that is principally accounted for by the effect of a major gene, the 
deficit should approximate a classical Mendelian pattern of segregation in families 
and increase the power to detect linkage. This strategy has not been widely exploited 
in psychiatric research (Freedman et al. , 1999). Since autism may result from 
different influences, some of them genetic and others environmental, each of the 
genetic traits should have its own biological phenotype that contributes to the 
pathogenesis of the illness. If this phenotype can be recognised independently from 
the full clinical syndrome, then the genes underlying the phenotype could be easier to 
detect and give a clearer understanding of the genetic, neurobiological, and 
neuropsychological basis of autism and related disorders. 
This principle is illustrated by the study of families affected with 
haemochromatosis. Certain individuals were noted to have increased serum ferritin 
levels, and it was established that these serum levels were related to the presence of 
the major gene responsible for the illness (Borecki et al. , 1990). A few gene carriers 
had haemochromatosis, whereas many other gene carriers had only elevated serum 
ferritin levels. If a similar measurement were available for autism, then its presence 
could be used as an alternative phenotype for the illness itself. 
There are several potential advantages to such alternative phenotypes. 
Firstly, they greatly increase the power of genetic analysis, because they allow 
consideration of all members of the study. For autism there are no diagnostic criteria 
for parents and no clear cut way of establishing whether parents and siblings affected 
by milder subclinical forms of the disorder are unaffected or have a different degree 
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of the same condition. In the present statistical models, these family members are 
considered unknown, compromising the chance of determining the location of 
abnormal alleles by linkage. By using an alternative phenotype all abnormal 
members of the pedigree could be identified, increasing the amount of data derived 
from the pedigree. It has been estimated that hundreds of sib-pair families are 
needed for sufficient power to find genes related to autism, however if a sub­
phenotype definition with, for example, an autosomal dominant inheritance is found, 
linkage could be detected in as few as 20 families (Freedman et al. , 1999). 
Secondly, possible biological differences between autistic probands could be 
detected. If different groups of patients had entirely different genetic predispositions 
but showed the same clinical phenotype, an alternative phenotype could discriminate 
between the two groups and select for a biologically more homogeneous set of 
patients, thus increasing the overall probability of detecting linkage. 
One such alternative phenotype in autism could be cognitive impairment. 
Family studies have shown that the relatives of people with autism are affected by 
milder sub clinical forms of the disorder, with a particularly high rate of cognitive 
deficits (see section 1.5.2.3). There are four cognitive processes known to be 
impaired in autism. These include theory of mind, executive function, central 
coherence, and structural language skills. By examining the patterns of segregation 
of these deficits in families, DNA markers may be found that link to these 
impairments. Identifying the genetic basis of these cognitive deficits would greatly 
assist in the early detection of children in high-risk families, so that early remediation 
programmes could be implemented. Alternative phenotypes could also provide a 
clearer understanding of the genetic and neurological basis of autism. 
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4.5.2 Alternative Family Structures 
4.5.2.1 Cousin Pairs 
Affected relative pairs that are more distantly related, for example cousins, 
contain more information on linkage than affected sib pairs if the susceptibility allele 
is rare (Badner et al. , 1998). This is because more distant relatives share fewer 
genes/markers (::s;25%) by chance than sibling pairs (50%), and those they do share 
that are identical by descent (IBD) are likely to be linked to the susceptibility locus. 
Also, since the power to detect genetic linkage is dependent on both the relationship 
of the affected pair and the number of pairs in the sample, the number of families 
needed to achieve the same power as the sib-pair approach is significantly smaller 
(Teng and Siegmund, 1997). 
This approach would be useful in eliminating some of the irrelevant loci 
located using the sib-pair approach. Unfortunately, since cousin-pairs are quite 
uncommon, it is unlikely that enough cousin-pair families could be collected to 
provide sufficient power to detect susceptibility loci in a whole genome scan. What 
must be kept in mind is the fact that any gene located through this method is 
generally going to be a single gene with a large effect, since cousins have only a 
slight chance of sharing all of the genes that may be needed to cause this disorder. 
4.5.2.2 Pairs Discordant for Disease 
Ifwe assume that the genes contributing to autism have some detectable 
behavioural manifestation, such as cognitive function (see section 4.5.1), siblings 
extremely discordant for a specific trait may be used as another appro_ach to eliminate 
false positive linkage results detected using the sib-pair method. Discordant sib-pairs 
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are used to detect loci by assuming that allele sharing between these siblings will be 
significantly less than expected by chance (as opposed to linkage, which assumes the 
opposite). A discordant sib-pair is chosen by selecting an unaffected sibling who has 
no identifiable autistic-like social or cognitive traits, and an autistic individual from 
the same sibship. For such extremely discordant sib-pairs, the chromosomal regions 
of reduced allele sharing would likely contain the genes that cause autism. 
The number of sib-pairs required for this method is far fewer then those 
needed in methods that rely on pairs concordant for the phenotype (ASP method). 
Risch and Zhang (1995) have shown that a sample size I 0- to 40-fold smaller would 
be sufficient. This approach has also been shown to be the only method that is 
uniformly powerful regardless of how the disorder is inherited (with the exception of 
rare recessives), whether genes are common or rare in the population, and whether 
there are multiple genes or only one (Folstein et al. , 1998). 
However, there are some limitations to this approach. Firstly, it was 
suggested by Folstein et al. (1998) that only approximately 35% of siblings are 
expected to have none of the traits that signal the presence of an autism gene, so 
many families will need to be screened to obtain a large enough sample size of 
discordant pairs. Secondly, there may not presently be adequate methods to detect 
all of the traits and behaviours resulting from genes that contribute to the autism 
phenotype. For example, some contributing genes may have no behavioural 
manifestations at all. Therefore, distinguishing between individuals who are 
concordant or discordant for a trait is not clear-cut in the majority of cases. Unless 
quantitative trait loci (QTL) can be identified for autism and the extreme phenotypes 
can be accurately identified, this procedure has limited applications for use in 
identifying the genes that cause autism. 
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4.5.2.3 Extended Families 
Another alternative family structure includes families with multiple affected 
individuals. The proportion of extended families with several affected individuals is 
small for autism. For those that do exist (see Figure 35), autism will generally be 
caused by one gene. If traditional genetic linkage methods were to be used to 
identify the causative genes, autism research groups from around the world would 
have to collaborative to obtain a sufficient number of such families. A new approach 
has been developed that requires only a few affected individuals from a single 
extended family to identify susceptibility loci. This approach is called "shared 
segment analysis" and involves the pooling of DNA from all the affected individuals 
followed by a search for segments with reduced diversity, ie. where the same marker 
alleles are shared by the pooled samples (Sheffield et al. , 1997). This approach, 
however, has only been used successfully in locating genes for rare recessive 
disorders, and as yet has not been used with multigenic diseases. 
Figure 35: Autistic family with multiple affected individuals 
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4.5.3 Association Studies 
Linkage analysis carries an advantage over association studies in that it 
extends over greater genetic distances and may therefore be detected using fewer 
markers. However, association has the advantage that it is considerably more 
powerful than linkage for genes with a small genetic influence (As < 2) and therefore 
requires smaller study populations (Table 32). This is especially the case if there is a 
marker extremely close to or within the disease locus, and if polymorphisms of 
functional significance are used (Spielman et al. , 1993). For example, Risch and 
Merikangas (1996) showed that in a genome-wide association study using the 
transmission-disequilibrium test, 695 parent-child trios provide 80% power to detect 
an allele with a population frequency of 0 . 1 ,  assuming that it confers a two-fold 
increase in disease risk in the heterozygous state ( compared to homozygosity for the 
more common allele). This compares with a requirement of 5382 affected sib pairs 
for a model-independent linkage study (Table 32). Since trios are easier to ascertain, 
this difference is enormous. 
Table 32: Comparison of Number of Sib-Pairs Required for  Linkage vs. Association 
Studies. 
Genotype relative 
risk (GRR) 
4 
2 
1 .5 
Population 
Frequency of 
mutation (p) 
0 .0 1  
0 . 1  
0 .0 1  
0 . 1 
0 . 0 1  
0 . 1 
Linkage TDT 
(sib-pairs) (trios) 
4260 1 098 
1 85 150  
296,7 1 0  5 823 
5382 695 
4,620,807 1 9,320 
67, 8 1 6  22 1 8  
(Risch and Merikangas, 1 996) 
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In autism, genetic studies have been carried out using linkage analysis with 
no single major locus being found. The suggestions that the genetic basis of the 
disease is controlled by a number of loci of modest effect indicate that genome-wide 
scans for linkage will probably be ineffectual. Other approaches, such as the 
candidate gene approach and/or genome-wide association studies, may be required to 
detect these susceptibility loci. 
4.5.3. 1 Candidate Gene Approach 
Once a candidate region has been defined and then replicated by another 
research group, the candidate gene approach could be used to search for sequence 
variants. The choice of gene(s) that are most likely involved in the predisposition to 
the disorder among the many genes mapped in that interval (there could be up to 
several hundred), is based on their hypothetical function, expression pattern and so 
forth. In the case of autism these genes could be selected on the basis of known or 
expected role in brain development. More than 30,000 human genes, or Expressed 
Sequence Tags (ESTs), have been placed relative to a framework map as part of the 
Human Genome Project (HGP). These maps are very important for the successful 
identification of susceptibility genes for complex disorders. However, finding the 
DNA sequence variation that confers risk for a complex disorder, such as autism, 
will be more complicated than identifying the mutation responsible for a single gene 
disorder. 
Chromosomal rearrangements or null mutations that abolish the function of a 
protein are unlikely to be found in complex disorders. More subtle sequence 
variations, such as amino acid substitutions producing a different protein isoform, 
can be fairly common in the general population and are more likely to represent the 
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susceptibility alleles in complex disorders. One such allelic sequence variation has 
been identified to cause susceptibility to the psychiatric disorder Alzheimer disease. 
This allelic sequence variation is in the apolipoprotein E (APOE) gene, and is 
referred to as the APOE-E4 allele. Different dosages of this allele have been shown 
to increase risk and decrease the age of onset in both late-onset familial Alzheimer 
disease and sporadic Alzheimer disease (Pericak-Vance and Haines, 1995). 
In other cases, the susceptibility allele could lie outside the gene-coding 
region and influence the levels of expression and the regulation of the gene. This has 
been shown in insulin-dependent diabetes (IDDM) where sequence variation at a 
minisatellite 5' to the insulin gene influences susceptibility to the disease (Bennett et 
al. , 1995). 
Singletons could be used to find the sequence variants in the genes identified 
as candidates for autism. These families, sometimes referred to as trios when both 
parents are used in the analysis, contain only one autistic child and are by far the 
most frequent type of autism family (-97%). Cook et al. (1997b) used trios to 
determine whether two distinct polymorphisms of the serotonin transporter gene 
(HTT) were associated with autism (see section 1.8. 5.8). Genes that regulate 
serotonin biochemistry are likely candidates for causing autism, due to the inefficient 
serotonin metabolism and defective brain receptors for serotonin found in autistic 
individuals (Cook et al. , 1997b ). A number of genes that have been identified and 
characterised are involved in this system (Table 33). Those that correspond to 
regions replicated by multiple groups could be used as candidate genes for further 
study. 
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Table 33: Chromosomal Positions of Some Serotonin Receptors 
Serotonin Receptor 
5-HTiA 
5 -HTIB 
5-HTrn 
5-HTIE 
5-HT2A 
5-HT28 
5-HT2c 
5-HT3 
5-HT4 
5-HTsA 
5-HTsB 
5-HT6 
5-HT1 
5-HTT 
4.5.3.2 Single Nucleotide Polymorphisms 
Chromosome 
5 
6ql 3  
l p35 
6q l 4- 15  
3p 
1 3q l4 .  l - 14.2 
2q36 .3-2q37. l 
Xq2 1 
l l q23 .  l -q23 .2 
5q 
7q36. l 
2q l l -q l 3  
lp35-36 
l Oq 
17ql l . l -q l 2  
(Cook and Leventhal, 1 996) 
As previously mentioned, association studies are limited in that the gene(s) 
must be tentatively identified before the test can be performed, and the actual 
polymorphism within the gene ( or one in strong disequilibrium) must be available. 
Therefore, at present, genome-wide association studies are not feasible. However, 
with advances in the Human Genome Project (HGP) aiming to identify the majority 
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of human genes ( 50, 000-100, OOO) and the simple, biallelic polymorphisms (SNPs) in 
these genes, Risch and Merikangas ( 1996) propose that association to genes with As 
as low as 1.5 could be obtained with a significance level of 5x10·8 . SNPs are single 
nucleotide polymorphisms present throughout the genome in great abundance. These 
markers can be typed using high-throughput, low-cost automated genotyping 
technologies, such as DNA chips. SNPs throughout the entire genome can then be 
scanned for association to disease loci in many families in a fast and effective 
manner. With new advances in technology, the genes to autism may eventually be 
identified. 
4.6 Conclusions and Outlook 
Given the power of this study to reliably detect genes of moderate effect 
(As>3.0, see Table 5), the findings shown here and in the overall genome scan (Risch 
et al. , 1999) provide substantial evidence for the absence of such genes. The data 
were most consistent with a model of :2: 15 susceptibility loci, each with a small effect 
on the disorder. Regions that may contain disease-predisposing loci, however, were 
identified. These include: regions on chromosomes 1 p and 22q. Results from other 
smaller genome scans also indicate these regions as possible candidates for loci 
involved in the aetiology of autism. Our results could also not exclude chromosomes 
7q, 9q, lOq, l lp and 17, which have previously been suggested to contain 
susceptibility loci. 
These results are important for future studies. In particular, they have shown 
the requirement for a large sample size to detect genes of small effect. By combining 
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our data with those from the other linkage studies on autism (IMGSAC, 1998; 
Philippe et al. , 1999) there may be sufficient power to produce a significant linkage 
result. A simultaneous evaluation of all available data with unified methods of 
analysis may help to eliminate some genetic models for this disease, as well as define 
the most promising chromosomal regions for follow-up. Replication of promising 
loci could be achieved using a number of methods, including samples with different 
family structures, such as cousin pairs, extremely discordant sibling pairs and 
extended families. If these approaches fail to detect susceptibility loci, other 
methods such as the use of alternative phenotypes, linkage disequilibrium studies of 
candidate genes, and/or genome-wide association studies using SNPs may be 
required. 
With advances in the Human Genome Project, the development of rigorous 
statistical approaches to the analysis of multifactorial diseases, and the availability of 
new technologies for the high-throughput assay of genetic markers, the molecular 
characterisation of the genes that control liability to complex disorders, such as 
autism, could soon be feasible. With these advances should come insight into the 
biology and pathology of brain development and behaviour, and improved diagnosis 
and management of the childhood disorder autism. 
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APPENDIX 6.2 : SOLUTION AND BUFFER PROTOCOLS 
(NOTE: all solution protocols are taken from Sambrook et al., 1989) 
12% FCS/RPMl 1640 
Powdered Medium (RPMl 1640) 32.72g 
Sodium Bicarbonate 4g 
Fetal Bovine Serum 240ml 
Penicillin/Streptomycin 40ml 
adjust pH to 7.2, make up to a final volume of 2 litres with dH20, sterilise media by 
membrane filtration through a 0.2um filter under positive pressure, aseptically 
dispense into sterile bottles and store in the dark at 2-8°C. 
RCLB 
I M  Tris (pH 7.6) 10ml 
SM NaCl 2ml 
I M  MgCh 5ml 
make up to a final volume of 1 litre with dH20 and store at room temp. 
Final concentration of reagents was lOmM ofTris, lOmM ofNaCl and SmM of 
MgCh 
250 
WCLB 
I M  Tris (pH 7.6) 1 0ml 
0.5M EDTA, di-Sodium Salt 20ml 
5M NaCl 1 0ml 
0% SDS 20ml 
make up to a final volume of 1 litre with dH20 and store at room temp. 
Final concentration of reagents was lOmM ofTris, lOmM of EDTA, 50mM of NaCl 
and 0.2%SDS. 
50xTAE BUFFER (for lL) 
Tris Base 242g 
Glacial Acetic Acid 57.4ml 
Na2EDTA.2H20 37.2g 
make up to a final volume of 1 litre with dH20 and store at room temp. 
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l OxTBE BUFFER (for lL) 
Tris Base 1 08g 
Boric Acid 55g 
Na2EDTA.2H20 8.3g 
made up to 1 1  with dH20 
The working solution ( lxTBE) consists of 89mM Tris-base, 89mM Boric acid, 2mM 
EDTA, pH -8.3 at ambient temperatures. 
FICOLL LOADING BUFFER (6x) 
50mM Tris HCl, pH 8.0 
EDTA 1 %  (w/v) 
Sarcosyl 7.5% (w/v) 
Ficoll 400 (ave. mol. Wt. = 400 OOO) 
0.05% bromophenol blue 
0.05% xylene cyanol 
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6% POLYACRYLAMIDE-UREA GEL SOLUTION FOR USE IN THE ABI 
PRISM™ 377 GENETIC ANALYSER (fluorescent detection) 
4 0g urea 
12ml 4 0% acrylamide stock soln. (per 1 00ml contains acylamide 3 8g and bis­
acrylamide 2g) 
23ml dH20 
Stir the ingredients together while gently warming in a water bath until the urea 
crystals begin to dissolve and the flask is slightly warm when touched. Continue to 
stir the soln. with no additional heating until all the urea has dissolved. 
Filter the acrylamide soln. through a 0.2um cellulose acetate filter in a cup filter unit 
under vacuum, and then degas for five minutes. 
Transfer the acrylamide soln. to a 1 00ml graduated cylinder containing 8ml of filtered 
1 Ox TBE buffer. 
Adjust the volume to 80ml with dH20. 
6% POLYACRYLAMIDE DENATURING GEL SOLUTION (19: 1) FOR USE 
WITH THE SE1600 POKER FACE II SEQUENCER (radioactive detection) 
Acrylamide 
B is-acrylamide 
Urea 
57g 
3g 
420.Sg 
Dissolve the acrylamide, bis-acrylamide and urea in 850ml of dH20 and adjust the pH 
to 7.0. 
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or 
Liqui-Mix 19 
Urea 
150ml 
420.Sg 
Dissolve the urea in 600ml of dH20 and add Liqui-Mix-19. 
Add 5g of mixed bead resin (5g/L) to deionise the soln. and stir for 30min. 
Filter and make up to 900ml with dH20. 
Add 100ml of 1 OxTBE. 
Degas for 30min. 
Wrap bottle in foil and store at 4°C. 
POLY ACRYLAMIDE GEL FIXING SOLUTION 
10% methanol / 10% acetic acid 
I 00ml of methanol 
100ml of acetic acid 
make up to a final volume of 11 with dH20 and store at room temp. 
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Peter Nicholas,3 Carmen Pingree,3 William M. McMahon,3 Donna Spiker,4•6 
Linda Lotspeich,4, Helena Kraemer,4 Patty McCague,4 Sue Dimiceli,4 Nassim Nouri,5 
Tawna Peachy,5 Joan Yang,5 David Hinds,5 Neil Risch5, and Richard M. Myers5 
Several studies have suggested a role for the histocompatibility complex of loci (HLA) in the 
genetic susceptibility to autism. We have tested this hypothesis by linkage analysis using ge­
netic marker loci in the HLA region on chromosome 6p in multiplex families with autism. We 
have examined sharing of alleles identical by descent in 97 affected sib pairs from 90 fami­
lies. Results demonstrate no deviation from the null expectation of 50% sharing of alleles in 
this region; in fact, for most marker loci, the observed sharing was less than 50%. Thus, it is 
unlikely that loci in this region contribute to the genetic etiology of autism to any significant 
extent in our families. 
KEY WORDS: Histocompatibility; HLA region; autism-affected sib pairs. 
INTRODUCTION 
Autism is a chronic developmental disorder char­
acterized by behavioral, communication, and social ab­
normalities that manifest in the first years of life. Al­
though the etiology of autism is unknown, there is 
general agreement that it results from early neuro­
developmental dysfunction. 
Several studies suggest that immune imbalances 
might contribute to the abnormal development of the 
brain. Two of the possible explanations for this obser­
vation are a viral etiology and an autoimmune etiology. 
Clinical studies have reported numerous prenatal infec­
tions in autistic patients, most of which are viral: rubella 
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(Chess, 1977), encephalitis (Deykin & MacMahon, 
1979; Markowitz, 1983), syphilis (Stubbs, 1978; Stubbs, 
Crawford, Burger, & Vanderbark, 1977), toxoplasmosis 
(Todd, 1986), and herpes simplex (Ghaziuddin, Tsai, Eil­
ers, & Ghaziuddin, 1992). Other investigators have also 
found evidence for a deficiency in T-cell-mediated im­
munity (Warren, Margaretten, Pace, & Foster, 1986), de­
pressed lymphocyte responsiveness (Stubbs, et al., 
1977), and antibodies a against brain antigens (Weiz­
man, Weizman, Szekely, Wijsenbeek, & Livini, 1982; 
Plioplys, Greaves, Kazemi, & Silverman, 1994; Singh, 
Warren, Odell, Warren & Cole, 1993) in autistic patients. 
It has been proposed that these autoimmune and/or viral 
processes in some way affect the nervous system and 
alter central nervous system (CNS) activity, which lead 
to the deficits observed in autistic children (Van Gent, 
Heijnen, & Trefferes, 1997). 
The genetic composition of a person plays a crit­
ical role in the immune system's ability to respond to 
many antigens. Some of the genes that mediate immune 
response are located in the human leukocyte antigen 
(HLA) complex on chromosome 6. Investigators have 
reported associations between alleles of  the HLA 
0162-3257/99/060().0195$16.00IO C 1999 Plenum Publishing Corpomion 
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complex and autism when compared to normal con­
trols. These autism-associated alleles include the null 
allele of the C4B gene (Warren et al., 1991) ,  the ex­
tended haplotype B44-S30-DR4 (Daniels et al., 1 995 
Warren et al., 1 992;), the third hypervariable region of 
HLA-DRB l (Warren, Odell, et al., 1 996) and two al­
leles of the DR beta 1 gene (Warren, Singh, et al., 
1996). The third hypervariable region of HLA-DRBI 
showed the strongest association with autism (relative 
risk of 1 9.8  for allele I and 4.2 for allele 3, respec­
tively; Warren, Odell, et al., 1 996). 
Family and twin studies strongly suggest a genetic 
etiology for autism (Bolton & Rutter, 1990). Family 
studies demonstrate that the risk of autism among sib­
lings of probands with autism is 3-5%, which is 50 to 
I 00 times greater than in the general population (Bolton, 
et al., 1 994; Smalley, 1991) .  Twin studies have demon­
strated that the concordance rate for monozygotic twins 
is approximately 25-fold higher than for dizygotic twins 
(Bailey et al., 1 995; Folstein & Rutter, 1 977; Ritvo, 
Freeman, Mason-Brothers, Mo, & Ritvo, 1985; Stef­
fenburg et al., 1989). These data strongly suggest the 
interaction of multiple genetic loci in the etiology of 
autism. Thus, the reports of associations between spe­
cific HLA alleles and autism suggest that this region 
may harbor one such contribution. Therefore, the HLA 
region on chromosome 6p deserves further exploration, 
to determine the extent to which such associations might 
contribute to the genetic etiology of autism. 
To test the hypothesis that a susceptibility gene 
in the HLA region contributes to the etiology of 
autism, we employed multipoint sib-pair analysis 
(Risch, 1 990, 1 993) .  This method detects how fre­
quently two affected sibs share the same chromoso­
mal region using the principle of identity by descent 
(ibd). Sib-pair analysis is very useful in studying 
autism because it is independent of both the affected 
status of parents and the mode of inheritance. The 
power of the sib-pair method to detect linkage depends 
on the risk ratio "-•· The risk ratio "-• is the increase in 
the risk of the disorder in sibs of an affected individ­
ual, compared with the general population prevalence. 
Assumptions about genetic model parameters, such as 
number of alleles at a given locus, gene frequencies, 
and penetrances are not required in sib-pair analysis 
(Risch, 1 990). In the case of autism, the "-• (increase 
in risk to siblings) is equal to 75. The value of 75 is 
the ratio of recurrence risk (3%) over the prevalence 
of autism in the general population (estimated to be 
1/2500; Smalley, 1991) .  Because the "-• value of 75 is 
high, affected sib-pair analysis may be a powerful tool 
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for mapping susceptibility genes in autism, depend­
ing on how many individual genes determine the total 
value of "-•· 
Because our sample is based on multiplex sibships, 
we can test for linkage, or the sharing of alleles, in the 
HLA region among siblings with autism. In this fash­
ion, we have attempted to determine the extent to which 
genes in the HLA region contribute to the etiology of 
autism. As part of a larger general genome screen, 
97 sib pairs from 90 families were analyzed for marker 
loci in the HLA region by using the multipoint sib-pair 
method to examine this question. 
METHOD 
Participants and Diagnosis 
Families with two or more children with clinical 
diagnoses of autism or Pervasive Developmental Dis­
order Not Otherwise Specified (PDDNOS) were re­
cruited. All presumed affected children were then eval­
uated with two standardized diagnostic instruments, the 
Autism Diagnostic Interview (ADI; Le Couteur et al., 
1989; Lord, Rutter, & Le Couteur, 1 994) and the Autism 
Diagnostic Observation Schedule (ADOS; Lord et al., 
1 989), to determine the research diagnosis of autism. 
The ADI is a semistructured interview, based on ICD-
10 and DSM-IV criteria for autism, that is adminis­
tered to the parents of the autistic children. The ADOS 
is a semistructured observation instrument used to ob­
serve the behavior of the child and corroborate the 
ADI information. This instrument was designed to 
elicit social, language, and communication behaviors . 
To check the reliability of diagnoses, all evaluations 
were videotaped and some were randomly selected and 
blindly assessed independently by other trained diag­
nosticians. To be eligible as a sib pair, affected chil­
dren must have scores above the prespecified cutoff 
points in all four areas of the ADI (i .e. ,  social im­
pairment, language and communication impairment, 
unusual and restricted interests and routines, and age 
of onset prior to 3 years); also, review of the ADOS 
videotape by two or more diagnosticians was required 
to confirm the presence of significant deficits in so­
cial and communicative reciprocity consistent with a 
diagnosis of autism. Families were excluded if there 
was no concensus that all affected siblings had such 
significant deficits. This resulted in the exclusion of 
cases that would have clinical diagnoses of PDDNOS. 
For more details on the diagnostic protocol, see Spiker 
et al. ( 1 994). 
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A total of 97 affected sib pairs from 90 families 
were available for the study, with a male to female ratio 
of 3.6 : I for the affected individuals and 0.8 : 1 for the 
unaffected individuals. The number of families with 
four, three, and two affected children was 2, 3, and 85, 
respectively. For families with n affected children, 
where n is greater than 2, n- 1 sib pairs were formed by 
matching the first listed child (oldest) with each of the 
subsequent children; these pairs are fully independent. 
Both parents were available for genetic analysis in 67 
families, and one parent in the remainder. In those fam­
ilies where one parent was absent, unaffected siblings 
were included when possible (8 families) to reconstruct 
missing parents for ibd tallies. 
The affected siblings ranged in age at the time of 
the ADI administration from 2.9 to 40.9 years (M = 9.8 
years, SD = 7.3, Mdn = 7.3, 25th-75th percentiles = 
4.9-1 1 .3 years). Children' s  diagnostic evaluation and 
school records were gathered to obtain IQ and mental 
age data. When available, nonverbal IQ scores were ob­
tained from the performance subtests of the Wechsler 
Scales or Stanford-Binet Intelligence (4th ed.), or the 
full Leiter International Performance Scale or Merrill­
Palmer Scale. When these scores were unavailable, 
scores from such tests as the Stanford-Binet.Intelligence 
Scale (3rd ed.), Slossen Intelligence Scale, or McCarthy 
Scales were used, or ratio IQ scores were based on non­
verbal scales from various developmental inventories 
(e.g., Daily Living Domain of the Vineland Adaptive 
Behavior Scale, the full Bayley Scales, or Developmen­
tal Profile II). The mean IQ was 66 (SD = 28, Mdn = 66, 
range = 15-160). One hundred eight children had scores 
below 70 (57% ). The mean mental age was 68 months 
(Mdn = 52, SD = 55, range = 13-373 months). There 
were no families in which the IQs of all the affected 
siblings were below 30. In one family, one affected 
child had a mental age below 1 8  months. 
Genotyping 
DNA was extracted either from whole blood or 
immortalized lymphoblastoid cell lines by using stan­
dard proteinase K digestion and salting out procedures. 
Genotyping was carried out in two laboratories inde­
pendently with slightly different procedures. In one lab­
oratory, polymerase chain reactions (PCR) were car­
ried out in 5 µl and contained 5 ng DNA, 200 µM 
dNTPs, 0.1 3-0.4 µM of each primer (the forward 
primer had been fluorescently labeled using HEX, TET, 
and FAM dyes), 50 mM KCl, 10 µM Tris-HCl, 1 .5 mM 
MgC}z, and 1 .25 U Taq-Polymerase (Perkin Elmer). The 
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solutions were pipetted into a capillary tube (Biotech) 
using a programmable pipettor (Corbett Research), and 
processed in a thermocycler (MJ Research). After de­
naturation for 5 rnin at 94 °C, 27 cycles were carried out, 
each cycle consisting of 30 sec at 94°C, 75 sec at 55°C, 
and 15 sec at 72°C. A final extension step was performed 
for 5 rnin at 72°C. After completion, 1 2  µl of formarnide 
and 0.8 µI of GS500 Tamra standard dye were added, 
then the samples were denatured for 5 rnin at 94°C and 
loaded onto a Perkin Elmer 3 10  Capillary Sequencer. In 
the other laboratory, the PCR reactions were performed 
in a 10 µl volume in 96-well plates and included 30 ng 
or DNA, 67 mM Tris-Hcl pH 8 .8 ,  200 µM dNTPs, 
16 mM <NH4hS04, 0.01 % Tween-20, 1 .5-3 mM MgC12, 
0.2 µM of each primer, 0.2 U Taq polymerase (Perkin 
Elmer), using Perkin Elmer 9700 thermal cyders. The 
· forward primers for each marker were labeled as above. 
The reaction was first denatured at 95°C for 75 sec, then 
35 cycles of 45 sec at 95°C, 45 sec at 57°C, 60 sec at 
72°C were performed with a final elongation step of 
7 min at 72°C. PCR products from 12 markers at a time 
were pooled and run on ABI Prizm 377 DNA sequencers. 
The products were resolved using the Applied Biosys­
tems' GeneScan and Genotyper software packages. In 
both laboratories, polymorphic bands were scored and 
alleles were assigned to the pedigree members. 
The following markers were used in the analysis: 
D6S285, D6S 1959, D6S 1029, D6S276, D6S1014, 
D6S497, D6S439, D6S 10 19, GGAA 15B08, and 
D6S426. Location and distance of markers are given in 
Figure 1 and are based on a composite of the published 
Marshfield, CHLC, and Southampton linkage maps 
available on the Internet. 
Unaffected sibs were also included in the geno­
typing of the families. Individuals performing the geno­
typing were blind to the diagnostic status of the sub­
jects, although they were aware of the family structures. 
Statistical Analysis 
Linkage analysis was performed by using multi­
point sib-pair analysis. This mapping approach pro­
vides optimal use of information by analyzing multi­
ple markers, instead of flanking markers which are used 
in interval mapping (Hauser, Boehnke, Guo, & Risch, 
1996; Olson, 1995). Also, the simultaneous use of mul­
tiple markers reduces the effect of recombination and 
allows for localization of a disease-susceptibility locus 
(Risch, 1990). 
The method is based on the sharing of a chromo­
somal region by affected sib pairs. A random pair of 
198 Rogers et al. 
0.0 0. 1 0.2 0.3 
1 .5 
1 .0 
� � ·  
0. C ,c "'1" r-... -:;-- r-... - 0\ - � 
a:) N 0 � C "' - - <"'l (/) .... - i cS§ "' IO 'C C'.f) IO - C -a C 8 C :'( 0 
� 
d 
Fig. 1. Results of multipoint exclusion mapping in the HLA region. The vertical axis gives the smallest value of As excluded (lod score < -2). The horizontal axis is map location on chromosome 6p measured in morgans (M), with O corresponding to 6p-ter. The HLA region is at . 18M, near the marker D6S276. 
sibs will share an allele at a genetic locus from a given 
parent half the time. Therefore, considering both par­
ents simultaneously, the probability they will inherit 
the same allele from each of the two parents is 25%. 
Similarly, the probability they inherit different alleles 
from each parent is 25%. The probability they share an 
allele from one parent but not the other is 50%. 
If an allele or alleles at a given locus increases the 
risk of autism, there will be an excess of sharing of al­
leles by affected sib pairs over the prior expectations 
for a random pair. The amount of excess depends on 
the frequency of the allele (or alleles), and how much 
the risk of autism is increased in those who carry it. 
One simple way to parameterize this excess is in terms 
of A.5, the ratio of risk to a sib of an individual with 
autism compared to the population prevalence of autism 
due to this locus, Specifically, the probability an af­
fected sib pair shares O alleles ibd at this locus, denoted 
Zo, is given by .25/A., (Risch, 1990). Assuming a model 
where the parental contributions are independent, we 
can obtain the probability z2 that the affected pair shares 
2 alleles ibd (z2) as ( 1  - 1/2 F. )2, and for one allele 
ibd the probability z 1 is (2 F. - 1 )/2 A.,. 
At a given chromosomal location, the ibd proba­
bilities, or equivalently the value of A.,, can be esti­
mated and its statistical significance assessed. This 
can be done for all genetic markers in a region simul­
taneously. The lod score for a sib pair at a given map 
location is the log 1 0  of the likelihood ratio of the 
marker data, given a value of As > 1 versus a value of 
"• == 1 .  These lod scores were calculated for each sib 
pair at each marker location as well as at points be­
tween these markers, under the assumption of a spe­
cific A. value. The lod scores at each interval were then 
summed over all sib pairs to give the total lod score. 
If this score was < -2, linkage was excluded for that 
value of A.,; a lod score > 3 was considered suggestive 
of linkage. 
All calculations were carried out by using ASPEX, 
a set of computer programs for performing multipoint 
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exclusion mapping of affected sibling pair data for dis­
crete traits (D. Hinds and N. Risch, personal commu­
nication) . Two analyses were performed. In the first 
analysis, only ibd data were included from families with 
both parents typed, and in families with only one par­
ent when an unaffected sib (or sibs) was available for 
reconstruction. In the second analysis, data on identity 
by state (ibs) were included for those families with 
missing parents, using likelihoods based on allele fre­
quencies at the marker loci in these families. The results 
of these two analyses were similar; only the results for 
the ibd (first) analysis are presented. 
We also performed analysis of linkage disequilib­
rium via the TDT test (Spielman et al., 1993) in fami­
lies with genotyped parents. For each of the micro­
satellite loci, we tested each allele with a frequency 
greater than 1 0% for excess transmission to affected 
children from heterozygous parents . 
RESULTS 
This analysis is based on allelic sharing, or ibd, be­
tween affected sibs at each of the marker loci, as well as 
a multipoint analysis of all the marker data considered 
simultaneously. For each marker, the null hypothesis 
value for allelic sharing, combining across the two par­
ents, is 50%. The observed sharing at each of the mark­
ers is given in Table I. The sharing is less than 50% for 
all markers except one (D6S285), but does not differ sig­
nificantly from 50% for any of the markers. Marker 
D6S285 had 56 out of a total 1 09 alleles shared (5 1 %). 
Because the ibd in the HLA region was essentially neg­
ative (lod scores < 0), we calculated at each location on 
the map the smallest value of )., that would be excluded 
(lod score < -2) (see Figure 1 ). Values of A; > 1 .6 can 
be excluded from the entire region, and values > 1 .5 can 
Table I. Results of Identity by Descent Analysis of Autism Sibling Pairs 
Marker Total % Shared 
D6S285 109 5 1 .4 D6Sl959 67 46.3 D6S1029 7 1  40.8 D6S276 123 47.2 D6Sl0l4 109 48.6 D6S497 88 42.0 
D6S439 82 45. 1 D6S l0l9 9 1  46.2 GGAA15B08 1 30 45.4 D6S426 1 32 46.2 
x2 
0.08 0.37 2.38 0.40 0.08 2.23 0.78 0.54 1 . 1 1 0.76 
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be excluded for most of the region involving the HLA 
loci (closest to markers D6S276 and D6S10I4). Thus, 
we can exclude a gene of moderate effect on autism sus­
ceptibility from residing in this region. 
We also tested each of the markers in the region 
for linkage disequilibrium using the TDT test. The re­
sults of these tests were also negative. After correction 
for the number of loci tested, there were no significant 
findings of excess allele transmission for any marker. 
DISCUSSION 
Specific HLA alleles have been associated with a 
variety of disorders. A few of the best documented as­
sociations include IDDM, multiple sclerosis, celiac dis­
ease, and Graves disease (Farid et al. , 1 979; Haile 
et al., 1983; Mackintosh & Asquith, 1 978;  Svejgaard 
& Ryder, 1989). Similar association studies have sug­
gested that a susceptibility locus for autism is located 
in the HLA region. These association studies compared 
autistic subjects to normal controls to calculate relative 
risks for autism. In the study presented here, 90 fami­
lies with at least two affected individuals were tested. 
Identity-by-descent information could be obtained for 
most families, thus allowing calculations to be inde­
pendent of any gene or allele frequencies, mode of in­
heritance, and population stratification. 
The linkage results presented here demonstrate that 
a moderate gene effect in the HLA region can be ex­
cluded. For a moderate gene effect to exist, )., values 
greater than 1 .5 would result in positive lod scores. In 
this study, positive lod scores could not be found for 
any )., values greater than 1 .0, thus excluding a moder­
ate gene effect. However, linkage analysis could not for­
mally exclude smaller gene effects. Similarly, TDT 
analysis did not produce any positive findings. These 
results are consistent with those of Spence et al., ( 1 985), 
who also found no evidence for linkage with HLA in 
27 multiplex autism sibships. 
Other results of HLA association studies in autism 
were based on singleton cases, whereas our analysis 
was based on multiplex sibships. One possible expla­
nation for the apparent discrepancy between our results 
and previous studies is that the relative risks associated 
with alleles in the HLA region must be moderately large 
to produce a detectable linkage signal by sib-pair analy­
sis. Thus, while our results do not entirely exclude a 
possible association between autism and alleles in the 
HLA region, they do indicate that if an association ex­
ists, it must be weak, and contributes little to the fa­
milial recurrence in autism. 
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Alternatively, certain alleles in the HLA region may 
predispose to autism only for a subset of patients, per­
haps those with a suspected autoimmune etiology or 
those exposed to recurrent infection or immunologic in­
sult. Our families were unselected in this regard, and 
may have contained few with this type of etiology. How­
ever, based on our results, it is also likely that if HLA 
were involved in a significant way in these cases, they 
account for a relatively small proportion of all multiplex 
families. 
Thus, putative immunological abnormalities found 
in autistic children (Plioplys et al., 1 994; Singh et al., 
1 993; Stubbs, 1 977;  Warren et al., 1986; Weizman 
et al., 1982) are unlikely to be related to susceptibility 
genes in the HLA region. The immune system is con­
nected to the brain in an integrated regulatory circuit 
that is only slowly beginning to be understood. An al­
tered immune response during early childhood might 
produce changes in brain development. Although it ap­
pears that genes in the HLA region have little or no 
effect on this process, we have not excluded the possi­
bility that genes of immunologic interest other than 
HLA might be involved in the pathophysiology of 
autism. 
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Chromosomal region 15qll-ql3 has been im­
plicated to harbor a susceptibility gene or 
genes underlying autism. Evidence has been 
derived from the existence of cytogenetic 
anomalies in this region associated with au­
tism, and the report of linkage in a modest 
collection of multiplex families. Most re­
cently, linkage disequilibrium with the 
marker GABRB3-155CA2 in the candidate 
locus GABRB3, located in this region, has 
been reported. We searched for linkage us­
ing eight microsatellite markers located in 
this region of chromosome 15 in 147 affected 
sib-pairs from 139 multiplex autism fami­
lies. We also tested for linkage disequilib­
rium in the same set of families with the 
same markers. We found no evidence for ex­
cess allele sharing (linkage) for the markers 
in this region. Also, we found no evidence of 
linkage disequilibrium, including for the lo­
cus GABRB3-155CA2. Thus, it appears that 
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the role of this region of chromosome 15 is  
minor, at best, in the majority of individuals 
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INTRODUCTION 
Twin and family studies strongly support the notion 
that genetic factors play a significant role in the etiol­
ogy of autism. The concordance rate for autism is much 
higher in monozygotic twins than in dizygotic twins 
[Bailey et al., 1995; Folstein and Rutter, 1977; Ritvo et 
al., 1985; Steffenburg et al. ,  1989] , and family studies 
indicate that the sibling recurrence risR is 50-100 
times greater than the risk for autism in the general 
population [reviewed in Smalley, 1997] . As in other 
psychiatric disorders, there is no simple mode of inher­
itance. Instead, the observed family pattern is compat­
ible with a complex mode of transmission involving 
several or many genes. The effect of each separate gene 
may be modest, and interactions between genes would 
be expected to further complicate the genetic mecha­
nisms involved. 
Cytogenetic abnormalities have frequently been used 
to identify genes associated with inherited syndromes. 
Cytogenetic studies in autism have suggested an asso­
ciation with chromosomal anomalies in the 15qll-q13 
region. Such cytogenetic abnormalities may indicate 
that a susceptibility gene (or genes) for autism is lo­
cated in this region. Furthermore, symptoms of autism 
have been reported in individuals with Prader-Willi 
and Angelman syndromes [Arrieta, 1994] , both of 
which result from alterations in the 15qll-q13 region. 
When only the paternal region of human chromosome 
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15ql l-q13 is inherited, either by deletion of the mater­
nal gene or by uniparental disomy, Prader-Willi syn­
drome results. Angelman syndrome results when only 
maternal copies of 15ql l-q13 are inherited [Christian 
et al. ,  1995; Sutcliff et al., 1997] . The most common 
cytogenetic abnormality reported in autism involves 
duplications within the 15qll-q13 region [Baker et al., 
1994; Bundey et al. ,  1994; Cook et al., 1997a; Crolla et 
al., 1995; Flejter et al. , 1996; Gillberg et al., 1991; Hotof 
and Bolton, 1995; Leana-Cox et al. ,  1994; Rineer et al. ,  
1998; Robinson et  al. , 1993; Schinzel et  al. ,  1994; 
Schroer et al. ,  1998] . Cook et al. [1997a] described a 
family with two affected children in which a maternal 
15q duplication segregates with autism. The authors 
suggested that, although large genetic abnormalities in 
the 15ql l-q13 region are quite uncommon in autistic 
patients, there may be a higher rate of small, cytologi­
cally undetectable abnormalities in this chromosomal 
region in some cases of autism. 
Several investigators have recently examined the 
15qll-q13 region for genetic linkage to autism. Cook et 
al. [1998] carried out linkage disequilibrium mapping 
of markers in this region. Evidence for linkage disequi­
librium was found at the GABRB3 locus with the 
marker GABRB3 155CA-2, but not with the marker 
D 15S97. No evidence of imprinting effects were de­
tected. Most of the 140 families included in this study 
were singleton affected cases. Pericak-Vance et al. 
[1997] ,  using sib-pair analysis with 37 autistic multi­
plex families, obtained a peak lod score of 2 .5 for the 
microsatellite marker D15S156, which is located ap­
proximately 5 cM distal to the GABRB3 locus, and a lod 
score for GABRB3 of 1 .4. A recently reported whole 
genome linkage scan found several areas potentially of 
interest, most notably one on chromosome 7 with a lod 
score of 2.5 [International Autism Consortium, 1998] . 
These researchers did not find significant linkage to 
autism for markers on chromosome 15. However, this 
genome scan included only one marker, D15S128, in 
the 15qll-q13 region. 
In the present study, we used multipoint sib-pair 
analysis to test for linkage between autism and eight 
markers in the proximal region of chromosome 15q. We 
analyzed 14 7 affected sib-pairs from 139 families by 
genotyping fluorescently labeled microsatellite mark­
ers. To be included in the analyses, autistic individuals 
had to satisfy criteria for all three symptom areas of 
the Autism Diagnostic Interview (ADI) (social impair­
ment, language and communication impairment, un­
usual routines, and restricted interests), plus an age­
of-onset prior to 3 years. This linkage study of proximal 
chromosome 15q is part of a larger investigation of the 
genetics of autism that includes an entire genome scan, 
which will be reported elsewhere. Our results indicate 
that the proximal region of chromosome 15q, in par­
ticular markers in the 15qll-q13 region, does not show 
evidence of linkage to autism in these families. Fur­
thermore, we find no evidence of linkage disequilib­
rium with the two GABRB3 microsatellite markers 
GABRB3CA or GABRB3-155CA2. 
MATERIALS AND METHODS 
Recruitment of Families and 
Diagnostic Assessment 
Families were recruited for the study if they had at 
least two siblings with a clinical diagnosis of autism or 
pervasive developmental disorder-not otherwise speci­
fied (PDD-NOS). All children were subsequently as­
sessed by using the (ADI) [LeCouteur et al. ,  1989; Lord 
et al. ,  1994, 1997] and the Autism Diagnosis Observa­
tion Schedule (ADOS) [Lord et al. ,  1989] to determine a 
research diagnosis of autism. The ADI is a semistruc­
tured interview of parents based on International Clas­
sification of Diseases (ICD-10) and Diagnostic and Sta­
tistical Manual of Mental Disorders (DSM-IV) criteria 
for the diagnosis of autism. The ADOS is a semistruc­
tured observational instrument that assesses the child 
by observing his/her behavior, and is used to corrobo­
rate the ADI interview. The diagnostic assessments 
(ADI and ADOS) were videotaped and subjected to in­
dependent reliability checks by other trained inter­
viewers (typically the senior clinical investigators).  To 
be considered affected in the sib-pair analysis, an indi­
vidual had to satisfy the prespecified cut-off scores in 
all three symptom areas of the ADI (social impairment, 
language and communication impairment, unusual 
and restricted interests) and the age-of-onset had to be 
prior to 3 years. Review of the ADOS tape by two or 
more diagnosticians was used to exclude children who 
did not show significant impairments in social and 
communicative reciprocity. Families were excluded if 
there was no consensus that at least two affected chil­
dren had such deficits consistent with a diagnosis of 
autism (e.g. , exclusion of cases that would have a clini­
cal diagnosis of PDD-NOS); this entailed exclusion of 
33 families. We also excluded families where all af­
fected sibs were severely retarded (IQ <30; seven fami­
lies), or had significant medical conditions likely to ac­
count for the autism (six families). For more details on 
the diagnostic protocol, see Spiker et al. [1994] . 
Children's records were reviewed to obtain IQ and 
mental age information. When available, nonverbal IQ 
scores were obtained from performance subtests from 
the Wechsler Scales; Stanford-Binet Intelligence Scale, 
fourth edition; the Leiter International Performance 
Scale; or the Merrill-Palmer Scale. When unavailable, 
scores from such tests as the Stanford-Binet Intelli­
gence Scale, third edition; Slossen Intelligence Scale; or 
McCarthy Scales were used. For children without these 
tests, mental ages and ratio IQ scores were derived 
from nonverbal scales of various developmental instru­
ments (e.g. , Daily Living Scale of the Vineland Adap­
tive Behavior Scale, the Bayley Mental Scale, Develop­
mental Inventory II). 
Geno typing 
Blood was collected on all affected individuals and, if 
available, their parents and siblings. Lymphoblast cell 
lines were established and genomic DNA was extracted 
from peripheral blood lymphocytes or cell lines by us­
ing standard proteinase K digestion and salting out 
procedures. 
Genotyping was carried out in two laboratories inde­
pendently with slightly different procedures. In one 
lab, polymerase chain reaction (PCR) assays were per­
formed in 8 microliter volume reactions containing 10 
ng genomic DNA; 2.5 mM of each dNTP; 0.2-0.6 mi­
cromolar of each primer pair labeled with Fam, Hex, or 
Tet; 0.8 microliters of lOx buffer (Perkin-Elmer, Nor­
walk, CT); 1 .5-2.5 mM MgC12; and 0.2 units AmpliTaq 
Gold Polymerase (Perkin Elmer). PCR assays were per­
formed in an Applied Biosystems (Foster City, CA) 
9600 Thermocycler by denaturing for 10 minutes at 
94 °C, then 15 cycles of 30 sec at 94 °C, 15 sec at 60°C, 
and 15 sec at 72°C. Another 20 cycles of 30 sec at 94°C, 
15 sec at 65°C, and 15 sec at 72°C were performed, and 
these were followed by a final extension step of 10 min 
at 72°C. In the other lab, PCR reactions were per­
formed in a 10 µ,L volume in 96 well plates and in­
cluded 30 ng of DNA, 67 mM Tris-Hcl pH 8.8, 200 µ,M 
dNTPs, 16 mM (NH4)2S04, 0.01 % Tween-20, 1 .5-3 mM 
MgC12, 0.2 µ,M of each primer, 0.2 U Taq polymerase 
(Perkin Elmer), using Perkin Elmer 9700 thermal cy­
ders. The forward primers for each marker were la­
beled as above. The reaction was first denatured at 95°C 
for 75 sec, then 35 cycles of 45 sec at 95°C, 45 sec at 57°C, 
60 sec at 72°C were performed with a final elongation 
step of 7 min at 72°C. Fluorescently labeled markers 
were analyzed on Applied Biosystems 373 or 377 Ge­
netic Analyzers, and the data were further analyzed by 
using Applied Biosystems Genescan and Genotyper 
software. In both labs, polymorphic bands were scored 
and alleles were assigned to the pedigree members. 
The following eight markers were typed: D15Sl28, 
GABRB3CA, GABRB3-155CA2, D15S822, D15S156, 
D15Sl65, Dl5S1232, and ACTC. These loci span ap­
proximately 25 cM of chromosome 15, in the region of 
15qll-q13. Figure 1 shows the position of these mark­
ers and the distances between them. 
Statistical Analyses 
Multipoint sib-pair linkage analysis was used to de­
tect or exclude linkage. Multipoint sib-pair analysis is 
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Fig. 1. Multipoint exclusion plot for an autism susceptibility locus on 
chromosome 15qll- 13. The top scale is map distance (in centimorgans), 
and the Y axis is the lod score. The relative location of the various chro­
mosome 15ql l-13 markers is given along the bottom. The solid line is for 
As = 2.0; the dashed line is for As = 1.5. 
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based on allele sharing, or identity by descent (ibd) 
between affected siblings over a number ofloci. At each 
locus, the null hypothesis is that the likelihood of af­
fected sibs sharing an allele is 50%. Lod scores are 
calculated per sib-pair at points between markers and 
at markers by using a specific value of As, which is the 
sibling recurrence risk ratio due to the locus in this 
region [Risch, 1990] . Each lod score is the loglO of the 
ratio of the likelihood of observing the marker data at 
a given value of As (>1) versus the likelihood at a value 
of As = 1. For a specific value of As and marker dis­
tance, lod scores are calculated for each sib-pair. The 
total lod score is an overall sum for all sib-pairs. For a 
given value of As, a lod score less than -2 is indicative 
of strong exclusion of linkage [Hauser et al. ,  1996] and 
values larger than 3 suggest linkage. Lod scores are 
calculated at multiple points over a genetic distance. 
The advantages of this type of analysis compared with 
interval mapping with flanking markers are that it al­
lows all of the information to be used simultaneously, 
and it reduces the effect of recombination in defining a 
disease-causing locus [Risch, 1990] . For the six families 
with n affected sibs, where n > 2, n - 1 sib pairs were 
formed with one sib randomly selected. These pairs are 
fully independent for ibd scoring. Thus, in total, there 
are 147 independent affeded sib pairs. The transmis­
sion disequilibrium test (TDT) [Spielman et al . ,  1993] 
was used to test for linkage disequilibrium for the 
tested markers. In this case, w_e employed two tests, 
one that calculates a total chi-square statistic on the 
full 2xn table, and the second that calculates the maxi­
mum chi-square across each tested allele; the level of 
significance for both tests was calculated using Monte­
Carlo resampling [Lazzeroni and Lange, 1998] . Be­
cause we are dealing with multiplex sibships, all resa­
mpling was conditional on parental genotypes; the two 
alleles of each parent were switched with 50% probabil­
ity [Martin et al. ,  1998] . All statistical analyses were 
performed by using the program package ASPEX 
(Hinds D, Risch N: ftp site //lahmed.stanford.edu/pub/ 
aspex). 
RESULTS 
Family Recruitment 
One hundred thirty-nine families encompassing 147 
independent sib-pairs were tested. Each family con­
tained two or more affected siblings that satisfied the 
inclusion criteria for this study. One hundred thirty­
five families had two affected sibs, four had three af­
fected sibs, and two had four affected sibs. Among af­
fected individuals, the male-to-female ratio was 3.4: 1 ,  
and for unaffected individuals, the ratio was 0.8: 1 .  In 
115 of these families, DNA from both parents was 
available for testing; in the remaining 24 families, only 
one parent had DNA available . In those families where 
one parent was absent, unaffected siblings were in­
cluded when possible (eight families) to reconstruct 
missing parents and ibd tallies. 
At the time of the ADI administration, the affected 
siblings ranged in age from 2_8 to 40.9 years (mean = 
8.7 years, SD = 6.4; 25th-75th centiles = 4.7-10.1 
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years) .  Mental age and IQ estimates were obtained 
based on available diagnostic evaluations and school 
records. The mean nonverbal IQ was 64 (SD = 27; 
range = 15-160). One hundred and seventy children 
(59%) had IQ scores below 70. The mean mental age 
was 61 months (SD = 48 months; range = 13-373 
months). There were no families for which all affected 
children had IQ scores below 30. In four families, one 
affected child had a mental age below 18 months. 
Approximately 90% of our families were Caucasian 
of mixed European origin. The remaining 10% were a 
mix of African/African-American, Asian, and Hispanic. 
Multipoint Sib-Pair Analysis 
The number of shared alleles between affected sib­
lings at each locus tested is shown in Table I .  None of 
the loci showed a significant excess of sharing. In fact, 
six of the loci showed less than or equal to 50% sharing, 
while the other two showed sharing only slightly 
greater than 50%. The estimate of sharing at each of 
these loci based on multipoint analysis is also given in 
Table I. Overall, the estimate of sharing in this region 
hovers around 50%. The multipoint lod scores for this 
region were also negative at all loci for all values of As . 
We calculated the lod scores for two values of As: As = 
2.0 and 1.5. These results are given in Figure 1. Values 
of As of2.0 or larger could be strongly excluded over the 
entire interval, while a locus with As = 1.5 could be 
strongly excluded from the region surrounding 
GABRB3. 
The chromosomal region 15qll-13 is subject to geno­
mic imprinting, and thus allelic expression might de­
pend on sex of transmitting parent. Indeed, Cook et al. 
[1997b] found a duplication in this region to be ex­
pressed only when maternally inherited, and noted 
similar observations in other studies. Therefore, we ex­
amined our ibd data separately for alleles inherited 
from fathers versus mothers (Table I) . Sharing across 
the 15qll-13 region in our families was somewhat 
greater for paternally versus maternally derived al­
leles (although the difference was not statistically sig­
nificant), contrary to prediction based on the prior cy­
togenetic evidence. 
Linkage Disequilibrium 
The TDT was used to test for linkage disequilibrium 
at the eight marker loci, including the markers 
GABRB3CA, which is adjacent to the gene GABRB3,  
and the marker GABRB3-155CA2, within the GABRB3 
gene and previously found to be in disequilibrium with 
autism [Cook et al., 1998] . We found no evidence of 
preferential allele transmission at any locus, either 
based on a global test of all alleles ,  or the allele giving 
maximum deviation. The results for GABRB3-155CA2 
are given in Table II. Our allele frequency distribution 
is very close to that reported by Cook et al. [1998] . In 
that study, allele "103" demonstrated excess transmis­
sion to affected offspring. The corresponding allele ac­
cording to our nomenclature is the "108" allele. In our 
families, this allele was transmitted 79 times and not 
transmitted 62 times, giving a nonsignificant chi 
square of 2.0. 
DISCUSSION 
By using multipoint sib-pair analysis, we excluded 
the existence of a gene in the region of chromosome 
15qll-q13 conferring a moderately increased risk for 
autism in our set of 139 multiplex families. The entire 
region is strongly excluded for As values greater than 2, 
while values of As less than 1.5 could be excluded using 
the less stringent criterion of -1. Our uniformly nega­
tive lod scores across this region of chromosome 15 for 
all values of As do not support the presence of a sus­
ceptibility gene of strong or moderate effect. 
Our results are in contrast to those from the study of 
Pericak-Vance et al. [1997] and Cook et al. [1998] . Peri­
cak-Vance et al. [1997] reported evidence for linkage in 
38 affected sib-pairs and nine cousin pairs on chromo­
some 15qll-q13. Their maximum lod score was 2.5 at 
D15S156, a score below the critical value of 3 .  The ob­
served sharing at this marker in our families was 
53. 7%, and the multipoint sharing at this marker was 
50.3%. The International Autism Consortium [1998] 
also scanned chromosome 15q (primarily marker 
D15S128) in 39 multiplex families and found no evi­
dence of a major susceptibility gene for autism, consis­
tent with our results. 
The study of Cook et al. [1998] used the multiallelic 
transmission-disequilibrium test and revealed linkage 
disequilibrium between autistic disorder and a micro­
satellite marker in the gamma-aminobutyric acid A re­
ceptor subunit gene, GABRB3 155CA-2 (MTDT 28.63, 
10 df, P= . 0014). We tested two microsatellite markers 
at this locus, GABRB3CA [Mutirangura et al., 1992] 
and GABRB3-155CA2. We found no evidence oflinkage 
disequilibrium with either marker. 
The seemingly contradictory nature of the results be­
tween the respective studies must be interpreted in the 
TABLE I. ,Results of ldentity by Descent (Allele Sharing) Analysis of Chromosome 15qll-q13 Markers in 147 Autism Sibling Pairs 
Multipoint 
Paternal Maternal Total sharing 
Marker (%) (%) (%) (%) 
D 15S128 52/95 (54.7) 41/96 (42.7) 93/191 (48.7) 49.4 
GABRB3CA 47/84 (56.0) 39/91 (42.9) 87/177 (49.2) 49.2 
GABRB3-155CA2 52/94 (55.3) 44/98 (44.9) 96/192 (50.0) 49.2 
D15S822 36/67 (53.7) 31/69 (44.9) 68/138 (49.3) 50. 1 
D158156 30/53 (56.5) 29/56 (51.8) 66/123 (53.7) 50.3 
D15S165 23/46 (50.0) 27/56 (48.2) 50/102 (49.0) 50.6 
Dl581232 38/72 (52.8) 37/70 (52.9) 77/146 (52.7) 49.2 
ACTC 30/63 (47.6) 31/67 (46.3) 61/130 (46.9) 47.9 
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TABLE II. Parental Allele Frequency Distribution and 
Transmission Disequilibrium Test Results for Locus 
GABRB3-155CA2 for 286 With Autism 
Allele 
size N (o/o) 
92 179 (35.2) 
94 45 (8.9) 
96 4 (0.8) 
98 0 (0.0) 
100 16 (3.1) 
102 16 (3.1) 
104 80 ( 15.7) 
106 50 (9.8) 
108c 75 ( 14.8) 
110 17 (3.3) 
112 10 (2.0) 
114 8 (1 .6) 
116 7 ( 1.4) 
118 1 (0.2) 
0TR is transmitted alleles. 
bNT is nontransmitted alleles. 
TRa NTb 
97 111 
44 48 
4 4 
13 19 
17 10 
73 78 
44 41 
79 62 
18 17 
17 4 
5 9 
5 9 
xz 
0.94 
0.17 
0.00 
1.13 
1.81 
0.17 
0. 11  
2.05 
0.03 
8.05 
3.56 
1.15 
<AJlele "108" corresponds to allele "103" from the study of Cook et al .  (1998). 
context of the difficulties of detecting genes in a com­
plex psychiatric disorder such as autism. Segregation 
analysis [Jorde et al. ,  1991] and twin studies [Bailey et 
al. ,  1995; Folstein and Rutter, 1977; Ritvo et al. ,  1985 ; 
Steffenburg et al. ,  1989;] provide strong evidence that 
autism is not caused by a single major gene. Because 
there do not appear to be genes of major effect, differ­
ences between autism linkage studies could be ac­
counted for by statistical fluctuations suggesting link­
age where none is present, or linkage is present but the 
gene effect is weak or applies to only a small subset of 
patients. If the latter is the case, very large samples 
will be necessary to provide compelling linkage evi­
dence. Alternatively, if chromosome 15q-associated 
cases of autism could be identified by distinct clinical or 
other phenotypic characteristics, creating a homoge­
neous collection of such families might provide greater 
power to detect linkage in this region. 
Despite our strong negative results on chromosome 
15qll-ql3 , this region should still be viewed as an area 
of strong interest, given the number ofreports showing 
association between autism and cytogenetic abnormali­
ties in this region. However, our results clearly indicate 
that, for the majority of affected sib-pairs, there is no 
major gene in this region causing autism. 
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Summary 
We have conducted a genome screen of autism, by link­
age analysis in an initial set of 90 multiplex sibships, 
with parents, containing 97 independent affected sib 
pairs (ASPs), with follow-up in 49 additional multiplex 
sibships, containing 50 ASPs. In total, 519 markers were 
genotyped, including 362 for the initial screen, and an 
additional 157 were genotyped in the follow-up. As a 
control, we also included in the analysis unaffected sibs, 
which provided 51  discordant sib pairs (DSPs) for the 
initial screen and 29 for the follow-up. In the initial 
phase of the work, we observed increased identity by 
descent (IBD) in the ASPs (sharing of 51.6%) compared 
with the DSPs (sharing of 50.8%). The excess sharing 
in the ASPs could not be attributed to the effect of a 
small number of loci but, rather, was due to the modest 
increase in the entire distribution of IBD. These results 
are most compatible with a model specifying a large 
number of loci (perhaps ;,,:15) and are less compatible 
with models specifying ::;;;10 loci. The largest LOD score 
obtained in the initial scan was for a marker on chro­
mosome lp; this region also showed positive sharing in 
the replication family set, giving a maximum multipoint 
LOD score of 2.15 for both sets combined. Thus, there 
may exist a gene of moderate effect in this region. We 
had only modestly positive or negative linkage evidence 
in candidate regions identified in other studies. Our re­
sults suggest that positional cloning of susceptibility loci 
by linkage analysis may be a formidable task and that 
other approaches may be necessary. 
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Introduction 
Autism (MIM 209850) is a pervasive neurodevelop­
mental disorder with symptoms usually apparent during 
the first 3 years of life. It is characterized by a triad of 
features, including limited or absent verbal communi­
cation, a lack of social reciprocity or responsiveness, and 
limited, stereotypical, and ritualized interests and be­
haviors. Autism is the most severe of the disorders now 
characterized as "pervasive developmental disorders" 
(PDD) (MIM 209850), which also include Asperger syn­
drome (MIM 209850) and PPD that is not otherwise 
specified (PDD-NOS). 
Autism was first typified as a distinct clinical entity 
by Kanner (1943) .  The etiology of this syndrome has 
been debated ever since, with various proponents fa­
voring behavioral, environmental, dietary, viral/immu­
nologic, autoimmune, or genetic theories. On the basis 
of the prevalence studies that have been performed, the 
indication is that autism is generally rare, with a mean 
prevalence of 1/2,500 children (Smalley et al. 1988) .  
The infrequency of familial cases of autism probably 
led some early theorists to doubt an inherited component 
in this disorder (Hanson and Gottesman 1976). For ex­
ample, for a typical rare recessive disease, multiple-in­
cidence sibships are not unusual, since the recurrence 
risk in sibships is 25% .  The recurrence risk of autism 
in sibships is far below that 25% figure. However, with 
the completion of several systematic family studies, it is 
now possible to provide a consistent sibling recurrence 
figure of 2 %-6%, which is substantially higher than the 
population prevalence of 1/2,500, or 0.04% (Smalley et 
al. 1988; Bolton et al. 1994). The most recent summary 
of family studies provided an overall sibling recurrence 
risk of 2.2% (13/597), with a 95% confidence limit of 
1 . 1  %-3.3% (Szatmari et al. 1998) .  Thus, although fa­
milial cases are rare, they are substantially more frequent 
than would be predicted to occur by chance. 
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Further supporting a genetic etiology in autism are the 
results of twin studies, which have documented a dra­
matically higher concordance rate in MZ twins than in 
DZ twins (Folstein and Rutter 1977). Summarizing the 
largest and most systematic of these studies (Steffenburg 
et al. 1989;  Bailey et al. 1995), we can derive MZ-twin 
and DZ-twin probandwise concordances of 81 % (47/ 
58)  and 0%,  respectively, for autism. The latter figure 
is likely to be an underestimate as a result of small sam­
ple sizes, and the true DZ-twin concordance is likely to 
be similar to the nontwin-sib rate of 2 %-6%. Using a 
3% rate gives an MZ-twin concordance:DZ-twin con­
cordance ratio (MZ:DZ concordance ratio) of -25-fold. 
We note that, whereas the sib recurrence is based on 
numerous. studies and a sizable total sibling population 
(n = 597), the MZ-twin concordance rate is based on a 
much smaller sample and thus is more susceptible to 
statistical fluctuation. Nonetheless, it is likely that the 
MZ:DZ concordance ratio in autism is quite large. 
Autistic features have also been described in individ­
uals with well-characterized genetic disorders, most no­
tably fragile X syndrome (FMRl [MIM 309550) ) (Fein­
stein and Reiss 1998) and tuberous sclerosis (TSCl 
[MIM 191100]) (Smalley 1998). In addition, case studies 
have been reported that show associations between au­
tism and a variety of isolated chromosomal transloca­
tions, inversions, and deletions (Gillberg 1 998). These 
findings provide evidence that genetic abnormalities can, 
in some cases, produce behaviors typical of autism, but 
they account for only a small percentage of cases and 
do not explain the familial aggregation of autism. 
Autism does not follow a simple mode of inheritance. 
Genealogical studies suggested an increased risk pri­
marily in close relatives (sibs) Oorde et al. 1990), and a 
reported segregation analysis was most consistent with 
a polygenic model of inheritance Uorde et al. 1991) .  
These results suggest that family recurrence is unlikely 
to be explained by a simple, monogenic mechanism. 
The first linkage study in autism was performed by 
Spence et al. ( 1985), using 20 classic blood-group and 
serum-protein markers on 34 multiplex sibships and as­
suming a recessive model. No significant linkage findings 
were obtained. 
Recent advances in molecular biology have allowed 
genome surveys for disease-susceptibility loci to be per­
formed on a much larger scale. For example, Hallmayer 
et al. ( 1996) examined 35 microsatellite markers on the 
X chromosome in 38  multiplex autism families. Al­
though they excluded most of the chromosome from 
carrying a gene of large effect, including the fragile X 
region, they found modest evidence (maximum LOD 
score 1 .24) for linkage in one region on proximal Xq. 
A genome screen of the full genome, using 3 16  mi­
crosatellite markers on 39 multiplex families, has also 
been reported recently (International Molecular Genetic 
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Study of Autism Consortium 1998) .  Initial positive find­
ings were followed up in an additional 60 families. No 
statistically significant findings were obtained. The most 
positive finding was a LOD score of 2.53, on chromo­
some 7q, with the next most positive finding being a 
LOD score of 1.97, near the telomere of chromosome 
16p. 
In this report we describe the results of what, to date, 
is the largest genome screen in autism. We have surveyed 
90 multiplex sibships with 97 independent affected sib 
pairs (ASPs) in an initial analysis of 362 rnicrosatellite 
markers. Regions with positive results, as well as other 
candidate regions, were then followed up with addi­
tional markers, as well as by analysis of a second set of 
49 multiplex sibships containing 50 independent ASPs. 
A total of 519 markers was analyzed in the first set of 
families, and 149 of these markers were also analyzed 
in the second set of families. 
Families And Methods 
Family Recruitment and Diagnostic Assessments 
Families were recruited nationwide for this study, by 
advertisement with local and national parent support 
groups and by referrals from clinicians. Initial intake 
criteria required that at least two siblings have a clinical 
diagnosis of a PDD. If both the initial telephone intake 
interview of parents and collected medical records were 
consistent with a presumptive diagnosis of autism in at 
least two children, then a follow-up visit by a diagnos­
tician was arranged with the family. During these visits, 
the children were assessed-both by interview, of o ne 
or both parents, using the Autism Diagnostic Interview 
(ADI) (LeCouteur et al. 1989; Lord et al. 1994, 1 997), 
and by observation of the children, using the Autism 
Diagnosis Observation Schedule (ADOS) (Lord et al. 
1989)-to determine a research diagnosis of autism. The 
ADI is a scored, semistructured interview of parents that 
is based on ICD-10 and DSM-IV criteria for the diag­
nosis of autism. The ADOS is a semistructured instru­
ment, which allows assessment of the child through o b­
servation of his or her behavior and which is used to 
corroborate the results of the ADI interview. Diagnostic 
assessments (by ADI and ADOS) were videotaped and 
subjected to independent reliability checks by other 
trained interviewers (typically, the senior clinical inves­
tigators). To be considered affected in the linkage anal­
ysis, an individual had to satisfy the prespecified cutoff 
scores in all three symptom areas of the ADI ( social 
impairment, language and communication impairment, 
and unusual and restricted interests) as well as have an 
age at onset of <3 years. In addition, review of the ADOS 
tape by two or more diagnosticians was used to exclude 
children who did not show significant impairments in 
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Table 1 
Distribution of Family Structures 
No. OF 
GROUP AND No. Unaffected Available 
OF AFFECTED SIBS Sibs Parents Families 
FS1: 
2 0 2 48 
2 0 1 15  
2 1 2 13  
2 1 1 5 
2 2 2 2 
2 3 1 2 
3 0 2 2 
3 1 2 1 
4 0 2 1 
4 1 1 1 
FS2: 
2 0 2 34 
2 0 1 1 
2 1 2 12 
2 2 2 1 
3 1 2 1 
social and communicative reciprocity, irrespective of the 
results of the ADI interview (e.g., this would lead to the 
exclusion of some individuals who would have had a 
clinical diagnosis of PDD-NOS). Families were excluded 
from subsequent analysis if, on the basis of all available 
information, there was no consensus that at least two 
affected children had deficits consistent with a diagnosis 
of autism. For more details on the diagnostic protocol 
and ret'iability of videotapes of the ADI assessments, see 
the work of Spiker et al. ( 1994). 
Children's records were reviewed to obtain IQ and 
mental-age ( MA) information. When available, nonver­
bal IQ scores were obtained from performance subtests 
of either the Wechsler Scales or the Stanford-Binet In­
telligence Scale-4th Edition, from the Leiter Interna­
tional Performance Scale, or from the Merrill-Palmer 
Scale. When unavailable, scores from such tests as the 
Stanford-Binet Intelligence Scale-3rd Edition, Slossen In­
telligence Scale, or McCarthy Scales were used. For chil­
dren for whom results of these tests were not available, 
MAs and ratio IQ scores were derived from nonverbal 
scales of various developmental instruments (e.g., Daily 
Living Scale of the Vineland Adaptive Behavior Scale, 
the Bayley Mental Scale, and Developmental Inventory 
II). 
For inclusion in the linkage analysis, we also required 
that at least one affected child have both an MA of ;:;.18  
mo and a nonverbal IQ ;:;.JO. This led to the exclusion 
of some additional families (N = 6) in which all children 
were severely impaired ( MA <18 mo and IQ <30). 
Two-Stage Analysis 
Families were analyzed in two stages. The initial stage 
involved genotyping of family set 1 (FSl ), which in-
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eluded 90 multiplex families. These families comprise a 
total of 1 87 affected and 30 unaffected sibs; 67 families 
have two parents available, and the remaining 23 have 
one parent. The precise breakdown of family structures 
is given in table 1. Among the affected sibs, the male: 
female ratio is 3.6:1, whereas in the unaffected sibs it is 
0.8: 1 .  
Subsequent to the initial genome screen performed on 
FSl ,  a follow-up study was conducted on a second fam­
ily set (FS2), which comprises a total of 49 multiplex 
families, ascertained in a manner similar to that used 
with FSl .  These families contain a total of 99 affected 
and 15  unaffected sibs; 48 of the 49 families have both 
parents available, whereas the single remaining family 
has one parent. The precise breakdown, by family struc­
ture, is given in table 1 .  The male:female ratio in the 
affected sibs is 3.0:1, versus 0.7:1 in the unaffected sibs. 
Laboratory Procedures 
Blood was collected from all affected individuals and, 
if available, from their parents and unaffected siblings. 
Blood samples were drawn into Vacutainer sodium hep­
arin (green cap) tubes. The lymphoblasts were isolated 
and immortalized with fresh or frozen virus stocks, by 
standard Epstein-Barr-virus transformation protocols 
(Anderson and Gusella 1984). The DNA was extracted 
from both whole blood and immortalized lymphoblast 
cell lines, by standard proteinase K-digestion and salt­
ing-out procedures. 
Genotyping was performed in two laboratories in-
Table 2 
Markers with Highest Sharing in ASPs and DSPs 
in Initial Genome Screen 
Marker No. (%) Sharing Z Score 
ASPs: 
D1S1631 80/122 (65.6) 3.44 
D13S779 64/101 (63.4) 2.69 
D9S282 60/95 (63.2) 2.66 
D1S1609 79/130 (60.8) 2.46 
D3S2418 60/96 (62.5) 2.45 
D17S1298 51/81 (63.0) 2.33 
D15S652 79/132 (59.8) 2.26 
D10S1412 53/86 (61 .6) 2 .16  
D 15534 8 1/137 (59.1 )  2.14 
DSPs: 
GATA145DO 34/49 (69.4) 2.71 
D16S403 42/63 (66.7) 2.65 
D 18S844 39/60 (65.0) 2.32 
D16S3253 29/43 (67.4) 2.29 
D7Sl819 35/54 (65.3) 2 .18  
D4S2361 32/49 (65.3) 2.08 
D11S2371 26/39 (66.7) 2.08 
D4S2366 34/53 (64.2) 2.06 
D20S482 31/48 (64.6) 2.02 
D16S769 32/50 (64.0) 1 .98 
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dependently, according to somewhat different proce­
dures. In one lab, PCR was performed, by Perkin-Elmer 
9700 thermal cyders, in a 10-µl volume in 96-well plates 
and included 30 ng of genomic DNA, 67 mM Tris-HCl 
pH 8 .8, 200 µM of ·each dNTP, 16 mM (NH4)2S04, 
0.01 % Tween-20, 1 .5-3 mM MgC12, 0.2 µM of each 
primer, and 0.2 units of AmpliTaq polymerase (Perkin­
Elmer). The forward primers for each marker were flu­
orescently labeled with FAM, HEX, or TET dyes. The 
reaction was first denatured for 7 5 s at 9 5°C; then, 35 
cycles of 45 s at 95°C, 45 s at 57° C, and 60 s at 72° 
C were performed, .followed by a final elongation step 
of 7-12 min at 72° C. PCR products were pooled from 
-7-15 markers that were separable on the basis of size 
and dye color and were run on ABI Prizm 377 DNA 
sequencers. Tamara-labeled DNA internal-size standards 
were run in each lane, and the products were resolved 
by the GeneScan and Genotyper software packages from 
Applied Biosystems. Three CEPH control DNAs from 
individuals 133 1-01 ,  1331-02, and 1347-02 were used 
to verify the sizes of PCR products for each marker. 
In the second lab, PCR assays were performed in 8-
µl reactions containing 10 ng of genomic DNA; 2.5 mM 
of each dNTP; 0.2-0.6 mM of each primer pair labeled 
with the fluorescent dyes FAM, HEX, or TET; 0.8 µl of 
10 x buffer (Perkin-Elmer) ;  1.5-2.5 mM MgCl2, and 0.2 
units of AmpliTaq Gold Polymerase (Perkin-Elmer). 
PCR assays were performed in an Applied Biosystems 
9600 Thermocycler by denaturation for 10 min at 94°C, 
15 s at 60°C, and 15 s at 72°C. Another 20 cycles of 
30 s at 94°C, 15 s at 65°C, and 15 s at 72°C were 
performed, and these were followed by a final extension 
step of 10 min at 72°C. Fluorescently labeled markers 
were analyzed on an Applied Biosystems 373 Genetic 
Analyzer, by Genescan and Genotyper software. In both 
labs, polymorphic bands were scored, and alleles were 
assigned to the pedigree members, by researchers who 
were blind to affection status. 
Genetic Markers 
Marker set 1 (MS 7) . -The genetic analysis was per­
formed in two stages. The first stage consisted of a ge­
nome screen on the 90 multiplex FS1 families and used 
a total of 362 microsatellite markers. These were derived 
from version 8 .0 of the Marshfield fluorescently labeled 
genome screening set ( Center for Medical Genetics, 
Marshfield Medical Research Foundation) and were ob­
tained from Research Genetics. Of these markers, 346 
are autosomal, 14 are X linked, and 2 are pseudoau­
tosomal. If a sex-averaged total autosomal map length 
of 3,500 cM is assumed, the average spacing between 
markers for the autosomal component is 10 cM; if a 
length of 1 80 cM for the X chromosome is assumed, 
the average spacing on that chromosome is 12 cM. Of 
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the intermarker intervals, 28 have an interval length >15 
cM, although only 7 are >20 cM; the largest gap is 23 
cM. 
Marker set 2 (M52). -Additional microsatellite mark­
ers were obtained from Research Genetics and were an­
alyzed subsequent to the initial genome screen. The 
choice of markers was based on ( 1 )  saturation of regions 
giving positive linkage evidence in the analysis of FS1 
with MSl;  (2) follow-up of specific regions, on the basis 
of either candidate loci (chromosome regions 6p and 
15q) or the genome screen of the International Molec­
ular Genetic Study of Autism Consortium ( 1 998)  (chro­
mosome region 7q); and (3 )  addition of markers in 
regions that had large gaps in the initial screen with MS1 
and that did not have significantly negative linkage ev­
idence in the preliminary analysis. In total, 157 addi­
tional markers were typed, which constituted MS2. All 
of these markers were typed in FS1; 89 of these were 
also typed in FS2. In addition, 60 of the original MS 1 
markers were genotyped in FS2 in the follow-up, for 
reasons ( 1 )  and (2) above. Thus, in total, 5 19 markers 
were typed in FSl, and 149 were typed in FS2. 
Statistical Analysis 
Linkage analysis. -Because all siblings had at least one 
parent available and most had both parents available, 
the statistical analyses were based entirely on identity by 
descent (IBD), obviating the need to use allele frequen­
cies of the parents. When one parent is missing, a sib 
pair can be scored for IBD with the included parent, 
without bias, provided that the typed parent is hetero­
zygous and that each of the two sibs inherits from the 
untyped parent an allele that is distinct from the alleles 
of the typed parent. Also, sharing from the untyped par­
ent was scored, when possible, by reconstruction of the 
genotype of the missing parent, by use of one affected 
sib and all unaffected sibs (in the ASP analysis) .  If the 
genotype of the parent can be so reconstructed, then 
unbiased scoring can be performed by comparison of 
the affected sib with each remaining affected sib, who 
was not used for reconstruction. 
Sib-pair analyses were based on fully independent 
pairs. When a family contained three or more affected 
sibs, independent pairs were formed between the first 
sib and each remaining sib (giving n - l pairs for a fam­
ily with n affected sibs). In the 90 multiplex FS1 families, 
there are thus a total of 97 independent ASPs; in the 49 
multiplex FS2 families, there are 50 independent ASPs 
(see table 1 ) .  
Initially, the number of alleles shared versus the num­
ber of alleles unshared, at each marker across sib pairs, 
was evaluated and compared to a x2 distribution. Under 
the null hypothesis of no linkage, the expectation is that 
sharing will be 50%. Subsequently, multipoint sib-pair 
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analysis was performed to extract the maximum infor­
mation from the genetic-marker data. This analysis is 
parameterized in terms of the value As, the sibling re­
currence ratio, which translates into specific values for 
ASP IBD. For a genetic model with no dominance var­
iance, the probability Zo of an ASP sharing no alleles IBD 
is .25f"s, the probability z1 of an ASP sharing one allele 
IBD is .50, and the probability z2 of an ASP sharing two 
alleles IBD is .25 (2 - -t, ) ; the overall sharing is y = 
.25(3  - -t, ) .  For a multiplicative model which allows 
dominance variance, again Zo = ·�; , Z1 = ( � - i )!As, 
and z2 = ( 1  - ! �)2; the overall sharing is y = 1 -
t �- We use the latter model in all the multipoint anal­
yses that we present, although, for modest gene effects, 
results are nearly identical in either model. 
Multipoint LOD scores can be calculated for a fixed 
model (i.e., fixed value of Ash this approach allows for 
exclusion mapping. For a fixed value of As, negative 
LOD scores can be obtained if the model gives a poorer 
representation of the marker data than does no gene 
effect. We use the LOD-score criterion of -2 for exclu­
sion of a locus with a given As value; this provides a 
conservative exclusion level (Hauser et al. 1996). Alter­
natively, the likelihood of the marker data can be max­
imized at each point, as a function of the genetic model 
(As value), to derive a maximum LOD score (MLS) curve. 
This curve never drops to <0, the value obtained when 
As = l. 
Unkage-disequilibrium analysis (LO). -We also ex­
amined LD, with all 5 19  autosomal and X-linked loci, 
using a transmission/disequilibrium test (IDT) (Spiel­
man et al. 1 993) .  For families with both parents, we 
scored directly transmissions to all affected children 
from heterozygous parents. As in the linkage analysis, 
we can still score children from single parents, provided 
that the parent is heterozygous and that the child is 
heterozygous for alleles different than those in the typed 
parent. We can also score transmissions from the missing 
parent when the genotype of that parent can be recon­
structed on the basis of the unaffected sibs. 
We examined two statistical tests-a "global x2" 
(GCS) test, which sums X = (observed-expected)2/ex­
pected across each allele tested, and a "maximum x2" 
(MCS) test, which takes the maximum value of the sta­
tistic 'X across all tested alleles. In this case, neither sta­
tistic has a formal x2 distribution when multiple sibs 
from the same family are tested, if linkage is present 
(Spielman et al. 1993). To make our test of LD inde­
pendent of any linkage present, we calculated the level 
of significance empirically, using Monte Carlo simula­
tion; we simply randomly inverted or not, with proba­
bility 50%, the allele label for the two alleles of hetero­
zygous parents and recalculated the two statistics for 
each permutation step. The proportion of simulated sta­
tistics that exceed the observed value is the derived em-
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pirical significance level. This procedure allows us to 
assess LD, conditional on the degree of sharing of alleles, 
at a given locus, by sibs from multiplex families (Martin 
et al. 1997; Lazzeroni and Lange 1998) .  
Computer program. -All statistical analysis, including 
the pointwise and multipoint sib-pair analyses and the 
IDT analyses, were performed with the ASPEX program 
package. We also used this package to confirm relation­
ships among study subjects and to search for and elim­
inate unlikely double crossovers in the multipoint anal­
yses, in regions that had dense markers. 
Controls 
In the course of this study, a number of controls were 
employed, to determine the degree to which potential 
biases might be confounding our results. After -60 
markers were run in FSl,  we examined the distribution 
of IBD for all sib pairs, to confirm the presumed rela­
tionships, identify any mixup of samples, and identify 
any potential half-sibs. All families segregated appro­
priately according to presumed relationships ( no half­
sibs were identified), with the exception of two sib pairs, 
in which IBD was nearly 100%. These pairs were re­
ported to us to be DZ twins, whereas our genotyping 
determined them to be MZ. We left these twin· pairs in 
the·analysis, both as a positive control and to determine 
the genotyping-error rate. The lab remained blind to the 
identity of these pairs. 
As another control for our genetic analyses, we also 
included unaffected sibs in our molecular and statistical 
analyses. FS 1 contains 30 unaffected sibs, which allowed 
us to construct 51 independent affected-unaffected sib 
pairs, or DSPs. These were derived by pairing, in each 
family, one unaffected sib with each affected sib. Re­
maining unaffected sibs were used for reconstruction of 
the genotypes of untyped parents. This selection scheme 
allowed us to tally IBD for these pairs as fully indepen­
dent. Because of the typically modest recurrence risk of 
autism in sibships (Smalley et al. 1988), we assume that 
the DSPs should deviate little from the null expectation 
of 50% sharing-and that they thus can serve as a useful 
negative control. 
Results 
Family Recruitment 
The first stage of analysis included the 90 multiplex 
FSl families comprising 187 affected offspring, 30 un­
affected sibs, and 157 parents. Two additional families 
with affected MZ twins (originally thought to be DZ) 
were also included. At the time of ADI administration, 
the age range of the affected siblings was 2.9-40.9 years 
(mean 9.8 years, SD 7.3 years, 25th-75th percentile 
4.9-11 .3 years) .  MA and IQ estimates were determined 
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on the basis of available diagnostic evaluations and 
school records. The mean nonverbal IQ was 66 (SD 28, 
range 16-160) . One hundred eight subjects (57%) had 
IQ scores <70. The mean MA was 68  mo (SD 55 mo, 
range 13-373 mo). There were no families in which all 
affected children had IQ scores <30. In one family, one 
affected child had an MA of <18 mo. 
The second set of study subjects, obtained with similar 
recruitment and inclusion/exclusion criteria, comprised 
a total of 99 affected children, 15 unaffected sibs, and 
97 parents, from 49 families. For this group, at the time 
of ADI administration, the age range of affected subjects 
was 2.8-25 .3 years (mean 6 .6 years, SD 3.5 years, 
25th-75th percentile 4.3-7.6 years) .  The mean nonver­
bal IQ was 61 (SD 23, range 15-124). Sixty-two subjects 
(63%)  had IQ scores <70. Mean MA was 47 mo (SD 
23 mo, range 13-150 mo) .  Again, there were no families 
in which all children had IQ scores <30, and there were 
three children with MA <18 mo. 
The unaffected children were presumed to be devel­
oping normally, on the basis of parental report; all of 
these children were in regular educational programs and 
schools. None had any clinical diagnoses, according to 
parental report, nor, during telephone intake interviews, 
did parents report any developmental concerns. Children 
with a possible PDD diagnosis based on the ADI inter­
view but who did not meet the ADI criteria.for autism 
were categorized as being of uncertain status and were 
not included in this analysis. Eighty-eight percent of our 
sample was white ( of varied European and Middle East­
ern origin),  5% was black, 3% was Hispanic, and 4% 
was Asian. The vast majority of affected subjects were 
living with parents, and a small number were in resi­
dential living facilities. 
FS 7 :  Pointwise /BO Scores 
A total of 346 autosomal, 14 X-linked, and 2 pseu­
doautosomal microsatellite loci were studied in FSl, 
which contained 97 independent ASPs and 51 indepen­
dent DSPs. Tallying the total number of alleles shared 
across all 346 autosomal markers gives 19,902138,572, 
or 51 .6%, for the ASPs and 9,344/18,386, or 50.8%, 
for the DSPs. The slight increase in IBD, to >50%, in 
the DSPs suggests the possibility of some modest scoring 
bias toward allele sharing in sibships. 
Of greatest interest is the right-hand tail of the ob­
served IBD distribution in the ASPs and DSPs. For each 
marker, we calculated a Z score, Z = (s - u)/.Js + u , 
where s is the number of shared alleles and u is the 
number of unshared alleles. Under the null hypothesis 
of no linkage, Z should have a normal distribution with 
mean O and variance 1 .  When a threshold of 1 .96 
(P = .025 for a one-sided Z test) is assumed, there are 
9 loci in the ASP group that exceed this threshold and 
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10 loci in the DSP group that exceed this threshold, 
which are listed in table 2. These numbers are not dif­
ferent from the number expected ( .025 x 360 = 9.0) 
under the null hypothesis of no linkage. The most sig­
nificant locus, in either group, was D1S163 1,  for the 
ASPs, with a sharing of 65.6% and a Z score of 3 .44. 
The remaining loci in the ASP group were found on 
chromosomes 1 (two additional loci) ,  3 ,  9, 10, 13, 15, 
and 17. The locus on chromosome 15, D15S652, is telo­
meric of and not linked to the candidate region, on prox­
imal 15q, associated with the inverted duplication found 
in some autistic subjects (Gillberg et al. 1991;  Cook et 
al. 1997). Aside from locus D1S1631, there appears to 
be no substantial difference between the tail Z scores 
for the ASP group and those for the DSP group. 
We also examined the full distribution of Z scores, 
for both the ASPs and the DSPs. These distributions are 
given in figure 1 .  For convenience, we have p lotted each 
Z score as a function of cp-1[(R - ! )/S], where R is the 
ordered rank of that Z score, S = 346 is the total number 
of autosomal markers, and <Ii is the cumulative normal­
distribution function. Under the null hypothesis (no link­
age), this curve should fit the line y = x. In figure 1, the 
line y = x is depicted as the thin unbroken line; the thick 
dotted line represents DSPs, and the thick dashed line 
represents ASPs. As can be seen in the figure, both the 
ASP and DSP lines run parallel but above the line y = 
x, but more so in the case of the ASP line. This indicates 
that the entire distribution of Z scores for the ASPs is 
shifted upward, compared with that for the DSPs, and 
this shift is most noticeable at the left end of the distri-
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Figure 1 Observed distribution o f  Z scores for sharing a t  346 autosomal marker loci in ASPs and DSPs, compared with the expected distribution under no linkage. The thin unbroken line represents no linkage; the thick dashed line represents sharing for ASPs; the thick dotted line represents sharing for DSPs. 
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bution (i.e., deficiency of negative sharing). The final 
" blip" at the right end of the ASP line is due to marker 
D1S1631 .  
Observed versus Expected Distribution Of 180 Scores 
As discussed above, family and twin studies suggest 
that autism is a highly heritable disorder. However, these 
data alone cannot reveal the precise mode of inheritance. 
The very high MZ:DZ concordance ratio, taken at face 
value, is strongly suggestive of multiple interacting loci 
( epistasis), with no single locus having a substantial ef­
fect. The results of our initial genome screen would seem 
to support this conclusion. However, given the high re­
currence-risk ratio for sibs (As = 75-100) and the high 
( 15-25) MZ:DZ concordance ratio, one may reasonably 
ask what the distribution of IBD scores would look like 
for various genetic models consistent with those values. 
For the purpose of computational simplification, we as­
sume a multiplicative epistatic model (Risch 1990) with 
K loci of equal effect. Given the 1 5-25 MZ:DZ con­
cordance ratio, models with as few as two loci can be 
excluded. For a model with K loci, the ith locus will 
have an individual value of As; = (>-.5);: for i = 1 ,  . . .  ,K 
(Risch 1990). The ASP sharing Y; at each of these loci 
will be Y; = 1 - .5(As;ri = 1 - .5(>-.5rf. according to a 
multiplicative model. For example, for K = 3, Y; = 
75.7%; for K = 5, Y; = 67.5%;  for K = 10, Y; = 
59.7o/o'; and, for K = 20, Y; = 55.1%. If As = 150, then 
the corresponding Y; values for K = 3, 5, 10, and 20 are 
only slightly higher-namely, 78.3%, 69.7%, 61 .1  %, 
and 55.9%, respectively. Similar numbers can be ob­
tained by parameterization in terms of the MZ:DZ con­
cordance ratio, which we here denote as "}..MD· "  Ac­
cording to a multiplicative model, for K contributing 
loci of equal effect, the total >-.MD is (>-.MDf, where >-.MDi 
is the ratio contributed by the ith locus. Furthermore, 
the expected ASP IBD sha
�
ing for a locus with value AMD; 
is given simply by Y; = f >-.Mo;· Since, in a model with 
K loci of equal effect, >-.Mo; = (>-.M0)i: for i = 1, . . .  ,K, we 
can calculate the expected sharing, under the assumption 
that >-.Mo = 25, for K = 3, 5, 10, and 20 as being 85.5%, 
69.0%, 58.7%, and 54.2%, respectively. It can be seen 
that these numbers are larger than those based on the 
sib risk ratio for smaller K values (i.e., <.5) but that they 
begin to converge at K > 5. 
Certainly our data are not consistent with a three­
locus model, since we do not have three regions with 
sharing approaching 70%.  Recombination will tend to 
decrease sharing away from these high values, but, given 
our map density, if is unlikely that the sharing would be 
significantly diminished. In fact, we can calculate sys­
tematically, making some simplifying assumptions, what 
the distribution of sharing (and associated Z scores) 
should be under these alternative genetic models. 
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Consider the distribution of Z scores derived from a 
genome screen. Fo�iven marker, Z is defined, as 
above, as (s - u)I-Js + u. Under the null hypothesis of 
no linkage, Z is approximately normally distributed, 
with mean O and variance 1. Now consider a genetic 
model of K disease loci, each of which has sharing Y;· 
We assume that the loci are unlinked. Assume a genetic 
map with a marker every w cM. On average, the distance 
of a disease locus to the closest marker will be -'.f; the 
distances to remaining markers, in order of distance, are 
3.;" , 
5
.;" ,  
7
.;" ,  etc. For a marker at recombination distance 
r from a disease locus, the sharing will be y(r) = [r2 + 
( 1  - r}2]y + 2r(1 - r)( l  - y) . Thus, assuming a map 
function relating recombination fraction r to map dis­
tance w-for example, r = f(w)-we can calculate the 
expected values of sharing y for markers surrounding a· 
disease locus. 
In the present analysis, we assume the Kosambi map­
ping function r = f(w) = (1 - e-4w}/2( 1  + e-4w). As in 
our screen, we assume a map density of 10 cM, with a 
total map length of 3,500 cM. For each of K putative 
disease loci, we estimate sharing y(r) at neighboring loci 
at distances 2.5 cM, 7.5 cM, 12.5 cM, . . .  , up to 47.5 
cM, using the Kosambi map function and the y(r) for­
mula given above. 
For the model with K loci of equal effect, there are K 
loci each with value y(r), where y(r) ranges over the 10 
values based on the 10 different marker distances. In our 
genome screen of ASPs, the average total number of 
transmissions scored at a locus was 1 10 (i.e., s + u, in 
the notation above) .  Therefore, for the K markers with 
expected sharing y(r), we used sampling from a normal 
distribution with mean y(r) and variance v(r) = 
y(r) [l  - y(r)]/110 to obtain the expected distribution 
of their observed sharing. We selected the K points from 
this distribution to be equally spaced to preserve the 
mean y(r) and variance v(r). For exampl
�
, for K = 5 we 
chose the five points y1 (r) = y(r) - 2v(rb_y2 (r) = 
y(r) -./v(r)/2, .Yl.{d_ = y(r), y4 (r) = y(r) + ,/v(r)/2, and 
y5(r) = y(r) + ,/2v(r). These five points have sample 
mean y(r) and variance v(r). For the jth such point, the 
e
j
ected Z score was then derived by taking Z;(r) = 
2 1 10[y;(r) - f] = 10.49[2y;(r) - 1 ] .  As an example, 
consider the genetic model with As = 75, K = 5, and the 
third-closest marker ( 12.5 cM). For this case, y = 
.675, r = .122, y(r) = .600, y1 (r) = .534, y2 (r) = .567, 
y3(r) = .600, y4(r) = .633, and y5(r) = .666; Z 1 (r) = 
.71, Z2 (r) = 1.41, Z3(r) = 2.10, Z4 (r) = 2.79, and 
Z5(r) = 3.48. 
In this fashion, Z scores for 10K markers were de­
rived. For the remaining 346 - 10K markers, we dis­
tributed their Z scores as above but according to a nor­
mal distribution with mean O and variance 1 .  We have 
calculated these expected distributions, assuming that 
As = 75 and K = 3-20. The results for K = 3, 5, 1 0, 
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and 20 are given in figure 2. As in figure 1 ,  we have 
plotted the Z scores as a function of <1>- 1 [(R - ! )IS], 
where R is the rank of the observed Z score and S is 
the total number of markers (346). A normal distribu­
tion appears as a straight line (y = x) on this plot and, 
in figure 2, is depicted by the thick unbroken line. The 
expected curve corresponding to K = 3 is given by the 
thin dashed lined, for K = 5 by the thin dotted line, for 
K = 10  by the thin short-dashed line, and for K = 20 
by the thin unbroken line. The curve for the actual data 
is given by the thick dashed line. In calculating the Z 
scores for the actual data, we used 50.8% for expected 
sharing under the null hypothesis, instead of 50%, to 
allow for some potential genotyping bias, as observed 
in the DSPs. As can be seen in figure 2, the actual data 
most closely approximate the expectations for the model 
with K = 20. The fact that the thick dashed line lies 
above the y = x line at the left end of the plot indicates 
that the excess sharing in ASPs compared with DSPs is 
due to the entire distribution being shifted to the right, 
rather than to a small subset of marker loci showing 
increased sharing. The right end of the plot, although 
reasonably consistent with K = 20, is quite deviant from 
the distribution expected for K = 5 or 10 ,  with the ex­
ception of the final marker (D1S1631 ). For other values 
of K, the distributions lie between the curves in figure 
2. For example, for K = 15 the distribution lies ap­
proximately midway between the line for K = 10 and 
that for J( = 20; for K = 13 the distribution is somewhat 
closer to the line for K = 10. 
To assess goodness of fit of each predicted distribution 
to the observed distribution, we calculated the statistic 
W = E;.:f(Z;1 - Z;o)
2, where Z,1 is the ith (rank-ordered) 
Z score for the expected distribution and Z;o is the cor­
responding Z score for the observed distribution. A small 
value of W indicates a good fit of the observed distri­
bution to the predicted distribution. The corresponding 
value of W for values of K = 3, 5, 10, 13,  15, 17, and 
20 is 53.1 ,  16.7, 5 .1 ,  3 .6, 3 .1 ,  2.8, and 2.7, respectively. 
Thus, models with �10 loci appear unlikely, whereas 
those with �15 seem more plausible. The best fit is given 
by the model with K = 20 loci, although the value of 
W does not increase much up to K = 15 .  Models spec­
ifying a small number of loci (i.e., one or two) with 
moderate effect (As = 2) also give a reasonable fit (al­
though not as good as is given by the model of 20 loci 
with equal effect), provided that the number of residual 
loci remains large (e.g., �15) .  Thus, our results, al­
though consistent with a genetic basis of autism, suggest 
that the most likely model is one with many (�15) con­
tributing loci, with a possible gene of larger effect on 
chromosome 1 .  
In calculating the expected distributions, we have 
made a number of simplifying assumptions, such as 
equal spacing and equal polymorphism of the markers. 
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Figure 2 Observed distribution of Z scores for sharing at 346 
autosomal marker loci in ASPs, compared with the expected distri­
bution, when a model of K = 3, 5, 10, or 20 loci of equal effect is 
assumed. The thick unbroken line represents no linkage; the thick 
dashed line represents the observed data for ASPs; the thin long-dashed 
line represents K = 3; the thin dotted line represents K = 5; the thin 
short-dashed line represents K = 1 O; the thin unbroken line represents 
K =  10. 
Most significant among these assumptions, however, is 
that the disease-susceptibility loci are unlinked, which 
will be unlikely for models with K � 20. The effect of 
having linked disease loci is to increase sharing locally 
in the region of the linked loci-and to decrease it, on 
average, elsewhere. Thus, the impact will be to create a 
distribution more similar to the case of fewer disease loci 
with larger effect. Therefore, our modeling is actually 
conservative in concluding that the observed distribution 
is most compatible with a large number of disease loci. 
Sharing by Gender of Parent 
The observation of genomewide excess sharing and a 
putative model of many genes of small effect accounting 
for the total familial effect in autism allow us to posit 
a further prediction. If, in fact, there are many genes 
scattered around the genome, then the excess of sharing 
that we have observed should differ when tallied sepa­
rately for paternal versus maternal meioses. The reason 
is that the female linkage map, at 4,200 cM, is -1 .5 
times the genetic length of the male map, at  2,800 cM. 
Because there is globally less recombination in males, 
the expected genetic distance (recombination fraction 
[8]) to a disease-susceptibility locus in males is expected 
to be less than that in females, and thus the expected 
allele sharing at a marker linked to the disease locus is 
expected to be greater when one examines fathers than 
when one examines mothers. 
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Table 3 
Global Allele Sharing in ASPs and DSPs, by Sex of Parent and Genetic 
Map-Interval Male:Female Ratio 
SEX RATIO 
(Male:Female) 
ASPs: 
No. (%)  SHARING 
Paternal Maternal 
2,336/4,560 (51 .2) 2,413/4,712 (51.2) >1 (85 markers) 
<1 (261 markers) 
Total 
7,459/14,275 (52.3) 7,694/15,025 (51.2) 
9,795/18,835 (52.0) l0,107/19,737 (51.2) 
Total (maternal + paternal) 
DSPs: 
1 9,902/38,572 (51 .6 )  
l,1 10/2,160 (51 .4) l,167/2,304 (50.7) > 1 ( 85 markers) 
<1 (261 markers) 
Total 
3,401/6,722 (50.6) 3,66617,200 (50.9) 
4,51118,882 (50.8) 4,83319,504 (50.9) 
Total (maternal + paternal) 
To quantitate this prediction, define d(O) = y - !, 
where y is the sharing at a disease locus. Then, at 
0 distance, the value of y is y(O) = [02 + (1 - 0)2]y + 
20(1 - 0)(1 - y), so that d(O) = y(O) - i = ( 1  -
20)2d(O). If we assume a uniform distribution for the 
map distance, w, from a random marker locus to the 
nearest disease locus, then, over some total map length 
L, the expected value of d is 
L 
E(d) = "f, J d(O)[l - 20(w)]2dw , 
0 
where w is some mapping function relating map distance 
to 0. For the Haldane mapping function O(w) = ( 1  -
e-2w)l2, E(d) = d(O)( l - e-4L)/L = d(O)IL, for L > so 
cM. Similarly, for the Kosambi mapping function 
O(w) = (e4w - 1 )!2(e4w + 1), E(d) = d(O)[( l  + e2Lr ! -
log( l + e-2L) + log2 - t]/L = . 193d(O)/L for L > 50 
cM. In either case, E(d) ex: t. Therefore, if female map 
distances are 1.5 times male map distances and if we let 
dm represent the d value for male (paternal) meioses and 
let d1 represent that for female meioses, then we have 
E(dm )/E(d1) ex: 1 .5. Therefore, when the observed sharing 
rate of .508 (from the discordant pairs) is used as the 
null value, the observed sharing for concordant pairs, 
.516, gives a sex-averaged value of E(d) = .008. There­
fore, the prediction discussed above would give sex- spe­
cific E(d) values of E(dm) = .010 and E(d1) = .006, or 
sex-specific sharing values of Ym = 5 1 .8% and y1 = 
51 .4%. If we use 50% for the null-hypothesis sharing 
value, then the sex-specific sharing becomes Ym = 
51.9% and y1 = 51 .3%. 
The observed total sharing for ASPs, stratified by sex 
of parent, is Ym = 9,795/18,835 = 52.0% and Yf = 
10,107119,737 = 51 .2% (table 3),  close to the predic­
tion. For comparison, we also examined the parent-spe­
cific allele sharing for the DSPs. There was no difference 
9,344/18,386 (50.8) 
in overall allele sharing, by sex of parent, for this group 
(50.8% paternal, 50.9% maternal). 
We can make this prediction more precise by  noting 
that the male:female ratio of map distances is not uni­
form throughout the genome but, rather, is region spe­
cific. Some regions (e.g., telomeres) tend to show an ex­
cess of recombination in males. Thus, we would expect 
the observed excess of paternal allele sharing to be re­
stricted to those regions where the female map distances 
exceed those of the male. To test this hypothesis, we 
identified the location of each of the 346 marker loci on 
the Marshfield genetic maps (Center for Medical Ge­
netics, Marshfield Medical Research Foundation).  By ex­
amining, for each locus, flanking markers up to 10 cM 
away (sex averaged) ,  we determined whether the genetic 
length of the flanking interval was greater in males (male: 
female ratio >1 ) or in females (male:female <1 ) .  As ex­
pected, the number of markers with a male:female ratio 
>1 (n = 85) was approximately one-third the number 
with a male:female ratio <1 (n = 261 ). As predicted, the 
paternal excess of sharing in ASPs was restricted to 
markers lying in regions with a male:female ratio <1 
(52.3% paternal sharing vs. 51 .2% maternal sharing) 
(table 3). Again, the DSPs showed no such trend, since 
the paternal and maternal sharing were nearly equal in 
both groups (table 3) .  
Multipoint Sib-Pair Analysis in FS T 
We performed multipoint sib-pair analysis on the data 
from FSl ,  for the 360 autosomal and X-linked markers 
of MSl .  The results are shown in figure 3. In the figure, 
the MLS curve is represented by the dashed line. There 
were nine locations that gave an MLS � 1 .0 :  chromo­
somes lp (MLS 1.87), .lq (MLS 1.19), 7p (MLS 1 .00), 
llp (MLS 1 .25), 13q (MLS 1 .49), 15q (MLS 1 .75),  1 7p 
(MLS 1 .30), 18q (MLS 1 .00), and 20p (MLS 1 .09) .  The 
MLS on chromosome lp was diminished compared with 
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the significance obtained with marker DlS1631 (table 
2), because of less sharing at neighboring markers. 
These results are consistent with those shown in fig­
ures 1 and 2, in that no regions revealed linkage evidence 
that was near significance, even when a liberal criterion 
of MLS 3 .0 was used. Thus, it is unlikely that any genes 
of moderate to large effect underlie this disorder. 
Follow-up in FS2 
The 49 families of FS2, comprising 50 ASPs, were 
analyzed for a total of 149 markers, 60 of which were 
original (i .e., MS1 )  markers typed in FS1 .  A total of 157 
additional markers (MS2) were typed in FS1; 89 of these 
were also typed in FS2. Many new markers were typed 
only in FS1 ,  either to fill in larger gaps in the original 
screen or to increase marker density in certain candidate 
regions, in particular on chromosomes 6p and 15q. On 
the basis of preliminary positive results in the first stage 
of analysis, markers were added on chromosomes 1 ( two 
regions), 3, 9, 10, 13 ,  15, and 17. 
Results of multipoint analysis of the combined data 
from both FS1 and FS2, for all 517 autosomal and X­
linked loci, are given in figure 3 (the MLS curve for the 
total data is represented by the unbroken line; the ex­
clusion curve fixing As; = 3.0 is represented by the dotted 
line). The linkage evidence, in FS2, for markers on prox­
imal chromosome 1 p was positive, with allele sharing 
of 50%..-66% (average 56%};  in FS1,  maximal sharing 
in multipoint analysis was observed near marker 
D1S163l .  With the inclusion of FS2 and additional 
markers in this region, the MLS of 2.15 now occurs at 
a slightly more proximal location (near marker 
D 1S1675} .  This location gives, by far, the strongest link­
age evidence in our study. The next most significant re­
sult is on chromosome 17p, where the MLS peaked at 
1 .21, near marker D l  7S1876. Only two other regions 
had an MLS ;;;,,t.O, one each on chromosome 7p (MLS 
1 .01,  near marker D7S2564} and 18q (MLS 1.00, near 
marker D18S878}.  All other regions with MLS ;;,,LO in 
the initial scan were less positive in FS2, leading to a 
reduction in the total MLS for FS1 and FS2 combined. 
Notably, only chromosome lp had substantially positive 
allele sharing in FS2, leading to a modest increase in the 
MLS for FS1 and FS2 combined. 
Proximal chromosome 15q is a candidate region for 
an autism-susceptibility locus, because of reported in­
verted duplications in a number of patients (Gillberg et 
al. 1991; Cook et al. 1997). Furthermore, some positive 
linkage results were reported in this region in a small 
collection of multiplex families (Pericak-Vance et al. 
1997). We previously have reported that, in this region 
of chromosome 15, there is a lack of linkage evidence 
in the 97 FS1 ASPs (Salmon et al., in press) .  The addition 
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of 50 ASPs from FS2 has not altered this conclusion, 
since our linkage evidence is still uniformly negative 
across the entire region (fig. 3 ). The positive linkage 
results that we obtained on this chromosome were near 
marker D15S1050, which is 62 cM away. 
We have also previously reported a lack of linkage 
evidence with markers in the HLA region on chromo­
some 6p in FS1 (Rogers et al., in press} .  The data in this 
region remain negative with the addition of FS2. 
In a previous analysis of 38 of the ASPs included in 
the present study, we examined markers on the X chro­
mosome. Although we excluded most of the chromo­
some, including the fragile X region, from harboring a 
gene of large effect, a region of Xq did show modest 
evidence of linkage, with a LOD score of 1.24. In the 
present study, based on a much larger number of fam­
ilies, there is no evidence of linkage anywhere on the X 
chromosome. 
A genome screen of 39 multiplex families with autism, 
with follow-up in an additional 60 families, found sug­
gestive evidence of linkage on chromosomes 7 q and 1 6p 
(International Molecular Genetic Study of Autism Con­
sortium 1998). The MLS in the same region of 7q is 
0.62 (for marker D7S684}, on the basis of a total of 139 
families and 147 ASPs. We had a slightly more positive 
result at marker D7S1804 (MLS 0.93), located 10.3 cM 
more proximal. The original study had an MLS of 2.53. 
Thus, if a susceptibility locus resides in this region, its 
effect is likely to be small, given the modest LOD scores 
observed. 
In our initial scan (i.e., with FS1 ) ,  a region of chro­
mosome 13q had an MLS of 1 .65, near marker 
D13S779. In our follow-up, the linkage evidence at this 
location was negative (46.3% sharing); however, a re­
gion of modestly increased sharing appeared somewhat 
distal in the same area, with an MLS of 0.68, near 
marker D13S800 (fig. 3 ) .  This region has also been re­
ported in another recent genome screen (Vieland et al. 
1998) .  Again, the modest level of linkage evidence in 
our collection of 14 7 ASPs suggests that a gene of large 
effect in this region is unlikely. 
Using a strict exclusion criterion of -2 (Hauser et al. 
1996), we were able to exclude -95% of the genome, 
for a value of As; = 3.0 (fig. 3 ) .  When the less strict 
exclusion criterion of - 1  was used, 99% of the genome 
could be excluded. 
Positive Controls 
In our study, we had initially included two twin pairs 
originally thought to be DZ but subsequently, through 
our genotyping, shown to be MZ. These subjects were 
left in the study as a positive control and to estimate the 
rate of genotyping error. The individuals performing ge-
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Figure 3 Multipoint sib-pair analysis of ASPs. The dashed line represents the MLS for FS1 with MS1 ;  the unbroken line represents the MLS for FS1 + FS2, with all markers; the dotted line represents the exclusion plot for As = 3.0, with all families and markers. 
notyping were blinded to the status of these subjects. 
Considering a total of 946 loci scored for these two pairs, 
we found them to be genotypically discordant at 10 loci, 
or a rate of 1 .0%. It should be noted that, in our study, 
families were analyzed intact, so that some genotyping 
errors (Mendelian inconsistencies) could be identified. 
These Mendelian inconsistencies were identified and cor­
rected (by additional genotyping, if necessary) and were 
not included in the error rate given above. 
As a second positive control, we included the pseu-
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doautosomal marker DXYS154. This marker is com­
pletely linked to sex, since it does not recombine between 
the X and Y chromosomes. In our study, we had a large 
predominance of affected males (male:female ratio 3.6:  
1 in FS1 and 2.8: 1 in FS2) .  Thus, a majority of our ASPs 
are brother pairs, whereas a minority are sister pairs or 
of mixed sex. Overall, 73 % of our ASPs are concordant 
for sex (63% males and 10% females). Therefore, we 
expect, at locus DXYS154, excess sharing of alleles in­
herited from the fathers, but not of those inherited from 
the mothers. In FS1 and FS2 combined, there were 58  
paternal alleles shared and 22 paternal alleles not shared, 
giving a x2 of 16 .2 (the LOD score equivalent of which 
is 3.52). By contrast, there was no difference in the shar­
ing of maternal alleles: 42 alleles were shared and 45 
alleles were not shared. The significantly increased shar­
ing of paternal alleles at this marker demonstrates that 
our methodology was sufficiently sensitive to detect a 
real excess of sharing of this magnitude (i.e., 73 % ) when 
such an excess was present. 
LO 
We performed TDTs for all 5 17 autosomal and X­
linked loci analyzed in this study. Here we report the 
results of the GCS test (see the Linkage-Disequilibrium 
analysis [LD] subsection, above). In figure 4 we have 
plotted the distribution of observed ( empirically derived) 
P values, as a function of their rank. Under the null 
hypothesis of no LD, the distribution of P values should 
be uniform, and thus this plot should approximate the 
line y = x, which, in figure 4, is represented by the 
straight unbroken solid line; the values for affected off­
spring are represented by the dashed line, and those for 
unaffected offspring are represented as the jagged un­
broken line. As can be seen in the figure, for P < .OS the 
observed and expected distributions are the same for the 
two types of offspring and fit the line y = x well. These 
results are not unexpected, in that it is a priori unlikely 
that a disease locus would lie very close to and in LD 
Discussion 
We have performed a genomic screen by linkage anal­
ysis of 90 multiplex sibships with autism, including 97 
independent ASPs, with 3 60 autosomal and X-linked 
markers. Regions that, in this screen, initially either (a) 
had positive results, (b) had gaps, or (c) were identified 
as specific candidate regions were subjected to follow­
up with additional markers. We also genotyped a second 
set of 49 multiplex sibships (50 ASPs), with markers in 
specific target regions. In total, 519  markers were run 
on FS1, and 149 were run on FS2. More than 160,000 
genotypes were generated. 
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Figure 4 Observed distribution of P values from IDT tests for 519  markers for affected and unaffected offspring. The straight un­broken line represents expectation under no LD; the dashed line rep­resents unaffected offspring; the jagged unbroken line represents af­fected offspring. 
Analysis of allelic sharing for the initial 360 markers 
in FS 1 was most consistent with a multigenic inheritance 
pattern, in that a global excess of allele sharing was 
observed in the ASPs versus the DSPs, but not specifically 
for a small number of loci. The overall distribution of 
allele sharing was most consistent with a model of ;,,JS 
susceptibility loci. 
These results are not inconsistent with the observed 
recurrence risks in nuclear families and twins. The very 
high (25-fold) MZ:DZ concordance ratio is indicative 
of at least several interacting loci and, potentially, of 
many such loci. Multilocus inheritance does not preclude 
the possibility of one or a few loci with larger effects; 
there is a limit, however, on how large these effects can 
be, given our modest linkage findings. A previous study 
of family recurrence risks in autism found a model with 
3 interactive loci as providing the best fit to the data, 
with a range of 2-10 loci (Pickles et al. 1995) .  Our 
results clearly exclude a model with as few as 3 loci and 
are also inconsistent with a model with as few as 1 0  
loci. 
Our results also do not preclude the possibility of 
etiologic heterogeneity, with a subset of cases having a 
simpler (e.g., Mendelian) etiology. However, as ex­
plained above, such a group would need to be relatively 
minor, given both our results and the large MZ:DZ con­
cordance ratio. 
Our most significant findings were for proximal chro­
mosome 1 p. The most significant increase in sharing in 
our initial screen was for marker D1S1631 ,  with 66% 
sharing and a Z score of  3.44 (table 2 ) .  The multipoint 
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analysis of FS 1 brought this score down to an MLS of 
1 .88 ;  however, this region was also the most positive in 
our follow-up and, in 147 ASPs, gave a total MLS of 
2.15 and sharing of 60%. We note, however, that this 
result falls short of formal statistical significance for a 
genome screen (Lander and Kruglyak 1995). The MLS 
location after follow-up was somewhat more proximal 
than that in the initial screen, near marker D151675. 
No other region had an MLS >1.3 in our follow-up. 
Our next most significant finding was for chromosome 
17p, where the MLS was 1 .21 .  We had modestly positive 
LOD scores in regions identified in other genome 
screens-chromosomes 7q and 13q. Our results for 
chromosome 15q, in the Prader-Willi region, which, on 
the basis of cytogenetic evidence, is a candidate region 
for an autism-susceptibility locus, were uniformly neg­
ative, consistent with our earlier results (Salmon et al., 
in press) . However, in our initial screen, we did identify 
another region, more distal on chromosome 15q, that 
had an MLS of 1 .75; but, in the follow-up, the MLS in 
this region decreased to 0 .81 .  
We employed several controls in this study, to identify 
potential biases. First, we analyzed unaffected siblings 
in our multiplex sibships, to create a comparison group 
for our linkage and LD results. Second, we kept two 
pairs of MZ twins, originally thought to be DZ, in the 
genotyping set, as a positive control for our genotyping, 
as well as to estimate the error rate in genotyping. Fi­
nally, we included a pseudoautosomal marker com­
plete1y linked to sex, as a positive control, reflecting the 
excess of sex-concordant (primarily brother) pairs in our 
study. As predicted, this marker showed a clear, statis­
tically significant paternal excess of sharing (MLS 3 .52). 
These controls provide confidence in the validity of our 
conclusions. 
We also took a conservative approach to phenotyping. 
All study subjects were evaluated by both ADI assess­
ment and ADOS assessment, and all questionable cases 
were excluded from analysis. Furthermore, to reduce po­
tential heterogeneity, we excluded families in which all 
affected children had extremely low IQ, since this group 
may have distinct etiologies related to their severe-to­
profound mental retardation. In total, we excluded 45 
families from further analysis. The primary reason for 
the family exclusions was that not all affected sibs had 
a strict diagnosis of autism, as defined by agreement of 
all diagnosticians. As a result, the families in our study 
included few broadly defined, questionable, or mild 
cases (e.g., clinical diagnoses of either PDD-NOS or As­
perger syndrome), even though most of the children in 
these excluded families did exhibit symptoms and be­
haviors indicative of the autism spectrum, some at the 
very high end of the spectrum and some at the very low 
end. 
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We employed these conservative diagnostic rules for 
inclusion within the study, which were applied equally 
to all affected subjects in a family, for two reasons. First, 
we wanted to enhance our chances of detecting any link­
age, by creating a more homogeneous set of families. 
Second, we wanted to gain confidence that any negative 
results that we might obtain would not be due to the 
use of a too-broad diagnostic spectrum whose genetic 
basis is still uncertain (even though a number of recent 
family studies of autism probands suggest the presence 
of a broad range of mild behavioral symptoms and pos­
sibly related disorders in these families [Bailey et al. 
1998]) .  Although our exclusion of "mild" or autism 
"spectrum" cases might be questioned by some who ar­
gue strongly for their inclusion within genetic studies, 
the only negative effect that this exclusion would have 
on our analysis would be to reduce the sample size. A 
homogeneous group of strictly defined affected subjects 
should maximize the chances of detection of linkage, for 
any plausible genetic model. 
Although our genomic-screen results are largely neg­
ative, in that we did not identify a chromosomal region 
with significant linkage evidence, we have not formally 
excluded the possibility of one or a few disease-predis­
posing loci of moderate effect. On the basis of our re­
sults, the most likely location for such a locus or loci is 
on chromosome 1 p-and, possibly, on chromosome 
17p. We are currently examining these regions more 
closely. However, given the lack of strong linkage evi­
dence in this large collection of families, positional clon­
ing of any susceptibility genes in this disorder may be a 
difficult undertaking, and other approaches, such as LD 
studies of candidate genes and/or genomewide associa­
tion studies may be required. 
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